data_2jvb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jvb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.494 ' HZ3' ' CG ' ' A' ' 176' ' ' ASN . 7.1 ttmm . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.836 0.35 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.0 -32.78 7.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.121 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.436 ' CG2' ' O ' ' A' ' 103' ' ' ILE . 1.3 tt -117.03 108.17 44.61 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.308 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -79.06 140.86 16.13 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.732 1.622 . . . . 0.0 112.045 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.41 141.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.582 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -142.82 145.65 33.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.73 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -128.86 173.46 19.33 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -127.54 127.63 44.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 110.749 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.24 113.48 25.99 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.639 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.578 ' CD1' ' N ' ' A' ' 110' ' ' ILE . 0.0 OUTLIER -110.29 139.6 33.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.018 0.437 . . . . 0.0 110.654 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.633 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -117.95 156.28 28.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.216 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.708 HD22 ' H ' ' A' ' 116' ' ' SER . 0.0 OUTLIER -58.64 172.68 0.48 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.164 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -64.69 -29.23 70.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.737 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.96 4.23 48.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.992 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.402 ' CA ' ' ND2' ' A' ' 112' ' ' ASN . 1.5 mp 43.43 43.29 4.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.452 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.708 ' H ' HD22 ' A' ' 112' ' ' ASN . 8.1 t -124.19 -5.23 7.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.726 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.425 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 86.8 mttt -138.8 157.55 45.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.839 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.438 HG22 HD12 ' A' ' 118' ' ' ILE . 25.4 mm -109.66 140.04 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.99 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.514 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 2.2 tt -101.18 111.03 23.14 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.329 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 120' ' ' LEU . 1.7 mm? -104.44 161.0 14.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.0 m -137.69 162.99 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.314 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -98.26 127.45 44.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.63 -165.4 34.6 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 72.4 p -59.92 -24.07 64.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.362 . . . . 0.0 110.38 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.24 160.37 27.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.3 m -72.81 -102.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.97 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -77.07 72.14 3.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.414 ' C ' ' CG ' ' A' ' 129' ' ' TRP . 54.3 p -128.39 156.13 43.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.351 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.414 ' CG ' ' C ' ' A' ' 128' ' ' SER . 56.5 m95 -151.37 110.79 3.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.671 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.56 176.46 6.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.514 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 29.1 m-85 -77.53 153.72 81.37 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.92 149.61 59.75 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.934 1.756 . . . . 0.0 112.03 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -149.37 177.74 9.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.841 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 160.51 -174.81 37.26 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -79.17 143.47 35.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.64 0.257 . . . . 0.0 110.475 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.5 pt -110.81 152.52 12.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.465 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.8 m -65.08 145.55 56.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.504 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -93.32 161.13 14.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.413 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 63.0 34.79 13.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.511 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -137.13 145.18 43.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.377 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -60.63 130.72 47.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.127 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -50.55 -37.73 41.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.024 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.2 mt -68.77 -54.39 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.584 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -56.95 -37.52 71.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.304 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -32.05 73.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.144 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -65.02 -48.9 72.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.682 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.52 -48.47 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.872 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -62.11 -40.49 96.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.527 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -82.61 -20.64 36.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.9 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 146' ' ' CYS . 20.5 t -85.05 -51.54 13.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.631 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.27 -28.45 69.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.053 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -81.71 -36.34 28.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.899 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -82.11 -61.54 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.284 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 15.1 mt -72.79 -33.52 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.559 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.27 -14.3 59.7 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.53 ' CE2' ' O ' ' A' ' 157' ' ' ASP . 62.4 t80 -116.41 143.63 45.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.69 0.281 . . . . 0.0 110.506 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.53 ' O ' ' CE2' ' A' ' 156' ' ' PHE . 44.8 p30 -106.6 140.11 40.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.5 111.14 23.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.037 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.7 p -90.22 -61.61 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.721 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.436 ' OD1' ' CD2' ' A' ' 161' ' ' TYR . 55.6 p30 -107.45 8.74 29.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.564 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.436 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 79.1 m-85 -106.87 15.89 24.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 tt -117.38 140.04 41.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.705 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -69.04 148.19 50.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.151 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 22.3 p-10 -76.37 -57.87 3.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.229 0.538 . . . . 0.0 111.54 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.436 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 91.0 m-20 -131.41 60.75 1.66 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.421 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.483 ' O ' ' CE1' ' A' ' 180' ' ' PHE . 50.0 tt0 -129.61 107.83 9.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.942 0.401 . . . . 0.0 110.387 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -152.94 162.32 41.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.379 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 24.1 pt -129.55 147.64 33.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -121.25 138.76 54.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.039 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.499 ' NH2' ' O ' ' A' ' 226' ' ' SER . 8.1 tpt180 -159.25 132.97 7.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.559 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -107.19 115.07 29.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 61.2 mt -109.48 129.33 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.442 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.432 ' C ' ' H ' ' A' ' 175' ' ' LYS . 6.5 mm-40 52.1 43.24 30.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.385 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.44 -5.81 3.84 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 173' ' ' GLN . 84.8 tttt -89.4 128.34 35.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 111.037 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.494 ' CG ' ' HZ3' ' A' ' 101' ' ' LYS . 42.6 t30 -75.15 123.28 24.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.759 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -132.98 110.08 10.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.44 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -108.92 141.3 41.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.333 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.17 127.63 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.981 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.483 ' CE1' ' O ' ' A' ' 166' ' ' GLN . 1.9 t80 -95.76 123.99 39.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.481 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.69 126.28 29.52 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.494 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.95 101.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.205 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.1 p -125.38 161.54 26.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.609 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 120.45 8.03 8.67 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 9.0 m -75.18 161.05 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.716 0.294 . . . . 0.0 110.465 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 62.2 m -104.61 158.46 16.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.804 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.91 -2.24 57.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.397 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 46.5 t -71.07 -27.85 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.508 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.448 ' CE1' ' O ' ' A' ' 190' ' ' ASN . 48.7 t80 -100.19 144.37 29.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.349 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.448 ' O ' ' CE1' ' A' ' 189' ' ' PHE . 9.3 p30 -97.99 125.38 42.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -104.83 126.65 52.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.339 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -127.23 149.68 70.3 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.238 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -70.04 143.57 49.88 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.079 1.853 . . . . 0.0 111.986 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -141.3 83.57 1.88 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.536 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.15 -165.0 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.324 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -45.58 152.61 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.142 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.39 109.39 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.617 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.496 ' CG ' ' H ' ' A' ' 199' ' ' ILE . 2.2 tt0 -161.87 -113.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.057 0.456 . . . . 0.0 110.62 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.496 ' H ' ' CG ' ' A' ' 198' ' ' GLU . 49.7 mt -113.97 131.91 64.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.429 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.08 101.05 6.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.39 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -137.69 140.97 41.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.9 tt -113.65 140.38 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.455 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -144.55 120.71 10.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.549 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.09 101.5 13.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.172 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -98.72 134.4 41.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.722 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 207' ' ' PHE . 65.2 t0 -72.17 139.94 48.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.486 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.461 ' N ' ' OD1' ' A' ' 206' ' ' ASP . 76.4 t80 -53.86 -31.21 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.566 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.416 ' O ' ' OG ' ' A' ' 211' ' ' SER . 37.6 mttt -50.76 -52.65 38.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.507 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -58.81 -43.83 90.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.801 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . 0.413 ' O ' ' OG1' ' A' ' 213' ' ' THR . 83.8 mt -62.45 -35.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.585 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 208' ' ' LYS . 60.4 p -68.35 -19.33 64.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.373 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -102.61 20.9 16.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.647 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 210' ' ' ILE . 0.0 OUTLIER -44.81 -31.3 1.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' MET . . . . . 0.515 ' C ' ' H ' ' A' ' 216' ' ' LYS . 34.0 mtt -54.75 -29.84 54.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.566 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.528 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 51.2 t80 -72.17 22.71 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.116 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 214' ' ' MET . 1.9 pttp -64.55 138.26 58.31 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.44 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.5 p -126.67 -21.46 4.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.707 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -137.02 -102.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.661 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 17.1 tt -113.67 122.61 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.665 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -132.78 162.02 32.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.277 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.55 ' N ' ' CD1' ' A' ' 221' ' ' TYR . 0.1 OUTLIER -91.35 93.6 9.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.688 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -74.78 -10.05 59.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 79.8 mt -53.25 -51.78 61.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.691 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 228' ' ' MET . 15.6 tt -72.24 -29.94 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.8 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -54.28 -44.19 71.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.644 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.499 ' O ' ' NH2' ' A' ' 170' ' ' ARG . 75.3 m -68.68 -33.05 73.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.704 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 73.8 mtm -92.35 2.01 56.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 224' ' ' ILE . 38.2 ttp -60.56 -38.86 85.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.491 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.444 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -56.47 -64.62 2.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.677 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 17.7 Cg_endo -60.81 -52.02 4.16 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.111 1.874 . . . . 0.0 112.019 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.408 ' C ' ' CD2' ' A' ' 231' ' ' LEU . 6.4 tt -48.99 -50.84 33.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.594 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 23.0 t -64.19 -59.2 4.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.442 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 86.7 mtp -50.99 -53.5 32.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.746 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -62.04 -50.31 72.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.087 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 41.3 tp -57.78 -30.39 65.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.034 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -34.43 77.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.371 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -65.21 -43.27 92.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.686 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -58.91 -36.15 74.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.772 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -64.29 -32.41 73.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.017 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -65.71 -42.05 91.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 11.1 mm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.808 -179.725 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.838 0.351 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.5 m -92.0 -29.43 16.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.491 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.83 107.83 28.56 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.346 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.36 141.52 11.41 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.025 1.817 . . . . 0.0 112.086 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.86 141.84 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.451 ' HE ' ' CD1' ' A' ' 136' ' ' ILE . 45.7 ttp85 -123.14 152.1 41.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.458 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -125.94 156.83 19.72 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.492 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -103.55 161.15 14.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 0.0 110.844 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -141.54 111.34 6.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.458 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.57 133.5 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.202 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.86 158.92 41.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.455 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 116' ' ' SER . 37.4 p-10 -55.3 166.42 0.6 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.296 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -63.9 -25.51 68.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.371 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -90.72 6.08 45.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.793 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.8 mt 45.31 44.23 8.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.623 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.536 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 0.7 OUTLIER -125.01 -2.03 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.639 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -133.29 149.42 51.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 118' ' ' ILE . 34.2 mm -115.66 127.21 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.92 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.522 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 1.3 tt -89.03 105.61 17.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.563 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -118.78 157.2 28.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.226 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.35 174.35 11.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.762 0.315 . . . . 0.0 110.407 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -88.58 127.76 35.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.386 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.05 -176.04 39.37 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.5 p -52.25 -35.67 50.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 0.0 110.21 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -55.33 -176.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.003 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.2 m -85.21 -76.85 0.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.834 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -109.54 75.82 0.96 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.677 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.1 t -128.14 142.6 51.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.651 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.594 ' NE1' ' CE1' ' A' ' 221' ' ' TYR . 0.0 OUTLIER -122.94 111.88 17.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.449 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.2 168.76 26.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.808 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 43.5 m-85 -82.08 153.04 69.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.236 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -43.68 148.67 0.82 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.837 1.691 . . . . 0.0 111.45 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -126.43 170.01 12.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.648 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 175.12 177.38 44.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -97.35 147.39 24.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.739 0.304 . . . . 0.0 110.538 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.451 ' CD1' ' HE ' ' A' ' 106' ' ' ARG . 18.2 tt -133.53 140.56 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.594 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.7 m -71.65 150.33 44.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.501 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -93.84 156.24 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.548 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 56.87 42.66 26.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.436 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -142.48 158.57 43.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.011 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -58.09 124.73 20.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.881 0.372 . . . . 0.0 110.396 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 44.8 p-10 -77.95 -32.36 51.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.006 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.512 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 10.7 tp -65.32 -38.27 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 110.326 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -72.32 -35.32 68.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.415 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 63.6 m -82.48 -37.43 25.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.01 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 142' ' ' ASP . 66.7 m -65.66 -53.06 46.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.815 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.3 tt -64.52 -35.68 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.19 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -65.81 -42.12 91.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.278 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -76.45 -34.87 58.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.97 0.414 . . . . 0.0 110.826 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.78 -49.8 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.99 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -65.52 -38.57 90.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.281 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -70.64 -37.48 73.77 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.965 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -77.52 -56.75 4.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.122 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 87.3 mt -71.49 -32.28 45.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.994 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.63 -8.43 78.65 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -104.17 125.99 50.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 110.485 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -91.29 126.58 36.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.765 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 8.5 mt -100.42 110.42 22.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.859 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.9 m -90.67 -61.7 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.703 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.514 ' OD1' ' CE2' ' A' ' 161' ' ' TYR . 49.8 p30 -101.7 2.92 39.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.262 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.514 ' CE2' ' OD1' ' A' ' 160' ' ' ASP . 20.9 m-85 -107.21 16.82 23.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.299 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.8 tp -114.02 129.6 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 181' ' ' LEU . 91.1 m-20 -73.68 144.69 45.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.227 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -70.08 -66.95 0.53 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.461 0.648 . . . . 0.0 111.345 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -133.35 66.6 1.55 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.025 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -128.51 108.56 10.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.539 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -152.89 157.74 41.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.651 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.5 mt -121.45 136.85 57.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.664 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 170' ' ' ARG . 0.9 OUTLIER -89.77 129.35 36.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.006 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.452 ' N ' ' OE1' ' A' ' 169' ' ' GLU . 12.4 tpp180 -149.93 114.63 5.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.55 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -110.24 116.01 30.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.405 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 15.9 pt -116.99 142.2 31.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.69 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.536 ' C ' ' H ' ' A' ' 175' ' ' LYS . 55.1 mt-30 51.97 41.09 29.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.413 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 63.67 -4.01 1.21 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.536 ' H ' ' C ' ' A' ' 173' ' ' GLN . 2.1 tppp? -89.64 125.23 35.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.409 . . . . 0.0 110.451 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -75.98 128.7 35.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.896 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.47 119.3 13.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.457 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 107' ' ' GLY . 24.5 mttp -99.92 135.25 41.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.193 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 33.8 mm -113.03 120.23 62.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.96 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -97.65 120.75 38.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.962 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.43 ' O ' ' OD2' ' A' ' 163' ' ' ASP . 14.2 mt -78.98 125.68 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.934 0.397 . . . . 0.0 110.874 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.3 mt -137.23 103.59 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.328 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 94.3 p -110.88 150.36 29.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.497 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 103.52 1.48 46.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.3 p -48.69 149.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 110.704 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.9 m -80.34 101.52 9.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.666 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -67.97 -23.85 65.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.7 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.8 m -74.79 -18.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.682 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -96.33 136.92 36.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.319 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -87.16 133.83 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.517 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -111.89 138.34 48.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.01 109.27 10.67 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.037 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.03 156.68 15.18 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.061 1.841 . . . . 0.0 112.68 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.68 115.07 19.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.089 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 10.4 m -134.3 -168.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.472 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -41.52 146.13 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.321 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -69.94 114.19 7.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.831 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 4.6 tt0 -172.53 -112.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.138 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.436 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 94.7 mt -109.05 120.42 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.519 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 200' ' ' ASP . 33.6 p-10 -123.18 101.07 7.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.28 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -137.04 140.4 42.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.655 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 71.5 mt -99.82 135.49 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.473 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -147.22 117.75 7.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.43 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.63 104.04 16.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.51 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -94.22 132.51 38.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.962 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -68.42 137.48 54.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.421 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -55.23 -43.16 74.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -60.43 -45.04 95.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.126 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 213' ' ' THR . 40.7 mttt -62.34 -38.81 90.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.053 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 90.1 mt -69.91 -30.06 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 9.6 m -66.88 -33.83 76.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.423 ' O ' ' OG1' ' A' ' 213' ' ' THR . 16.8 ptmt -105.44 -33.08 8.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.044 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 209' ' ' LYS . 17.3 p 55.13 65.25 1.54 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.642 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' MET . . . . . 0.49 ' C ' ' H ' ' A' ' 216' ' ' LYS . 12.2 tmm? -58.67 -28.27 65.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.48 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 63.3 t80 -67.7 8.77 0.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.114 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 214' ' ' MET . 20.7 tttt -59.7 120.77 10.13 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.824 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.3 p -132.29 -44.75 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.295 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 218' ' ' ASN . 1.0 OUTLIER -144.2 -39.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.447 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 45.1 pt -126.7 154.99 37.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.712 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.19 142.38 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.294 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.594 ' CE1' ' NE1' ' A' ' 129' ' ' TRP . 0.2 OUTLIER -67.06 118.87 11.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -97.63 -6.07 34.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.71 -42.33 91.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 228' ' ' MET . 35.8 mm -96.66 -40.04 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.278 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -48.3 -53.83 15.93 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.779 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 67.5 m -65.68 -38.99 90.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 110.376 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 27.7 ttm -74.59 -15.03 60.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.384 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' MET . . . . . 0.55 ' N ' ' O ' ' A' ' 224' ' ' ILE . 32.0 ttp -57.96 -42.86 85.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.794 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.445 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 5.3 mtt180 -56.58 -65.22 1.75 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.009 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 24.8 Cg_endo -61.58 -48.31 9.53 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.2 1.933 . . . . 0.0 112.42 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.3 tp -55.94 -39.56 71.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.783 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 37.1 t -63.49 -38.64 91.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.08 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 5.0 mtm -71.48 -52.12 20.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.147 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -55.99 -56.98 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.43 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 95.3 mt -54.86 -31.23 59.41 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.68 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -75.42 -28.7 59.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.389 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -72.87 -55.64 6.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.47 ' C ' ' N ' ' A' ' 240' ' ' GLN . 95.8 mm-40 -53.78 -39.39 65.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.543 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 -47.24 -15.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.355 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.47 ' N ' ' C ' ' A' ' 238' ' ' GLN . 3.0 tp-100 -82.69 -59.21 2.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 7.6 tt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.622 -179.792 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.4 pttt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.879 0.371 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.9 t -73.42 -22.46 60.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.535 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -102.29 109.03 59.37 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.41 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.32 139.03 18.29 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.717 1.611 . . . . 0.0 112.565 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.84 148.13 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.209 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -140.15 158.72 43.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.278 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -138.84 178.18 19.62 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.471 ' O ' ' CB ' ' A' ' 131' ' ' PHE . . . -118.62 163.06 17.37 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.083 0.468 . . . . 0.0 111.289 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.37 113.0 8.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.998 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.75 131.54 50.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.373 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.37 160.3 43.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.149 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -49.17 139.68 10.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.262 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.34 -30.24 50.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -85.88 6.73 27.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.516 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 mt 47.0 57.71 5.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.385 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.85 -16.67 7.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.933 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -137.07 157.52 46.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.399 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.17 132.49 68.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.188 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.509 ' O ' ' CZ ' ' A' ' 131' ' ' PHE . 0.6 OUTLIER -92.06 115.57 28.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.818 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.9 mt -126.34 163.61 22.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.075 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.4 m -143.34 156.69 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.403 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -101.96 150.58 23.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.635 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -134.93 -162.44 9.79 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.0 t -52.22 -27.63 15.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.773 0.321 . . . . 0.0 110.649 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.465 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 53.7 mp0 -55.27 153.7 6.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.189 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.7 t -68.23 -84.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.957 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -113.12 69.29 0.69 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 m -128.43 147.97 50.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.521 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.451 ' CD1' ' N ' ' A' ' 129' ' ' TRP . 1.3 m95 -133.77 116.3 15.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.26 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.52 167.66 28.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.0 111.081 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.509 ' CZ ' ' O ' ' A' ' 119' ' ' LEU . 41.2 m-85 -77.5 153.9 81.49 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.508 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -41.46 144.76 0.68 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.791 1.661 . . . . 0.0 111.399 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.432 ' CZ ' ' OH ' ' A' ' 177' ' ' TYR . 7.9 ptm180 -139.01 174.85 10.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.747 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.59 177.16 47.68 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 110.23 21.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.711 0.291 . . . . 0.0 110.511 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.9 tt -128.1 136.48 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.541 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.5 m -64.78 157.39 27.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.594 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 22.8 mttp -93.09 178.09 5.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.722 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 6.8 t0 77.07 28.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.492 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -133.11 156.07 48.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.367 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.418 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 71.0 m-80 -58.81 127.66 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.623 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.491 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 67.4 m-20 -73.2 -39.24 65.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.155 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' A' ' 144' ' ' ASP . 13.6 tt -61.82 -46.58 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.739 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.402 ' N ' ' CG2' ' A' ' 143' ' ' ILE . 18.4 t70 -68.64 -39.21 80.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.388 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 141' ' ' ASN . 89.0 m -72.92 -35.63 67.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.578 ' SG ' ' CD2' ' A' ' 180' ' ' PHE . 34.8 m -61.45 -53.96 49.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.721 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 83.9 mt -59.1 -41.64 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.729 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -64.74 -41.34 96.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.91 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.03 -31.6 61.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.957 0.408 . . . . 0.0 110.373 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.72 -47.97 41.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.088 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -23.59 63.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.584 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -78.39 -40.69 35.37 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.641 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -83.69 -58.01 2.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.459 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 90.0 mt -72.36 -33.67 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.803 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.27 -13.82 64.18 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.473 ' CD2' ' CE2' ' A' ' 189' ' ' PHE . 51.8 t80 -110.9 133.65 53.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.774 0.321 . . . . 0.0 110.223 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -96.81 141.76 29.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.138 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.7 mt -111.92 110.39 20.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.131 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.1 m -91.07 -62.02 1.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.425 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -106.37 1.74 25.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.036 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -99.92 16.46 23.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.576 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 7.4 tt -125.59 136.76 59.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.702 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -70.99 144.1 50.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.681 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.33 -28.74 15.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.478 . . . . 0.0 111.197 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -133.98 59.35 1.74 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.317 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -149.34 108.12 3.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.966 0.412 . . . . 0.0 110.116 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -159.9 158.43 30.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.385 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 85.2 mt -133.59 155.58 40.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.714 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -102.73 137.22 41.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.029 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 177' ' ' TYR . 64.4 mtt180 -140.82 112.18 7.35 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.923 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 175' ' ' LYS . 49.5 t-20 -119.72 111.78 18.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.431 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.38 139.09 47.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.376 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 53.16 36.95 23.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.634 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.48 -5.0 11.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 171' ' ' ASN . 49.4 mttp -85.29 119.46 25.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 0.0 110.404 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.1 118.77 19.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.903 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.432 ' OH ' ' CZ ' ' A' ' 133' ' ' ARG . 3.8 m-85 -131.99 109.17 9.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.566 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 107' ' ' GLY . 0.6 OUTLIER -102.78 139.74 37.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.75 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.9 mt -136.67 128.35 43.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.961 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.578 ' CD2' ' SG ' ' A' ' 146' ' ' CYS . 1.8 p90 -93.08 127.65 38.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.356 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 24.9 mt -74.01 139.86 45.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.082 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 59.9 mt -136.41 107.64 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.127 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 79.9 p -119.03 158.03 26.63 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.876 0.37 . . . . 0.0 110.483 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.68 16.43 48.88 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.36 115.73 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.038 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 54.1 m -63.3 151.38 40.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.415 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -99.41 6.29 46.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.354 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.15 -20.64 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.353 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 189' ' ' PHE . 1.3 p90 -99.72 128.03 45.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.913 0.387 . . . . 0.0 110.83 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -125.44 134.17 52.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.393 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -112.15 159.27 18.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.588 ' CD ' ' N ' ' A' ' 192' ' ' LYS . 0.0 OUTLIER -105.19 161.49 22.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.262 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -38.34 116.13 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.918 2.412 . . . . 0.0 112.644 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -145.95 69.7 1.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.028 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.512 ' CG1' ' H ' ' A' ' 196' ' ' ARG . 38.7 t -139.67 173.61 10.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.638 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.512 ' H ' ' CG1' ' A' ' 195' ' ' VAL . 36.7 mtt85 -52.42 148.94 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.536 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.9 105.72 0.18 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.499 ' CG ' ' H ' ' A' ' 199' ' ' ILE . 0.9 OUTLIER -171.97 -113.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.406 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.499 ' H ' ' CG ' ' A' ' 198' ' ' GLU . 3.5 mm -123.57 120.03 58.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.246 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -129.77 111.75 12.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.818 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -142.06 128.01 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.234 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.13 136.14 38.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -150.82 126.66 10.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.324 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.13 110.4 22.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.408 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -103.92 150.83 23.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.022 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -65.82 124.4 22.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.867 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -46.04 -35.37 4.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.952 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -56.02 -32.87 64.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.636 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -48.31 -51.46 25.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.1 mt -66.41 -38.74 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 44.0 m -66.75 -45.04 79.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.796 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 214' ' ' MET . 28.8 mttt -56.72 -18.73 13.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.516 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 3.4 m -66.02 56.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.558 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 212' ' ' LYS . 48.8 mtt -95.51 -72.8 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.846 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.15 -9.92 54.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -77.4 106.74 9.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.88 0.371 . . . . 0.0 110.593 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 22.8 t -95.87 -14.08 23.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.646 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -44.4 -62.9 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 18.7 tt -137.92 130.23 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.864 0.364 . . . . 0.0 111.072 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -138.93 147.62 42.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.371 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -108.69 86.22 2.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.542 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -50.5 -23.27 2.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 75.4 mt -50.68 -57.18 8.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 228' ' ' MET . 76.7 mt -109.7 -28.53 2.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.857 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -53.3 -43.85 67.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.93 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.7 m -72.1 -42.23 66.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 227' ' ' MET . 0.0 OUTLIER -86.98 3.11 47.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.142 -179.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 224' ' ' ILE . 28.0 ttp -51.39 -31.69 23.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.052 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.454 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 2.2 mpp_? -66.76 -65.84 1.48 Allowed Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.345 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 10.3 Cg_endo -53.48 -39.21 83.0 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.039 1.826 . . . . 0.0 111.92 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.8 tt -68.67 -39.41 80.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.539 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 78.5 p -70.46 -34.21 72.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.751 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 13.7 mmt -70.85 -50.7 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.059 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -55.63 -57.35 12.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.859 0.361 . . . . 0.0 110.93 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -57.14 -25.83 59.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.047 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 -57.65 -42.73 84.06 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.066 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -60.8 -40.51 92.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.701 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -63.59 -30.97 72.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -73.09 -32.35 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.621 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.07 -40.55 85.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.687 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 13.5 mm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.698 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.745 0.307 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.7 m -73.57 -21.98 60.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.42 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.9 mt -105.41 107.7 59.75 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.459 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.98 118.84 3.1 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 121.994 1.796 . . . . 0.0 112.154 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.42 141.51 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.982 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -137.19 141.65 42.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.001 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.2 146.77 17.42 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 131' ' ' PHE . . . -100.25 119.22 38.05 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.886 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -109.13 120.55 42.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.431 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mt -127.3 122.84 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.112 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -126.62 161.42 28.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.82 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.527 ' ND2' ' OG ' ' A' ' 116' ' ' SER . 4.1 m120 -61.05 177.87 0.3 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.595 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -61.26 -39.52 90.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.05 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -123.87 39.55 3.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.746 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 mp 51.05 36.57 15.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.527 ' OG ' ' ND2' ' A' ' 112' ' ' ASN . 93.2 p -67.08 -34.34 77.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.48 ' N ' ' HG ' ' A' ' 116' ' ' SER . 26.9 mttm -151.05 161.76 42.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.873 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.6 mm -118.89 123.14 71.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.537 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 4.5 tp -80.41 115.09 19.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.319 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.3 mt -123.08 157.23 33.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.615 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.6 163.36 33.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 0.0 110.406 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -93.69 130.46 39.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.634 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -100.91 -171.24 28.77 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.0 t -56.74 -29.41 62.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.625 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -54.94 -172.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.223 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.3 t -86.04 -120.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.716 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -81.21 71.14 8.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.812 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 m -128.3 147.6 50.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -126.49 122.29 34.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.385 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.1 t -166.39 166.42 16.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.946 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.537 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 39.4 m-85 -73.38 152.52 90.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.006 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.22 154.9 51.91 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.032 1.821 . . . . 0.0 112.196 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -131.6 172.16 12.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.206 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 169.21 179.02 40.92 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.7 mttm -101.88 154.64 18.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 pt -129.3 156.0 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.702 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.3 t -82.78 145.23 29.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.554 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -86.91 178.94 6.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.541 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 66.45 33.32 6.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.511 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -141.71 155.56 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.342 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -64.81 142.8 58.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.47 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.48 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 74.6 m-20 -58.32 -38.1 76.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 20.8 tt -67.03 -39.1 82.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.773 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -66.86 -39.88 87.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.727 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 80.6 m -66.68 -42.53 86.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.771 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.586 ' SG ' ' CD2' ' A' ' 180' ' ' PHE . 64.9 m -62.5 -48.15 80.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.464 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 97.1 mt -60.45 -40.99 85.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.954 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -58.39 -44.14 88.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.003 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.431 ' O ' ' OE2' ' A' ' 153' ' ' GLU . 81.2 mm-40 -78.09 -37.19 46.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.885 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.34 -50.41 46.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.788 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -60.52 -29.51 69.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.559 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -80.32 -45.45 17.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.823 0.344 . . . . 0.0 110.652 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -70.41 -58.68 3.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.22 -179.418 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.525 ' N ' ' CD1' ' A' ' 154' ' ' ILE . 1.6 mp -72.35 -32.97 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 110.98 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.34 -13.66 61.39 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -119.69 135.04 54.99 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.854 0.359 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -92.61 128.88 38.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.725 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.558 ' N ' ' CD1' ' A' ' 158' ' ' LEU . 6.2 mp -91.73 113.3 25.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.547 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.5 p -90.02 -54.84 3.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 57.0 t0 -105.0 -17.46 14.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.642 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -85.48 20.65 1.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.666 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.4 tt -117.91 136.93 53.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.494 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.54 152.95 43.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.369 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 165' ' ' ASN . 1.2 p30 -75.47 -66.02 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.384 0.612 . . . . 0.0 111.024 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 67.7 m-80 -130.21 67.72 1.47 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.171 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -132.16 107.13 8.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.901 0.381 . . . . 0.0 110.688 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.516 ' CD2' ' OE2' ' A' ' 169' ' ' GLU . 45.8 p90 -156.31 154.04 29.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.355 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 6.6 tt -123.86 137.87 55.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.516 ' OE2' ' CD2' ' A' ' 167' ' ' PHE . 3.9 mp0 -116.69 133.42 56.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.036 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -160.23 148.43 16.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.987 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.97 112.29 24.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.997 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.4 pt -120.97 152.48 24.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.769 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.537 ' C ' ' H ' ' A' ' 175' ' ' LYS . 42.0 mt-30 50.9 32.82 7.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.572 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.33 -25.25 0.72 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.537 ' H ' ' C ' ' A' ' 173' ' ' GLN . 41.7 tttt -84.96 137.36 33.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.841 0.353 . . . . 0.0 110.816 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 176' ' ' ASN . 9.1 p-10 -74.94 131.97 41.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.037 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.14 115.48 13.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.494 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -108.37 138.22 45.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.7 mt -137.19 134.74 47.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.15 0.5 . . . . 0.0 111.816 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.586 ' CD2' ' SG ' ' A' ' 146' ' ' CYS . 4.4 t80 -100.26 122.36 42.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.783 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.8 mt -69.85 125.95 28.26 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.468 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 3.1 mm -130.58 103.15 7.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.301 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.8 t -130.4 153.23 48.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.625 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 107.31 -1.68 34.92 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 3.8 m -57.72 148.12 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.47 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.71 115.79 17.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.691 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -69.84 -22.03 63.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.57 -8.1 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.265 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -102.36 122.23 43.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.262 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -87.77 134.88 33.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.516 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -99.01 134.59 41.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.62 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.14 156.52 38.23 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.177 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.13 123.8 11.03 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.286 1.991 . . . . 0.0 112.027 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -147.78 69.65 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.766 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.04 -177.88 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.147 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -42.97 148.91 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.11 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -73.38 102.11 3.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 0.0 110.589 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -157.89 -113.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.119 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 57.3 mt -126.58 102.95 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.06 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -131.27 139.1 49.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.92 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -144.26 141.33 29.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.354 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 4.1 pt -102.9 128.5 55.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.76 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -158.03 135.82 10.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.256 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.28 104.49 16.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.498 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -83.81 125.81 32.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.736 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.04 132.44 49.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.266 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -51.13 -37.01 43.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.669 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.1 -36.7 80.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.039 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -59.69 -49.85 76.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.782 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 11.8 mt -56.35 -48.13 80.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.738 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.523 ' C ' ' H ' ' A' ' 213' ' ' THR . 5.0 m -60.49 -32.65 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -73.29 20.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.757 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' THR . . . . . 0.523 ' H ' ' C ' ' A' ' 211' ' ' SER . 1.3 t -53.36 -31.83 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.556 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 10.8 tpp -47.44 -31.03 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.727 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.522 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 63.1 t80 -87.9 20.38 3.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.763 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 213' ' ' THR . 23.0 pttm -58.61 135.65 57.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.666 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 4.0 m -98.83 -45.53 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -163.59 16.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.682 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 17.1 tt -125.48 137.62 57.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.448 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -134.67 142.1 46.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -66.21 154.15 40.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.059 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -100.26 -73.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.9 tt -74.1 -56.43 4.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.1 mt -58.05 -32.5 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.61 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.459 ' CG ' ' N ' ' A' ' 226' ' ' SER . 0.1 OUTLIER -43.73 -57.9 2.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.393 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.459 ' N ' ' CG ' ' A' ' 225' ' ' ASN . 79.6 p -87.13 -27.81 22.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.435 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 65.9 mtp -84.95 1.7 46.2 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.95 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 224' ' ' ILE . 13.6 ttp -51.28 -37.11 45.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.965 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.459 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -64.9 -65.5 1.91 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.5 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 10.7 Cg_endo -55.42 -44.56 47.47 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.266 1.978 . . . . 0.0 112.258 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.56 -50.99 61.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.171 0.51 . . . . 0.0 110.155 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 28.8 p -71.39 -37.24 71.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.165 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 34.7 ttm -67.25 -62.03 1.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.261 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -45.88 -60.85 2.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.82 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.91 -25.45 11.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 41.0 ttm-85 -61.23 -40.52 94.31 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.586 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -68.64 -44.34 74.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.052 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -52.97 -36.7 60.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.84 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -72.41 -28.95 63.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.214 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.16 -51.76 34.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 110.461 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 3.4 mm . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.027 -179.727 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 tttp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.88 0.371 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.9 m -74.74 -31.82 61.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.083 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 103' ' ' ILE . 13.6 tt -124.36 108.66 29.28 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.809 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.2 137.38 10.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.978 1.785 . . . . 0.0 112.155 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.88 138.7 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.494 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -148.18 145.13 28.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.797 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -133.24 168.52 23.0 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' A' ' 131' ' ' PHE . . . -112.15 125.81 54.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.684 0.278 . . . . 0.0 111.036 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.5 117.25 33.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.429 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.88 133.92 65.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.138 0.494 . . . . 0.0 110.941 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.611 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -137.27 149.21 46.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.994 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.58 ' ND2' ' H ' ' A' ' 116' ' ' SER . 43.8 p-10 -50.42 155.19 1.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.994 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -57.81 -25.95 61.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.023 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -92.06 7.21 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.078 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.425 ' N ' ' OD1' ' A' ' 112' ' ' ASN . 12.6 mt 42.93 52.5 5.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 0.0 110.532 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.58 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 0.5 OUTLIER -123.55 -13.7 7.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.112 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -133.24 146.42 51.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.261 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.445 HD13 HG21 ' A' ' 118' ' ' ILE . 30.6 mm -115.31 124.58 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.215 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.544 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 1.2 tt -86.27 103.58 15.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.697 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.7 mt -117.83 162.82 17.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.129 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.15 160.19 40.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.488 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.436 ' OE1' ' O ' ' A' ' 123' ' ' GLY . 0.4 OUTLIER -98.89 114.33 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.336 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.436 ' O ' ' OE1' ' A' ' 122' ' ' GLN . . . -96.31 -151.66 28.26 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 87.5 m -53.97 -34.86 60.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 110.656 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -47.02 157.53 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.7 m -69.18 -70.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.852 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -133.53 69.61 1.47 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.508 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -127.45 143.21 51.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.33 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -113.21 115.35 28.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.326 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.9 t -156.87 164.88 37.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.681 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.544 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 44.6 m-85 -73.28 151.9 90.09 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -67.55 139.34 48.56 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.888 1.725 . . . . 0.0 111.667 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -125.0 177.99 5.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.566 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 158.68 179.8 33.79 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -86.63 145.84 26.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.707 0.289 . . . . 0.0 110.641 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.6 tt -127.1 147.33 32.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.219 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.7 p -70.13 153.09 43.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -112.61 176.58 4.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.179 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 53.89 42.33 31.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.258 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -148.44 158.76 44.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.363 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -58.7 125.62 24.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.525 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.421 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 23.3 p-10 -64.38 -39.42 93.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.138 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 7.0 tt -66.85 -37.39 79.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.498 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -69.79 -42.36 73.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.569 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 64.9 m -73.86 -40.18 63.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 142' ' ' ASP . 33.1 m -55.21 -52.89 61.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.24 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.15 -42.76 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -62.2 -41.3 98.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.337 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -79.25 -35.22 41.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.94 0.4 . . . . 0.0 110.561 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.11 -53.8 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -45.3 89.37 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.651 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.32 -28.63 65.21 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -89.23 -62.6 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 8.8 mt -84.96 -33.65 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.03 -13.37 60.48 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -102.69 135.27 44.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.0 110.385 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 25.0 p30 -106.86 127.45 53.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.814 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 mp -96.38 112.44 24.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.922 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.2 m -89.52 -61.88 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.74 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -98.97 0.19 43.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.122 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -109.63 21.11 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.63 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -111.91 133.04 58.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.641 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -101.3 135.68 42.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.242 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -95.9 -10.81 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.938 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -133.74 56.7 1.84 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.303 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.517 HE22 ' CG ' ' A' ' 238' ' ' GLN . 35.3 tt0 -150.53 107.65 3.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.316 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -164.77 166.5 19.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.62 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 63.4 mt -125.96 130.8 72.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.078 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -113.37 128.08 56.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.296 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.655 ' NH2' ' HG ' ' A' ' 226' ' ' SER . 0.0 OUTLIER -160.06 159.11 31.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.945 0.402 . . . . 0.0 110.911 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.463 ' ND2' HD21 ' A' ' 176' ' ' ASN . 4.2 m120 -104.48 102.59 12.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.938 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 83.7 mt -97.27 117.02 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.339 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 52.15 40.26 28.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.363 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 80.88 -20.09 6.87 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -83.97 124.32 30.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.412 . . . . 0.0 110.707 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.463 HD21 ' ND2' ' A' ' 171' ' ' ASN . 21.8 m120 -75.2 136.55 40.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.473 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.35 140.56 51.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.284 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -143.92 94.86 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 10.6 pt -112.57 145.67 18.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.022 0.439 . . . . 0.0 111.628 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 180' ' ' PHE . 11.2 p90 -99.89 132.43 45.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.598 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 9.7 mt -91.48 129.06 37.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.548 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.02 129.68 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.908 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.1 m -132.14 162.0 31.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.415 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.48 7.91 55.31 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.8 m -75.93 142.99 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.654 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 52.1 p -77.29 137.12 38.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.647 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.455 ' OE1' ' CZ2' ' A' ' 204' ' ' TRP . 70.9 mm-40 -96.55 -8.54 31.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.603 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.0 -27.73 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.473 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -98.23 123.62 42.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.4 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -106.57 132.75 52.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.665 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.68 152.73 39.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.574 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.53 157.23 38.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.291 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.51 142.96 41.56 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.343 2.029 . . . . 0.0 112.219 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -135.65 82.94 1.98 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.105 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.09 -177.59 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.719 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -48.46 145.77 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.52 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -46.21 102.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.698 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -147.3 -113.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.415 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.88 122.86 65.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.363 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -93.24 107.55 19.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.753 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -160.3 126.97 4.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.46 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.2 tt -127.32 154.21 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.46 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -167.71 156.59 9.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.698 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' TRP . . . . . 0.455 ' CZ2' ' OE1' ' A' ' 187' ' ' GLU . 0.0 OUTLIER -106.85 100.58 10.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.734 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.71 135.08 33.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.296 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -72.03 133.3 45.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.485 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -49.16 -32.08 9.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -59.2 -43.65 92.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.676 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -54.81 -32.27 60.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.364 . . . . 0.0 110.234 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . 0.436 ' O ' ' OG1' ' A' ' 213' ' ' THR . 82.7 mt -79.17 -23.07 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.358 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.4 t -85.1 -10.66 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 215' ' ' TYR . 47.6 mttp -95.44 10.07 37.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.769 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 210' ' ' ILE . 0.2 OUTLIER -43.07 -36.2 1.54 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.345 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 40.6 mtt -52.95 -33.82 52.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.352 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.414 ' N ' ' O ' ' A' ' 212' ' ' LYS . 77.4 t80 -66.8 -46.58 74.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.446 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 216' ' ' LYS . 11.1 ptmt -113.1 110.25 20.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 57.7 m -92.14 -10.41 38.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.841 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -58.76 -37.67 76.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.684 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 79.2 mt -128.94 134.05 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.539 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -130.43 145.03 51.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.642 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 225' ' ' ASN . 87.2 m-85 -104.66 86.85 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.427 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -66.1 -27.99 68.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.212 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 223' ' ' LEU . 7.8 mp -69.5 -39.13 77.77 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.778 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 228' ' ' MET . 97.0 mt -95.7 -40.2 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.676 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 221' ' ' TYR . 62.4 t-20 -59.98 -47.95 83.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.341 . . . . 0.0 110.561 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.655 ' HG ' ' NH2' ' A' ' 170' ' ' ARG . 7.9 t -68.84 -30.46 69.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.556 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 76.9 mtp -96.54 2.41 52.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 224' ' ' ILE . 18.7 ttt -48.33 -38.97 20.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.221 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.45 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -68.96 -65.51 1.26 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.602 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 19.6 Cg_endo -60.17 -47.56 14.5 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.213 1.942 . . . . 0.0 112.366 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 5.1 tt -56.2 -39.48 72.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.894 0.378 . . . . 0.0 110.626 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 68.9 m -75.74 -40.09 56.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.994 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 10.7 mmt -66.46 -52.89 41.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.289 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -55.06 -54.4 43.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.759 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.56 -22.16 31.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.599 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -42.16 72.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.658 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -61.96 -44.28 97.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.598 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.517 ' CG ' HE22 ' A' ' 166' ' ' GLN . 68.8 mt-30 -58.6 -34.64 71.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.673 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -62.07 -24.46 67.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -81.74 -58.72 2.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.41 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.1 pttt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.91 0.386 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.0 m -73.51 -32.88 64.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.59 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 103' ' ' ILE . 17.0 tt -117.8 108.39 42.85 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.484 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -82.25 135.88 8.64 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.937 1.758 . . . . 0.0 112.224 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.53 140.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.048 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.1 ttp85 -123.74 146.76 48.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.802 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -122.86 149.44 16.86 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -101.87 142.42 33.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.865 0.364 . . . . 0.0 111.222 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.29 99.34 3.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.263 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 mp -108.79 142.2 22.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.505 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -127.34 163.94 22.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.145 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.635 HD22 ' H ' ' A' ' 116' ' ' SER . 26.1 p-10 -65.33 166.16 10.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.886 0.374 . . . . 0.0 110.875 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 185' ' ' VAL . 61.6 mm-40 -58.63 -33.45 70.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.621 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -89.43 6.98 38.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.988 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mp 42.91 45.23 4.26 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.592 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.635 ' H ' HD22 ' A' ' 112' ' ' ASN . 3.9 t -120.95 -9.24 9.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.01 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -136.8 170.32 16.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.771 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.5 tt -134.03 131.41 55.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.758 0.313 . . . . 0.0 110.584 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.531 ' O ' ' CZ ' ' A' ' 131' ' ' PHE . 2.5 tt -83.11 127.71 33.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.205 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -121.27 156.68 31.98 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.4 m -143.69 172.69 6.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.669 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.533 ' NE2' ' CG2' ' A' ' 199' ' ' ILE . 1.4 tm0? -92.17 124.64 36.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.49 -165.86 32.17 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.462 ' OG1' ' NH2' ' A' ' 196' ' ' ARG . 40.3 m -47.22 -37.1 9.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.891 0.377 . . . . 0.0 110.221 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 56.9 mp0 -51.4 160.06 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.04 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.7 t -64.61 -62.57 1.51 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.972 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -137.1 69.53 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.777 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 p -125.08 139.09 54.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.137 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -94.37 110.45 22.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.586 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.1 p -153.84 176.57 12.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.732 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 46.1 m-85 -97.83 152.6 38.19 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.317 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.8 155.71 67.85 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.968 1.779 . . . . 0.0 111.4 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -140.85 177.07 8.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.089 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 168.11 178.59 40.08 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -93.94 150.06 20.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.686 0.279 . . . . 0.0 110.617 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 16.6 pt -108.58 149.99 11.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.516 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.9 t -76.24 140.94 41.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.748 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 63.3 mttp -89.2 162.26 16.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.503 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 3.0 t70 75.37 1.89 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.645 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -114.36 155.33 26.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.474 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -64.58 143.77 57.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.379 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -55.37 -39.59 70.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' A' ' 144' ' ' ASP . 6.7 tt -65.59 -42.59 93.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.709 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.452 ' N ' ' CG2' ' A' ' 143' ' ' ILE . 43.0 t0 -63.51 -33.14 74.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.692 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 13.8 m -78.27 -42.01 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.559 ' SG ' ' CG ' ' A' ' 180' ' ' PHE . 8.5 t -65.12 -50.53 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.021 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 148' ' ' ARG . 9.7 tt -61.11 -38.49 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.146 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.428 ' N ' ' CG2' ' A' ' 147' ' ' ILE . 17.0 ttm105 -71.32 -38.98 71.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.903 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 153' ' ' GLU . 85.3 tt0 -78.28 -29.82 48.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 110.445 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.3 t -74.17 -52.48 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.783 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -28.2 69.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.668 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -76.33 -41.11 49.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.714 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 149' ' ' GLU . 0.4 OUTLIER -75.35 -53.17 9.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.428 HG23 HD12 ' A' ' 154' ' ' ILE . 28.7 mm -71.0 -31.5 45.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 0.0 110.422 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 92.2 -14.31 64.88 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -115.96 133.09 56.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.725 0.298 . . . . 0.0 110.337 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 43.7 p-10 -96.61 125.1 40.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.036 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.13 110.43 20.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.078 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.0 p -91.0 -55.21 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 0.0 111.054 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -58.97 -39.15 80.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.307 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 184' ' ' GLY . 39.2 m-85 -90.82 18.74 6.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.052 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 162' ' ' ILE . 0.3 OUTLIER -87.4 134.6 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.985 0.421 . . . . 0.0 110.256 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -92.27 140.5 29.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.408 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -70.56 -66.18 0.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.339 0.59 . . . . 0.0 110.881 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -133.02 66.89 1.55 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.123 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.624 ' NE2' ' NE1' ' A' ' 234' ' ' TRP . 8.5 tp60 -127.89 107.45 9.87 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.815 0.34 . . . . 0.0 110.606 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -167.23 159.31 12.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.181 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.2 mt -124.05 138.98 51.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.788 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -95.08 136.29 35.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.187 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.499 ' C ' HD21 ' A' ' 171' ' ' ASN . 0.0 OUTLIER -152.73 121.39 6.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.845 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.499 HD21 ' C ' ' A' ' 170' ' ' ARG . 3.0 m120 -112.17 112.51 24.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.119 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.5 tt -109.3 132.46 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.261 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.494 ' C ' ' H ' ' A' ' 175' ' ' LYS . 24.4 mt-30 52.32 46.07 27.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.232 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.02 -3.27 1.66 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.494 ' H ' ' C ' ' A' ' 173' ' ' GLN . 3.7 tptm -84.14 125.58 32.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.79 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -75.42 123.88 26.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.744 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -140.12 128.99 23.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.566 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 107' ' ' GLY . 26.0 ttmt -120.96 142.29 49.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.013 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.8 mm -123.15 121.29 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.598 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.559 ' CG ' ' SG ' ' A' ' 146' ' ' CYS . 0.2 OUTLIER -98.44 127.47 44.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.387 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.2 mt -82.93 124.27 30.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 3.1 tt -143.71 101.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.411 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.4 t -117.54 154.23 31.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.626 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.51 ' O ' ' CD1' ' A' ' 161' ' ' TYR . . . 106.95 10.07 28.94 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' A' ' 113' ' ' GLU . 1.5 m -67.97 138.99 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.659 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 32.9 t -66.81 120.69 13.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.429 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -85.44 -16.62 39.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.131 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 85.4 t -69.86 -28.13 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.566 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.52 ' CE1' ' O ' ' A' ' 190' ' ' ASN . 63.1 t80 -88.7 133.87 34.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.632 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.52 ' O ' ' CE1' ' A' ' 189' ' ' PHE . 33.5 p-10 -90.79 131.42 36.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.444 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -127.67 158.57 37.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.391 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -139.48 156.57 71.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.308 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.4 142.89 46.25 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.309 2.006 . . . . 0.0 112.09 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -131.02 69.8 1.47 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.458 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.478 ' CG2' ' N ' ' A' ' 196' ' ' ARG . 11.9 m -130.23 -138.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.478 ' N ' ' CG2' ' A' ' 195' ' ' VAL . 78.4 mtm-85 -52.75 146.03 11.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.029 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -74.38 108.88 7.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.373 . . . . 0.0 110.771 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.511 ' CG ' ' H ' ' A' ' 199' ' ' ILE . 1.0 OUTLIER -150.61 -113.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.54 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.533 ' CG2' ' NE2' ' A' ' 122' ' ' GLN . 19.5 tt -130.39 136.7 57.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.471 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 200' ' ' ASP . 39.8 p-10 -102.68 114.54 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.736 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -133.33 123.18 24.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.389 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.97 146.76 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.421 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -165.89 140.83 4.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.601 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.38 112.91 26.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.481 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -104.83 151.7 23.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.625 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.03 127.79 34.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.4 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.05 -42.77 91.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.994 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -36.65 71.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -59.71 -46.34 89.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.175 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 45.4 pt -71.24 -19.53 20.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.144 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 44.0 m -82.5 -22.07 35.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.796 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -111.37 28.41 8.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 8.8 t -81.44 1.78 31.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.689 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 74.4 mtp -54.84 -30.69 58.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.383 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -67.61 -31.92 72.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.56 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -105.18 121.28 43.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.542 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.4 m -92.06 -11.59 35.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.464 ' N ' HD21 ' A' ' 218' ' ' ASN . 2.2 m120 -55.65 -34.35 64.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.606 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.5 mt -125.65 134.05 67.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.506 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -133.65 156.08 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.569 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -113.97 135.95 53.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.364 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -101.49 -72.52 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.187 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.67 -50.86 55.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.177 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.4 mm -56.48 -47.45 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 110.679 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -52.25 -43.2 64.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.568 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.5 m -69.06 -38.37 79.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.983 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 55.4 mtt -88.37 -2.9 58.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.863 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' MET . . . . . 0.483 ' N ' ' O ' ' A' ' 224' ' ' ILE . 5.0 ttp -58.62 -44.04 89.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.721 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.441 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 23.0 mtm-85 -56.14 -64.1 2.67 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.312 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 20.1 Cg_endo -61.3 -51.11 4.73 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.28 1.987 . . . . 0.0 112.423 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -46.86 81.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.2 t -65.77 -38.54 89.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.026 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 49.2 ttm -60.52 -48.34 82.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.24 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.624 ' NE1' ' NE2' ' A' ' 166' ' ' GLN . 1.4 t-105 -70.54 -42.92 70.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.53 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.11 -37.87 81.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.379 . . . . 0.0 110.597 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -60.47 -36.15 77.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.796 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -69.28 -37.06 77.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.781 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -64.23 -29.58 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.052 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -72.57 -41.23 65.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 111.028 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -58.32 -38.66 77.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.26 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 81.6 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.547 179.879 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.811 0.338 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 m -79.45 -30.47 42.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.957 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -100.98 108.47 54.51 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.596 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.73 127.4 6.31 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.93 1.753 . . . . 0.0 112.325 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 t -132.71 145.93 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.052 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' A' ' 107' ' ' GLY . 46.3 ttp85 -135.49 150.58 49.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.705 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.402 ' O ' ' NH1' ' A' ' 106' ' ' ARG . . . -129.89 154.37 20.46 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -102.22 149.88 23.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.955 0.407 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -141.86 95.13 2.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.307 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.87 131.4 67.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 121.248 0.547 . . . . 0.0 111.573 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.6 159.39 39.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.92 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -55.95 151.35 11.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.864 0.364 . . . . 0.0 110.373 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -51.07 -40.47 58.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.809 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -80.55 -1.21 41.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 0.0 110.554 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mt 53.41 56.04 7.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.665 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 p -122.23 -16.27 7.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.745 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -138.18 156.5 47.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.541 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 205' ' ' PHE . 30.0 mm -112.75 136.07 50.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.049 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.517 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 1.7 tt -102.8 110.91 22.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 111.194 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 120' ' ' LEU . 1.4 mm? -111.93 174.17 6.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.175 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 m -143.88 169.99 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.203 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.542 HE22 ' H ' ' A' ' 128' ' ' SER . 55.0 tp60 -109.04 134.44 51.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -125.37 -145.37 6.49 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.67 -43.26 65.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 110.748 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -43.52 151.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.947 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.7 p -61.46 -83.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.025 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -126.67 70.15 1.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.475 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.542 ' H ' HE22 ' A' ' 122' ' ' GLN . 46.5 m -125.8 153.28 44.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.589 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 129' ' ' TRP . 0.9 OUTLIER -115.75 119.14 35.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.379 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 76.1 p -163.71 173.03 13.38 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.882 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 43.3 m-85 -83.29 152.05 63.87 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.207 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.93 142.93 39.8 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.848 1.699 . . . . 0.0 111.831 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -146.41 171.7 14.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.238 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.29 -169.53 34.33 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.97 137.23 35.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.664 0.268 . . . . 0.0 110.57 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 pt -114.02 157.1 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.384 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.9 m -64.59 144.15 57.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.435 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -92.17 173.88 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.636 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 59.63 37.28 22.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -136.36 162.51 32.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.253 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -79.4 146.03 33.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.466 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -49.34 -37.75 25.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.556 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 50.0 mt -72.68 -43.84 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -62.31 -41.93 98.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.585 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -73.87 -39.13 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.934 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.593 ' SG ' ' CE1' ' A' ' 180' ' ' PHE . 43.9 t -69.82 -56.82 6.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.043 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 148' ' ' ARG . 2.1 tp -54.44 -39.98 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.005 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.444 ' N ' ' CG2' ' A' ' 147' ' ' ILE . 31.6 ttm180 -66.27 -39.38 89.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.908 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -76.91 -27.54 54.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.0 110.44 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.12 -54.56 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.846 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -26.72 67.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.903 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -84.75 -34.84 22.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 110.995 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -72.6 -60.48 2.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.677 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 21.8 mt -82.52 -33.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.776 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 104.5 -12.89 51.09 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -103.65 130.73 51.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.672 0.272 . . . . 0.0 110.455 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -104.49 148.46 26.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.985 0.421 . . . . 0.0 111.048 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.0 mt -106.27 115.22 29.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.815 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.31 -61.73 1.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.391 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.518 ' OD1' ' CD2' ' A' ' 161' ' ' TYR . 43.4 p-10 -104.47 0.43 28.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.105 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.518 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 68.3 m-85 -105.3 14.9 28.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.65 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.1 tp -93.22 130.93 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.601 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 181' ' ' LEU . 77.9 m-20 -72.03 153.54 41.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.364 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -85.57 -67.38 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.497 0.665 . . . . 0.0 111.123 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -132.06 70.46 1.47 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.759 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -132.78 107.62 8.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.494 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.5 165.85 20.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.81 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 34.2 pt -128.53 146.3 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.537 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.48 135.01 54.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.265 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -159.74 137.38 9.89 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.661 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -102.93 112.99 26.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.352 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 54.9 mt -99.02 120.78 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.33 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 175' ' ' LYS . 65.2 mt-30 54.0 49.69 18.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.79 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 69.52 -17.28 0.65 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.511 ' H ' ' C ' ' A' ' 173' ' ' GLN . 42.4 mttt -85.4 134.04 34.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -75.16 131.56 40.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.594 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -134.98 105.24 6.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.608 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -100.05 130.64 46.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.334 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.96 127.51 61.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 111.081 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.593 ' CE1' ' SG ' ' A' ' 146' ' ' CYS . 0.3 OUTLIER -99.31 133.33 43.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.734 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.41 ' O ' ' OD2' ' A' ' 163' ' ' ASP . 8.8 mt -87.75 137.05 32.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.991 0.424 . . . . 0.0 111.285 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.57 106.64 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.904 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 p -125.24 151.33 46.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.402 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 117.29 -12.49 14.1 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 4.4 m -53.29 146.68 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 34.9 p -77.75 127.75 32.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.795 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -83.06 -10.79 58.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.43 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 25.2 m -72.52 -16.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.249 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -95.92 134.32 39.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.308 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -88.81 127.32 35.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.632 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -95.72 128.14 42.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.428 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -105.13 152.8 39.79 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.311 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.53 141.68 28.48 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.305 2.003 . . . . 0.0 112.436 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -149.51 78.18 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.98 177.07 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.756 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -51.73 154.05 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.113 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -46.25 102.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.287 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -150.81 -113.45 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.255 0.55 . . . . 0.0 110.407 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.5 mm -124.99 126.34 71.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.239 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.19 103.94 13.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.498 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.499 ' NZ ' ' OE2' ' A' ' 203' ' ' GLU . 61.4 tttm -163.69 134.87 4.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.012 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.1 pt -120.9 154.24 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.241 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.499 ' OE2' ' NZ ' ' A' ' 201' ' ' LYS . 44.0 mt-10 -152.44 138.19 17.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.412 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.51 103.2 13.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.348 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.419 ' CE2' ' CE3' ' A' ' 129' ' ' TRP . 60.8 m-85 -105.93 152.72 22.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.904 0.383 . . . . 0.0 110.842 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -81.96 139.25 34.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.643 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -51.71 -55.51 19.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -56.61 -43.36 80.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.82 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -57.58 -48.4 79.48 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.883 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 87.5 mt -55.11 -25.11 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.482 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -89.89 -13.79 35.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -104.38 15.86 27.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.071 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 15.3 p -81.29 10.9 4.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 110.74 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 70.8 mtm -53.96 -35.29 61.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.315 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -55.87 -34.53 65.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.449 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -100.07 109.04 21.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.557 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 82.5 p -92.78 -23.15 18.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.709 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -56.5 -42.4 78.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.542 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.1 mt -126.16 110.34 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.473 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -139.44 148.91 43.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.559 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 221' ' ' TYR . 0.0 OUTLIER -117.05 117.84 30.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.459 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -82.81 -35.72 26.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.042 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 10.7 mp -53.69 -48.64 69.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.002 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 tp -69.23 -33.87 60.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.85 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -58.85 -41.69 87.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.24 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 68.9 m -67.52 -38.32 84.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.053 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -83.44 2.77 35.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.155 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' MET . . . . . . . . . . . . . 42.1 ttp -52.42 -59.92 3.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.124 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.426 ' O ' ' OG ' ' A' ' 232' ' ' SER . 6.3 mtm-85 -77.5 -51.22 1.94 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.143 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 229' ' ' ARG . 53.6 Cg_exo -49.39 -52.64 8.42 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.099 1.866 . . . . 0.0 112.154 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.34 -36.49 84.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.041 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 229' ' ' ARG . 86.9 p -66.12 -36.33 82.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.824 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 79.3 mmm -67.4 -56.19 10.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.283 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 30.3 m95 -54.75 -57.91 9.66 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.064 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 97.1 mt -51.94 -24.7 6.79 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.41 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -61.42 -44.3 97.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 0.0 110.11 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -64.72 -44.06 91.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.852 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -59.62 -41.14 89.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.018 0.437 . . . . 0.0 110.597 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -63.98 -30.64 71.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -62.97 -41.39 99.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.498 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 10.9 mm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.695 -179.815 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.692 0.282 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.4 t -126.21 -18.75 4.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.635 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.446 ' CG2' ' O ' ' A' ' 103' ' ' ILE . 10.0 tt -119.21 108.44 40.2 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.278 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.83 130.52 6.73 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.987 1.791 . . . . 0.0 112.206 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -143.83 139.26 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.326 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.518 HH12 ' NZ ' ' A' ' 178' ' ' LYS . 57.7 mtp85 -132.59 149.6 52.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -137.93 -179.29 16.89 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.3 124.21 20.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.223 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 129.99 54.19 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.9 mt -122.88 136.39 59.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.244 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -124.3 153.06 42.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.682 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.456 ' ND2' ' CE2' ' A' ' 204' ' ' TRP . 0.9 OUTLIER -56.16 149.18 16.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.294 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -52.29 -28.71 20.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.899 0.38 . . . . 0.0 110.228 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -95.81 3.46 53.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.371 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.1 mt 51.99 45.18 28.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.368 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.423 ' HG ' ' HZ3' ' A' ' 117' ' ' LYS . 2.2 t -107.29 -21.47 12.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.587 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.423 ' HZ3' ' HG ' ' A' ' 116' ' ' SER . 9.3 mttp -140.11 176.51 8.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.3 tt -139.32 134.28 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.222 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.526 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 3.0 tt -82.69 126.98 32.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.012 0.434 . . . . 0.0 111.572 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.1 mt -133.23 152.2 51.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.466 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.41 170.99 13.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.615 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -99.48 143.53 29.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.94 -164.85 12.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.522 ' OG1' ' NH2' ' A' ' 196' ' ' ARG . 38.9 m -44.55 -35.75 2.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.262 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -47.39 156.87 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.151 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.6 t -70.08 -59.16 3.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.853 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -137.21 69.15 1.41 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.986 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 t -128.8 141.51 51.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.578 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -115.6 120.86 40.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.467 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.2 p -164.03 175.61 10.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.958 0.408 . . . . 0.0 110.937 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.526 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 36.7 m-85 -80.58 153.11 73.33 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.332 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.53 153.4 54.96 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.016 1.811 . . . . 0.0 112.175 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.644 ' HE ' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -159.26 -173.92 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.521 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 175.69 -175.55 47.31 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -89.92 147.01 23.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.316 . . . . 0.0 110.712 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 1.1 pp -130.24 156.84 42.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.438 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.0 m -75.63 141.72 42.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.591 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -76.12 167.38 21.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.057 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 59.71 41.59 18.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.512 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -135.45 148.37 49.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -60.7 134.11 56.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.57 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 29.8 p-10 -63.76 -36.67 84.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.876 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.507 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 3.2 mm -60.09 -54.66 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.841 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -64.87 -38.97 92.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 1.1 m -60.58 -39.85 89.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.903 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.585 ' SG ' ' CE1' ' A' ' 180' ' ' PHE . 71.1 m -63.69 -61.57 2.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.281 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.6 tp -60.93 -17.68 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.29 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.0 ttp85 -77.14 -48.41 17.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.704 0.288 . . . . 0.0 111.337 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -74.21 -35.28 63.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.019 0.438 . . . . 0.0 110.595 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.12 -61.07 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.09 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 152' ' ' GLU . 16.3 pttm -58.71 -44.35 90.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.79 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 151' ' ' LYS . 47.0 tp10 -60.01 -45.39 92.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.48 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 133' ' ' ARG . 97.3 mt-10 -73.83 -58.15 3.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.528 ' CG2' ' H ' ' A' ' 156' ' ' PHE . 7.8 tt -71.31 -24.24 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.342 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 151' ' ' LYS . . . 82.89 8.63 85.57 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.528 ' H ' ' CG2' ' A' ' 154' ' ' ILE . 25.9 t80 -151.36 150.84 30.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -128.3 133.73 48.79 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.932 0.396 . . . . 0.0 111.53 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.84 154.35 25.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.741 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.9 p -72.76 -14.51 61.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.023 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -105.35 13.89 29.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.05 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.27 -7.63 59.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.84 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.4 tp -125.81 137.15 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -106.61 156.11 18.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.248 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 3.4 p30 -69.08 -67.81 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.355 0.598 . . . . 0.0 111.052 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -134.43 60.72 1.69 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.111 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -145.27 107.9 4.45 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.556 -0.457 . . . . 0.0 111.013 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -156.36 163.84 39.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.309 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.9 tt -127.56 133.41 67.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -110.58 132.05 54.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.806 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -159.75 136.4 9.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.922 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -109.59 116.06 31.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.289 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 19.1 pt -119.74 150.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.612 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 175' ' ' LYS . 25.9 mt-30 47.11 36.77 4.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.395 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 70.51 -14.65 1.31 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.503 ' H ' ' C ' ' A' ' 173' ' ' GLN . 51.1 mttm -88.51 129.33 35.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 110.907 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -75.08 120.99 21.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.503 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -117.24 125.21 50.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.993 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.518 ' NZ ' HH12 ' A' ' 106' ' ' ARG . 23.5 mtpt -122.44 129.85 52.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.676 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.7 mt -137.72 134.02 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.361 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.585 ' CE1' ' SG ' ' A' ' 146' ' ' CYS . 0.0 OUTLIER -93.27 137.49 32.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.303 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 234' ' ' TRP . 10.8 mt -95.32 125.93 40.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.709 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.14 106.26 3.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.709 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 63.6 p -111.35 154.82 24.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.408 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 99.52 13.23 38.84 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.6 m -88.77 147.33 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.719 0.295 . . . . 0.0 110.554 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 60.5 p -61.96 124.51 20.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.971 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -93.49 -5.56 48.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.579 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.39 -28.29 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.376 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.53 148.93 49.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.237 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -92.56 131.78 37.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.552 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -110.83 138.08 47.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.509 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -140.7 122.77 9.52 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.3 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.27 116.43 4.14 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.79 1.66 . . . . 0.0 112.321 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -106.13 99.78 9.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.328 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 32.0 m -147.42 -160.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.7 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.522 ' NH2' ' OG1' ' A' ' 124' ' ' THR . 12.5 mtp180 -42.72 148.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.614 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -70.95 117.2 12.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.538 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 1.9 tt0 -172.65 -111.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.489 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.514 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 58.9 mt -113.9 118.35 58.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.771 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 200' ' ' ASP . 2.9 p30 -128.47 100.49 5.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.045 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -139.88 138.63 35.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.592 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 36.0 pt -109.16 145.09 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.199 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -156.78 133.55 10.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.301 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' TRP . . . . . 0.456 ' CE2' ' ND2' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -101.21 113.52 26.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.271 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -107.83 148.54 29.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.047 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.73 136.71 43.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.101 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -51.53 -40.11 59.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.56 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -64.44 -39.78 94.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -60.35 -32.79 71.6 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.512 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 98.0 mt -71.84 -33.05 46.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 50.0 m -80.71 -28.41 36.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.636 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -12.11 61.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.585 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 52.5 p -50.91 -26.46 5.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 62.5 mtt -62.47 -35.36 79.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.604 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -69.4 -43.26 73.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.677 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -86.42 116.02 24.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.403 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 70.9 m -96.21 9.86 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.752 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -75.64 -68.93 0.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.505 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.0 tp -132.09 123.57 51.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.524 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -138.12 159.28 42.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.385 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -106.48 101.7 11.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.557 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -66.15 -33.87 76.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.55 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 4.9 tp -55.51 -43.57 75.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.0 mm -86.85 -27.43 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.95 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -53.1 -45.67 68.34 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.744 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.1 m -69.82 -37.86 76.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.776 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 34.5 ttm -78.48 -23.79 46.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 224' ' ' ILE . 46.5 ttp -58.65 -38.74 78.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.457 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 2.2 mmm180 -54.31 -65.51 1.26 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.888 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 28.8 Cg_endo -62.56 -44.1 19.13 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.174 1.916 . . . . 0.0 111.85 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.7 tp -53.06 -35.28 59.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.855 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 33.7 t -72.89 -33.77 66.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.752 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 5.6 ttm -70.59 -59.54 2.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.21 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.409 ' CD1' ' CD1' ' A' ' 181' ' ' LEU . 4.7 t-105 -57.46 -49.32 76.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.946 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 30.0 tp -56.56 -29.02 61.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -41.57 97.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.541 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -57.02 -44.61 83.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.775 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -60.86 -34.71 75.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.966 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -70.44 -36.09 73.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.797 0.332 . . . . 0.0 110.827 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -64.28 -44.89 90.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.736 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 86.2 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.821 -179.787 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.8 mttt . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.798 0.333 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.8 p -73.72 -21.52 60.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.391 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 103' ' ' ILE . 1.3 tt -95.04 110.03 47.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.295 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.8 149.9 23.55 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.835 1.69 . . . . 0.0 112.366 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.21 145.89 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.983 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.543 ' NE ' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -143.59 160.23 41.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.615 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -133.0 161.44 24.12 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 131' ' ' PHE . . . -108.47 120.42 42.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.717 0.294 . . . . 0.0 110.905 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -103.38 126.92 50.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.422 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mt -124.96 129.25 73.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.972 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 3.5 m-85 -115.76 154.26 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.903 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.617 HD22 ' H ' ' A' ' 116' ' ' SER . 40.5 p-10 -60.02 148.84 34.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.556 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -48.74 -29.82 4.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.64 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -87.8 4.61 43.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.756 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.459 ' O ' ' NH1' ' A' ' 239' ' ' ARG . 1.1 mp 41.7 42.66 2.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.519 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.617 ' H ' HD22 ' A' ' 112' ' ' ASN . 0.1 OUTLIER -123.08 -10.4 8.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.18 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.614 ' NZ ' ' CD1' ' A' ' 204' ' ' TRP . 7.7 mtpm? -134.29 168.55 18.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.044 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.38 144.0 35.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 tt -108.25 121.6 45.22 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.826 0.346 . . . . 0.0 111.008 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.0 mt -120.92 158.86 26.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.093 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.93 170.73 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.706 0.289 . . . . 0.0 110.309 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -93.19 119.79 32.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.758 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -96.18 -157.17 31.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.1 t -54.05 -34.73 60.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.435 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -51.47 158.08 0.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.162 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.6 m -65.72 -62.9 1.25 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.028 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -137.07 73.4 1.44 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.844 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -128.47 145.8 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.599 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.418 ' CD2' ' N ' ' A' ' 129' ' ' TRP . 0.1 OUTLIER -108.49 110.81 22.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.441 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.2 m -161.25 172.06 17.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.481 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 108' ' ' ALA . 37.8 m-85 -80.89 151.42 70.66 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.077 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.83 145.65 63.29 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.011 1.807 . . . . 0.0 111.984 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -104.7 171.78 7.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.793 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -174.42 -151.77 8.61 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -133.48 166.94 21.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.766 0.317 . . . . 0.0 110.532 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.3 mt -115.11 136.62 51.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.9 t -76.61 134.64 39.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.447 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -74.41 151.08 39.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.813 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 54.4 41.75 31.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.674 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -149.45 145.9 27.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.392 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -60.11 137.11 58.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.433 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -59.91 -32.35 70.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.517 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 83.9 mt -61.37 -46.51 96.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.541 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -62.37 -37.4 85.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.723 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 47.6 m -72.34 -40.37 67.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.985 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 87.8 m -70.72 -54.69 10.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' A' ' 148' ' ' ARG . 17.4 tt -57.63 -40.99 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.956 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.452 ' N ' ' CG2' ' A' ' 147' ' ' ILE . 67.6 ttt-85 -65.01 -39.5 93.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.945 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -78.67 -28.25 45.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.794 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.01 -51.28 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.814 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -36.68 80.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.937 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -71.75 -36.07 70.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.208 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.422 ' O ' ' OE1' ' A' ' 194' ' ' GLN . 86.6 tt0 -77.71 -59.73 2.66 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.414 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 23.1 mt -71.68 -32.38 45.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.763 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.62 -14.56 61.83 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -112.33 133.58 54.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.764 0.316 . . . . 0.0 110.227 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 48.4 p30 -95.03 151.89 18.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.042 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.5 mt -111.6 110.19 20.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.101 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 91.4 m -90.47 -61.7 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.828 0.347 . . . . 0.0 111.239 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -100.23 -5.98 26.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -98.89 16.75 21.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.829 0.347 . . . . 0.0 110.354 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.5 tt -107.71 137.85 36.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -79.9 147.22 31.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.401 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.525 ' CG ' ' H ' ' A' ' 165' ' ' ASN . 8.6 p-10 -75.62 -64.99 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.395 0.617 . . . . 0.0 111.008 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.525 ' H ' ' CG ' ' A' ' 164' ' ' ASP . 36.5 t30 -131.98 67.84 1.51 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.089 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -129.84 107.49 9.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.322 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -154.73 156.59 36.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.267 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.9 mt -124.62 129.16 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.505 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -99.59 137.62 37.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 tpt85 -159.51 127.65 4.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.607 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -100.29 115.05 29.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.133 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.7 tt -112.67 131.72 63.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.635 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.522 ' C ' ' H ' ' A' ' 175' ' ' LYS . 89.3 mm-40 53.62 43.14 31.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.402 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 63.45 -4.2 1.04 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 173' ' ' GLN . 20.6 tttm -90.66 132.15 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 110.794 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -74.69 119.54 19.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.489 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -129.5 121.99 28.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.573 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 107' ' ' GLY . 55.1 mttp -120.5 144.19 48.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.957 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.76 132.2 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -101.42 123.63 45.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.183 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 13.4 mt -84.01 126.92 33.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.607 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 3.7 pt -145.48 100.9 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.293 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.5 m -114.28 157.2 23.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.515 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 118.63 -6.21 14.17 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.4 m -61.73 153.02 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.301 . . . . 0.0 110.363 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 20.8 t -98.46 132.89 43.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.613 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -73.59 -7.53 52.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.594 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.9 m -69.83 -20.28 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.429 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 190' ' ' ASN . 10.8 t80 -86.2 151.86 23.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.351 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.446 ' N ' ' CD1' ' A' ' 189' ' ' PHE . 47.4 t30 -85.55 110.59 19.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -96.89 124.01 40.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.207 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -140.62 147.43 48.96 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.436 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.93 149.46 42.15 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.139 1.893 . . . . 0.0 112.233 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.422 ' OE1' ' O ' ' A' ' 153' ' ' GLU . 89.0 mt-30 -142.41 78.37 1.62 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.203 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.84 -166.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.536 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -46.84 150.5 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.21 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -56.74 125.46 22.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.957 0.408 . . . . 0.0 110.918 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -171.37 -113.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.08 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -130.46 129.64 64.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.301 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -97.77 108.61 21.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.497 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -137.73 133.89 34.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.422 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.7 tt -121.76 141.82 40.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.169 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -144.84 131.29 19.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.177 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' TRP . . . . . 0.614 ' CD1' ' NZ ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -98.09 101.42 12.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.825 0.345 . . . . 0.0 110.207 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -95.88 136.43 36.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -66.4 131.21 45.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.481 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -62.02 -36.82 82.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.438 ' CD ' ' N ' ' A' ' 208' ' ' LYS . 0.0 OUTLIER -52.44 -42.45 64.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.842 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -65.13 -42.89 93.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.663 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 213' ' ' THR . 96.1 mt -66.56 -26.4 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.554 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 83.9 p -80.49 -59.19 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.77 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.539 ' C ' ' H ' ' A' ' 214' ' ' MET . 97.5 mttt -63.24 -48.3 78.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.764 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 210' ' ' ILE . 18.5 p 51.13 7.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.048 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' MET . . . . . 0.539 ' H ' ' C ' ' A' ' 212' ' ' LYS . 11.9 mmt -73.62 -43.23 60.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.898 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -72.98 -31.54 64.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.867 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -98.25 120.74 39.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 2.8 t -131.51 -29.42 1.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.43 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -54.81 -46.15 74.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.747 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.7 pt -136.14 144.51 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.692 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -139.32 151.41 46.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.582 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -85.82 81.78 8.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.305 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -49.89 -40.3 42.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.071 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 10.5 mt -57.7 -52.63 64.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.038 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 228' ' ' MET . 47.2 mt -78.39 -27.5 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -50.73 -34.8 28.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.648 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.4 m -76.07 -36.73 58.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.966 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 73.3 mtm -95.24 0.74 54.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.972 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' MET . . . . . 0.523 ' N ' ' O ' ' A' ' 224' ' ' ILE . 2.5 ppp? -62.87 -32.81 74.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.971 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.417 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 7.9 mtt180 -67.18 -63.35 2.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.059 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 29.5 Cg_endo -63.79 -40.83 26.82 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.014 1.809 . . . . 0.0 112.124 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.55 -41.79 90.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.559 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' SER . . . . . 0.452 ' O ' ' CG ' ' A' ' 236' ' ' ARG . 44.7 t -61.39 -39.09 89.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.587 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 86.3 mtp -73.57 -46.83 44.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -61.21 -51.51 68.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.738 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 41.8 tp -60.73 -35.72 77.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 110.305 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.452 ' CG ' ' O ' ' A' ' 232' ' ' SER . 9.4 mmt85 -64.26 -33.56 76.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.495 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.17 -43.24 74.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.48 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -53.59 -36.84 62.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.647 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.459 ' NH1' ' O ' ' A' ' 115' ' ' LEU . 62.2 mtp85 -57.12 -15.31 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.416 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -80.91 -52.46 7.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.967 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 94.8 mt . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.997 -179.49 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 81.7 tttt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.781 0.324 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.8 m -73.41 -33.15 64.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.507 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.14 107.71 57.42 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.388 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -82.38 152.62 15.8 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 121.948 1.766 . . . . 0.0 112.33 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.76 127.05 66.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.959 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.59 ' NH1' ' SG ' ' A' ' 145' ' ' CYS . 97.0 mtt180 -132.1 144.11 50.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.292 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -134.71 165.98 24.39 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 131' ' ' PHE . . . -110.1 137.55 47.71 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.137 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.83 120.72 41.72 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.707 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mp -133.15 142.81 41.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.766 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.72 160.58 43.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.101 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -47.23 151.93 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.141 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 185' ' ' VAL . 87.1 mt-10 -63.25 -24.48 67.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.926 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -101.92 13.17 35.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.192 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 115' ' ' LEU . 3.9 mm? 50.65 47.25 24.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.109 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.05 -26.49 13.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.1 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.489 ' NZ ' ' OD2' ' A' ' 206' ' ' ASP . 21.2 mtpp -143.93 178.77 7.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.042 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.4 tt -140.74 131.54 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.431 . . . . 0.0 110.49 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.524 ' O ' ' CZ ' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -75.73 121.83 23.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.261 -179.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -125.64 156.35 39.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.7 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.3 m -143.18 173.5 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.52 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -102.34 124.69 48.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.678 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.58 -165.69 36.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 47.0 p -61.1 -25.33 66.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 0.0 110.442 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.405 ' OE1' ' CB ' ' A' ' 128' ' ' SER . 56.7 mt-10 -51.78 165.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.25 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.5 m -67.37 -67.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.021 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -136.99 68.92 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.991 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.405 ' CB ' ' OE1' ' A' ' 125' ' ' GLU . 14.1 m -128.84 143.52 50.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.383 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.468 ' CE3' ' CZ ' ' A' ' 221' ' ' TYR . 9.7 m0 -107.68 118.73 37.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.604 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.6 m -156.24 170.33 22.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.759 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.524 ' CZ ' ' O ' ' A' ' 119' ' ' LEU . 39.9 m-85 -81.21 152.78 71.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.061 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.35 137.92 41.26 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.901 1.734 . . . . 0.0 111.735 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.529 ' NE ' ' OH ' ' A' ' 177' ' ' TYR . 45.1 ptt85 -150.07 -170.3 3.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.177 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.76 177.93 25.12 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -81.21 137.0 35.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.9 tt -125.95 155.38 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.451 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.4 p -64.72 157.51 27.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.633 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 65.1 mttm -89.88 -178.9 5.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.603 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 4.6 t0 77.7 38.15 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.406 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -137.77 158.7 43.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.567 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -84.9 151.38 24.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.398 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 36.3 p-10 -53.19 -37.07 61.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.622 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.526 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 19.1 tt -79.75 -45.73 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.552 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.447 ' N ' ' CG2' ' A' ' 143' ' ' ILE . 57.2 t0 -62.56 -34.51 77.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.827 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.59 ' SG ' ' NH1' ' A' ' 106' ' ' ARG . 6.1 p -64.62 -41.03 96.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.589 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.58 ' N ' ' HG ' ' A' ' 145' ' ' CYS . 0.0 OUTLIER -63.75 -46.04 87.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.298 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.526 ' N ' ' SG ' ' A' ' 146' ' ' CYS . 80.0 mt -59.34 -52.16 64.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.969 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -60.04 -40.77 90.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.548 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -79.06 -28.84 43.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.879 0.371 . . . . 0.0 110.726 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 146' ' ' CYS . 4.1 t -64.8 -50.99 72.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.719 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER -70.13 -44.33 69.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.933 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -47.15 -34.43 6.17 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.399 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 194' ' ' GLN . 78.2 mm-40 -91.61 -62.13 1.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.023 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 81.9 mt -81.04 -33.63 13.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 151' ' ' LYS . . . 100.6 -14.15 59.28 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -125.12 137.89 54.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 50.1 p30 -135.17 156.92 48.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 111.036 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.563 ' N ' ' CD1' ' A' ' 158' ' ' LEU . 4.5 mp -103.01 122.91 45.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.958 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.429 ' HG1' ' H ' ' A' ' 160' ' ' ASP . 24.0 p -90.4 -61.52 1.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.384 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.429 ' H ' ' HG1' ' A' ' 159' ' ' THR . 33.4 p30 -103.3 11.79 36.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.82 17.7 22.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.838 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.6 pt -130.95 149.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.06 0.457 . . . . 0.0 111.184 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -71.2 156.19 39.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.649 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.62 -17.88 21.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.078 0.466 . . . . 0.0 110.936 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -134.34 58.02 1.78 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.362 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -139.38 106.99 5.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.105 0.478 . . . . 0.0 110.679 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -166.09 163.32 18.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.651 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.0 pt -129.24 150.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.399 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 169' ' ' GLU . 1.2 pt-20 -144.18 96.43 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.684 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -127.72 153.0 47.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.468 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -106.15 122.11 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.495 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 58.9 mt -103.72 121.8 55.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.353 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.498 ' NE2' ' CE2' ' A' ' 222' ' ' TYR . 87.2 mt-30 53.48 43.28 31.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.426 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.48 -11.53 12.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -86.42 124.62 32.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.8 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.565 ' N ' HD21 ' A' ' 176' ' ' ASN . 0.0 OUTLIER -74.3 119.99 19.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.464 -178.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.529 ' OH ' ' NE ' ' A' ' 133' ' ' ARG . 0.2 OUTLIER -122.91 104.91 9.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.769 -179.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -108.18 129.89 55.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 54.7 mt -138.44 136.2 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.529 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -95.5 136.35 35.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.75 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.5 mt -84.75 133.32 34.36 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.854 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 65.0 mt -133.05 108.84 13.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.308 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.9 t -117.26 147.94 42.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.563 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 102.74 8.24 43.14 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.428 ' O ' ' CG ' ' A' ' 113' ' ' GLU . 5.6 p -50.04 133.05 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 110.625 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 48.6 m -81.67 143.51 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.424 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -93.46 -9.73 37.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.365 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.64 -28.33 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.664 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -83.04 144.63 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.715 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -81.47 139.89 34.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.257 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -99.63 124.55 44.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.726 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -143.3 109.85 5.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.18 136.76 13.05 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.736 1.624 . . . . 0.0 111.972 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 153' ' ' GLU . 83.6 mt-30 -126.5 111.55 14.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.648 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.63 178.96 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -43.69 146.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.364 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -56.99 102.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.802 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -155.36 -113.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.146 0.498 . . . . 0.0 110.276 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 32.6 mt -122.41 110.04 25.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.069 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 200' ' ' ASP . 32.2 p-10 -106.0 119.88 40.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -136.01 123.9 22.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.33 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.2 tt -107.35 138.77 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -166.05 152.67 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.405 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -115.79 110.96 19.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.446 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -97.52 143.72 27.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.489 ' OD2' ' NZ ' ' A' ' 117' ' ' LYS . 1.1 t0 -70.67 129.64 39.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.368 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -46.54 -33.74 4.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.352 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -64.43 -45.37 87.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.14 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -53.1 -49.09 67.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.965 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.24 -19.76 25.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.805 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.42 -13.02 44.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.488 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -98.41 24.46 7.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.487 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.2 m -49.94 -36.49 28.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.797 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 76.5 mmm -53.69 -38.72 64.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.795 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -67.73 -26.26 66.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.662 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -93.65 133.87 36.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.518 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.4 t -113.96 -42.17 3.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.01 -44.06 97.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.748 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.0 mt -124.66 127.17 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.58 135.35 38.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.37 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.468 ' CZ ' ' CE3' ' A' ' 129' ' ' TRP . 53.5 m-85 -107.35 105.23 15.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.712 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.498 ' CE2' ' NE2' ' A' ' 173' ' ' GLN . 23.2 p90 -90.98 -36.57 14.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.423 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 222' ' ' TYR . 2.5 tp -51.19 -45.45 61.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.313 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 228' ' ' MET . 2.8 tp -73.31 -29.69 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.753 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -56.63 -43.56 80.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.552 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.1 t -63.66 -34.31 77.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.598 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 227' ' ' MET . 0.0 OUTLIER -86.76 -29.36 22.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.702 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' MET . . . . . 0.492 ' N ' ' O ' ' A' ' 224' ' ' ILE . 32.0 ttm -54.99 -40.32 69.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.354 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.499 HH11 ' CG ' ' A' ' 229' ' ' ARG . 0.1 OUTLIER -62.1 -64.08 3.48 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.532 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 37.2 Cg_endo -64.97 -47.88 4.36 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.291 1.994 . . . . 0.0 112.235 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 6.0 tt -51.05 -40.7 58.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.627 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 34.9 t -66.8 -49.05 67.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.04 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 8.3 tpp -60.17 -50.89 71.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.264 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.431 ' O ' ' OE1' ' A' ' 238' ' ' GLN . 13.0 m95 -53.83 -66.83 0.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.112 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 87.3 mt -51.25 -32.32 23.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.027 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -67.35 -29.39 68.93 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.127 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -75.66 -53.64 8.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.751 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.431 ' OE1' ' O ' ' A' ' 234' ' ' TRP . 5.5 mp0 -56.42 -38.57 71.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.8 -26.74 64.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.61 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -72.82 -44.86 60.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.786 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 15.9 mm . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.039 -179.652 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.2 mttt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.494 ' HZ3' ' CG ' ' A' ' 176' ' ' ASN . 7.1 ttmm -94.8 101.97 13.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.717 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.0 -32.78 7.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.121 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.436 ' CG2' ' O ' ' A' ' 103' ' ' ILE . 1.3 tt -117.03 108.17 44.61 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.308 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -79.06 140.86 16.13 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.732 1.622 . . . . 0.0 112.045 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.41 141.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.582 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -142.82 145.65 33.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.73 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -128.86 173.46 19.33 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -127.54 127.63 44.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 110.749 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.24 113.48 25.99 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.639 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.578 ' CD1' ' N ' ' A' ' 110' ' ' ILE . 0.0 OUTLIER -110.29 139.6 33.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.018 0.437 . . . . 0.0 110.654 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.633 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -117.95 156.28 28.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.216 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.708 HD22 ' H ' ' A' ' 116' ' ' SER . 0.0 OUTLIER -58.64 172.68 0.48 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.164 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -64.69 -29.23 70.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.737 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.96 4.23 48.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.992 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.402 ' CA ' ' ND2' ' A' ' 112' ' ' ASN . 1.5 mp 43.43 43.29 4.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.452 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.708 ' H ' HD22 ' A' ' 112' ' ' ASN . 8.1 t -124.19 -5.23 7.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.726 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.425 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 86.8 mttt -138.8 157.55 45.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.839 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.438 HG22 HD12 ' A' ' 118' ' ' ILE . 25.4 mm -109.66 140.04 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.99 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.514 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 2.2 tt -101.18 111.03 23.14 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.329 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 120' ' ' LEU . 1.7 mm? -104.44 161.0 14.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.0 m -137.69 162.99 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.314 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -98.26 127.45 44.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.63 -165.4 34.6 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 72.4 p -59.92 -24.07 64.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.362 . . . . 0.0 110.38 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.24 160.37 27.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.3 m -72.81 -102.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.97 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -77.07 72.14 3.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.414 ' C ' ' CG ' ' A' ' 129' ' ' TRP . 54.3 p -128.39 156.13 43.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.351 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.414 ' CG ' ' C ' ' A' ' 128' ' ' SER . 56.5 m95 -151.37 110.79 3.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.671 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.56 176.46 6.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.514 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 29.1 m-85 -77.53 153.72 81.37 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.92 149.61 59.75 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.934 1.756 . . . . 0.0 112.03 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -149.37 177.74 9.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.841 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 160.51 -174.81 37.26 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -79.17 143.47 35.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.64 0.257 . . . . 0.0 110.475 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.5 pt -110.81 152.52 12.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.465 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.8 m -65.08 145.55 56.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.504 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -93.32 161.13 14.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.413 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 63.0 34.79 13.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.511 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -137.13 145.18 43.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.377 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -60.63 130.72 47.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.127 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -50.55 -37.73 41.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.024 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.2 mt -68.77 -54.39 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.584 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -56.95 -37.52 71.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.304 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -32.05 73.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.144 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -65.02 -48.9 72.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.682 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.52 -48.47 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.872 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -62.11 -40.49 96.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.527 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -82.61 -20.64 36.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.9 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 146' ' ' CYS . 20.5 t -85.05 -51.54 13.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.631 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.27 -28.45 69.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.053 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -81.71 -36.34 28.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.899 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -82.11 -61.54 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.284 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 15.1 mt -72.79 -33.52 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.559 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.27 -14.3 59.7 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.53 ' CE2' ' O ' ' A' ' 157' ' ' ASP . 62.4 t80 -116.41 143.63 45.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.69 0.281 . . . . 0.0 110.506 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.53 ' O ' ' CE2' ' A' ' 156' ' ' PHE . 44.8 p30 -106.6 140.11 40.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.5 111.14 23.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.037 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.7 p -90.22 -61.61 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.721 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.436 ' OD1' ' CD2' ' A' ' 161' ' ' TYR . 55.6 p30 -107.45 8.74 29.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.564 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.436 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 79.1 m-85 -106.87 15.89 24.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 tt -117.38 140.04 41.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.705 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -69.04 148.19 50.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.151 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 22.3 p-10 -76.37 -57.87 3.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.229 0.538 . . . . 0.0 111.54 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.436 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 91.0 m-20 -131.41 60.75 1.66 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.421 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.483 ' O ' ' CE1' ' A' ' 180' ' ' PHE . 50.0 tt0 -129.61 107.83 9.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.942 0.401 . . . . 0.0 110.387 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -152.94 162.32 41.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.379 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 24.1 pt -129.55 147.64 33.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -121.25 138.76 54.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.039 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.499 ' NH2' ' O ' ' A' ' 226' ' ' SER . 8.1 tpt180 -159.25 132.97 7.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.559 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -107.19 115.07 29.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 61.2 mt -109.48 129.33 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.442 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.432 ' C ' ' H ' ' A' ' 175' ' ' LYS . 6.5 mm-40 52.1 43.24 30.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.385 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.44 -5.81 3.84 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 173' ' ' GLN . 84.8 tttt -89.4 128.34 35.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 111.037 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.494 ' CG ' ' HZ3' ' A' ' 101' ' ' LYS . 42.6 t30 -75.15 123.28 24.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.759 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -132.98 110.08 10.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.44 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -108.92 141.3 41.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.333 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.17 127.63 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.981 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.483 ' CE1' ' O ' ' A' ' 166' ' ' GLN . 1.9 t80 -95.76 123.99 39.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.481 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.69 126.28 29.52 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.494 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.95 101.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.205 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.1 p -125.38 161.54 26.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.609 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 120.45 8.03 8.67 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 9.0 m -75.18 161.05 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.716 0.294 . . . . 0.0 110.465 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 62.2 m -104.61 158.46 16.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.804 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.91 -2.24 57.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.397 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 46.5 t -71.07 -27.85 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.508 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.448 ' CE1' ' O ' ' A' ' 190' ' ' ASN . 48.7 t80 -100.19 144.37 29.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.349 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.448 ' O ' ' CE1' ' A' ' 189' ' ' PHE . 9.3 p30 -97.99 125.38 42.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -104.83 126.65 52.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.339 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -127.23 149.68 70.3 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.238 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -70.04 143.57 49.88 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.079 1.853 . . . . 0.0 111.986 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -141.3 83.57 1.88 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.536 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.15 -165.0 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.324 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -45.58 152.61 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.142 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.39 109.39 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.617 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.496 ' CG ' ' H ' ' A' ' 199' ' ' ILE . 2.2 tt0 -161.87 -113.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.057 0.456 . . . . 0.0 110.62 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.496 ' H ' ' CG ' ' A' ' 198' ' ' GLU . 49.7 mt -113.97 131.91 64.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.429 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.08 101.05 6.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.39 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -137.69 140.97 41.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.9 tt -113.65 140.38 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.455 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -144.55 120.71 10.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.549 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.09 101.5 13.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.172 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -98.72 134.4 41.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.722 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 207' ' ' PHE . 65.2 t0 -72.17 139.94 48.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.486 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.461 ' N ' ' OD1' ' A' ' 206' ' ' ASP . 76.4 t80 -53.86 -31.21 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.566 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.416 ' O ' ' OG ' ' A' ' 211' ' ' SER . 37.6 mttt -50.76 -52.65 38.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.507 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -58.81 -43.83 90.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.801 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . 0.413 ' O ' ' OG1' ' A' ' 213' ' ' THR . 83.8 mt -62.45 -35.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.585 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 208' ' ' LYS . 60.4 p -68.35 -19.33 64.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.373 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -102.61 20.9 16.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.647 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 210' ' ' ILE . 0.0 OUTLIER -44.81 -31.3 1.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' MET . . . . . 0.515 ' C ' ' H ' ' A' ' 216' ' ' LYS . 34.0 mtt -54.75 -29.84 54.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.566 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.528 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 51.2 t80 -72.17 22.71 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.116 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 214' ' ' MET . 1.9 pttp -64.55 138.26 58.31 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.44 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.5 p -126.67 -21.46 4.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.707 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -137.02 -102.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.661 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 17.1 tt -113.67 122.61 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.665 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -132.78 162.02 32.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.277 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.55 ' N ' ' CD1' ' A' ' 221' ' ' TYR . 0.1 OUTLIER -91.35 93.6 9.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.688 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -74.78 -10.05 59.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 79.8 mt -53.25 -51.78 61.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.691 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 228' ' ' MET . 15.6 tt -72.24 -29.94 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.8 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -54.28 -44.19 71.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.644 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.499 ' O ' ' NH2' ' A' ' 170' ' ' ARG . 75.3 m -68.68 -33.05 73.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.704 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 73.8 mtm -92.35 2.01 56.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 224' ' ' ILE . 38.2 ttp -60.56 -38.86 85.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.491 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.444 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -56.47 -64.62 2.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.677 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 17.7 Cg_endo -60.81 -52.02 4.16 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.111 1.874 . . . . 0.0 112.019 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.408 ' C ' ' CD2' ' A' ' 231' ' ' LEU . 6.4 tt -48.99 -50.84 33.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.594 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 23.0 t -64.19 -59.2 4.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.442 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 86.7 mtp -50.99 -53.5 32.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.746 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -62.04 -50.31 72.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.087 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 41.3 tp -57.78 -30.39 65.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.034 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -34.43 77.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.371 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -65.21 -43.27 92.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.686 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -58.91 -36.15 74.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.772 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -64.29 -32.41 73.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.017 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -65.71 -42.05 91.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 11.1 mm -65.24 -29.27 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.808 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -46.34 -27.7 1.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.201 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -54.34 165.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.494 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -68.08 -28.34 67.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.289 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.639 -179.921 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.6 tttp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -85.53 89.18 7.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.685 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.5 m -92.0 -29.43 16.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.491 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.83 107.83 28.56 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.346 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.36 141.52 11.41 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.025 1.817 . . . . 0.0 112.086 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.86 141.84 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.451 ' HE ' ' CD1' ' A' ' 136' ' ' ILE . 45.7 ttp85 -123.14 152.1 41.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.458 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -125.94 156.83 19.72 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.492 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -103.55 161.15 14.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 0.0 110.844 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -141.54 111.34 6.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.458 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.57 133.5 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.202 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.86 158.92 41.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.455 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 116' ' ' SER . 37.4 p-10 -55.3 166.42 0.6 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.296 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -63.9 -25.51 68.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.371 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -90.72 6.08 45.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.793 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.8 mt 45.31 44.23 8.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.623 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.536 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 0.7 OUTLIER -125.01 -2.03 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.639 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -133.29 149.42 51.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 118' ' ' ILE . 34.2 mm -115.66 127.21 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.92 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.522 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 1.3 tt -89.03 105.61 17.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.563 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -118.78 157.2 28.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.226 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.35 174.35 11.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.762 0.315 . . . . 0.0 110.407 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -88.58 127.76 35.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.386 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.05 -176.04 39.37 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.5 p -52.25 -35.67 50.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 0.0 110.21 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -55.33 -176.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.003 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.2 m -85.21 -76.85 0.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.834 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -109.54 75.82 0.96 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.677 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.1 t -128.14 142.6 51.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.651 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.594 ' NE1' ' CE1' ' A' ' 221' ' ' TYR . 0.0 OUTLIER -122.94 111.88 17.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.449 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.2 168.76 26.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.808 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 43.5 m-85 -82.08 153.04 69.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.236 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -43.68 148.67 0.82 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.837 1.691 . . . . 0.0 111.45 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -126.43 170.01 12.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.648 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 175.12 177.38 44.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -97.35 147.39 24.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.739 0.304 . . . . 0.0 110.538 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.451 ' CD1' ' HE ' ' A' ' 106' ' ' ARG . 18.2 tt -133.53 140.56 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.594 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.7 m -71.65 150.33 44.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.501 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -93.84 156.24 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.548 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 56.87 42.66 26.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.436 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -142.48 158.57 43.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.011 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -58.09 124.73 20.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.881 0.372 . . . . 0.0 110.396 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 44.8 p-10 -77.95 -32.36 51.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.006 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.512 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 10.7 tp -65.32 -38.27 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 110.326 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -72.32 -35.32 68.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.415 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 63.6 m -82.48 -37.43 25.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.01 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 142' ' ' ASP . 66.7 m -65.66 -53.06 46.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.815 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.3 tt -64.52 -35.68 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.19 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -65.81 -42.12 91.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.278 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -76.45 -34.87 58.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.97 0.414 . . . . 0.0 110.826 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.78 -49.8 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.99 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -65.52 -38.57 90.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.281 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -70.64 -37.48 73.77 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.965 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -77.52 -56.75 4.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.122 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 87.3 mt -71.49 -32.28 45.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.994 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.63 -8.43 78.65 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -104.17 125.99 50.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 110.485 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -91.29 126.58 36.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.765 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 8.5 mt -100.42 110.42 22.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.859 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.9 m -90.67 -61.7 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.703 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.514 ' OD1' ' CE2' ' A' ' 161' ' ' TYR . 49.8 p30 -101.7 2.92 39.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.262 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.514 ' CE2' ' OD1' ' A' ' 160' ' ' ASP . 20.9 m-85 -107.21 16.82 23.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.299 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.8 tp -114.02 129.6 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 181' ' ' LEU . 91.1 m-20 -73.68 144.69 45.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.227 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -70.08 -66.95 0.53 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.461 0.648 . . . . 0.0 111.345 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -133.35 66.6 1.55 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.025 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -128.51 108.56 10.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.539 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -152.89 157.74 41.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.651 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.5 mt -121.45 136.85 57.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.664 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 170' ' ' ARG . 0.9 OUTLIER -89.77 129.35 36.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.006 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.452 ' N ' ' OE1' ' A' ' 169' ' ' GLU . 12.4 tpp180 -149.93 114.63 5.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.55 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -110.24 116.01 30.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.405 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 15.9 pt -116.99 142.2 31.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.69 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.536 ' C ' ' H ' ' A' ' 175' ' ' LYS . 55.1 mt-30 51.97 41.09 29.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.413 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 63.67 -4.01 1.21 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.536 ' H ' ' C ' ' A' ' 173' ' ' GLN . 2.1 tppp? -89.64 125.23 35.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.409 . . . . 0.0 110.451 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -75.98 128.7 35.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.896 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.47 119.3 13.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.457 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 107' ' ' GLY . 24.5 mttp -99.92 135.25 41.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.193 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 33.8 mm -113.03 120.23 62.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.96 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -97.65 120.75 38.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.962 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.43 ' O ' ' OD2' ' A' ' 163' ' ' ASP . 14.2 mt -78.98 125.68 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.934 0.397 . . . . 0.0 110.874 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.3 mt -137.23 103.59 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.328 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 94.3 p -110.88 150.36 29.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.497 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 103.52 1.48 46.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.3 p -48.69 149.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 110.704 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.9 m -80.34 101.52 9.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.666 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -67.97 -23.85 65.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.7 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.8 m -74.79 -18.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.682 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -96.33 136.92 36.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.319 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -87.16 133.83 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.517 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -111.89 138.34 48.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.01 109.27 10.67 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.037 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.03 156.68 15.18 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.061 1.841 . . . . 0.0 112.68 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.68 115.07 19.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.089 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 10.4 m -134.3 -168.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.472 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -41.52 146.13 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.321 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -69.94 114.19 7.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.831 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 4.6 tt0 -172.53 -112.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.138 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.436 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 94.7 mt -109.05 120.42 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.519 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 200' ' ' ASP . 33.6 p-10 -123.18 101.07 7.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.28 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -137.04 140.4 42.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.655 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 71.5 mt -99.82 135.49 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.473 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -147.22 117.75 7.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.43 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.63 104.04 16.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.51 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -94.22 132.51 38.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.962 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -68.42 137.48 54.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.421 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -55.23 -43.16 74.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -60.43 -45.04 95.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.126 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 213' ' ' THR . 40.7 mttt -62.34 -38.81 90.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.053 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 90.1 mt -69.91 -30.06 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 9.6 m -66.88 -33.83 76.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.423 ' O ' ' OG1' ' A' ' 213' ' ' THR . 16.8 ptmt -105.44 -33.08 8.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.044 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 209' ' ' LYS . 17.3 p 55.13 65.25 1.54 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.642 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' MET . . . . . 0.49 ' C ' ' H ' ' A' ' 216' ' ' LYS . 12.2 tmm? -58.67 -28.27 65.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.48 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 63.3 t80 -67.7 8.77 0.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.114 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 214' ' ' MET . 20.7 tttt -59.7 120.77 10.13 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.824 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.3 p -132.29 -44.75 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.295 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 218' ' ' ASN . 1.0 OUTLIER -144.2 -39.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.447 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 45.1 pt -126.7 154.99 37.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.712 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.19 142.38 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.294 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.594 ' CE1' ' NE1' ' A' ' 129' ' ' TRP . 0.2 OUTLIER -67.06 118.87 11.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -97.63 -6.07 34.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.71 -42.33 91.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 228' ' ' MET . 35.8 mm -96.66 -40.04 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.278 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -48.3 -53.83 15.93 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.779 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 67.5 m -65.68 -38.99 90.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 110.376 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 27.7 ttm -74.59 -15.03 60.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.384 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' MET . . . . . 0.55 ' N ' ' O ' ' A' ' 224' ' ' ILE . 32.0 ttp -57.96 -42.86 85.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.794 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.445 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 5.3 mtt180 -56.58 -65.22 1.75 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.009 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 24.8 Cg_endo -61.58 -48.31 9.53 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.2 1.933 . . . . 0.0 112.42 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.3 tp -55.94 -39.56 71.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.783 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 37.1 t -63.49 -38.64 91.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.08 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 5.0 mtm -71.48 -52.12 20.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.147 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -55.99 -56.98 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.43 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 95.3 mt -54.86 -31.23 59.41 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.68 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -75.42 -28.7 59.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.389 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -72.87 -55.64 6.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.47 ' C ' ' N ' ' A' ' 240' ' ' GLN . 95.8 mm-40 -53.78 -39.39 65.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.543 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 -47.24 -15.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.355 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.47 ' N ' ' C ' ' A' ' 238' ' ' GLN . 3.0 tp-100 -82.69 -59.21 2.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 7.6 tt -64.28 -10.15 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.622 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -50.62 -31.45 16.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.464 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -75.79 175.07 9.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.355 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -64.87 136.24 56.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 110.494 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.8 p30 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.669 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -142.51 67.0 1.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.446 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.9 t -73.42 -22.46 60.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.535 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -102.29 109.03 59.37 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.41 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.32 139.03 18.29 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.717 1.611 . . . . 0.0 112.565 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.84 148.13 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.209 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -140.15 158.72 43.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.278 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -138.84 178.18 19.62 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.471 ' O ' ' CB ' ' A' ' 131' ' ' PHE . . . -118.62 163.06 17.37 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.083 0.468 . . . . 0.0 111.289 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.37 113.0 8.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.998 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.0 mp -135.75 131.54 50.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.373 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.37 160.3 43.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.149 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -49.17 139.68 10.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.262 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.34 -30.24 50.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -85.88 6.73 27.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.516 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 mt 47.0 57.71 5.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.385 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.85 -16.67 7.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.933 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -137.07 157.52 46.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.399 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.17 132.49 68.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.188 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.509 ' O ' ' CZ ' ' A' ' 131' ' ' PHE . 0.6 OUTLIER -92.06 115.57 28.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.818 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.9 mt -126.34 163.61 22.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.075 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.4 m -143.34 156.69 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.403 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -101.96 150.58 23.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.635 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -134.93 -162.44 9.79 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.0 t -52.22 -27.63 15.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.773 0.321 . . . . 0.0 110.649 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.465 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 53.7 mp0 -55.27 153.7 6.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.189 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.7 t -68.23 -84.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.957 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -113.12 69.29 0.69 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 m -128.43 147.97 50.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.521 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.451 ' CD1' ' N ' ' A' ' 129' ' ' TRP . 1.3 m95 -133.77 116.3 15.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.26 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.52 167.66 28.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.0 111.081 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.509 ' CZ ' ' O ' ' A' ' 119' ' ' LEU . 41.2 m-85 -77.5 153.9 81.49 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.508 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -41.46 144.76 0.68 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.791 1.661 . . . . 0.0 111.399 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.432 ' CZ ' ' OH ' ' A' ' 177' ' ' TYR . 7.9 ptm180 -139.01 174.85 10.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.747 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.59 177.16 47.68 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 110.23 21.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.711 0.291 . . . . 0.0 110.511 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.9 tt -128.1 136.48 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.541 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.5 m -64.78 157.39 27.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.594 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 22.8 mttp -93.09 178.09 5.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.722 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 6.8 t0 77.07 28.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.492 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -133.11 156.07 48.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.367 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.418 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 71.0 m-80 -58.81 127.66 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.623 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.491 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 67.4 m-20 -73.2 -39.24 65.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.155 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' A' ' 144' ' ' ASP . 13.6 tt -61.82 -46.58 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.739 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.402 ' N ' ' CG2' ' A' ' 143' ' ' ILE . 18.4 t70 -68.64 -39.21 80.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.388 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 141' ' ' ASN . 89.0 m -72.92 -35.63 67.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.578 ' SG ' ' CD2' ' A' ' 180' ' ' PHE . 34.8 m -61.45 -53.96 49.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.721 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 83.9 mt -59.1 -41.64 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.729 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -64.74 -41.34 96.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.91 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.03 -31.6 61.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.957 0.408 . . . . 0.0 110.373 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.72 -47.97 41.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.088 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -23.59 63.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.584 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -78.39 -40.69 35.37 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.641 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -83.69 -58.01 2.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.459 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 90.0 mt -72.36 -33.67 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.803 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.27 -13.82 64.18 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.473 ' CD2' ' CE2' ' A' ' 189' ' ' PHE . 51.8 t80 -110.9 133.65 53.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.774 0.321 . . . . 0.0 110.223 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -96.81 141.76 29.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.138 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.7 mt -111.92 110.39 20.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.131 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.1 m -91.07 -62.02 1.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.425 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -106.37 1.74 25.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.036 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -99.92 16.46 23.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.576 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 7.4 tt -125.59 136.76 59.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.702 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -70.99 144.1 50.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.681 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.33 -28.74 15.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.478 . . . . 0.0 111.197 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -133.98 59.35 1.74 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.317 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -149.34 108.12 3.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.966 0.412 . . . . 0.0 110.116 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -159.9 158.43 30.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.385 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 85.2 mt -133.59 155.58 40.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.714 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -102.73 137.22 41.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.029 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 177' ' ' TYR . 64.4 mtt180 -140.82 112.18 7.35 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.923 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 175' ' ' LYS . 49.5 t-20 -119.72 111.78 18.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.431 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.38 139.09 47.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.376 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 53.16 36.95 23.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.634 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.48 -5.0 11.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 171' ' ' ASN . 49.4 mttp -85.29 119.46 25.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 0.0 110.404 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.1 118.77 19.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.903 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.432 ' OH ' ' CZ ' ' A' ' 133' ' ' ARG . 3.8 m-85 -131.99 109.17 9.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.566 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 107' ' ' GLY . 0.6 OUTLIER -102.78 139.74 37.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.75 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.9 mt -136.67 128.35 43.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.961 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.578 ' CD2' ' SG ' ' A' ' 146' ' ' CYS . 1.8 p90 -93.08 127.65 38.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.356 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 24.9 mt -74.01 139.86 45.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.082 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 59.9 mt -136.41 107.64 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.127 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 79.9 p -119.03 158.03 26.63 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.876 0.37 . . . . 0.0 110.483 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.68 16.43 48.88 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.36 115.73 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.038 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 54.1 m -63.3 151.38 40.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.415 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -99.41 6.29 46.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.354 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.15 -20.64 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.353 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 189' ' ' PHE . 1.3 p90 -99.72 128.03 45.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.913 0.387 . . . . 0.0 110.83 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -125.44 134.17 52.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.393 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -112.15 159.27 18.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.588 ' CD ' ' N ' ' A' ' 192' ' ' LYS . 0.0 OUTLIER -105.19 161.49 22.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.262 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -38.34 116.13 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.918 2.412 . . . . 0.0 112.644 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -145.95 69.7 1.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.028 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.512 ' CG1' ' H ' ' A' ' 196' ' ' ARG . 38.7 t -139.67 173.61 10.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.638 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.512 ' H ' ' CG1' ' A' ' 195' ' ' VAL . 36.7 mtt85 -52.42 148.94 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.536 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.9 105.72 0.18 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.499 ' CG ' ' H ' ' A' ' 199' ' ' ILE . 0.9 OUTLIER -171.97 -113.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.406 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.499 ' H ' ' CG ' ' A' ' 198' ' ' GLU . 3.5 mm -123.57 120.03 58.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.246 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -129.77 111.75 12.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.818 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -142.06 128.01 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.234 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.13 136.14 38.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -150.82 126.66 10.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.324 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.13 110.4 22.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.408 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -103.92 150.83 23.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.022 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -65.82 124.4 22.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.867 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -46.04 -35.37 4.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.952 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -56.02 -32.87 64.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.636 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -48.31 -51.46 25.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.1 mt -66.41 -38.74 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 44.0 m -66.75 -45.04 79.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.796 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 214' ' ' MET . 28.8 mttt -56.72 -18.73 13.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.516 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 3.4 m -66.02 56.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.558 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 212' ' ' LYS . 48.8 mtt -95.51 -72.8 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.846 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.15 -9.92 54.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -77.4 106.74 9.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.88 0.371 . . . . 0.0 110.593 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 22.8 t -95.87 -14.08 23.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.646 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -44.4 -62.9 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 18.7 tt -137.92 130.23 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.864 0.364 . . . . 0.0 111.072 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -138.93 147.62 42.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.371 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -108.69 86.22 2.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.542 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -50.5 -23.27 2.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 75.4 mt -50.68 -57.18 8.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 228' ' ' MET . 76.7 mt -109.7 -28.53 2.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.857 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -53.3 -43.85 67.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.93 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.7 m -72.1 -42.23 66.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 227' ' ' MET . 0.0 OUTLIER -86.98 3.11 47.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.142 -179.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 224' ' ' ILE . 28.0 ttp -51.39 -31.69 23.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.052 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.454 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 2.2 mpp_? -66.76 -65.84 1.48 Allowed Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.345 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 10.3 Cg_endo -53.48 -39.21 83.0 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.039 1.826 . . . . 0.0 111.92 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.8 tt -68.67 -39.41 80.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.539 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 78.5 p -70.46 -34.21 72.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.751 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 13.7 mmt -70.85 -50.7 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.059 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -55.63 -57.35 12.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.859 0.361 . . . . 0.0 110.93 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -57.14 -25.83 59.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.047 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 -57.65 -42.73 84.06 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.066 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -60.8 -40.51 92.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.701 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -63.59 -30.97 72.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -73.09 -32.35 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.621 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.07 -40.55 85.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.687 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 13.5 mm -75.48 -39.75 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.698 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.31 -31.96 62.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.632 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 243' ' ' ASN . 21.2 p-10 -43.5 131.78 4.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.728 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -121.09 146.36 46.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.46 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 52.3 t0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.567 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.4 pttt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm -140.7 50.12 1.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.543 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.7 m -73.57 -21.98 60.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.42 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.9 mt -105.41 107.7 59.75 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.459 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.98 118.84 3.1 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 121.994 1.796 . . . . 0.0 112.154 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.42 141.51 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.982 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -137.19 141.65 42.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.001 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.2 146.77 17.42 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 131' ' ' PHE . . . -100.25 119.22 38.05 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.886 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -109.13 120.55 42.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.431 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mt -127.3 122.84 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.112 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -126.62 161.42 28.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.82 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.527 ' ND2' ' OG ' ' A' ' 116' ' ' SER . 4.1 m120 -61.05 177.87 0.3 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.595 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -61.26 -39.52 90.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.05 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -123.87 39.55 3.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.746 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 mp 51.05 36.57 15.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.527 ' OG ' ' ND2' ' A' ' 112' ' ' ASN . 93.2 p -67.08 -34.34 77.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.48 ' N ' ' HG ' ' A' ' 116' ' ' SER . 26.9 mttm -151.05 161.76 42.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.873 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.6 mm -118.89 123.14 71.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.537 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 4.5 tp -80.41 115.09 19.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.319 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.3 mt -123.08 157.23 33.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.615 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.6 163.36 33.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 0.0 110.406 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -93.69 130.46 39.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.634 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -100.91 -171.24 28.77 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.0 t -56.74 -29.41 62.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.625 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -54.94 -172.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.223 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.3 t -86.04 -120.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.716 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -81.21 71.14 8.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.812 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 m -128.3 147.6 50.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -126.49 122.29 34.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.385 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.1 t -166.39 166.42 16.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.946 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.537 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 39.4 m-85 -73.38 152.52 90.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.006 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.22 154.9 51.91 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.032 1.821 . . . . 0.0 112.196 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -131.6 172.16 12.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.206 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 169.21 179.02 40.92 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.7 mttm -101.88 154.64 18.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 pt -129.3 156.0 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.702 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.3 t -82.78 145.23 29.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.554 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -86.91 178.94 6.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.541 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 66.45 33.32 6.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.511 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -141.71 155.56 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.342 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -64.81 142.8 58.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.47 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.48 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 74.6 m-20 -58.32 -38.1 76.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 20.8 tt -67.03 -39.1 82.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.773 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -66.86 -39.88 87.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.727 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 80.6 m -66.68 -42.53 86.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.771 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.586 ' SG ' ' CD2' ' A' ' 180' ' ' PHE . 64.9 m -62.5 -48.15 80.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.464 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 97.1 mt -60.45 -40.99 85.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.954 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -58.39 -44.14 88.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.003 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.431 ' O ' ' OE2' ' A' ' 153' ' ' GLU . 81.2 mm-40 -78.09 -37.19 46.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.885 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.34 -50.41 46.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.788 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -60.52 -29.51 69.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.559 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -80.32 -45.45 17.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.823 0.344 . . . . 0.0 110.652 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -70.41 -58.68 3.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.22 -179.418 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.525 ' N ' ' CD1' ' A' ' 154' ' ' ILE . 1.6 mp -72.35 -32.97 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 110.98 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.34 -13.66 61.39 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -119.69 135.04 54.99 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.854 0.359 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -92.61 128.88 38.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.725 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.558 ' N ' ' CD1' ' A' ' 158' ' ' LEU . 6.2 mp -91.73 113.3 25.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.547 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.5 p -90.02 -54.84 3.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 57.0 t0 -105.0 -17.46 14.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.642 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -85.48 20.65 1.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.666 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.4 tt -117.91 136.93 53.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.494 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.54 152.95 43.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.369 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 165' ' ' ASN . 1.2 p30 -75.47 -66.02 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.384 0.612 . . . . 0.0 111.024 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 67.7 m-80 -130.21 67.72 1.47 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.171 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -132.16 107.13 8.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.901 0.381 . . . . 0.0 110.688 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.516 ' CD2' ' OE2' ' A' ' 169' ' ' GLU . 45.8 p90 -156.31 154.04 29.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.355 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 6.6 tt -123.86 137.87 55.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.516 ' OE2' ' CD2' ' A' ' 167' ' ' PHE . 3.9 mp0 -116.69 133.42 56.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.036 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -160.23 148.43 16.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.987 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.97 112.29 24.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.997 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.4 pt -120.97 152.48 24.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.769 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.537 ' C ' ' H ' ' A' ' 175' ' ' LYS . 42.0 mt-30 50.9 32.82 7.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.572 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.33 -25.25 0.72 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.537 ' H ' ' C ' ' A' ' 173' ' ' GLN . 41.7 tttt -84.96 137.36 33.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.841 0.353 . . . . 0.0 110.816 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 176' ' ' ASN . 9.1 p-10 -74.94 131.97 41.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.037 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.14 115.48 13.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.494 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -108.37 138.22 45.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.7 mt -137.19 134.74 47.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.15 0.5 . . . . 0.0 111.816 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.586 ' CD2' ' SG ' ' A' ' 146' ' ' CYS . 4.4 t80 -100.26 122.36 42.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.783 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.8 mt -69.85 125.95 28.26 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.468 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 3.1 mm -130.58 103.15 7.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.301 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.8 t -130.4 153.23 48.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.625 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 107.31 -1.68 34.92 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 3.8 m -57.72 148.12 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.47 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.71 115.79 17.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.691 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -69.84 -22.03 63.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.57 -8.1 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.265 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -102.36 122.23 43.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.262 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -87.77 134.88 33.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.516 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -99.01 134.59 41.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.62 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.14 156.52 38.23 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.177 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.13 123.8 11.03 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.286 1.991 . . . . 0.0 112.027 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -147.78 69.65 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.766 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.04 -177.88 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.147 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -42.97 148.91 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.11 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -73.38 102.11 3.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 0.0 110.589 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -157.89 -113.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.119 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 57.3 mt -126.58 102.95 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.06 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -131.27 139.1 49.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.92 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -144.26 141.33 29.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.354 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 4.1 pt -102.9 128.5 55.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.76 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -158.03 135.82 10.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.256 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.28 104.49 16.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.498 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -83.81 125.81 32.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.736 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.04 132.44 49.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.266 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -51.13 -37.01 43.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.669 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.1 -36.7 80.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.039 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -59.69 -49.85 76.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.782 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 11.8 mt -56.35 -48.13 80.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.738 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.523 ' C ' ' H ' ' A' ' 213' ' ' THR . 5.0 m -60.49 -32.65 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -73.29 20.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.757 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.523 ' H ' ' C ' ' A' ' 211' ' ' SER . 1.3 t -53.36 -31.83 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.556 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 10.8 tpp -47.44 -31.03 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.727 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.522 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 63.1 t80 -87.9 20.38 3.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.763 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 213' ' ' THR . 23.0 pttm -58.61 135.65 57.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.666 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 4.0 m -98.83 -45.53 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -163.59 16.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.682 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 17.1 tt -125.48 137.62 57.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.448 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -134.67 142.1 46.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -66.21 154.15 40.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.059 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -100.26 -73.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.9 tt -74.1 -56.43 4.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.1 mt -58.05 -32.5 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.61 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.459 ' CG ' ' N ' ' A' ' 226' ' ' SER . 0.1 OUTLIER -43.73 -57.9 2.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.393 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.459 ' N ' ' CG ' ' A' ' 225' ' ' ASN . 79.6 p -87.13 -27.81 22.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.435 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 65.9 mtp -84.95 1.7 46.2 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.95 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 224' ' ' ILE . 13.6 ttp -51.28 -37.11 45.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.965 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.459 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -64.9 -65.5 1.91 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.5 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 10.7 Cg_endo -55.42 -44.56 47.47 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.266 1.978 . . . . 0.0 112.258 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.56 -50.99 61.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.171 0.51 . . . . 0.0 110.155 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 28.8 p -71.39 -37.24 71.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.165 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 34.7 ttm -67.25 -62.03 1.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.261 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -45.88 -60.85 2.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.82 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.91 -25.45 11.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 41.0 ttm-85 -61.23 -40.52 94.31 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.586 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -68.64 -44.34 74.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.052 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -52.97 -36.7 60.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.84 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -72.41 -28.95 63.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.214 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.16 -51.76 34.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 110.461 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 3.4 mm -64.53 -25.26 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.027 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -51.14 -50.52 58.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.215 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . 0.566 ' N ' ' OD1' ' A' ' 243' ' ' ASN . 0.2 OUTLIER -79.08 127.16 31.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.376 . . . . 0.0 109.996 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.55 -33.21 74.47 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.615 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 62.9 t0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.441 179.917 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.6 tttm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 tttp 63.44 22.57 13.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.9 m -74.74 -31.82 61.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.083 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 103' ' ' ILE . 13.6 tt -124.36 108.66 29.28 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.809 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.2 137.38 10.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.978 1.785 . . . . 0.0 112.155 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.88 138.7 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.494 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -148.18 145.13 28.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.797 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -133.24 168.52 23.0 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' A' ' 131' ' ' PHE . . . -112.15 125.81 54.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.684 0.278 . . . . 0.0 111.036 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.5 117.25 33.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.429 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.88 133.92 65.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.138 0.494 . . . . 0.0 110.941 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.611 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -137.27 149.21 46.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.994 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.58 ' ND2' ' H ' ' A' ' 116' ' ' SER . 43.8 p-10 -50.42 155.19 1.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.994 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -57.81 -25.95 61.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.023 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -92.06 7.21 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.078 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.425 ' N ' ' OD1' ' A' ' 112' ' ' ASN . 12.6 mt 42.93 52.5 5.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 0.0 110.532 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.58 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 0.5 OUTLIER -123.55 -13.7 7.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.112 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -133.24 146.42 51.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.261 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.445 HD13 HG21 ' A' ' 118' ' ' ILE . 30.6 mm -115.31 124.58 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.215 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.544 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 1.2 tt -86.27 103.58 15.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.697 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.7 mt -117.83 162.82 17.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.129 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.15 160.19 40.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.488 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.436 ' OE1' ' O ' ' A' ' 123' ' ' GLY . 0.4 OUTLIER -98.89 114.33 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.336 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.436 ' O ' ' OE1' ' A' ' 122' ' ' GLN . . . -96.31 -151.66 28.26 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 87.5 m -53.97 -34.86 60.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 110.656 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -47.02 157.53 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.7 m -69.18 -70.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.852 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -133.53 69.61 1.47 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.508 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -127.45 143.21 51.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.33 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -113.21 115.35 28.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.326 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.9 t -156.87 164.88 37.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.681 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.544 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 44.6 m-85 -73.28 151.9 90.09 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -67.55 139.34 48.56 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.888 1.725 . . . . 0.0 111.667 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -125.0 177.99 5.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.566 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 158.68 179.8 33.79 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -86.63 145.84 26.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.707 0.289 . . . . 0.0 110.641 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.6 tt -127.1 147.33 32.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.219 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.7 p -70.13 153.09 43.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -112.61 176.58 4.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.179 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 53.89 42.33 31.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.258 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -148.44 158.76 44.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.363 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -58.7 125.62 24.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.525 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.421 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 23.3 p-10 -64.38 -39.42 93.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.138 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 7.0 tt -66.85 -37.39 79.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.498 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -69.79 -42.36 73.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.569 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 64.9 m -73.86 -40.18 63.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 142' ' ' ASP . 33.1 m -55.21 -52.89 61.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.24 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.15 -42.76 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -62.2 -41.3 98.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.337 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -79.25 -35.22 41.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.94 0.4 . . . . 0.0 110.561 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.11 -53.8 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -45.3 89.37 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.651 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.32 -28.63 65.21 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -89.23 -62.6 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 8.8 mt -84.96 -33.65 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.03 -13.37 60.48 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -102.69 135.27 44.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.0 110.385 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 25.0 p30 -106.86 127.45 53.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.814 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 mp -96.38 112.44 24.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.922 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.2 m -89.52 -61.88 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.74 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -98.97 0.19 43.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.122 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -109.63 21.11 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.63 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -111.91 133.04 58.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.641 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -101.3 135.68 42.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.242 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -95.9 -10.81 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.938 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -133.74 56.7 1.84 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.303 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.517 HE22 ' CG ' ' A' ' 238' ' ' GLN . 35.3 tt0 -150.53 107.65 3.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.316 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -164.77 166.5 19.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.62 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 63.4 mt -125.96 130.8 72.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.078 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -113.37 128.08 56.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.296 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.655 ' NH2' ' HG ' ' A' ' 226' ' ' SER . 0.0 OUTLIER -160.06 159.11 31.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.945 0.402 . . . . 0.0 110.911 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.463 ' ND2' HD21 ' A' ' 176' ' ' ASN . 4.2 m120 -104.48 102.59 12.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.938 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 83.7 mt -97.27 117.02 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.339 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 52.15 40.26 28.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.363 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 80.88 -20.09 6.87 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -83.97 124.32 30.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.412 . . . . 0.0 110.707 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.463 HD21 ' ND2' ' A' ' 171' ' ' ASN . 21.8 m120 -75.2 136.55 40.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.473 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.35 140.56 51.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.284 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -143.92 94.86 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 10.6 pt -112.57 145.67 18.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.022 0.439 . . . . 0.0 111.628 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 180' ' ' PHE . 11.2 p90 -99.89 132.43 45.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.598 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 9.7 mt -91.48 129.06 37.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.548 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.02 129.68 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.908 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.1 m -132.14 162.0 31.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.415 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.48 7.91 55.31 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.8 m -75.93 142.99 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.654 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 52.1 p -77.29 137.12 38.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.647 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.455 ' OE1' ' CZ2' ' A' ' 204' ' ' TRP . 70.9 mm-40 -96.55 -8.54 31.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.603 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.0 -27.73 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.473 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -98.23 123.62 42.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.4 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -106.57 132.75 52.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.665 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.68 152.73 39.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.574 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.53 157.23 38.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.291 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.51 142.96 41.56 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.343 2.029 . . . . 0.0 112.219 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -135.65 82.94 1.98 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.105 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.09 -177.59 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.719 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -48.46 145.77 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.52 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -46.21 102.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.698 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -147.3 -113.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.415 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.88 122.86 65.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.363 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -93.24 107.55 19.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.753 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -160.3 126.97 4.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.46 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.2 tt -127.32 154.21 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.46 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -167.71 156.59 9.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.698 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' TRP . . . . . 0.455 ' CZ2' ' OE1' ' A' ' 187' ' ' GLU . 0.0 OUTLIER -106.85 100.58 10.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.734 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.71 135.08 33.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.296 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -72.03 133.3 45.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.485 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -49.16 -32.08 9.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -59.2 -43.65 92.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.676 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -54.81 -32.27 60.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.364 . . . . 0.0 110.234 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . 0.436 ' O ' ' OG1' ' A' ' 213' ' ' THR . 82.7 mt -79.17 -23.07 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.358 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.4 t -85.1 -10.66 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 215' ' ' TYR . 47.6 mttp -95.44 10.07 37.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.769 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 210' ' ' ILE . 0.2 OUTLIER -43.07 -36.2 1.54 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.345 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 40.6 mtt -52.95 -33.82 52.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.352 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.414 ' N ' ' O ' ' A' ' 212' ' ' LYS . 77.4 t80 -66.8 -46.58 74.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.446 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 216' ' ' LYS . 11.1 ptmt -113.1 110.25 20.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 57.7 m -92.14 -10.41 38.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.841 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -58.76 -37.67 76.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.684 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 79.2 mt -128.94 134.05 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.539 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -130.43 145.03 51.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.642 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 225' ' ' ASN . 87.2 m-85 -104.66 86.85 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.427 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -66.1 -27.99 68.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.212 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 223' ' ' LEU . 7.8 mp -69.5 -39.13 77.77 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.778 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 228' ' ' MET . 97.0 mt -95.7 -40.2 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.676 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 221' ' ' TYR . 62.4 t-20 -59.98 -47.95 83.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.341 . . . . 0.0 110.561 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.655 ' HG ' ' NH2' ' A' ' 170' ' ' ARG . 7.9 t -68.84 -30.46 69.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.556 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 76.9 mtp -96.54 2.41 52.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 224' ' ' ILE . 18.7 ttt -48.33 -38.97 20.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.221 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.45 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -68.96 -65.51 1.26 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.602 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 19.6 Cg_endo -60.17 -47.56 14.5 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.213 1.942 . . . . 0.0 112.366 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 5.1 tt -56.2 -39.48 72.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.894 0.378 . . . . 0.0 110.626 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 68.9 m -75.74 -40.09 56.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.994 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 10.7 mmt -66.46 -52.89 41.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.289 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -55.06 -54.4 43.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.759 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.56 -22.16 31.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.599 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -42.16 72.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.658 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -61.96 -44.28 97.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.598 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.517 ' CG ' HE22 ' A' ' 166' ' ' GLN . 68.8 mt-30 -58.6 -34.64 71.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.673 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -62.07 -24.46 67.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -81.74 -58.72 2.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 6.1 tt -61.5 -12.26 6.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.41 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -50.76 -26.9 6.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.615 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -80.83 12.19 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 48.07 -120.66 1.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.594 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.575 -179.99 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.2 mttp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -108.65 79.9 1.28 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.644 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.0 m -73.51 -32.88 64.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.59 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 103' ' ' ILE . 17.0 tt -117.8 108.39 42.85 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.484 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -82.25 135.88 8.64 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.937 1.758 . . . . 0.0 112.224 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.53 140.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.048 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.1 ttp85 -123.74 146.76 48.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.802 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -122.86 149.44 16.86 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -101.87 142.42 33.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.865 0.364 . . . . 0.0 111.222 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.29 99.34 3.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.263 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 mp -108.79 142.2 22.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.505 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -127.34 163.94 22.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.145 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.635 HD22 ' H ' ' A' ' 116' ' ' SER . 26.1 p-10 -65.33 166.16 10.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.886 0.374 . . . . 0.0 110.875 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 185' ' ' VAL . 61.6 mm-40 -58.63 -33.45 70.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.621 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -89.43 6.98 38.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.988 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mp 42.91 45.23 4.26 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.592 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.635 ' H ' HD22 ' A' ' 112' ' ' ASN . 3.9 t -120.95 -9.24 9.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.01 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -136.8 170.32 16.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.771 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.5 tt -134.03 131.41 55.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.758 0.313 . . . . 0.0 110.584 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.531 ' O ' ' CZ ' ' A' ' 131' ' ' PHE . 2.5 tt -83.11 127.71 33.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.205 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -121.27 156.68 31.98 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.4 m -143.69 172.69 6.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.669 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.533 ' NE2' ' CG2' ' A' ' 199' ' ' ILE . 1.4 tm0? -92.17 124.64 36.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.49 -165.86 32.17 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.462 ' OG1' ' NH2' ' A' ' 196' ' ' ARG . 40.3 m -47.22 -37.1 9.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.891 0.377 . . . . 0.0 110.221 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 56.9 mp0 -51.4 160.06 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.04 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.7 t -64.61 -62.57 1.51 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.972 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -137.1 69.53 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.777 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 p -125.08 139.09 54.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.137 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -94.37 110.45 22.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.586 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.1 p -153.84 176.57 12.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.732 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 46.1 m-85 -97.83 152.6 38.19 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.317 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.8 155.71 67.85 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.968 1.779 . . . . 0.0 111.4 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -140.85 177.07 8.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.089 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 168.11 178.59 40.08 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -93.94 150.06 20.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.686 0.279 . . . . 0.0 110.617 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 16.6 pt -108.58 149.99 11.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.516 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.9 t -76.24 140.94 41.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.748 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 63.3 mttp -89.2 162.26 16.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.503 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 3.0 t70 75.37 1.89 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.645 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -114.36 155.33 26.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.474 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -64.58 143.77 57.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.379 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -55.37 -39.59 70.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' A' ' 144' ' ' ASP . 6.7 tt -65.59 -42.59 93.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.709 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.452 ' N ' ' CG2' ' A' ' 143' ' ' ILE . 43.0 t0 -63.51 -33.14 74.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.692 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 13.8 m -78.27 -42.01 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.559 ' SG ' ' CG ' ' A' ' 180' ' ' PHE . 8.5 t -65.12 -50.53 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.021 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 148' ' ' ARG . 9.7 tt -61.11 -38.49 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.146 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.428 ' N ' ' CG2' ' A' ' 147' ' ' ILE . 17.0 ttm105 -71.32 -38.98 71.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.903 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 153' ' ' GLU . 85.3 tt0 -78.28 -29.82 48.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 110.445 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.3 t -74.17 -52.48 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.783 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -28.2 69.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.668 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -76.33 -41.11 49.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.714 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 149' ' ' GLU . 0.4 OUTLIER -75.35 -53.17 9.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.428 HG23 HD12 ' A' ' 154' ' ' ILE . 28.7 mm -71.0 -31.5 45.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 0.0 110.422 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 92.2 -14.31 64.88 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -115.96 133.09 56.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.725 0.298 . . . . 0.0 110.337 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 43.7 p-10 -96.61 125.1 40.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.036 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.13 110.43 20.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.078 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.0 p -91.0 -55.21 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 0.0 111.054 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -58.97 -39.15 80.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.307 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 184' ' ' GLY . 39.2 m-85 -90.82 18.74 6.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.052 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 162' ' ' ILE . 0.3 OUTLIER -87.4 134.6 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.985 0.421 . . . . 0.0 110.256 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -92.27 140.5 29.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.408 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -70.56 -66.18 0.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.339 0.59 . . . . 0.0 110.881 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -133.02 66.89 1.55 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.123 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.624 ' NE2' ' NE1' ' A' ' 234' ' ' TRP . 8.5 tp60 -127.89 107.45 9.87 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.815 0.34 . . . . 0.0 110.606 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -167.23 159.31 12.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.181 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.2 mt -124.05 138.98 51.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.788 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -95.08 136.29 35.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.187 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.499 ' C ' HD21 ' A' ' 171' ' ' ASN . 0.0 OUTLIER -152.73 121.39 6.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.845 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.499 HD21 ' C ' ' A' ' 170' ' ' ARG . 3.0 m120 -112.17 112.51 24.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.119 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.5 tt -109.3 132.46 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.261 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.494 ' C ' ' H ' ' A' ' 175' ' ' LYS . 24.4 mt-30 52.32 46.07 27.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.232 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.02 -3.27 1.66 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.494 ' H ' ' C ' ' A' ' 173' ' ' GLN . 3.7 tptm -84.14 125.58 32.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.79 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -75.42 123.88 26.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.744 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -140.12 128.99 23.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.566 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 107' ' ' GLY . 26.0 ttmt -120.96 142.29 49.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.013 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.8 mm -123.15 121.29 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.598 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.559 ' CG ' ' SG ' ' A' ' 146' ' ' CYS . 0.2 OUTLIER -98.44 127.47 44.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.387 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.2 mt -82.93 124.27 30.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 3.1 tt -143.71 101.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.411 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.4 t -117.54 154.23 31.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.626 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.51 ' O ' ' CD1' ' A' ' 161' ' ' TYR . . . 106.95 10.07 28.94 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' A' ' 113' ' ' GLU . 1.5 m -67.97 138.99 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.659 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 32.9 t -66.81 120.69 13.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.429 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -85.44 -16.62 39.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.131 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 85.4 t -69.86 -28.13 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.566 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.52 ' CE1' ' O ' ' A' ' 190' ' ' ASN . 63.1 t80 -88.7 133.87 34.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.632 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.52 ' O ' ' CE1' ' A' ' 189' ' ' PHE . 33.5 p-10 -90.79 131.42 36.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.444 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -127.67 158.57 37.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.391 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -139.48 156.57 71.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.308 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.4 142.89 46.25 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.309 2.006 . . . . 0.0 112.09 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -131.02 69.8 1.47 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.458 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.478 ' CG2' ' N ' ' A' ' 196' ' ' ARG . 11.9 m -130.23 -138.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.478 ' N ' ' CG2' ' A' ' 195' ' ' VAL . 78.4 mtm-85 -52.75 146.03 11.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.029 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -74.38 108.88 7.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.373 . . . . 0.0 110.771 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.511 ' CG ' ' H ' ' A' ' 199' ' ' ILE . 1.0 OUTLIER -150.61 -113.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.54 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.533 ' CG2' ' NE2' ' A' ' 122' ' ' GLN . 19.5 tt -130.39 136.7 57.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.471 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 200' ' ' ASP . 39.8 p-10 -102.68 114.54 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.736 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -133.33 123.18 24.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.389 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.97 146.76 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.421 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -165.89 140.83 4.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.601 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.38 112.91 26.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.481 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -104.83 151.7 23.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.625 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.03 127.79 34.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.4 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.05 -42.77 91.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.994 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -36.65 71.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -59.71 -46.34 89.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.175 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 45.4 pt -71.24 -19.53 20.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.144 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 44.0 m -82.5 -22.07 35.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.796 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -111.37 28.41 8.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 8.8 t -81.44 1.78 31.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.689 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 74.4 mtp -54.84 -30.69 58.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.383 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -67.61 -31.92 72.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.56 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -105.18 121.28 43.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.542 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.4 m -92.06 -11.59 35.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.464 ' N ' HD21 ' A' ' 218' ' ' ASN . 2.2 m120 -55.65 -34.35 64.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.606 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.5 mt -125.65 134.05 67.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.506 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -133.65 156.08 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.569 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -113.97 135.95 53.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.364 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -101.49 -72.52 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.187 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.67 -50.86 55.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.177 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.4 mm -56.48 -47.45 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 110.679 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -52.25 -43.2 64.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.568 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.5 m -69.06 -38.37 79.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.983 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 55.4 mtt -88.37 -2.9 58.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.863 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' MET . . . . . 0.483 ' N ' ' O ' ' A' ' 224' ' ' ILE . 5.0 ttp -58.62 -44.04 89.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.721 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.441 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 23.0 mtm-85 -56.14 -64.1 2.67 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.312 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 20.1 Cg_endo -61.3 -51.11 4.73 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.28 1.987 . . . . 0.0 112.423 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -46.86 81.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.2 t -65.77 -38.54 89.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.026 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 49.2 ttm -60.52 -48.34 82.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.24 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.624 ' NE1' ' NE2' ' A' ' 166' ' ' GLN . 1.4 t-105 -70.54 -42.92 70.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.53 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.11 -37.87 81.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.379 . . . . 0.0 110.597 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -60.47 -36.15 77.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.796 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -69.28 -37.06 77.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.781 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -64.23 -29.58 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.052 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' A' ' 243' ' ' ASN . 88.5 mtt180 -72.57 -41.23 65.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 111.028 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.497 ' O ' ' ND2' ' A' ' 243' ' ' ASN . 50.9 mt-30 -58.32 -38.66 77.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.26 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 81.6 mt -70.94 -28.14 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.547 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -58.8 -38.14 77.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.732 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 240' ' ' GLN . 0.5 OUTLIER -84.56 108.31 17.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.941 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -66.49 -28.33 68.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.334 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 . . . . . 0 C--N 1.333 -0.139 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.667 179.874 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.1 pttp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -146.96 48.46 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.243 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 m -79.45 -30.47 42.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.957 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -100.98 108.47 54.51 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.596 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.73 127.4 6.31 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.93 1.753 . . . . 0.0 112.325 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 t -132.71 145.93 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.052 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' A' ' 107' ' ' GLY . 46.3 ttp85 -135.49 150.58 49.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.705 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.402 ' O ' ' NH1' ' A' ' 106' ' ' ARG . . . -129.89 154.37 20.46 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -102.22 149.88 23.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.955 0.407 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -141.86 95.13 2.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.307 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.87 131.4 67.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 121.248 0.547 . . . . 0.0 111.573 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.6 159.39 39.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.92 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -55.95 151.35 11.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.864 0.364 . . . . 0.0 110.373 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -51.07 -40.47 58.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.809 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.637 HD21 ' NZ ' ' A' ' 242' ' ' LYS . 28.4 t-20 -80.55 -1.21 41.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 0.0 110.554 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mt 53.41 56.04 7.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.665 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 p -122.23 -16.27 7.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.745 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -138.18 156.5 47.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.541 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 205' ' ' PHE . 30.0 mm -112.75 136.07 50.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.049 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.517 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 1.7 tt -102.8 110.91 22.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 111.194 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 120' ' ' LEU . 1.4 mm? -111.93 174.17 6.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.175 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 m -143.88 169.99 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.203 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.542 HE22 ' H ' ' A' ' 128' ' ' SER . 55.0 tp60 -109.04 134.44 51.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -125.37 -145.37 6.49 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.67 -43.26 65.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 110.748 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -43.52 151.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.947 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.7 p -61.46 -83.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.025 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -126.67 70.15 1.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.475 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.542 ' H ' HE22 ' A' ' 122' ' ' GLN . 46.5 m -125.8 153.28 44.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.589 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 129' ' ' TRP . 0.9 OUTLIER -115.75 119.14 35.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.379 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 76.1 p -163.71 173.03 13.38 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.882 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 43.3 m-85 -83.29 152.05 63.87 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.207 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.93 142.93 39.8 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.848 1.699 . . . . 0.0 111.831 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -146.41 171.7 14.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.238 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.29 -169.53 34.33 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.97 137.23 35.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.664 0.268 . . . . 0.0 110.57 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 pt -114.02 157.1 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.384 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.9 m -64.59 144.15 57.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.435 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -92.17 173.88 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.636 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 59.63 37.28 22.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -136.36 162.51 32.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.253 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -79.4 146.03 33.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.466 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -49.34 -37.75 25.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.556 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 50.0 mt -72.68 -43.84 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -62.31 -41.93 98.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.585 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -73.87 -39.13 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.934 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.593 ' SG ' ' CE1' ' A' ' 180' ' ' PHE . 43.9 t -69.82 -56.82 6.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.043 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 148' ' ' ARG . 2.1 tp -54.44 -39.98 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.005 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.444 ' N ' ' CG2' ' A' ' 147' ' ' ILE . 31.6 ttm180 -66.27 -39.38 89.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.908 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -76.91 -27.54 54.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.0 110.44 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.12 -54.56 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.846 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -26.72 67.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.903 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -84.75 -34.84 22.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 110.995 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -72.6 -60.48 2.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.677 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 21.8 mt -82.52 -33.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.776 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 104.5 -12.89 51.09 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -103.65 130.73 51.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.672 0.272 . . . . 0.0 110.455 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -104.49 148.46 26.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.985 0.421 . . . . 0.0 111.048 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.0 mt -106.27 115.22 29.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.815 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.31 -61.73 1.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.391 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.518 ' OD1' ' CD2' ' A' ' 161' ' ' TYR . 43.4 p-10 -104.47 0.43 28.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.105 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.518 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 68.3 m-85 -105.3 14.9 28.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.65 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.1 tp -93.22 130.93 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.601 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 181' ' ' LEU . 77.9 m-20 -72.03 153.54 41.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.364 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -85.57 -67.38 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.497 0.665 . . . . 0.0 111.123 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -132.06 70.46 1.47 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.759 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -132.78 107.62 8.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.494 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.5 165.85 20.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.81 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 34.2 pt -128.53 146.3 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.537 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.48 135.01 54.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.265 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -159.74 137.38 9.89 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.661 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -102.93 112.99 26.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.352 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 54.9 mt -99.02 120.78 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.33 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 175' ' ' LYS . 65.2 mt-30 54.0 49.69 18.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.79 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 69.52 -17.28 0.65 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.511 ' H ' ' C ' ' A' ' 173' ' ' GLN . 42.4 mttt -85.4 134.04 34.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -75.16 131.56 40.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.594 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -134.98 105.24 6.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.608 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -100.05 130.64 46.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.334 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.96 127.51 61.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 111.081 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.593 ' CE1' ' SG ' ' A' ' 146' ' ' CYS . 0.3 OUTLIER -99.31 133.33 43.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.734 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.41 ' O ' ' OD2' ' A' ' 163' ' ' ASP . 8.8 mt -87.75 137.05 32.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.991 0.424 . . . . 0.0 111.285 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.57 106.64 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.904 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 p -125.24 151.33 46.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.402 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 117.29 -12.49 14.1 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 4.4 m -53.29 146.68 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 34.9 p -77.75 127.75 32.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.795 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -83.06 -10.79 58.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.43 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 25.2 m -72.52 -16.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.249 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -95.92 134.32 39.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.308 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -88.81 127.32 35.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.632 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -95.72 128.14 42.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.428 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -105.13 152.8 39.79 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.311 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.53 141.68 28.48 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.305 2.003 . . . . 0.0 112.436 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -149.51 78.18 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.98 177.07 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.756 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -51.73 154.05 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.113 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -46.25 102.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.287 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -150.81 -113.45 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.255 0.55 . . . . 0.0 110.407 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.5 mm -124.99 126.34 71.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.239 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.19 103.94 13.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.498 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.499 ' NZ ' ' OE2' ' A' ' 203' ' ' GLU . 61.4 tttm -163.69 134.87 4.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.012 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.1 pt -120.9 154.24 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.241 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.499 ' OE2' ' NZ ' ' A' ' 201' ' ' LYS . 44.0 mt-10 -152.44 138.19 17.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.412 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.51 103.2 13.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.348 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.419 ' CE2' ' CE3' ' A' ' 129' ' ' TRP . 60.8 m-85 -105.93 152.72 22.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.904 0.383 . . . . 0.0 110.842 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -81.96 139.25 34.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.643 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -51.71 -55.51 19.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -56.61 -43.36 80.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.82 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -57.58 -48.4 79.48 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.883 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 87.5 mt -55.11 -25.11 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.482 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -89.89 -13.79 35.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -104.38 15.86 27.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.071 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 15.3 p -81.29 10.9 4.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 110.74 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 70.8 mtm -53.96 -35.29 61.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.315 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -55.87 -34.53 65.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.449 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -100.07 109.04 21.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.557 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 82.5 p -92.78 -23.15 18.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.709 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -56.5 -42.4 78.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.542 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.1 mt -126.16 110.34 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.473 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -139.44 148.91 43.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.559 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 221' ' ' TYR . 0.0 OUTLIER -117.05 117.84 30.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.459 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -82.81 -35.72 26.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.042 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 10.7 mp -53.69 -48.64 69.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.002 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 tp -69.23 -33.87 60.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.85 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -58.85 -41.69 87.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.24 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 68.9 m -67.52 -38.32 84.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.053 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -83.44 2.77 35.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.155 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' MET . . . . . . . . . . . . . 42.1 ttp -52.42 -59.92 3.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.124 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.426 ' O ' ' OG ' ' A' ' 232' ' ' SER . 6.3 mtm-85 -77.5 -51.22 1.94 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.143 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 229' ' ' ARG . 53.6 Cg_exo -49.39 -52.64 8.42 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.099 1.866 . . . . 0.0 112.154 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.34 -36.49 84.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.041 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 229' ' ' ARG . 86.9 p -66.12 -36.33 82.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.824 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 79.3 mmm -67.4 -56.19 10.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.283 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 30.3 m95 -54.75 -57.91 9.66 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.064 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 97.1 mt -51.94 -24.7 6.79 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.41 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -61.42 -44.3 97.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 0.0 110.11 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -64.72 -44.06 91.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.852 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -59.62 -41.14 89.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.018 0.437 . . . . 0.0 110.597 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -63.98 -30.64 71.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 243' ' ' ASN . 42.2 tt0 -62.97 -41.39 99.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.498 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 10.9 mm -63.96 -37.34 79.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.695 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.637 ' NZ ' HD21 ' A' ' 114' ' ' ASN . 70.9 tttt -57.16 -54.13 50.22 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.413 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . 0.425 ' O ' ' OD1' ' A' ' 243' ' ' ASN . 38.0 p30 -90.4 138.96 31.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.535 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.8 -35.65 79.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.637 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.493 -179.962 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 41.3 tttm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -129.23 143.39 50.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.564 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.4 t -126.21 -18.75 4.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.635 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.446 ' CG2' ' O ' ' A' ' 103' ' ' ILE . 10.0 tt -119.21 108.44 40.2 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.278 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.83 130.52 6.73 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.987 1.791 . . . . 0.0 112.206 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -143.83 139.26 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.326 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.518 HH12 ' NZ ' ' A' ' 178' ' ' LYS . 57.7 mtp85 -132.59 149.6 52.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -137.93 -179.29 16.89 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.3 124.21 20.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.223 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 129.99 54.19 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.9 mt -122.88 136.39 59.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.244 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -124.3 153.06 42.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.682 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.456 ' ND2' ' CE2' ' A' ' 204' ' ' TRP . 0.9 OUTLIER -56.16 149.18 16.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.294 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -52.29 -28.71 20.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.899 0.38 . . . . 0.0 110.228 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -95.81 3.46 53.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.371 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.1 mt 51.99 45.18 28.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.368 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.423 ' HG ' ' HZ3' ' A' ' 117' ' ' LYS . 2.2 t -107.29 -21.47 12.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.587 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.423 ' HZ3' ' HG ' ' A' ' 116' ' ' SER . 9.3 mttp -140.11 176.51 8.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.3 tt -139.32 134.28 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.222 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.526 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 3.0 tt -82.69 126.98 32.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.012 0.434 . . . . 0.0 111.572 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.1 mt -133.23 152.2 51.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.466 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.41 170.99 13.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.615 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -99.48 143.53 29.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.94 -164.85 12.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.522 ' OG1' ' NH2' ' A' ' 196' ' ' ARG . 38.9 m -44.55 -35.75 2.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.262 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -47.39 156.87 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.151 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.6 t -70.08 -59.16 3.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.853 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -137.21 69.15 1.41 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.986 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 t -128.8 141.51 51.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.578 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -115.6 120.86 40.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.467 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.2 p -164.03 175.61 10.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.958 0.408 . . . . 0.0 110.937 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.526 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 36.7 m-85 -80.58 153.11 73.33 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.332 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.53 153.4 54.96 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.016 1.811 . . . . 0.0 112.175 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.644 ' HE ' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -159.26 -173.92 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.521 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 175.69 -175.55 47.31 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -89.92 147.01 23.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.316 . . . . 0.0 110.712 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 1.1 pp -130.24 156.84 42.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.438 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.0 m -75.63 141.72 42.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.591 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -76.12 167.38 21.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.057 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 59.71 41.59 18.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.512 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -135.45 148.37 49.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -60.7 134.11 56.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.57 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 29.8 p-10 -63.76 -36.67 84.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.876 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.507 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 3.2 mm -60.09 -54.66 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.841 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -64.87 -38.97 92.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 1.1 m -60.58 -39.85 89.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.903 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.585 ' SG ' ' CE1' ' A' ' 180' ' ' PHE . 71.1 m -63.69 -61.57 2.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.281 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.6 tp -60.93 -17.68 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.29 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.0 ttp85 -77.14 -48.41 17.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.704 0.288 . . . . 0.0 111.337 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -74.21 -35.28 63.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.019 0.438 . . . . 0.0 110.595 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.12 -61.07 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.09 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 152' ' ' GLU . 16.3 pttm -58.71 -44.35 90.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.79 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 151' ' ' LYS . 47.0 tp10 -60.01 -45.39 92.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.48 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 133' ' ' ARG . 97.3 mt-10 -73.83 -58.15 3.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.528 ' CG2' ' H ' ' A' ' 156' ' ' PHE . 7.8 tt -71.31 -24.24 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.342 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 151' ' ' LYS . . . 82.89 8.63 85.57 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.528 ' H ' ' CG2' ' A' ' 154' ' ' ILE . 25.9 t80 -151.36 150.84 30.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -128.3 133.73 48.79 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.932 0.396 . . . . 0.0 111.53 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.84 154.35 25.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.741 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.9 p -72.76 -14.51 61.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.023 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -105.35 13.89 29.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.05 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.27 -7.63 59.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.84 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.4 tp -125.81 137.15 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -106.61 156.11 18.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.248 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 3.4 p30 -69.08 -67.81 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.355 0.598 . . . . 0.0 111.052 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -134.43 60.72 1.69 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.111 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -145.27 107.9 4.45 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.556 -0.457 . . . . 0.0 111.013 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -156.36 163.84 39.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.309 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.9 tt -127.56 133.41 67.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -110.58 132.05 54.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.806 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -159.75 136.4 9.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.922 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -109.59 116.06 31.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.289 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 19.1 pt -119.74 150.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.612 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 175' ' ' LYS . 25.9 mt-30 47.11 36.77 4.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.395 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 70.51 -14.65 1.31 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.503 ' H ' ' C ' ' A' ' 173' ' ' GLN . 51.1 mttm -88.51 129.33 35.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 110.907 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -75.08 120.99 21.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.503 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -117.24 125.21 50.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.993 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.518 ' NZ ' HH12 ' A' ' 106' ' ' ARG . 23.5 mtpt -122.44 129.85 52.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.676 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.7 mt -137.72 134.02 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.361 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.585 ' CE1' ' SG ' ' A' ' 146' ' ' CYS . 0.0 OUTLIER -93.27 137.49 32.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.303 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 234' ' ' TRP . 10.8 mt -95.32 125.93 40.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.709 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.14 106.26 3.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.709 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 63.6 p -111.35 154.82 24.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.408 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 99.52 13.23 38.84 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.6 m -88.77 147.33 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.719 0.295 . . . . 0.0 110.554 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 60.5 p -61.96 124.51 20.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.971 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -93.49 -5.56 48.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.579 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.39 -28.29 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.376 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.53 148.93 49.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.237 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -92.56 131.78 37.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.552 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -110.83 138.08 47.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.509 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -140.7 122.77 9.52 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.3 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.27 116.43 4.14 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.79 1.66 . . . . 0.0 112.321 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -106.13 99.78 9.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.328 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 32.0 m -147.42 -160.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.7 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.522 ' NH2' ' OG1' ' A' ' 124' ' ' THR . 12.5 mtp180 -42.72 148.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.614 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -70.95 117.2 12.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.538 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 1.9 tt0 -172.65 -111.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.489 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.514 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 58.9 mt -113.9 118.35 58.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.771 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 200' ' ' ASP . 2.9 p30 -128.47 100.49 5.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.045 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -139.88 138.63 35.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.592 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 36.0 pt -109.16 145.09 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.199 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -156.78 133.55 10.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.301 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' TRP . . . . . 0.456 ' CE2' ' ND2' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -101.21 113.52 26.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.271 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -107.83 148.54 29.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.047 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.73 136.71 43.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.101 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -51.53 -40.11 59.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.56 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -64.44 -39.78 94.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -60.35 -32.79 71.6 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.512 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 98.0 mt -71.84 -33.05 46.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 50.0 m -80.71 -28.41 36.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.636 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -12.11 61.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.585 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 52.5 p -50.91 -26.46 5.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 62.5 mtt -62.47 -35.36 79.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.604 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -69.4 -43.26 73.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.677 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -86.42 116.02 24.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.403 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 70.9 m -96.21 9.86 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.752 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -75.64 -68.93 0.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.505 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.0 tp -132.09 123.57 51.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.524 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -138.12 159.28 42.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.385 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -106.48 101.7 11.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.557 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -66.15 -33.87 76.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.55 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 4.9 tp -55.51 -43.57 75.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.0 mm -86.85 -27.43 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.95 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -53.1 -45.67 68.34 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.744 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.1 m -69.82 -37.86 76.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.776 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 34.5 ttm -78.48 -23.79 46.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 224' ' ' ILE . 46.5 ttp -58.65 -38.74 78.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.457 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 2.2 mmm180 -54.31 -65.51 1.26 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.888 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 28.8 Cg_endo -62.56 -44.1 19.13 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.174 1.916 . . . . 0.0 111.85 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.7 tp -53.06 -35.28 59.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.855 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 33.7 t -72.89 -33.77 66.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.752 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 5.6 ttm -70.59 -59.54 2.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.21 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.409 ' CD1' ' CD1' ' A' ' 181' ' ' LEU . 4.7 t-105 -57.46 -49.32 76.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.946 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 30.0 tp -56.56 -29.02 61.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -41.57 97.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.541 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -57.02 -44.61 83.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.775 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -60.86 -34.71 75.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.966 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -70.44 -36.09 73.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.797 0.332 . . . . 0.0 110.827 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -64.28 -44.89 90.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.736 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.19 -31.13 50.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.821 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -55.91 -26.12 46.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.739 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 243' ' ' ASN . 33.2 p-10 -47.82 139.93 7.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.642 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -101.4 137.21 40.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.545 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.51 179.993 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.4 mttt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -87.18 5.13 39.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.655 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.8 p -73.72 -21.52 60.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.391 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 103' ' ' ILE . 1.3 tt -95.04 110.03 47.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.295 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.8 149.9 23.55 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.835 1.69 . . . . 0.0 112.366 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.21 145.89 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.983 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.543 ' NE ' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -143.59 160.23 41.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.615 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -133.0 161.44 24.12 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 131' ' ' PHE . . . -108.47 120.42 42.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.717 0.294 . . . . 0.0 110.905 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -103.38 126.92 50.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.422 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mt -124.96 129.25 73.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.972 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 3.5 m-85 -115.76 154.26 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.903 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.617 HD22 ' H ' ' A' ' 116' ' ' SER . 40.5 p-10 -60.02 148.84 34.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.556 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -48.74 -29.82 4.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.64 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -87.8 4.61 43.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.756 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.459 ' O ' ' NH1' ' A' ' 239' ' ' ARG . 1.1 mp 41.7 42.66 2.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.519 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.617 ' H ' HD22 ' A' ' 112' ' ' ASN . 0.1 OUTLIER -123.08 -10.4 8.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.18 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.614 ' NZ ' ' CD1' ' A' ' 204' ' ' TRP . 7.7 mtpm? -134.29 168.55 18.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.044 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.38 144.0 35.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 tt -108.25 121.6 45.22 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.826 0.346 . . . . 0.0 111.008 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.0 mt -120.92 158.86 26.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.093 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.93 170.73 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.706 0.289 . . . . 0.0 110.309 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -93.19 119.79 32.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.758 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -96.18 -157.17 31.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.1 t -54.05 -34.73 60.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.435 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -51.47 158.08 0.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.162 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.6 m -65.72 -62.9 1.25 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.028 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -137.07 73.4 1.44 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.844 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -128.47 145.8 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.599 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.418 ' CD2' ' N ' ' A' ' 129' ' ' TRP . 0.1 OUTLIER -108.49 110.81 22.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.441 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.2 m -161.25 172.06 17.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.481 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 108' ' ' ALA . 37.8 m-85 -80.89 151.42 70.66 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.077 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.83 145.65 63.29 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.011 1.807 . . . . 0.0 111.984 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -104.7 171.78 7.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.793 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -174.42 -151.77 8.61 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -133.48 166.94 21.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.766 0.317 . . . . 0.0 110.532 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.3 mt -115.11 136.62 51.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.9 t -76.61 134.64 39.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.447 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -74.41 151.08 39.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.813 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 54.4 41.75 31.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.674 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -149.45 145.9 27.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.392 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -60.11 137.11 58.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.433 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -59.91 -32.35 70.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.517 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 83.9 mt -61.37 -46.51 96.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.541 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -62.37 -37.4 85.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.723 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 47.6 m -72.34 -40.37 67.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.985 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 87.8 m -70.72 -54.69 10.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' A' ' 148' ' ' ARG . 17.4 tt -57.63 -40.99 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.956 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.452 ' N ' ' CG2' ' A' ' 147' ' ' ILE . 67.6 ttt-85 -65.01 -39.5 93.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.945 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -78.67 -28.25 45.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.794 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.01 -51.28 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.814 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -36.68 80.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.937 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -71.75 -36.07 70.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.208 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.422 ' O ' ' OE1' ' A' ' 194' ' ' GLN . 86.6 tt0 -77.71 -59.73 2.66 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.414 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 23.1 mt -71.68 -32.38 45.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.763 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.62 -14.56 61.83 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -112.33 133.58 54.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.764 0.316 . . . . 0.0 110.227 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 48.4 p30 -95.03 151.89 18.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.042 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.5 mt -111.6 110.19 20.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.101 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 91.4 m -90.47 -61.7 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.828 0.347 . . . . 0.0 111.239 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -100.23 -5.98 26.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -98.89 16.75 21.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.829 0.347 . . . . 0.0 110.354 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.5 tt -107.71 137.85 36.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -79.9 147.22 31.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.401 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.525 ' CG ' ' H ' ' A' ' 165' ' ' ASN . 8.6 p-10 -75.62 -64.99 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.395 0.617 . . . . 0.0 111.008 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.525 ' H ' ' CG ' ' A' ' 164' ' ' ASP . 36.5 t30 -131.98 67.84 1.51 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.089 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -129.84 107.49 9.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.322 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -154.73 156.59 36.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.267 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.9 mt -124.62 129.16 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.505 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -99.59 137.62 37.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 tpt85 -159.51 127.65 4.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.607 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -100.29 115.05 29.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.133 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.7 tt -112.67 131.72 63.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.635 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.522 ' C ' ' H ' ' A' ' 175' ' ' LYS . 89.3 mm-40 53.62 43.14 31.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.402 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 63.45 -4.2 1.04 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 173' ' ' GLN . 20.6 tttm -90.66 132.15 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 110.794 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -74.69 119.54 19.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.489 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -129.5 121.99 28.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.573 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 107' ' ' GLY . 55.1 mttp -120.5 144.19 48.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.957 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.76 132.2 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -101.42 123.63 45.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.183 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 13.4 mt -84.01 126.92 33.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.607 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 3.7 pt -145.48 100.9 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.293 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.5 m -114.28 157.2 23.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.515 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 118.63 -6.21 14.17 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.4 m -61.73 153.02 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.301 . . . . 0.0 110.363 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 20.8 t -98.46 132.89 43.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.613 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -73.59 -7.53 52.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.594 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.9 m -69.83 -20.28 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.429 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 190' ' ' ASN . 10.8 t80 -86.2 151.86 23.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.351 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.446 ' N ' ' CD1' ' A' ' 189' ' ' PHE . 47.4 t30 -85.55 110.59 19.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -96.89 124.01 40.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.207 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -140.62 147.43 48.96 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.436 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.93 149.46 42.15 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.139 1.893 . . . . 0.0 112.233 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.422 ' OE1' ' O ' ' A' ' 153' ' ' GLU . 89.0 mt-30 -142.41 78.37 1.62 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.203 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.84 -166.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.536 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -46.84 150.5 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.21 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -56.74 125.46 22.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.957 0.408 . . . . 0.0 110.918 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -171.37 -113.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.08 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -130.46 129.64 64.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.301 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -97.77 108.61 21.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.497 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -137.73 133.89 34.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.422 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.7 tt -121.76 141.82 40.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.169 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -144.84 131.29 19.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.177 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' TRP . . . . . 0.614 ' CD1' ' NZ ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -98.09 101.42 12.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.825 0.345 . . . . 0.0 110.207 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -95.88 136.43 36.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -66.4 131.21 45.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.481 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -62.02 -36.82 82.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.438 ' CD ' ' N ' ' A' ' 208' ' ' LYS . 0.0 OUTLIER -52.44 -42.45 64.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.842 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -65.13 -42.89 93.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.663 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 213' ' ' THR . 96.1 mt -66.56 -26.4 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.554 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 83.9 p -80.49 -59.19 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.77 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.539 ' C ' ' H ' ' A' ' 214' ' ' MET . 97.5 mttt -63.24 -48.3 78.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.764 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 210' ' ' ILE . 18.5 p 51.13 7.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.048 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' MET . . . . . 0.539 ' H ' ' C ' ' A' ' 212' ' ' LYS . 11.9 mmt -73.62 -43.23 60.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.898 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -72.98 -31.54 64.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.867 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -98.25 120.74 39.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 2.8 t -131.51 -29.42 1.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.43 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -54.81 -46.15 74.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.747 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.7 pt -136.14 144.51 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.692 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -139.32 151.41 46.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.582 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -85.82 81.78 8.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.305 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -49.89 -40.3 42.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.071 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 10.5 mt -57.7 -52.63 64.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.038 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 228' ' ' MET . 47.2 mt -78.39 -27.5 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -50.73 -34.8 28.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.648 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.4 m -76.07 -36.73 58.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.966 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 73.3 mtm -95.24 0.74 54.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.972 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' MET . . . . . 0.523 ' N ' ' O ' ' A' ' 224' ' ' ILE . 2.5 ppp? -62.87 -32.81 74.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.971 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.417 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 7.9 mtt180 -67.18 -63.35 2.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.059 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 29.5 Cg_endo -63.79 -40.83 26.82 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.014 1.809 . . . . 0.0 112.124 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.55 -41.79 90.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.559 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.452 ' O ' ' CG ' ' A' ' 236' ' ' ARG . 44.7 t -61.39 -39.09 89.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.587 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 86.3 mtp -73.57 -46.83 44.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -61.21 -51.51 68.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.738 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 41.8 tp -60.73 -35.72 77.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 110.305 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.452 ' CG ' ' O ' ' A' ' 232' ' ' SER . 9.4 mmt85 -64.26 -33.56 76.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.495 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.17 -43.24 74.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.48 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -53.59 -36.84 62.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.647 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.459 ' NH1' ' O ' ' A' ' 115' ' ' LEU . 62.2 mtp85 -57.12 -15.31 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.416 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -80.91 -52.46 7.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.967 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.18 -17.79 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.997 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -50.43 -50.01 53.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.63 151.72 23.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.958 0.409 . . . . 0.0 111.027 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -129.34 165.24 21.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.26 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 51.1 p30 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.485 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -141.46 60.83 1.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.68 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.8 m -73.41 -33.15 64.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.507 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.14 107.71 57.42 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.388 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -82.38 152.62 15.8 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 121.948 1.766 . . . . 0.0 112.33 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.76 127.05 66.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.959 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.59 ' NH1' ' SG ' ' A' ' 145' ' ' CYS . 97.0 mtt180 -132.1 144.11 50.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.292 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -134.71 165.98 24.39 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 131' ' ' PHE . . . -110.1 137.55 47.71 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.137 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.83 120.72 41.72 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.707 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mp -133.15 142.81 41.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.766 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.72 160.58 43.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.101 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -47.23 151.93 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.141 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 185' ' ' VAL . 87.1 mt-10 -63.25 -24.48 67.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.926 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -101.92 13.17 35.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.192 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.515 ' N ' ' CD2' ' A' ' 115' ' ' LEU . 3.9 mm? 50.65 47.25 24.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.109 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.05 -26.49 13.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.1 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.489 ' NZ ' ' OD2' ' A' ' 206' ' ' ASP . 21.2 mtpp -143.93 178.77 7.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.042 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.4 tt -140.74 131.54 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.431 . . . . 0.0 110.49 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.524 ' O ' ' CZ ' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -75.73 121.83 23.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.261 -179.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -125.64 156.35 39.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.7 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.3 m -143.18 173.5 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.52 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -102.34 124.69 48.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.678 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.58 -165.69 36.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 47.0 p -61.1 -25.33 66.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 0.0 110.442 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.405 ' OE1' ' CB ' ' A' ' 128' ' ' SER . 56.7 mt-10 -51.78 165.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.25 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.5 m -67.37 -67.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.021 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -136.99 68.92 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.991 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.405 ' CB ' ' OE1' ' A' ' 125' ' ' GLU . 14.1 m -128.84 143.52 50.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.383 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.468 ' CE3' ' CZ ' ' A' ' 221' ' ' TYR . 9.7 m0 -107.68 118.73 37.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.604 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.6 m -156.24 170.33 22.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.759 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.524 ' CZ ' ' O ' ' A' ' 119' ' ' LEU . 39.9 m-85 -81.21 152.78 71.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.061 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.35 137.92 41.26 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.901 1.734 . . . . 0.0 111.735 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.529 ' NE ' ' OH ' ' A' ' 177' ' ' TYR . 45.1 ptt85 -150.07 -170.3 3.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.177 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.76 177.93 25.12 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -81.21 137.0 35.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.9 tt -125.95 155.38 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.451 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.4 p -64.72 157.51 27.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.633 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 65.1 mttm -89.88 -178.9 5.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.603 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 4.6 t0 77.7 38.15 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.406 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -137.77 158.7 43.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.567 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -84.9 151.38 24.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.398 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 36.3 p-10 -53.19 -37.07 61.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.622 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.526 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 19.1 tt -79.75 -45.73 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.552 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.447 ' N ' ' CG2' ' A' ' 143' ' ' ILE . 57.2 t0 -62.56 -34.51 77.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.827 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.59 ' SG ' ' NH1' ' A' ' 106' ' ' ARG . 6.1 p -64.62 -41.03 96.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.589 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.58 ' N ' ' HG ' ' A' ' 145' ' ' CYS . 0.0 OUTLIER -63.75 -46.04 87.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.298 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.526 ' N ' ' SG ' ' A' ' 146' ' ' CYS . 80.0 mt -59.34 -52.16 64.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.969 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -60.04 -40.77 90.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.548 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -79.06 -28.84 43.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.879 0.371 . . . . 0.0 110.726 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 146' ' ' CYS . 4.1 t -64.8 -50.99 72.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.719 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER -70.13 -44.33 69.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.933 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -47.15 -34.43 6.17 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.399 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 194' ' ' GLN . 78.2 mm-40 -91.61 -62.13 1.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.023 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 81.9 mt -81.04 -33.63 13.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 151' ' ' LYS . . . 100.6 -14.15 59.28 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -125.12 137.89 54.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 50.1 p30 -135.17 156.92 48.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 111.036 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.563 ' N ' ' CD1' ' A' ' 158' ' ' LEU . 4.5 mp -103.01 122.91 45.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.958 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.429 ' HG1' ' H ' ' A' ' 160' ' ' ASP . 24.0 p -90.4 -61.52 1.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.384 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.429 ' H ' ' HG1' ' A' ' 159' ' ' THR . 33.4 p30 -103.3 11.79 36.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.82 17.7 22.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.838 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.6 pt -130.95 149.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.06 0.457 . . . . 0.0 111.184 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -71.2 156.19 39.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.649 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.62 -17.88 21.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.078 0.466 . . . . 0.0 110.936 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -134.34 58.02 1.78 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.362 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -139.38 106.99 5.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.105 0.478 . . . . 0.0 110.679 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -166.09 163.32 18.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.651 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.0 pt -129.24 150.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.399 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 169' ' ' GLU . 1.2 pt-20 -144.18 96.43 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.684 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -127.72 153.0 47.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.468 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -106.15 122.11 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.495 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 58.9 mt -103.72 121.8 55.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.353 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.498 ' NE2' ' CE2' ' A' ' 222' ' ' TYR . 87.2 mt-30 53.48 43.28 31.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.426 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.48 -11.53 12.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -86.42 124.62 32.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.8 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.565 ' N ' HD21 ' A' ' 176' ' ' ASN . 0.0 OUTLIER -74.3 119.99 19.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.464 -178.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.529 ' OH ' ' NE ' ' A' ' 133' ' ' ARG . 0.2 OUTLIER -122.91 104.91 9.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.769 -179.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -108.18 129.89 55.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 54.7 mt -138.44 136.2 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.529 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -95.5 136.35 35.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.75 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.5 mt -84.75 133.32 34.36 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.854 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 65.0 mt -133.05 108.84 13.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.308 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.9 t -117.26 147.94 42.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.563 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 102.74 8.24 43.14 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.428 ' O ' ' CG ' ' A' ' 113' ' ' GLU . 5.6 p -50.04 133.05 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 110.625 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 48.6 m -81.67 143.51 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.424 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -93.46 -9.73 37.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.365 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.64 -28.33 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.664 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -83.04 144.63 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.715 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -81.47 139.89 34.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.257 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -99.63 124.55 44.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.726 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -143.3 109.85 5.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.18 136.76 13.05 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.736 1.624 . . . . 0.0 111.972 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 153' ' ' GLU . 83.6 mt-30 -126.5 111.55 14.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.648 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.63 178.96 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -43.69 146.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.364 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -56.99 102.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.802 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -155.36 -113.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.146 0.498 . . . . 0.0 110.276 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 32.6 mt -122.41 110.04 25.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.069 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 200' ' ' ASP . 32.2 p-10 -106.0 119.88 40.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -136.01 123.9 22.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.33 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.2 tt -107.35 138.77 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -166.05 152.67 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.405 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -115.79 110.96 19.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.446 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -97.52 143.72 27.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.489 ' OD2' ' NZ ' ' A' ' 117' ' ' LYS . 1.1 t0 -70.67 129.64 39.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.368 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -46.54 -33.74 4.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.352 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -64.43 -45.37 87.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.14 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -53.1 -49.09 67.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.965 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.24 -19.76 25.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.805 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.42 -13.02 44.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.488 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -98.41 24.46 7.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.487 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.2 m -49.94 -36.49 28.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.797 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 76.5 mmm -53.69 -38.72 64.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.795 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -67.73 -26.26 66.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.662 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -93.65 133.87 36.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.518 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.4 t -113.96 -42.17 3.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.01 -44.06 97.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.748 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.0 mt -124.66 127.17 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.58 135.35 38.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.37 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.468 ' CZ ' ' CE3' ' A' ' 129' ' ' TRP . 53.5 m-85 -107.35 105.23 15.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.712 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.498 ' CE2' ' NE2' ' A' ' 173' ' ' GLN . 23.2 p90 -90.98 -36.57 14.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.423 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 222' ' ' TYR . 2.5 tp -51.19 -45.45 61.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.313 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 228' ' ' MET . 2.8 tp -73.31 -29.69 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.753 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -56.63 -43.56 80.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.552 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.1 t -63.66 -34.31 77.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.598 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 227' ' ' MET . 0.0 OUTLIER -86.76 -29.36 22.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.702 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' MET . . . . . 0.492 ' N ' ' O ' ' A' ' 224' ' ' ILE . 32.0 ttm -54.99 -40.32 69.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.354 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.499 HH11 ' CG ' ' A' ' 229' ' ' ARG . 0.1 OUTLIER -62.1 -64.08 3.48 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.532 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 37.2 Cg_endo -64.97 -47.88 4.36 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.291 1.994 . . . . 0.0 112.235 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 6.0 tt -51.05 -40.7 58.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.627 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 34.9 t -66.8 -49.05 67.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.04 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 8.3 tpp -60.17 -50.89 71.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.264 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.431 ' O ' ' OE1' ' A' ' 238' ' ' GLN . 13.0 m95 -53.83 -66.83 0.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.112 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 87.3 mt -51.25 -32.32 23.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.027 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -67.35 -29.39 68.93 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.127 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -75.66 -53.64 8.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.751 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.431 ' OE1' ' O ' ' A' ' 234' ' ' TRP . 5.5 mp0 -56.42 -38.57 71.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.8 -26.74 64.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.61 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -72.82 -44.86 60.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.786 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 15.9 mm -66.6 -28.67 44.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.039 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -52.82 -54.07 39.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.607 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . 0.573 ' OD1' ' N ' ' A' ' 243' ' ' ASN . 0.0 OUTLIER -79.54 -45.69 18.77 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.762 0.315 . . . . 0.0 110.871 -179.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -92.46 105.54 17.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.62 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 65.7 t0 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.539 179.876 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.1 ttmm . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.836 0.35 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.0 -32.78 7.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.121 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 103' ' ' ILE . 1.3 tt -117.03 108.17 44.61 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.308 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -79.06 140.86 16.13 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.732 1.622 . . . . 0.0 112.045 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.41 141.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.582 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -142.82 145.65 33.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.73 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -128.86 173.46 19.33 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.455 ' HB1' HD11 ' A' ' 182' ' ' ILE . . . -127.54 127.63 44.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 110.749 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.779 ' C ' HD13 ' A' ' 110' ' ' ILE . . . -111.24 113.48 25.99 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.639 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.815 HD13 ' N ' ' A' ' 110' ' ' ILE . 0.0 OUTLIER -110.29 139.6 33.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.018 0.437 . . . . 0.0 110.654 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -117.95 156.28 28.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.216 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.589 HD22 ' N ' ' A' ' 117' ' ' LYS . 14.4 p30 -58.64 172.68 0.48 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.164 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -64.69 -29.23 70.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.737 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -88.96 4.23 48.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.992 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 mp 43.43 43.29 4.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.452 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.437 ' H ' HD22 ' A' ' 112' ' ' ASN . 8.1 t -124.19 -5.23 7.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.726 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.589 ' N ' HD22 ' A' ' 112' ' ' ASN . 86.8 mttt -138.8 157.55 45.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.839 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 25.4 mm -109.66 140.04 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.99 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.514 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 2.2 tt -101.18 111.03 23.14 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.329 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.833 HD22 ' N ' ' A' ' 120' ' ' LEU . 1.7 mm? -104.44 161.0 14.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.0 m -137.69 162.99 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.314 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -98.26 127.45 44.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.63 -165.4 34.6 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 72.4 p -59.92 -24.07 64.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.362 . . . . 0.0 110.38 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.24 160.37 27.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.3 m -72.81 -102.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.97 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -77.07 72.14 3.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.414 ' C ' ' CG ' ' A' ' 129' ' ' TRP . 54.3 p -128.39 156.13 43.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.351 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.414 ' CG ' ' C ' ' A' ' 128' ' ' SER . 56.5 m95 -151.37 110.79 3.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.671 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.56 176.46 6.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.514 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 29.1 m-85 -77.53 153.72 81.37 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.92 149.61 59.75 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.934 1.756 . . . . 0.0 112.03 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.586 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -149.37 177.74 9.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.841 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 160.51 -174.81 37.26 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -79.17 143.47 35.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.64 0.257 . . . . 0.0 110.475 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.5 pt -110.81 152.52 12.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.465 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.8 m -65.08 145.55 56.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.504 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -93.32 161.13 14.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.413 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 63.0 34.79 13.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.511 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -137.13 145.18 43.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.377 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -60.63 130.72 47.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.127 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -50.55 -37.73 41.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.024 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.2 mt -68.77 -54.39 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.584 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -56.95 -37.52 71.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.304 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -32.05 73.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.144 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.44 ' O ' HG23 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -65.02 -48.9 72.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.682 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.52 -48.47 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.872 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -62.11 -40.49 96.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.527 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -82.61 -20.64 36.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.9 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.639 HG13 HD12 ' A' ' 154' ' ' ILE . 20.5 t -85.05 -51.54 13.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.631 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.27 -28.45 69.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.053 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -81.71 -36.34 28.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.899 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -82.11 -61.54 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.284 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.639 HD12 HG13 ' A' ' 150' ' ' VAL . 15.1 mt -72.79 -33.52 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.559 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.27 -14.3 59.7 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.53 ' CE2' ' O ' ' A' ' 157' ' ' ASP . 62.4 t80 -116.41 143.63 45.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.69 0.281 . . . . 0.0 110.506 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.53 ' O ' ' CE2' ' A' ' 156' ' ' PHE . 44.8 p30 -106.6 140.11 40.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.5 111.14 23.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.037 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.7 p -90.22 -61.61 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.721 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.436 ' OD1' ' CD2' ' A' ' 161' ' ' TYR . 55.6 p30 -107.45 8.74 29.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.564 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.436 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 79.1 m-85 -106.87 15.89 24.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 tt -117.38 140.04 41.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.705 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -69.04 148.19 50.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.151 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 165' ' ' ASN . 22.3 p-10 -76.37 -57.87 3.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.229 0.538 . . . . 0.0 111.54 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 91.0 m-20 -131.41 60.75 1.66 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.421 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.483 ' O ' ' CE1' ' A' ' 180' ' ' PHE . 50.0 tt0 -129.61 107.83 9.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.942 0.401 . . . . 0.0 110.387 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -152.94 162.32 41.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.379 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 24.1 pt -129.55 147.64 33.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -121.25 138.76 54.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.039 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.499 ' NH2' ' O ' ' A' ' 226' ' ' SER . 8.1 tpt180 -159.25 132.97 7.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.559 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -107.19 115.07 29.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 61.2 mt -109.48 129.33 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.442 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 52.1 43.24 30.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.385 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.44 -5.81 3.84 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -89.4 128.34 35.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 111.037 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -75.15 123.28 24.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.759 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -132.98 110.08 10.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.44 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -108.92 141.3 41.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.333 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.17 127.63 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.981 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.483 ' CE1' ' O ' ' A' ' 166' ' ' GLN . 1.9 t80 -95.76 123.99 39.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.481 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.69 126.28 29.52 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.494 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.455 HD11 ' HB1' ' A' ' 108' ' ' ALA . 0.8 OUTLIER -140.95 101.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.205 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.1 p -125.38 161.54 26.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.609 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 120.45 8.03 8.67 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 9.0 m -75.18 161.05 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.716 0.294 . . . . 0.0 110.465 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 62.2 m -104.61 158.46 16.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.804 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.91 -2.24 57.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.397 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 46.5 t -71.07 -27.85 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.508 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.448 ' CE1' ' O ' ' A' ' 190' ' ' ASN . 48.7 t80 -100.19 144.37 29.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.349 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.448 ' O ' ' CE1' ' A' ' 189' ' ' PHE . 9.3 p30 -97.99 125.38 42.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -104.83 126.65 52.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.339 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -127.23 149.68 70.3 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.238 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -70.04 143.57 49.88 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.079 1.853 . . . . 0.0 111.986 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -141.3 83.57 1.88 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.536 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.15 -165.0 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.324 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -45.58 152.61 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.142 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -62.39 109.39 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.617 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 2.2 tt0 -161.87 -113.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.057 0.456 . . . . 0.0 110.62 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.473 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 49.7 mt -113.97 131.91 64.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.429 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.08 101.05 6.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.39 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -137.69 140.97 41.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 119' ' ' LEU . 15.9 tt -113.65 140.38 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.455 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -144.55 120.71 10.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.549 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.09 101.5 13.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.172 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.436 ' HB2' HD23 ' A' ' 120' ' ' LEU . 2.2 m-85 -98.72 134.4 41.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.722 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 207' ' ' PHE . 65.2 t0 -72.17 139.94 48.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.486 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.461 ' N ' ' OD1' ' A' ' 206' ' ' ASP . 76.4 t80 -53.86 -31.21 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.566 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -50.76 -52.65 38.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.507 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -58.81 -43.83 90.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.801 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.491 HD13 HD13 ' A' ' 224' ' ' ILE . 83.8 mt -62.45 -35.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.585 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 60.4 p -68.35 -19.33 64.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.373 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -102.61 20.9 16.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.647 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.81 -31.3 1.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.477 ' C ' ' H ' ' A' ' 216' ' ' LYS . 34.0 mtt -54.75 -29.84 54.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.566 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.528 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 51.2 t80 -72.17 22.71 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.116 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 214' ' ' MET . 1.9 pttp -64.55 138.26 58.31 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.44 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.5 p -126.67 -21.46 4.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.707 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.694 ' OD1' HG22 ' A' ' 219' ' ' ILE . 22.5 t-20 -137.02 -102.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.661 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.694 HG22 ' OD1' ' A' ' 218' ' ' ASN . 17.1 tt -113.67 122.61 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.665 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -132.78 162.02 32.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.277 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.55 ' CD1' ' N ' ' A' ' 221' ' ' TYR . 0.1 OUTLIER -91.35 93.6 9.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.688 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -74.78 -10.05 59.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 79.8 mt -53.25 -51.78 61.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.691 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.491 HD13 HD13 ' A' ' 210' ' ' ILE . 15.6 tt -72.24 -29.94 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.8 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -54.28 -44.19 71.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.644 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.499 ' O ' ' NH2' ' A' ' 170' ' ' ARG . 75.3 m -68.68 -33.05 73.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.704 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 73.8 mtm -92.35 2.01 56.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 224' ' ' ILE . 38.2 ttp -60.56 -38.86 85.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.491 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.444 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -56.47 -64.62 2.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.677 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 17.7 Cg_endo -60.81 -52.02 4.16 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.111 1.874 . . . . 0.0 112.019 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.633 ' C ' HD23 ' A' ' 231' ' ' LEU . 6.4 tt -48.99 -50.84 33.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.594 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 23.0 t -64.19 -59.2 4.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.442 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 86.7 mtp -50.99 -53.5 32.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.746 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -62.04 -50.31 72.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.087 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 41.3 tp -57.78 -30.39 65.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.034 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -34.43 77.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.371 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -65.21 -43.27 92.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.686 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -58.91 -36.15 74.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.772 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -64.29 -32.41 73.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.017 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -65.71 -42.05 91.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 11.1 mm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.808 -179.725 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.838 0.351 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.5 m -92.0 -29.43 16.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.491 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.83 107.83 28.56 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.346 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.36 141.52 11.41 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.025 1.817 . . . . 0.0 112.086 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.464 HG11 ' CZ ' ' A' ' 177' ' ' TYR . 2.7 t -127.86 141.84 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.863 ' HE ' HD12 ' A' ' 136' ' ' ILE . 45.7 ttp85 -123.14 152.1 41.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.458 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -125.94 156.83 19.72 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.492 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -103.55 161.15 14.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 0.0 110.844 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 180' ' ' PHE . . . -141.54 111.34 6.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.458 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.57 133.5 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.202 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.86 158.92 41.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.455 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 116' ' ' SER . 37.4 p-10 -55.3 166.42 0.6 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.296 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -63.9 -25.51 68.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.371 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -90.72 6.08 45.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.793 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.8 mt 45.31 44.23 8.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.623 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.605 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 0.7 OUTLIER -125.01 -2.03 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.639 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -133.29 149.42 51.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.2 mm -115.66 127.21 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.92 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.522 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 1.3 tt -89.03 105.61 17.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.563 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -118.78 157.2 28.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.226 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.35 174.35 11.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.762 0.315 . . . . 0.0 110.407 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -88.58 127.76 35.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.386 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.05 -176.04 39.37 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 124' ' ' THR . 25.5 p -52.25 -35.67 50.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 0.0 110.21 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -55.33 -176.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.003 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.2 m -85.21 -76.85 0.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.834 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -109.54 75.82 0.96 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.677 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.1 t -128.14 142.6 51.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.651 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.594 ' NE1' ' CE1' ' A' ' 221' ' ' TYR . 0.0 OUTLIER -122.94 111.88 17.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.449 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.2 168.76 26.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.808 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 43.5 m-85 -82.08 153.04 69.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.236 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -43.68 148.67 0.82 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.837 1.691 . . . . 0.0 111.45 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -126.43 170.01 12.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.648 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 175.12 177.38 44.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -97.35 147.39 24.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.739 0.304 . . . . 0.0 110.538 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.863 HD12 ' HE ' ' A' ' 106' ' ' ARG . 18.2 tt -133.53 140.56 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.594 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.7 m -71.65 150.33 44.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.501 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -93.84 156.24 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.548 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 56.87 42.66 26.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.436 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -142.48 158.57 43.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.011 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -58.09 124.73 20.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.881 0.372 . . . . 0.0 110.396 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 44.8 p-10 -77.95 -32.36 51.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.006 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.512 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 10.7 tp -65.32 -38.27 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 110.326 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.453 ' N ' HG23 ' A' ' 143' ' ' ILE . 63.6 t0 -72.32 -35.32 68.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.415 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 63.6 m -82.48 -37.43 25.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.01 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 142' ' ' ASP . 66.7 m -65.66 -53.06 46.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.815 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.3 tt -64.52 -35.68 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.19 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -65.81 -42.12 91.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.278 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -76.45 -34.87 58.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.97 0.414 . . . . 0.0 110.826 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.587 HG13 HD12 ' A' ' 154' ' ' ILE . 2.5 t -72.78 -49.8 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.99 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -65.52 -38.57 90.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.281 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -70.64 -37.48 73.77 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.965 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -77.52 -56.75 4.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.122 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.587 HD12 HG13 ' A' ' 150' ' ' VAL . 87.3 mt -71.49 -32.28 45.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.994 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.63 -8.43 78.65 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -104.17 125.99 50.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 110.485 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -91.29 126.58 36.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.765 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 8.5 mt -100.42 110.42 22.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.859 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.9 m -90.67 -61.7 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.703 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.514 ' OD1' ' CE2' ' A' ' 161' ' ' TYR . 49.8 p30 -101.7 2.92 39.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.262 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.514 ' CE2' ' OD1' ' A' ' 160' ' ' ASP . 20.9 m-85 -107.21 16.82 23.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.299 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 162' ' ' ILE . 10.8 tp -114.02 129.6 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 181' ' ' LEU . 91.1 m-20 -73.68 144.69 45.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.227 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -70.08 -66.95 0.53 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.461 0.648 . . . . 0.0 111.345 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -133.35 66.6 1.55 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.025 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.465 ' HG2' HD12 ' A' ' 181' ' ' LEU . 6.2 tt0 -128.51 108.56 10.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.539 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -152.89 157.74 41.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.651 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.5 mt -121.45 136.85 57.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.664 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 170' ' ' ARG . 0.9 OUTLIER -89.77 129.35 36.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.006 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.452 ' N ' ' OE1' ' A' ' 169' ' ' GLU . 12.4 tpp180 -149.93 114.63 5.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.55 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -110.24 116.01 30.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.405 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 15.9 pt -116.99 142.2 31.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.69 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.512 ' C ' ' H ' ' A' ' 175' ' ' LYS . 55.1 mt-30 51.97 41.09 29.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.413 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 63.67 -4.01 1.21 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.512 ' H ' ' C ' ' A' ' 173' ' ' GLN . 2.1 tppp? -89.64 125.23 35.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.409 . . . . 0.0 110.451 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -75.98 128.7 35.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.896 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.464 ' CZ ' HG11 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -139.47 119.3 13.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.457 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 107' ' ' GLY . 24.5 mttp -99.92 135.25 41.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.193 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 33.8 mm -113.03 120.23 62.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.96 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.73 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 3.6 t80 -97.65 120.75 38.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.962 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.465 HD12 ' HG2' ' A' ' 166' ' ' GLN . 14.2 mt -78.98 125.68 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.934 0.397 . . . . 0.0 110.874 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.3 mt -137.23 103.59 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.328 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 94.3 p -110.88 150.36 29.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.497 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 103.52 1.48 46.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.3 p -48.69 149.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 110.704 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.9 m -80.34 101.52 9.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.666 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -67.97 -23.85 65.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.7 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.8 m -74.79 -18.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.682 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -96.33 136.92 36.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.319 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -87.16 133.83 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.517 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -111.89 138.34 48.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.01 109.27 10.67 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.037 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.03 156.68 15.18 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.061 1.841 . . . . 0.0 112.68 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.68 115.07 19.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.089 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 10.4 m -134.3 -168.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.472 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -41.52 146.13 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.321 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -69.94 114.19 7.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.831 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 4.6 tt0 -172.53 -112.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.138 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.436 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 94.7 mt -109.05 120.42 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.519 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 200' ' ' ASP . 33.6 p-10 -123.18 101.07 7.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.28 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -137.04 140.4 42.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.655 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 71.5 mt -99.82 135.49 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.473 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -147.22 117.75 7.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.43 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' TRP . . . . . 0.445 ' CZ2' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -89.63 104.04 16.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.51 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -94.22 132.51 38.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.962 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -68.42 137.48 54.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.421 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -55.23 -43.16 74.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -60.43 -45.04 95.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.126 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 213' ' ' THR . 40.7 mttt -62.34 -38.81 90.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.053 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.549 HG21 HG21 ' A' ' 224' ' ' ILE . 90.1 mt -69.91 -30.06 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 9.6 m -66.88 -33.83 76.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.422 ' O ' ' OG1' ' A' ' 213' ' ' THR . 16.8 ptmt -105.44 -33.08 8.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.044 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 209' ' ' LYS . 17.3 p 55.13 65.25 1.54 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.642 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.468 ' C ' ' H ' ' A' ' 216' ' ' LYS . 12.2 tmm? -58.67 -28.27 65.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.48 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 63.3 t80 -67.7 8.77 0.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.114 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 214' ' ' MET . 20.7 tttt -59.7 120.77 10.13 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.824 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.3 p -132.29 -44.75 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.295 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 218' ' ' ASN . 1.0 OUTLIER -144.2 -39.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.447 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 45.1 pt -126.7 154.99 37.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.712 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.19 142.38 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.294 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.594 ' CE1' ' NE1' ' A' ' 129' ' ' TRP . 0.2 OUTLIER -67.06 118.87 11.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -97.63 -6.07 34.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.71 -42.33 91.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 228' ' ' MET . 35.8 mm -96.66 -40.04 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.278 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -48.3 -53.83 15.93 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.779 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 67.5 m -65.68 -38.99 90.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 110.376 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 27.7 ttm -74.59 -15.03 60.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.384 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' MET . . . . . 0.55 ' N ' ' O ' ' A' ' 224' ' ' ILE . 32.0 ttp -57.96 -42.86 85.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.794 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.445 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 5.3 mtt180 -56.58 -65.22 1.75 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.009 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 24.8 Cg_endo -61.58 -48.31 9.53 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.2 1.933 . . . . 0.0 112.42 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.3 tp -55.94 -39.56 71.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.783 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 37.1 t -63.49 -38.64 91.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.08 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 5.0 mtm -71.48 -52.12 20.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.147 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -55.99 -56.98 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.43 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 95.3 mt -54.86 -31.23 59.41 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.68 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -75.42 -28.7 59.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.389 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -72.87 -55.64 6.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.47 ' C ' ' N ' ' A' ' 240' ' ' GLN . 95.8 mm-40 -53.78 -39.39 65.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.543 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 -47.24 -15.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.355 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.47 ' N ' ' C ' ' A' ' 238' ' ' GLN . 3.0 tp-100 -82.69 -59.21 2.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 241' ' ' ILE . 7.6 tt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.622 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.4 pttt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.879 0.371 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.9 t -73.42 -22.46 60.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.535 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -102.29 109.03 59.37 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.41 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.32 139.03 18.29 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.717 1.611 . . . . 0.0 112.565 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.84 148.13 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.209 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -140.15 158.72 43.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.278 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -138.84 178.18 19.62 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.471 ' O ' ' CB ' ' A' ' 131' ' ' PHE . . . -118.62 163.06 17.37 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.083 0.468 . . . . 0.0 111.289 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.37 113.0 8.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.998 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.488 HG23 HG11 ' A' ' 185' ' ' VAL . 4.0 mp -135.75 131.54 50.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.373 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.37 160.3 43.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.149 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -49.17 139.68 10.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.262 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.34 -30.24 50.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -85.88 6.73 27.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.516 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 mt 47.0 57.71 5.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.385 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.85 -16.67 7.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.933 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -137.07 157.52 46.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.399 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -128.17 132.49 68.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.188 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.509 ' O ' ' CZ ' ' A' ' 131' ' ' PHE . 0.6 OUTLIER -92.06 115.57 28.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.818 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.9 mt -126.34 163.61 22.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.075 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.4 m -143.34 156.69 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.403 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -101.96 150.58 23.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.635 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -134.93 -162.44 9.79 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.0 t -52.22 -27.63 15.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.773 0.321 . . . . 0.0 110.649 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.545 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 53.7 mp0 -55.27 153.7 6.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.189 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.7 t -68.23 -84.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.957 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -113.12 69.29 0.69 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 m -128.43 147.97 50.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.521 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.451 ' CD1' ' N ' ' A' ' 129' ' ' TRP . 1.3 m95 -133.77 116.3 15.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.26 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.448 ' OG ' HD13 ' A' ' 223' ' ' LEU . 0.7 OUTLIER -153.52 167.66 28.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.0 111.081 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.509 ' CZ ' ' O ' ' A' ' 119' ' ' LEU . 41.2 m-85 -77.5 153.9 81.49 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.508 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -41.46 144.76 0.68 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.791 1.661 . . . . 0.0 111.399 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.432 ' CZ ' ' OH ' ' A' ' 177' ' ' TYR . 7.9 ptm180 -139.01 174.85 10.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.747 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.59 177.16 47.68 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 110.23 21.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.711 0.291 . . . . 0.0 110.511 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.9 tt -128.1 136.48 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.541 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.5 m -64.78 157.39 27.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.594 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 22.8 mttp -93.09 178.09 5.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.722 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 6.8 t0 77.07 28.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.492 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -133.11 156.07 48.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.367 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.416 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 71.0 m-80 -58.81 127.66 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.623 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.491 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 67.4 m-20 -73.2 -39.24 65.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.155 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 144' ' ' ASP . 13.6 tt -61.82 -46.58 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.739 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.561 ' N ' HG23 ' A' ' 143' ' ' ILE . 18.4 t70 -68.64 -39.21 80.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.388 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 141' ' ' ASN . 89.0 m -72.92 -35.63 67.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.55 ' SG ' ' CD2' ' A' ' 180' ' ' PHE . 34.8 m -61.45 -53.96 49.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.721 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 83.9 mt -59.1 -41.64 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.729 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -64.74 -41.34 96.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.91 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.03 -31.6 61.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.957 0.408 . . . . 0.0 110.373 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.671 HG13 HD12 ' A' ' 154' ' ' ILE . 2.6 t -73.72 -47.97 41.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.088 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -23.59 63.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.584 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -78.39 -40.69 35.37 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.641 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.434 ' OE1' HG13 ' A' ' 195' ' ' VAL . 77.4 mm-40 -83.69 -58.01 2.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.459 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.671 HD12 HG13 ' A' ' 150' ' ' VAL . 90.0 mt -72.36 -33.67 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.803 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.27 -13.82 64.18 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.473 ' CD2' ' CE2' ' A' ' 189' ' ' PHE . 51.8 t80 -110.9 133.65 53.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.774 0.321 . . . . 0.0 110.223 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -96.81 141.76 29.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.138 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.7 mt -111.92 110.39 20.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.131 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.1 m -91.07 -62.02 1.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.425 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -106.37 1.74 25.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.036 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -99.92 16.46 23.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.576 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.585 ' HA ' HG23 ' A' ' 182' ' ' ILE . 7.4 tt -125.59 136.76 59.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.702 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -70.99 144.1 50.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.681 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.33 -28.74 15.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.478 . . . . 0.0 111.197 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -133.98 59.35 1.74 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.317 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -149.34 108.12 3.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.966 0.412 . . . . 0.0 110.116 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -159.9 158.43 30.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.385 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 169' ' ' GLU . 85.2 mt -133.59 155.58 40.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.714 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.475 ' N ' HG22 ' A' ' 168' ' ' ILE . 1.7 tm-20 -102.73 137.22 41.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.029 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 177' ' ' TYR . 64.4 mtt180 -140.82 112.18 7.35 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.923 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 175' ' ' LYS . 49.5 t-20 -119.72 111.78 18.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.431 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.467 HG22 ' HG3' ' A' ' 173' ' ' GLN . 62.3 mt -119.38 139.09 47.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.376 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.467 ' HG3' HG22 ' A' ' 172' ' ' ILE . 91.0 mt-30 53.16 36.95 23.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.634 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.48 -5.0 11.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 171' ' ' ASN . 49.4 mttp -85.29 119.46 25.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 0.0 110.404 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.1 118.77 19.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.903 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.432 ' OH ' ' CZ ' ' A' ' 133' ' ' ARG . 3.8 m-85 -131.99 109.17 9.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.566 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 107' ' ' GLY . 0.6 OUTLIER -102.78 139.74 37.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.75 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.9 mt -136.67 128.35 43.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.961 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.55 ' CD2' ' SG ' ' A' ' 146' ' ' CYS . 1.8 p90 -93.08 127.65 38.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.356 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' A' ' 168' ' ' ILE . 24.9 mt -74.01 139.86 45.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.082 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.585 HG23 ' HA ' ' A' ' 162' ' ' ILE . 59.9 mt -136.41 107.64 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.127 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 79.9 p -119.03 158.03 26.63 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.876 0.37 . . . . 0.0 110.483 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.68 16.43 48.88 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.488 HG11 HG23 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -94.36 115.73 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.038 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 54.1 m -63.3 151.38 40.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.415 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -99.41 6.29 46.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.354 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.15 -20.64 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.353 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 189' ' ' PHE . 1.3 p90 -99.72 128.03 45.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.913 0.387 . . . . 0.0 110.83 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -125.44 134.17 52.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.393 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.405 ' CZ ' HG23 ' A' ' 154' ' ' ILE . 3.5 p90 -112.15 159.27 18.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.588 ' N ' ' CD ' ' A' ' 192' ' ' LYS . 0.0 OUTLIER -105.19 161.49 22.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.262 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -38.34 116.13 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.918 2.412 . . . . 0.0 112.644 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -145.95 69.7 1.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.028 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.681 HG12 ' N ' ' A' ' 196' ' ' ARG . 38.7 t -139.67 173.61 10.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.638 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.681 ' N ' HG12 ' A' ' 195' ' ' VAL . 36.7 mtt85 -52.42 148.94 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.536 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.9 105.72 0.18 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.495 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 0.9 OUTLIER -171.97 -113.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.406 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.495 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 3.5 mm -123.57 120.03 58.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.246 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -129.77 111.75 12.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.818 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -142.06 128.01 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.234 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.13 136.14 38.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -150.82 126.66 10.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.324 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.13 110.4 22.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.408 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -103.92 150.83 23.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.022 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -65.82 124.4 22.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.867 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -46.04 -35.37 4.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.952 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -56.02 -32.87 64.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.636 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -48.31 -51.46 25.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.1 mt -66.41 -38.74 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 44.0 m -66.75 -45.04 79.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.796 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 214' ' ' MET . 28.8 mttt -56.72 -18.73 13.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.516 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 3.4 m -66.02 56.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.558 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 212' ' ' LYS . 48.8 mtt -95.51 -72.8 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.846 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.15 -9.92 54.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -77.4 106.74 9.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.88 0.371 . . . . 0.0 110.593 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 22.8 t -95.87 -14.08 23.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.646 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -44.4 -62.9 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 219' ' ' ILE . 18.7 tt -137.92 130.23 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.864 0.364 . . . . 0.0 111.072 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -138.93 147.62 42.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.371 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -108.69 86.22 2.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.542 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -50.5 -23.27 2.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.448 HD13 ' OG ' ' A' ' 130' ' ' SER . 75.4 mt -50.68 -57.18 8.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 228' ' ' MET . 76.7 mt -109.7 -28.53 2.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.857 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -53.3 -43.85 67.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.93 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.7 m -72.1 -42.23 66.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 227' ' ' MET . 0.0 OUTLIER -86.98 3.11 47.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.142 -179.541 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 228' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 224' ' ' ILE . 28.0 ttp -51.39 -31.69 23.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.052 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.454 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 2.2 mpp_? -66.76 -65.84 1.48 Allowed Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.345 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 10.3 Cg_endo -53.48 -39.21 83.0 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.039 1.826 . . . . 0.0 111.92 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.8 tt -68.67 -39.41 80.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.539 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 78.5 p -70.46 -34.21 72.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.751 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 13.7 mmt -70.85 -50.7 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.059 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -55.63 -57.35 12.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.859 0.361 . . . . 0.0 110.93 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -57.14 -25.83 59.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.047 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 -57.65 -42.73 84.06 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.066 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -60.8 -40.51 92.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.701 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -63.59 -30.97 72.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -73.09 -32.35 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.621 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.07 -40.55 85.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.687 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 13.5 mm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.698 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.745 0.307 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.7 m -73.57 -21.98 60.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.42 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.9 mt -105.41 107.7 59.75 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.459 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.98 118.84 3.1 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 121.994 1.796 . . . . 0.0 112.154 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.42 141.51 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.982 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -137.19 141.65 42.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.001 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.2 146.77 17.42 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 131' ' ' PHE . . . -100.25 119.22 38.05 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.886 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -109.13 120.55 42.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.431 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mt -127.3 122.84 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.112 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -126.62 161.42 28.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.82 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -61.05 177.87 0.3 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.595 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -61.26 -39.52 90.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.05 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -123.87 39.55 3.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.746 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 235' ' ' LEU . 5.9 mp 51.05 36.57 15.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 93.2 p -67.08 -34.34 77.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -151.05 161.76 42.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.873 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.6 mm -118.89 123.14 71.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.537 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 4.5 tp -80.41 115.09 19.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.319 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.3 mt -123.08 157.23 33.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.615 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.6 163.36 33.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 0.0 110.406 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -93.69 130.46 39.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.634 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -100.91 -171.24 28.77 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.0 t -56.74 -29.41 62.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.625 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -54.94 -172.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.223 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.3 t -86.04 -120.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.716 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -81.21 71.14 8.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.812 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 m -128.3 147.6 50.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -126.49 122.29 34.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.385 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.1 t -166.39 166.42 16.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.946 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.537 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 39.4 m-85 -73.38 152.52 90.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.006 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.22 154.9 51.91 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.032 1.821 . . . . 0.0 112.196 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -131.6 172.16 12.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.206 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 169.21 179.02 40.92 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.7 mttm -101.88 154.64 18.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 pt -129.3 156.0 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.702 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.3 t -82.78 145.23 29.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.554 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -86.91 178.94 6.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.541 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 66.45 33.32 6.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.511 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -141.71 155.56 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.342 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -64.81 142.8 58.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.47 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.48 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 74.6 m-20 -58.32 -38.1 76.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 144' ' ' ASP . 20.8 tt -67.03 -39.1 82.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.773 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.45 ' N ' HG23 ' A' ' 143' ' ' ILE . 95.0 m-20 -66.86 -39.88 87.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.727 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 80.6 m -66.68 -42.53 86.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.771 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.576 ' SG ' ' CD2' ' A' ' 180' ' ' PHE . 64.9 m -62.5 -48.15 80.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.464 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 97.1 mt -60.45 -40.99 85.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.954 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -58.39 -44.14 88.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.003 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.431 ' O ' ' OE2' ' A' ' 153' ' ' GLU . 81.2 mm-40 -78.09 -37.19 46.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.885 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.461 HG11 HD13 ' A' ' 158' ' ' LEU . 2.6 t -70.34 -50.41 46.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.788 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -60.52 -29.51 69.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.559 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -80.32 -45.45 17.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.823 0.344 . . . . 0.0 110.652 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -70.41 -58.68 3.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.22 -179.418 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 154' ' ' ILE . 1.6 mp -72.35 -32.97 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 110.98 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.34 -13.66 61.39 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -119.69 135.04 54.99 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.854 0.359 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -92.61 128.88 38.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.725 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.766 ' N ' HD12 ' A' ' 158' ' ' LEU . 6.2 mp -91.73 113.3 25.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.547 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.5 p -90.02 -54.84 3.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 160' ' ' ASP . 57.0 t0 -105.0 -17.46 14.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.642 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -85.48 20.65 1.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.666 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.4 tt -117.91 136.93 53.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.494 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.54 152.95 43.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.369 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 165' ' ' ASN . 1.2 p30 -75.47 -66.02 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.384 0.612 . . . . 0.0 111.024 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.454 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 67.7 m-80 -130.21 67.72 1.47 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.171 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.53 ' HG3' HD12 ' A' ' 181' ' ' LEU . 2.4 tp-100 -132.16 107.13 8.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.901 0.381 . . . . 0.0 110.688 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.516 ' CD2' ' OE2' ' A' ' 169' ' ' GLU . 45.8 p90 -156.31 154.04 29.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.355 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 234' ' ' TRP . 6.6 tt -123.86 137.87 55.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.516 ' OE2' ' CD2' ' A' ' 167' ' ' PHE . 3.9 mp0 -116.69 133.42 56.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.036 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -160.23 148.43 16.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.987 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.97 112.29 24.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.997 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.4 pt -120.97 152.48 24.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.769 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 175' ' ' LYS . 42.0 mt-30 50.9 32.82 7.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.572 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.33 -25.25 0.72 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 173' ' ' GLN . 41.7 tttt -84.96 137.36 33.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.841 0.353 . . . . 0.0 110.816 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 176' ' ' ASN . 9.1 p-10 -74.94 131.97 41.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.037 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.14 115.48 13.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.494 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -108.37 138.22 45.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.7 mt -137.19 134.74 47.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.15 0.5 . . . . 0.0 111.816 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.576 ' CD2' ' SG ' ' A' ' 146' ' ' CYS . 4.4 t80 -100.26 122.36 42.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.783 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.53 HD12 ' HG3' ' A' ' 166' ' ' GLN . 25.8 mt -69.85 125.95 28.26 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.468 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 3.1 mm -130.58 103.15 7.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.301 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.8 t -130.4 153.23 48.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.625 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 107.31 -1.68 34.92 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 3.8 m -57.72 148.12 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.47 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.71 115.79 17.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.691 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -69.84 -22.03 63.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.57 -8.1 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.265 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -102.36 122.23 43.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.262 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -87.77 134.88 33.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.516 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -99.01 134.59 41.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.62 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.14 156.52 38.23 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.177 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.13 123.8 11.03 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.286 1.991 . . . . 0.0 112.027 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -147.78 69.65 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.766 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.04 -177.88 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.147 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -42.97 148.91 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.11 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -73.38 102.11 3.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 0.0 110.589 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -157.89 -113.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.119 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 57.3 mt -126.58 102.95 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.06 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -131.27 139.1 49.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.92 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -144.26 141.33 29.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.354 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 4.1 pt -102.9 128.5 55.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.76 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -158.03 135.82 10.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.256 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.28 104.49 16.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.498 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -83.81 125.81 32.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.736 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.04 132.44 49.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.266 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -51.13 -37.01 43.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.669 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.1 -36.7 80.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.039 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -59.69 -49.85 76.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.782 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 11.8 mt -56.35 -48.13 80.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.738 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 213' ' ' THR . 5.0 m -60.49 -32.65 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -73.29 20.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.757 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' THR . . . . . 0.482 ' H ' ' C ' ' A' ' 211' ' ' SER . 1.3 t -53.36 -31.83 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.556 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 10.8 tpp -47.44 -31.03 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.727 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.522 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 63.1 t80 -87.9 20.38 3.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.763 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 213' ' ' THR . 23.0 pttm -58.61 135.65 57.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.666 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 4.0 m -98.83 -45.53 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -163.59 16.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.682 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 17.1 tt -125.48 137.62 57.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.448 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -134.67 142.1 46.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -66.21 154.15 40.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.059 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -100.26 -73.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.9 tt -74.1 -56.43 4.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.1 mt -58.05 -32.5 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.61 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.459 ' CG ' ' N ' ' A' ' 226' ' ' SER . 0.1 OUTLIER -43.73 -57.9 2.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.393 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.459 ' N ' ' CG ' ' A' ' 225' ' ' ASN . 79.6 p -87.13 -27.81 22.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.435 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 65.9 mtp -84.95 1.7 46.2 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.95 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 224' ' ' ILE . 13.6 ttp -51.28 -37.11 45.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.965 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.459 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -64.9 -65.5 1.91 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.5 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 10.7 Cg_endo -55.42 -44.56 47.47 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.266 1.978 . . . . 0.0 112.258 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 231' ' ' LEU . 0.2 OUTLIER -52.56 -50.99 61.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.171 0.51 . . . . 0.0 110.155 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 28.8 p -71.39 -37.24 71.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.165 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 34.7 ttm -67.25 -62.03 1.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.261 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.622 ' CD1' HD12 ' A' ' 168' ' ' ILE . 45.4 m95 -45.88 -60.85 2.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.82 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.467 ' HB3' HD11 ' A' ' 115' ' ' LEU . 93.4 mt -52.91 -25.45 11.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 41.0 ttm-85 -61.23 -40.52 94.31 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.586 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -68.64 -44.34 74.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.052 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -52.97 -36.7 60.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.84 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -72.41 -28.95 63.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.214 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.16 -51.76 34.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 110.461 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 3.4 mm . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.027 -179.727 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 tttp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.88 0.371 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.9 m -74.74 -31.82 61.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.083 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 103' ' ' ILE . 13.6 tt -124.36 108.66 29.28 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.809 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.2 137.38 10.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.978 1.785 . . . . 0.0 112.155 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.88 138.7 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.494 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -148.18 145.13 28.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.797 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.603 ' H ' HG22 ' A' ' 179' ' ' ILE . . . -133.24 168.52 23.0 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 180' ' ' PHE . . . -112.15 125.81 54.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.684 0.278 . . . . 0.0 111.036 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.5 117.25 33.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.429 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.88 133.92 65.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.138 0.494 . . . . 0.0 110.941 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -137.27 149.21 46.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.994 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.652 ' ND2' ' H ' ' A' ' 116' ' ' SER . 43.8 p-10 -50.42 155.19 1.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.994 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -57.81 -25.95 61.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.023 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -92.06 7.21 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.078 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.707 HD21 HD12 ' A' ' 235' ' ' LEU . 12.6 mt 42.93 52.5 5.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 0.0 110.532 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.652 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 0.5 OUTLIER -123.55 -13.7 7.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.112 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -133.24 146.42 51.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.261 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.6 mm -115.31 124.58 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.215 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 202' ' ' ILE . 1.2 tt -86.27 103.58 15.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.697 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.7 mt -117.83 162.82 17.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.129 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.15 160.19 40.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.488 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.586 ' NE2' ' O ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -98.89 114.33 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.336 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.586 ' O ' ' NE2' ' A' ' 122' ' ' GLN . . . -96.31 -151.66 28.26 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 87.5 m -53.97 -34.86 60.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 110.656 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -47.02 157.53 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.7 m -69.18 -70.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.852 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -133.53 69.61 1.47 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.508 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -127.45 143.21 51.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.33 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -113.21 115.35 28.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.326 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.9 t -156.87 164.88 37.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.681 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.544 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 44.6 m-85 -73.28 151.9 90.09 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -67.55 139.34 48.56 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.888 1.725 . . . . 0.0 111.667 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -125.0 177.99 5.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.566 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 158.68 179.8 33.79 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -86.63 145.84 26.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.707 0.289 . . . . 0.0 110.641 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.6 tt -127.1 147.33 32.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.219 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.7 p -70.13 153.09 43.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -112.61 176.58 4.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.179 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 53.89 42.33 31.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.258 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -148.44 158.76 44.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.363 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -58.7 125.62 24.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.525 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.421 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 23.3 p-10 -64.38 -39.42 93.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.138 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 7.0 tt -66.85 -37.39 79.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.498 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -69.79 -42.36 73.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.569 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 64.9 m -73.86 -40.18 63.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 142' ' ' ASP . 33.1 m -55.21 -52.89 61.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.24 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.15 -42.76 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -62.2 -41.3 98.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.337 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -79.25 -35.22 41.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.94 0.4 . . . . 0.0 110.561 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.11 -53.8 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -45.3 89.37 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.651 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.32 -28.63 65.21 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.515 ' OE2' HG12 ' A' ' 195' ' ' VAL . 27.3 mm-40 -89.23 -62.6 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 8.8 mt -84.96 -33.65 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.03 -13.37 60.48 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -102.69 135.27 44.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.0 110.385 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 25.0 p30 -106.86 127.45 53.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.814 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 mp -96.38 112.44 24.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.922 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.2 m -89.52 -61.88 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.74 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -98.97 0.19 43.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.122 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -109.63 21.11 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.63 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 162' ' ' ILE . 0.8 OUTLIER -111.91 133.04 58.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.641 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.504 ' H ' HD11 ' A' ' 182' ' ' ILE . 6.4 t0 -101.3 135.68 42.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.242 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -95.9 -10.81 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.938 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -133.74 56.7 1.84 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.303 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -150.53 107.65 3.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.316 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -164.77 166.5 19.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.62 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.519 HD11 HD11 ' A' ' 181' ' ' LEU . 63.4 mt -125.96 130.8 72.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.078 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -113.37 128.08 56.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.296 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.523 ' NH2' ' OG ' ' A' ' 226' ' ' SER . 0.0 OUTLIER -160.06 159.11 31.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.945 0.402 . . . . 0.0 110.911 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -104.48 102.59 12.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.938 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.47 HD13 ' HA ' ' A' ' 223' ' ' LEU . 83.7 mt -97.27 117.02 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.339 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 52.15 40.26 28.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.363 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 80.88 -20.09 6.87 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -83.97 124.32 30.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.412 . . . . 0.0 110.707 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -75.2 136.55 40.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.473 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.423 ' CD2' HD12 ' A' ' 172' ' ' ILE . 0.2 OUTLIER -128.35 140.56 51.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.284 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -143.92 94.86 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 107' ' ' GLY . 10.6 pt -112.57 145.67 18.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.022 0.439 . . . . 0.0 111.628 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 108' ' ' ALA . 11.2 p90 -99.89 132.43 45.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.598 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.639 ' O ' HD12 ' A' ' 182' ' ' ILE . 9.7 mt -91.48 129.06 37.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.548 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.0 OUTLIER -131.02 129.68 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.908 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.1 m -132.14 162.0 31.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.415 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.48 7.91 55.31 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.8 m -75.93 142.99 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.654 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 52.1 p -77.29 137.12 38.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.647 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.455 ' OE1' ' CZ2' ' A' ' 204' ' ' TRP . 70.9 mm-40 -96.55 -8.54 31.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.603 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.0 -27.73 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.473 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -98.23 123.62 42.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.4 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -106.57 132.75 52.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.665 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.68 152.73 39.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.574 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.53 157.23 38.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.291 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.51 142.96 41.56 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.343 2.029 . . . . 0.0 112.219 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -135.65 82.94 1.98 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.105 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.515 HG12 ' OE2' ' A' ' 153' ' ' GLU . 33.6 m -129.09 -177.59 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.719 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -48.46 145.77 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.52 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -46.21 102.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.698 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -147.3 -113.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.415 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.88 122.86 65.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.363 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -93.24 107.55 19.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.753 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -160.3 126.97 4.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.46 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.593 HD11 HD11 ' A' ' 119' ' ' LEU . 17.2 tt -127.32 154.21 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.46 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -167.71 156.59 9.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.698 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' TRP . . . . . 0.455 ' CZ2' ' OE1' ' A' ' 187' ' ' GLU . 0.0 OUTLIER -106.85 100.58 10.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.734 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.71 135.08 33.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.296 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -72.03 133.3 45.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.485 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -49.16 -32.08 9.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -59.2 -43.65 92.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.676 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -54.81 -32.27 60.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.364 . . . . 0.0 110.234 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.436 ' O ' ' OG1' ' A' ' 213' ' ' THR . 82.7 mt -79.17 -23.07 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.358 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.4 t -85.1 -10.66 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -95.44 10.07 37.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.769 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 210' ' ' ILE . 0.2 OUTLIER -43.07 -36.2 1.54 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.345 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 40.6 mtt -52.95 -33.82 52.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.352 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -66.8 -46.58 74.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.446 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 216' ' ' LYS . 11.1 ptmt -113.1 110.25 20.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 57.7 m -92.14 -10.41 38.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.841 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -58.76 -37.67 76.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.684 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 79.2 mt -128.94 134.05 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.539 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -130.43 145.03 51.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.642 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 225' ' ' ASN . 87.2 m-85 -104.66 86.85 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.427 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -66.1 -27.99 68.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.212 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.638 HD12 ' N ' ' A' ' 223' ' ' LEU . 7.8 mp -69.5 -39.13 77.77 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.778 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 228' ' ' MET . 97.0 mt -95.7 -40.2 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.676 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 221' ' ' TYR . 62.4 t-20 -59.98 -47.95 83.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.341 . . . . 0.0 110.561 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.523 ' OG ' ' NH2' ' A' ' 170' ' ' ARG . 7.9 t -68.84 -30.46 69.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.556 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 76.9 mtp -96.54 2.41 52.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 224' ' ' ILE . 18.7 ttt -48.33 -38.97 20.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.221 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.45 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -68.96 -65.51 1.26 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.602 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 19.6 Cg_endo -60.17 -47.56 14.5 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.213 1.942 . . . . 0.0 112.366 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 5.1 tt -56.2 -39.48 72.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.894 0.378 . . . . 0.0 110.626 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 68.9 m -75.74 -40.09 56.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.994 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 10.7 mmt -66.46 -52.89 41.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.289 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -55.06 -54.4 43.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.759 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.707 HD12 HD21 ' A' ' 115' ' ' LEU . 4.0 mm? -56.56 -22.16 31.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.599 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -42.16 72.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.658 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -61.96 -44.28 97.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.598 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.403 HE21 ' HA ' ' A' ' 235' ' ' LEU . 44.2 mt-30 -58.6 -34.64 71.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.673 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -62.07 -24.46 67.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -81.74 -58.72 2.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.41 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.1 pttt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.91 0.386 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.0 m -73.51 -32.88 64.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.59 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 103' ' ' ILE . 17.0 tt -117.8 108.39 42.85 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.484 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -82.25 135.88 8.64 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.937 1.758 . . . . 0.0 112.224 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.53 140.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.048 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.1 ttp85 -123.74 146.76 48.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.802 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -122.86 149.44 16.86 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -101.87 142.42 33.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.865 0.364 . . . . 0.0 111.222 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.29 99.34 3.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.263 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.455 HG23 HG11 ' A' ' 185' ' ' VAL . 2.7 mp -108.79 142.2 22.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.505 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -127.34 163.94 22.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.145 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.725 HD21 ' H ' ' A' ' 116' ' ' SER . 26.1 p-10 -65.33 166.16 10.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.886 0.374 . . . . 0.0 110.875 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 185' ' ' VAL . 61.6 mm-40 -58.63 -33.45 70.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.621 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -89.43 6.98 38.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.988 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mp 42.91 45.23 4.26 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.592 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.725 ' H ' HD21 ' A' ' 112' ' ' ASN . 3.9 t -120.95 -9.24 9.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.01 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -136.8 170.32 16.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.771 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.409 ' O ' HG23 ' A' ' 118' ' ' ILE . 11.5 tt -134.03 131.41 55.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.758 0.313 . . . . 0.0 110.584 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.531 ' O ' ' CZ ' ' A' ' 131' ' ' PHE . 2.5 tt -83.11 127.71 33.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.205 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.528 HD22 ' O ' ' A' ' 119' ' ' LEU . 3.3 mm? -121.27 156.68 31.98 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.4 m -143.69 172.69 6.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.669 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.17 124.64 36.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.49 -165.86 32.17 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.462 ' OG1' ' NH2' ' A' ' 196' ' ' ARG . 40.3 m -47.22 -37.1 9.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.891 0.377 . . . . 0.0 110.221 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 125' ' ' GLU . 56.9 mp0 -51.4 160.06 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.04 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.7 t -64.61 -62.57 1.51 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.972 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -137.1 69.53 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.777 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 p -125.08 139.09 54.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.137 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.515 ' C ' HD12 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -94.37 110.45 22.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.586 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.402 ' N ' HD12 ' A' ' 120' ' ' LEU . 14.1 p -153.84 176.57 12.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.732 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 46.1 m-85 -97.83 152.6 38.19 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.317 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.8 155.71 67.85 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.968 1.779 . . . . 0.0 111.4 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -140.85 177.07 8.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.089 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 168.11 178.59 40.08 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -93.94 150.06 20.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.686 0.279 . . . . 0.0 110.617 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 16.6 pt -108.58 149.99 11.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.516 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.9 t -76.24 140.94 41.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.748 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 63.3 mttp -89.2 162.26 16.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.503 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 3.0 t70 75.37 1.89 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.645 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -114.36 155.33 26.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.474 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -64.58 143.77 57.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.379 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -55.37 -39.59 70.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.537 HG23 ' N ' ' A' ' 144' ' ' ASP . 6.7 tt -65.59 -42.59 93.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.709 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.537 ' N ' HG23 ' A' ' 143' ' ' ILE . 43.0 t0 -63.51 -33.14 74.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.692 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 13.8 m -78.27 -42.01 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.559 ' SG ' ' CG ' ' A' ' 180' ' ' PHE . 8.5 t -65.12 -50.53 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.021 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 148' ' ' ARG . 9.7 tt -61.11 -38.49 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.146 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.428 ' N ' ' CG2' ' A' ' 147' ' ' ILE . 17.0 ttm105 -71.32 -38.98 71.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.903 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 153' ' ' GLU . 85.3 tt0 -78.28 -29.82 48.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 110.445 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.3 t -74.17 -52.48 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.783 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -28.2 69.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.668 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -76.33 -41.11 49.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.714 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 149' ' ' GLU . 0.4 OUTLIER -75.35 -53.17 9.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 28.7 mm -71.0 -31.5 45.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 0.0 110.422 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 92.2 -14.31 64.88 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -115.96 133.09 56.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.725 0.298 . . . . 0.0 110.337 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 43.7 p-10 -96.61 125.1 40.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.036 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.409 ' H ' HD12 ' A' ' 158' ' ' LEU . 0.7 OUTLIER -112.13 110.43 20.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.078 179.511 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.0 p -91.0 -55.21 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 0.0 111.054 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -58.97 -39.15 80.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.307 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 184' ' ' GLY . 39.2 m-85 -90.82 18.74 6.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.052 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.659 HD13 ' H ' ' A' ' 163' ' ' ASP . 0.3 OUTLIER -87.4 134.6 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.985 0.421 . . . . 0.0 110.256 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.659 ' H ' HD13 ' A' ' 162' ' ' ILE . 66.7 m-20 -92.27 140.5 29.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.408 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -70.56 -66.18 0.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.339 0.59 . . . . 0.0 110.881 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -133.02 66.89 1.55 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.123 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.554 ' HG3' HD12 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -127.89 107.45 9.87 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.815 0.34 . . . . 0.0 110.606 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -167.23 159.31 12.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.181 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.654 HD11 HD11 ' A' ' 181' ' ' LEU . 3.2 mt -124.05 138.98 51.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.788 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -95.08 136.29 35.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.187 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.73 121.39 6.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.845 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -112.17 112.51 24.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.119 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.5 tt -109.3 132.46 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.261 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.45 ' C ' ' H ' ' A' ' 175' ' ' LYS . 78.9 mt-30 52.32 46.07 27.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.232 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.02 -3.27 1.66 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 173' ' ' GLN . 3.7 tptm -84.14 125.58 32.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.79 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -75.42 123.88 26.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.744 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -140.12 128.99 23.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.566 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 107' ' ' GLY . 26.0 ttmt -120.96 142.29 49.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.013 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.8 mm -123.15 121.29 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.598 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.559 ' CG ' ' SG ' ' A' ' 146' ' ' CYS . 0.2 OUTLIER -98.44 127.47 44.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.387 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 168' ' ' ILE . 47.2 mt -82.93 124.27 30.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 182' ' ' ILE . 3.1 tt -143.71 101.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.411 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.4 t -117.54 154.23 31.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.626 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.51 ' O ' ' CD1' ' A' ' 161' ' ' TYR . . . 106.95 10.07 28.94 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.455 HG11 HG23 ' A' ' 110' ' ' ILE . 1.5 m -67.97 138.99 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.659 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 32.9 t -66.81 120.69 13.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.429 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -85.44 -16.62 39.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.131 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 85.4 t -69.86 -28.13 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.566 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.52 ' CE1' ' O ' ' A' ' 190' ' ' ASN . 63.1 t80 -88.7 133.87 34.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.632 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.52 ' O ' ' CE1' ' A' ' 189' ' ' PHE . 33.5 p-10 -90.79 131.42 36.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.444 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -127.67 158.57 37.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.391 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -139.48 156.57 71.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.308 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.4 142.89 46.25 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.309 2.006 . . . . 0.0 112.09 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -131.02 69.8 1.47 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.458 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.698 HG23 ' N ' ' A' ' 196' ' ' ARG . 11.9 m -130.23 -138.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.698 ' N ' HG23 ' A' ' 195' ' ' VAL . 78.4 mtm-85 -52.75 146.03 11.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.029 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -74.38 108.88 7.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.373 . . . . 0.0 110.771 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.469 ' CG ' ' H ' ' A' ' 199' ' ' ILE . 1.0 OUTLIER -150.61 -113.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.54 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.469 ' H ' ' CG ' ' A' ' 198' ' ' GLU . 19.5 tt -130.39 136.7 57.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.471 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 200' ' ' ASP . 39.8 p-10 -102.68 114.54 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.736 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -133.33 123.18 24.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.389 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.97 146.76 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.421 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -165.89 140.83 4.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.601 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.38 112.91 26.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.481 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -104.83 151.7 23.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.625 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.03 127.79 34.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.4 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.05 -42.77 91.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.994 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -36.65 71.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -59.71 -46.34 89.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.175 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 45.4 pt -71.24 -19.53 20.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.144 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 44.0 m -82.5 -22.07 35.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.796 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -111.37 28.41 8.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 8.8 t -81.44 1.78 31.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.689 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 74.4 mtp -54.84 -30.69 58.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.383 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -67.61 -31.92 72.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.56 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -105.18 121.28 43.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.542 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.4 m -92.06 -11.59 35.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -55.65 -34.35 64.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.606 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.5 mt -125.65 134.05 67.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.506 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -133.65 156.08 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.569 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -113.97 135.95 53.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.364 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -101.49 -72.52 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.187 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.67 -50.86 55.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.177 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.4 mm -56.48 -47.45 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 110.679 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -52.25 -43.2 64.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.568 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.5 m -69.06 -38.37 79.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.983 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 55.4 mtt -88.37 -2.9 58.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.863 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' MET . . . . . 0.483 ' N ' ' O ' ' A' ' 224' ' ' ILE . 5.0 ttp -58.62 -44.04 89.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.721 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.441 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 23.0 mtm-85 -56.14 -64.1 2.67 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.312 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 20.1 Cg_endo -61.3 -51.11 4.73 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.28 1.987 . . . . 0.0 112.423 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -46.86 81.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.2 t -65.77 -38.54 89.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.026 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 49.2 ttm -60.52 -48.34 82.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.24 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.468 ' NE1' ' OE1' ' A' ' 166' ' ' GLN . 1.4 t-105 -70.54 -42.92 70.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.53 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.11 -37.87 81.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.379 . . . . 0.0 110.597 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -60.47 -36.15 77.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.796 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -69.28 -37.06 77.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.781 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -64.23 -29.58 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.052 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -72.57 -41.23 65.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 111.028 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -58.32 -38.66 77.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.26 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 81.6 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.547 179.879 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.811 0.338 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 m -79.45 -30.47 42.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.957 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -100.98 108.47 54.51 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.596 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.73 127.4 6.31 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.93 1.753 . . . . 0.0 112.325 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 t -132.71 145.93 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.052 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' A' ' 107' ' ' GLY . 46.3 ttp85 -135.49 150.58 49.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.705 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -129.89 154.37 20.46 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -102.22 149.88 23.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.955 0.407 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -141.86 95.13 2.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.307 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.87 131.4 67.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 121.248 0.547 . . . . 0.0 111.573 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.6 159.39 39.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.92 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -55.95 151.35 11.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.864 0.364 . . . . 0.0 110.373 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -51.07 -40.47 58.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.809 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -80.55 -1.21 41.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 0.0 110.554 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mt 53.41 56.04 7.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.665 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 p -122.23 -16.27 7.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.745 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -138.18 156.5 47.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.541 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.0 mm -112.75 136.07 50.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.049 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.526 ' C ' HD22 ' A' ' 120' ' ' LEU . 1.7 tt -102.8 110.91 22.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 111.194 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.823 HD22 ' N ' ' A' ' 120' ' ' LEU . 1.4 mm? -111.93 174.17 6.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.175 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 m -143.88 169.99 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.203 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.648 HE22 ' H ' ' A' ' 128' ' ' SER . 55.0 tp60 -109.04 134.44 51.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -125.37 -145.37 6.49 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 124' ' ' THR . 0.1 OUTLIER -52.67 -43.26 65.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 110.748 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -43.52 151.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.947 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.7 p -61.46 -83.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.025 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -126.67 70.15 1.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.475 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.648 ' H ' HE22 ' A' ' 122' ' ' GLN . 46.5 m -125.8 153.28 44.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.589 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 129' ' ' TRP . 0.9 OUTLIER -115.75 119.14 35.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.379 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 76.1 p -163.71 173.03 13.38 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.882 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 43.3 m-85 -83.29 152.05 63.87 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.207 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.93 142.93 39.8 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.848 1.699 . . . . 0.0 111.831 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -146.41 171.7 14.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.238 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.29 -169.53 34.33 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.97 137.23 35.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.664 0.268 . . . . 0.0 110.57 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 pt -114.02 157.1 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.384 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.9 m -64.59 144.15 57.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.435 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -92.17 173.88 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.636 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 59.63 37.28 22.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -136.36 162.51 32.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.253 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -79.4 146.03 33.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.466 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -49.34 -37.75 25.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.556 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 147' ' ' ILE . 50.0 mt -72.68 -43.84 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -62.31 -41.93 98.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.585 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -73.87 -39.13 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.934 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.593 ' SG ' ' CE1' ' A' ' 180' ' ' PHE . 43.9 t -69.82 -56.82 6.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.043 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 148' ' ' ARG . 2.1 tp -54.44 -39.98 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.005 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.448 ' N ' HG23 ' A' ' 147' ' ' ILE . 31.6 ttm180 -66.27 -39.38 89.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.908 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -76.91 -27.54 54.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.0 110.44 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.12 -54.56 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.846 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -26.72 67.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.903 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -84.75 -34.84 22.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 110.995 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -72.6 -60.48 2.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.677 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 21.8 mt -82.52 -33.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.776 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 104.5 -12.89 51.09 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -103.65 130.73 51.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.672 0.272 . . . . 0.0 110.455 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -104.49 148.46 26.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.985 0.421 . . . . 0.0 111.048 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.0 mt -106.27 115.22 29.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.815 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.31 -61.73 1.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.391 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.518 ' OD1' ' CD2' ' A' ' 161' ' ' TYR . 43.4 p-10 -104.47 0.43 28.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.105 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.518 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 68.3 m-85 -105.3 14.9 28.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.65 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 162' ' ' ILE . 10.1 tp -93.22 130.93 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.601 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.464 ' OD2' ' NE2' ' A' ' 166' ' ' GLN . 77.9 m-20 -72.03 153.54 41.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.364 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -85.57 -67.38 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.497 0.665 . . . . 0.0 111.123 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -132.06 70.46 1.47 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.759 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.464 ' NE2' ' OD2' ' A' ' 163' ' ' ASP . 13.7 tt0 -132.78 107.62 8.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.494 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.5 165.85 20.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.81 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 34.2 pt -128.53 146.3 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.537 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.48 135.01 54.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.265 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -159.74 137.38 9.89 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.661 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -102.93 112.99 26.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.352 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 54.9 mt -99.02 120.78 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.33 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.485 ' C ' ' H ' ' A' ' 175' ' ' LYS . 65.2 mt-30 54.0 49.69 18.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.79 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 69.52 -17.28 0.65 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 173' ' ' GLN . 42.4 mttt -85.4 134.04 34.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -75.16 131.56 40.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.594 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -134.98 105.24 6.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.608 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 107' ' ' GLY . 11.9 mmtp -100.05 130.64 46.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.334 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.96 127.51 61.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 111.081 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.593 ' CE1' ' SG ' ' A' ' 146' ' ' CYS . 0.3 OUTLIER -99.31 133.33 43.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.734 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.41 ' O ' ' OD2' ' A' ' 163' ' ' ASP . 8.8 mt -87.75 137.05 32.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.991 0.424 . . . . 0.0 111.285 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.57 106.64 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.904 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 p -125.24 151.33 46.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.402 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 117.29 -12.49 14.1 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 4.4 m -53.29 146.68 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 34.9 p -77.75 127.75 32.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.795 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -83.06 -10.79 58.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.43 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 25.2 m -72.52 -16.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.249 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -95.92 134.32 39.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.308 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -88.81 127.32 35.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.632 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.427 ' O ' HD13 ' A' ' 202' ' ' ILE . 85.1 m-85 -95.72 128.14 42.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.428 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -105.13 152.8 39.79 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.311 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.53 141.68 28.48 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.305 2.003 . . . . 0.0 112.436 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -149.51 78.18 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.98 177.07 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.756 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -51.73 154.05 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.113 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -46.25 102.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.287 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -150.81 -113.45 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.255 0.55 . . . . 0.0 110.407 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.5 mm -124.99 126.34 71.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.239 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.19 103.94 13.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.498 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.487 ' NZ ' ' OE2' ' A' ' 203' ' ' GLU . 61.4 tttm -163.69 134.87 4.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.012 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.427 HD13 ' O ' ' A' ' 191' ' ' PHE . 18.1 pt -120.9 154.24 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.241 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.487 ' OE2' ' NZ ' ' A' ' 201' ' ' LYS . 44.0 mt-10 -152.44 138.19 17.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.412 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.51 103.2 13.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.348 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.419 ' CE2' ' CE3' ' A' ' 129' ' ' TRP . 60.8 m-85 -105.93 152.72 22.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.904 0.383 . . . . 0.0 110.842 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -81.96 139.25 34.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.643 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -51.71 -55.51 19.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -56.61 -43.36 80.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.82 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -57.58 -48.4 79.48 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.883 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 87.5 mt -55.11 -25.11 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.482 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -89.89 -13.79 35.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -104.38 15.86 27.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.071 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 15.3 p -81.29 10.9 4.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 110.74 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 70.8 mtm -53.96 -35.29 61.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.315 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -55.87 -34.53 65.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.449 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -100.07 109.04 21.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.557 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 82.5 p -92.78 -23.15 18.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.709 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -56.5 -42.4 78.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.542 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.1 mt -126.16 110.34 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.473 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -139.44 148.91 43.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.559 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 221' ' ' TYR . 0.0 OUTLIER -117.05 117.84 30.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.459 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -82.81 -35.72 26.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.042 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 223' ' ' LEU . 10.7 mp -53.69 -48.64 69.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.002 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 tp -69.23 -33.87 60.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.85 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' A' ' 221' ' ' TYR . 72.6 m-20 -58.85 -41.69 87.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.24 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 68.9 m -67.52 -38.32 84.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.053 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -83.44 2.77 35.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.155 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' MET . . . . . . . . . . . . . 42.1 ttp -52.42 -59.92 3.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.124 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.418 ' N ' ' CD ' ' A' ' 230' ' ' PRO . 6.3 mtm-85 -77.5 -51.22 1.94 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.143 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 229' ' ' ARG . 53.6 Cg_exo -49.39 -52.64 8.42 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.099 1.866 . . . . 0.0 112.154 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.34 -36.49 84.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.041 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 86.9 p -66.12 -36.33 82.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.824 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 79.3 mmm -67.4 -56.19 10.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.283 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 30.3 m95 -54.75 -57.91 9.66 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.064 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 97.1 mt -51.94 -24.7 6.79 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.41 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -61.42 -44.3 97.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 0.0 110.11 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -64.72 -44.06 91.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.852 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -59.62 -41.14 89.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.018 0.437 . . . . 0.0 110.597 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -63.98 -30.64 71.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -62.97 -41.39 99.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.498 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 10.9 mm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.695 -179.815 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.692 0.282 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.4 t -126.21 -18.75 4.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.635 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.693 HG23 ' O ' ' A' ' 103' ' ' ILE . 10.0 tt -119.21 108.44 40.2 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.278 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.83 130.52 6.73 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.987 1.791 . . . . 0.0 112.206 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -143.83 139.26 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.326 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.538 HH12 ' NZ ' ' A' ' 178' ' ' LYS . 57.7 mtp85 -132.59 149.6 52.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -137.93 -179.29 16.89 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.3 124.21 20.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.223 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 129.99 54.19 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.9 mt -122.88 136.39 59.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.244 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -124.3 153.06 42.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.682 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -56.16 149.18 16.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.294 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -52.29 -28.71 20.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.899 0.38 . . . . 0.0 110.228 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -95.81 3.46 53.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.371 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.446 ' CD2' HD11 ' A' ' 235' ' ' LEU . 6.1 mt 51.99 45.18 28.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.368 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 t -107.29 -21.47 12.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -140.11 176.51 8.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.3 tt -139.32 134.28 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.222 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.526 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 3.0 tt -82.69 126.98 32.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.012 0.434 . . . . 0.0 111.572 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.1 mt -133.23 152.2 51.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.466 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.41 170.99 13.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.615 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -99.48 143.53 29.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.94 -164.85 12.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.522 ' OG1' ' NH2' ' A' ' 196' ' ' ARG . 38.9 m -44.55 -35.75 2.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.262 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -47.39 156.87 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.151 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.6 t -70.08 -59.16 3.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.853 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -137.21 69.15 1.41 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.986 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 t -128.8 141.51 51.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.578 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -115.6 120.86 40.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.467 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.2 p -164.03 175.61 10.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.958 0.408 . . . . 0.0 110.937 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.526 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 36.7 m-85 -80.58 153.11 73.33 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.332 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.53 153.4 54.96 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.016 1.811 . . . . 0.0 112.175 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.707 ' H ' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -159.26 -173.92 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.521 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 175.69 -175.55 47.31 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -89.92 147.01 23.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.316 . . . . 0.0 110.712 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 1.1 pp -130.24 156.84 42.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.438 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.0 m -75.63 141.72 42.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.591 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -76.12 167.38 21.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.057 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 59.71 41.59 18.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.512 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -135.45 148.37 49.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -60.7 134.11 56.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.57 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 29.8 p-10 -63.76 -36.67 84.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.876 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.507 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 3.2 mm -60.09 -54.66 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.841 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -64.87 -38.97 92.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 1.1 m -60.58 -39.85 89.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.903 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 142' ' ' ASP . 71.1 m -63.69 -61.57 2.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.281 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.6 tp -60.93 -17.68 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.29 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.0 ttp85 -77.14 -48.41 17.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.704 0.288 . . . . 0.0 111.337 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -74.21 -35.28 63.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.019 0.438 . . . . 0.0 110.595 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.588 ' O ' HG22 ' A' ' 154' ' ' ILE . 2.5 t -57.12 -61.07 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.09 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 152' ' ' GLU . 16.3 pttm -58.71 -44.35 90.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.79 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 151' ' ' LYS . 47.0 tp10 -60.01 -45.39 92.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.48 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 133' ' ' ARG . 97.3 mt-10 -73.83 -58.15 3.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.84 HG23 ' H ' ' A' ' 156' ' ' PHE . 7.8 tt -71.31 -24.24 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.342 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 151' ' ' LYS . . . 82.89 8.63 85.57 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.84 ' H ' HG23 ' A' ' 154' ' ' ILE . 25.9 t80 -151.36 150.84 30.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -128.3 133.73 48.79 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.932 0.396 . . . . 0.0 111.53 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.84 154.35 25.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.741 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.9 p -72.76 -14.51 61.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.023 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -105.35 13.89 29.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.05 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.27 -7.63 59.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.84 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.4 tp -125.81 137.15 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -106.61 156.11 18.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.248 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 165' ' ' ASN . 3.4 p30 -69.08 -67.81 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.355 0.598 . . . . 0.0 111.052 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 32.6 t30 -134.43 60.72 1.69 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.111 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -145.27 107.9 4.45 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.556 -0.457 . . . . 0.0 111.013 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -156.36 163.84 39.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.309 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.9 tt -127.56 133.41 67.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -110.58 132.05 54.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.806 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -159.75 136.4 9.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.922 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -109.59 116.06 31.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.289 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 19.1 pt -119.74 150.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.612 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.471 ' C ' ' H ' ' A' ' 175' ' ' LYS . 85.1 mt-30 47.11 36.77 4.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.395 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 70.51 -14.65 1.31 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' A' ' 173' ' ' GLN . 51.1 mttm -88.51 129.33 35.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 110.907 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -75.08 120.99 21.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.503 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -117.24 125.21 50.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.993 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.538 ' NZ ' HH12 ' A' ' 106' ' ' ARG . 23.5 mtpt -122.44 129.85 52.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.676 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.7 mt -137.72 134.02 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.361 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.465 ' CZ ' ' SG ' ' A' ' 146' ' ' CYS . 0.0 OUTLIER -93.27 137.49 32.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.303 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.489 HD12 ' CD1' ' A' ' 234' ' ' TRP . 10.8 mt -95.32 125.93 40.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.709 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.14 106.26 3.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.709 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 63.6 p -111.35 154.82 24.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.408 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 99.52 13.23 38.84 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.6 m -88.77 147.33 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.719 0.295 . . . . 0.0 110.554 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 60.5 p -61.96 124.51 20.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.971 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -93.49 -5.56 48.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.579 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.39 -28.29 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.376 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.53 148.93 49.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.237 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -92.56 131.78 37.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.552 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.45 ' O ' HD13 ' A' ' 202' ' ' ILE . 63.2 m-85 -110.83 138.08 47.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.509 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -140.7 122.77 9.52 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.3 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.27 116.43 4.14 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.79 1.66 . . . . 0.0 112.321 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -106.13 99.78 9.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.328 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 32.0 m -147.42 -160.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.7 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.522 ' NH2' ' OG1' ' A' ' 124' ' ' THR . 12.5 mtp180 -42.72 148.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.614 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -70.95 117.2 12.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.538 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 1.9 tt0 -172.65 -111.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.489 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.514 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 58.9 mt -113.9 118.35 58.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.771 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 200' ' ' ASP . 2.9 p30 -128.47 100.49 5.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.045 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -139.88 138.63 35.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.592 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.45 HD13 ' O ' ' A' ' 191' ' ' PHE . 36.0 pt -109.16 145.09 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.199 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -156.78 133.55 10.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.301 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -101.21 113.52 26.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.271 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -107.83 148.54 29.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.047 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.73 136.71 43.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.101 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -51.53 -40.11 59.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.56 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -64.44 -39.78 94.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -60.35 -32.79 71.6 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.512 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 98.0 mt -71.84 -33.05 46.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 50.0 m -80.71 -28.41 36.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.636 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -12.11 61.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.585 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 52.5 p -50.91 -26.46 5.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 62.5 mtt -62.47 -35.36 79.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.604 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -69.4 -43.26 73.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.677 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -86.42 116.02 24.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.403 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 70.9 m -96.21 9.86 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.752 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -75.64 -68.93 0.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.505 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 219' ' ' ILE . 10.0 tp -132.09 123.57 51.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.524 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -138.12 159.28 42.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.385 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -106.48 101.7 11.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.557 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -66.15 -33.87 76.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.55 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 4.9 tp -55.51 -43.57 75.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.0 mm -86.85 -27.43 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.95 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -53.1 -45.67 68.34 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.744 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.1 m -69.82 -37.86 76.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.776 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 34.5 ttm -78.48 -23.79 46.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 224' ' ' ILE . 46.5 ttp -58.65 -38.74 78.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.457 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 2.2 mmm180 -54.31 -65.51 1.26 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.888 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 28.8 Cg_endo -62.56 -44.1 19.13 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.174 1.916 . . . . 0.0 111.85 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.7 tp -53.06 -35.28 59.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.855 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 33.7 t -72.89 -33.77 66.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.752 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 5.6 ttm -70.59 -59.54 2.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.21 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.489 ' CD1' HD12 ' A' ' 181' ' ' LEU . 4.7 t-105 -57.46 -49.32 76.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.946 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.446 HD11 ' CD2' ' A' ' 115' ' ' LEU . 30.0 tp -56.56 -29.02 61.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -41.57 97.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.541 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -57.02 -44.61 83.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.775 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -60.86 -34.71 75.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.966 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -70.44 -36.09 73.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.797 0.332 . . . . 0.0 110.827 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -64.28 -44.89 90.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.736 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 86.2 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.821 -179.787 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.8 mttt . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.798 0.333 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.8 p -73.72 -21.52 60.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.391 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.651 HG23 ' O ' ' A' ' 103' ' ' ILE . 1.3 tt -95.04 110.03 47.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.295 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.8 149.9 23.55 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.835 1.69 . . . . 0.0 112.366 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.21 145.89 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.983 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.543 ' NE ' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -143.59 160.23 41.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.615 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -133.0 161.44 24.12 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 131' ' ' PHE . . . -108.47 120.42 42.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.717 0.294 . . . . 0.0 110.905 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.521 ' HB2' ' CG1' ' A' ' 179' ' ' ILE . . . -103.38 126.92 50.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.422 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mt -124.96 129.25 73.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.972 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 3.5 m-85 -115.76 154.26 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.903 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.726 HD21 ' H ' ' A' ' 116' ' ' SER . 40.5 p-10 -60.02 148.84 34.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.556 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -48.74 -29.82 4.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.64 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -87.8 4.61 43.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.756 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.459 ' O ' ' NH1' ' A' ' 239' ' ' ARG . 1.1 mp 41.7 42.66 2.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.519 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.726 ' H ' HD21 ' A' ' 112' ' ' ASN . 0.1 OUTLIER -123.08 -10.4 8.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.18 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.614 ' NZ ' ' CD1' ' A' ' 204' ' ' TRP . 7.7 mtpm? -134.29 168.55 18.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.044 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.38 144.0 35.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 202' ' ' ILE . 4.8 tt -108.25 121.6 45.22 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.826 0.346 . . . . 0.0 111.008 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.0 mt -120.92 158.86 26.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.093 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.93 170.73 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.706 0.289 . . . . 0.0 110.309 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -93.19 119.79 32.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.758 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -96.18 -157.17 31.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.1 t -54.05 -34.73 60.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.435 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -51.47 158.08 0.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.162 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.6 m -65.72 -62.9 1.25 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.028 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -137.07 73.4 1.44 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.844 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -128.47 145.8 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.599 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.418 ' CD2' ' N ' ' A' ' 129' ' ' TRP . 0.1 OUTLIER -108.49 110.81 22.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.441 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.2 m -161.25 172.06 17.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.481 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 108' ' ' ALA . 37.8 m-85 -80.89 151.42 70.66 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.077 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.83 145.65 63.29 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.011 1.807 . . . . 0.0 111.984 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -104.7 171.78 7.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.793 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -174.42 -151.77 8.61 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -133.48 166.94 21.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.766 0.317 . . . . 0.0 110.532 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.3 mt -115.11 136.62 51.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.9 t -76.61 134.64 39.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.447 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -74.41 151.08 39.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.813 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 54.4 41.75 31.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.674 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -149.45 145.9 27.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.392 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -60.11 137.11 58.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.433 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -59.91 -32.35 70.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.517 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 147' ' ' ILE . 83.9 mt -61.37 -46.51 96.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.541 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -62.37 -37.4 85.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.723 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 47.6 m -72.34 -40.37 67.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.985 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 87.8 m -70.72 -54.69 10.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.508 HG23 ' N ' ' A' ' 148' ' ' ARG . 17.4 tt -57.63 -40.99 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.956 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.508 ' N ' HG23 ' A' ' 147' ' ' ILE . 67.6 ttt-85 -65.01 -39.5 93.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.945 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -78.67 -28.25 45.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.794 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.01 -51.28 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.814 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -36.68 80.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.937 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -71.75 -36.07 70.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.208 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.422 ' O ' ' OE1' ' A' ' 194' ' ' GLN . 86.6 tt0 -77.71 -59.73 2.66 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.414 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.567 HD13 ' CE2' ' A' ' 191' ' ' PHE . 23.1 mt -71.68 -32.38 45.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.763 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.62 -14.56 61.83 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -112.33 133.58 54.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.764 0.316 . . . . 0.0 110.227 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 48.4 p30 -95.03 151.89 18.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.042 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.5 mt -111.6 110.19 20.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.101 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 91.4 m -90.47 -61.7 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.828 0.347 . . . . 0.0 111.239 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -100.23 -5.98 26.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -98.89 16.75 21.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.829 0.347 . . . . 0.0 110.354 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.5 tt -107.71 137.85 36.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -79.9 147.22 31.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.401 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 164' ' ' ASP . 8.6 p-10 -75.62 -64.99 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.395 0.617 . . . . 0.0 111.008 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.48 ' H ' ' CG ' ' A' ' 164' ' ' ASP . 36.5 t30 -131.98 67.84 1.51 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.089 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.545 ' HG3' HD12 ' A' ' 181' ' ' LEU . 4.3 tp60 -129.84 107.49 9.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.322 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -154.73 156.59 36.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.267 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.9 mt -124.62 129.16 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.505 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -99.59 137.62 37.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 tpt85 -159.51 127.65 4.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.607 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -100.29 115.05 29.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.133 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.7 tt -112.67 131.72 63.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.635 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.482 ' C ' ' H ' ' A' ' 175' ' ' LYS . 89.3 mm-40 53.62 43.14 31.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.402 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 63.45 -4.2 1.04 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 173' ' ' GLN . 20.6 tttm -90.66 132.15 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 110.794 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -74.69 119.54 19.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.489 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -129.5 121.99 28.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.573 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 107' ' ' GLY . 55.1 mttp -120.5 144.19 48.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.957 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.521 ' CG1' ' HB2' ' A' ' 109' ' ' ALA . 0.9 OUTLIER -129.76 132.2 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -101.42 123.63 45.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.183 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.545 HD12 ' HG3' ' A' ' 166' ' ' GLN . 13.4 mt -84.01 126.92 33.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.607 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 3.7 pt -145.48 100.9 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.293 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.5 m -114.28 157.2 23.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.515 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 118.63 -6.21 14.17 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.426 HG13 ' H ' ' A' ' 185' ' ' VAL . 2.4 m -61.73 153.02 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.301 . . . . 0.0 110.363 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.6 ' OG ' HG22 ' A' ' 188' ' ' VAL . 20.8 t -98.46 132.89 43.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.613 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -73.59 -7.53 52.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.594 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.6 HG22 ' OG ' ' A' ' 186' ' ' SER . 11.9 m -69.83 -20.28 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.429 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 190' ' ' ASN . 10.8 t80 -86.2 151.86 23.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.351 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.446 ' N ' ' CD1' ' A' ' 189' ' ' PHE . 47.4 t30 -85.55 110.59 19.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.567 ' CE2' HD13 ' A' ' 154' ' ' ILE . 2.4 m-85 -96.89 124.01 40.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.207 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -140.62 147.43 48.96 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.436 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.93 149.46 42.15 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.139 1.893 . . . . 0.0 112.233 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.422 ' OE1' ' O ' ' A' ' 153' ' ' GLU . 89.0 mt-30 -142.41 78.37 1.62 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.203 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.84 -166.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.536 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -46.84 150.5 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.21 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -56.74 125.46 22.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.957 0.408 . . . . 0.0 110.918 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -171.37 -113.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.08 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 199' ' ' ILE . 0.8 OUTLIER -130.46 129.64 64.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.301 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -97.77 108.61 21.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.497 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -137.73 133.89 34.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.422 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.467 HD11 HD11 ' A' ' 119' ' ' LEU . 14.7 tt -121.76 141.82 40.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.169 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -144.84 131.29 19.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.177 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' TRP . . . . . 0.614 ' CD1' ' NZ ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -98.09 101.42 12.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.825 0.345 . . . . 0.0 110.207 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -95.88 136.43 36.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -66.4 131.21 45.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.481 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -62.02 -36.82 82.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' A' ' 208' ' ' LYS . 0.0 OUTLIER -52.44 -42.45 64.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.842 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -65.13 -42.89 93.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.663 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 213' ' ' THR . 96.1 mt -66.56 -26.4 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.554 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 83.9 p -80.49 -59.19 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.77 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 214' ' ' MET . 97.5 mttt -63.24 -48.3 78.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.764 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 210' ' ' ILE . 18.5 p 51.13 7.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.048 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.503 ' H ' ' C ' ' A' ' 212' ' ' LYS . 11.9 mmt -73.62 -43.23 60.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.898 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -72.98 -31.54 64.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.867 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -98.25 120.74 39.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 2.8 t -131.51 -29.42 1.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.43 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -54.81 -46.15 74.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.747 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.7 pt -136.14 144.51 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.692 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -139.32 151.41 46.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.582 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -85.82 81.78 8.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.305 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -49.89 -40.3 42.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.071 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 10.5 mt -57.7 -52.63 64.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.038 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 228' ' ' MET . 47.2 mt -78.39 -27.5 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -50.73 -34.8 28.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.648 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.4 m -76.07 -36.73 58.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.966 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 73.3 mtm -95.24 0.74 54.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.972 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' MET . . . . . 0.523 ' N ' ' O ' ' A' ' 224' ' ' ILE . 2.5 ppp? -62.87 -32.81 74.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.971 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.417 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 7.9 mtt180 -67.18 -63.35 2.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.059 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 29.5 Cg_endo -63.79 -40.83 26.82 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.014 1.809 . . . . 0.0 112.124 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.55 -41.79 90.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.559 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' SER . . . . . 0.452 ' O ' ' CG ' ' A' ' 236' ' ' ARG . 44.7 t -61.39 -39.09 89.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.587 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 86.3 mtp -73.57 -46.83 44.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -61.21 -51.51 68.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.738 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 41.8 tp -60.73 -35.72 77.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 110.305 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.452 ' CG ' ' O ' ' A' ' 232' ' ' SER . 9.4 mmt85 -64.26 -33.56 76.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.495 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.17 -43.24 74.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.48 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -53.59 -36.84 62.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.647 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.459 ' NH1' ' O ' ' A' ' 115' ' ' LEU . 62.2 mtp85 -57.12 -15.31 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.416 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -80.91 -52.46 7.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.967 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 94.8 mt . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.997 -179.49 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.544 ' HG3' HD21 ' A' ' 176' ' ' ASN . 81.7 tttt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.781 0.324 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.8 m -73.41 -33.15 64.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.507 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.14 107.71 57.42 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.388 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -82.38 152.62 15.8 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 121.948 1.766 . . . . 0.0 112.33 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.76 127.05 66.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.959 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.59 ' NH1' ' SG ' ' A' ' 145' ' ' CYS . 97.0 mtt180 -132.1 144.11 50.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.292 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -134.71 165.98 24.39 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 131' ' ' PHE . . . -110.1 137.55 47.71 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.137 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.83 120.72 41.72 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.707 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mp -133.15 142.81 41.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.766 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.429 ' CZ ' HD11 ' A' ' 235' ' ' LEU . 0.1 OUTLIER -151.72 160.58 43.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.101 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -47.23 151.93 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.141 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 185' ' ' VAL . 87.1 mt-10 -63.25 -24.48 67.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.926 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -101.92 13.17 35.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.192 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.554 HD22 ' N ' ' A' ' 115' ' ' LEU . 3.9 mm? 50.65 47.25 24.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.109 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.05 -26.49 13.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.1 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.489 ' NZ ' ' OD2' ' A' ' 206' ' ' ASP . 21.2 mtpp -143.93 178.77 7.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.042 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.419 HG21 HD12 ' A' ' 210' ' ' ILE . 14.4 tt -140.74 131.54 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.431 . . . . 0.0 110.49 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.597 ' O ' HD22 ' A' ' 120' ' ' LEU . 0.8 OUTLIER -75.73 121.83 23.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.261 -179.217 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.597 HD22 ' O ' ' A' ' 119' ' ' LEU . 2.6 mm? -125.64 156.35 39.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.7 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.3 m -143.18 173.5 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.52 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -102.34 124.69 48.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.678 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.58 -165.69 36.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.762 HG22 ' OE1' ' A' ' 198' ' ' GLU . 47.0 p -61.1 -25.33 66.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 0.0 110.442 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.405 ' OE1' ' CB ' ' A' ' 128' ' ' SER . 56.7 mt-10 -51.78 165.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.25 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.5 m -67.37 -67.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.021 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -136.99 68.92 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.991 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.405 ' CB ' ' OE1' ' A' ' 125' ' ' GLU . 14.1 m -128.84 143.52 50.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.383 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.487 ' C ' HD12 ' A' ' 120' ' ' LEU . 9.7 m0 -107.68 118.73 37.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.604 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.6 m -156.24 170.33 22.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.759 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.524 ' CZ ' ' O ' ' A' ' 119' ' ' LEU . 39.9 m-85 -81.21 152.78 71.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.061 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.35 137.92 41.26 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.901 1.734 . . . . 0.0 111.735 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.529 ' NE ' ' OH ' ' A' ' 177' ' ' TYR . 45.1 ptt85 -150.07 -170.3 3.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.177 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.76 177.93 25.12 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -81.21 137.0 35.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.9 tt -125.95 155.38 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.451 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.4 p -64.72 157.51 27.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.633 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 65.1 mttm -89.88 -178.9 5.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.603 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 4.6 t0 77.7 38.15 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.406 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -137.77 158.7 43.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.567 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -84.9 151.38 24.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.398 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 36.3 p-10 -53.19 -37.07 61.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.622 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.582 HG23 ' N ' ' A' ' 144' ' ' ASP . 19.1 tt -79.75 -45.73 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.552 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.582 ' N ' HG23 ' A' ' 143' ' ' ILE . 57.2 t0 -62.56 -34.51 77.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.827 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.59 ' SG ' ' NH1' ' A' ' 106' ' ' ARG . 6.1 p -64.62 -41.03 96.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.589 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.676 ' O ' HG23 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -63.75 -46.04 87.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.298 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.526 ' N ' ' SG ' ' A' ' 146' ' ' CYS . 80.0 mt -59.34 -52.16 64.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.969 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -60.04 -40.77 90.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.548 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -79.06 -28.84 43.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.879 0.371 . . . . 0.0 110.726 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 146' ' ' CYS . 4.1 t -64.8 -50.99 72.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.719 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER -70.13 -44.33 69.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.933 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -47.15 -34.43 6.17 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.399 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 194' ' ' GLN . 78.2 mm-40 -91.61 -62.13 1.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.023 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 81.9 mt -81.04 -33.63 13.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 151' ' ' LYS . . . 100.6 -14.15 59.28 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -125.12 137.89 54.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.512 ' C ' HD12 ' A' ' 158' ' ' LEU . 50.1 p30 -135.17 156.92 48.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 111.036 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.796 ' N ' HD12 ' A' ' 158' ' ' LEU . 4.5 mp -103.01 122.91 45.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.958 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 24.0 p -90.4 -61.52 1.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.384 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -103.3 11.79 36.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.662 ' HB3' HD23 ' A' ' 158' ' ' LEU . 0.2 OUTLIER -106.82 17.7 22.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.838 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.777 ' CG2' HG23 ' A' ' 182' ' ' ILE . 2.6 pt -130.95 149.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.06 0.457 . . . . 0.0 111.184 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -71.2 156.19 39.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.649 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.62 -17.88 21.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.078 0.466 . . . . 0.0 110.936 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -134.34 58.02 1.78 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.362 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.675 ' HG2' HD12 ' A' ' 181' ' ' LEU . 38.3 tt0 -139.38 106.99 5.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.105 0.478 . . . . 0.0 110.679 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -166.09 163.32 18.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.651 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.0 pt -129.24 150.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.399 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 169' ' ' GLU . 1.2 pt-20 -144.18 96.43 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.684 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -127.72 153.0 47.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.468 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -106.15 122.11 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.495 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.426 HD11 ' SD ' ' A' ' 227' ' ' MET . 58.9 mt -103.72 121.8 55.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.353 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.498 ' NE2' ' CE2' ' A' ' 222' ' ' TYR . 87.2 mt-30 53.48 43.28 31.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.426 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.48 -11.53 12.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -86.42 124.62 32.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.8 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.544 HD21 ' HG3' ' A' ' 101' ' ' LYS . 11.6 p30 -74.3 119.99 19.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.464 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.529 ' OH ' ' NE ' ' A' ' 133' ' ' ARG . 0.2 OUTLIER -122.91 104.91 9.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.769 -179.403 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -108.18 129.89 55.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 54.7 mt -138.44 136.2 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.529 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -95.5 136.35 35.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.75 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.675 HD12 ' HG2' ' A' ' 166' ' ' GLN . 61.5 mt -84.75 133.32 34.36 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.854 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.777 HG23 ' CG2' ' A' ' 162' ' ' ILE . 65.0 mt -133.05 108.84 13.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.308 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.9 t -117.26 147.94 42.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.563 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 102.74 8.24 43.14 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.483 ' HA ' HD21 ' A' ' 158' ' ' LEU . 5.6 p -50.04 133.05 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 110.625 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 48.6 m -81.67 143.51 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.424 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -93.46 -9.73 37.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.365 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.64 -28.33 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.664 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -83.04 144.63 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.715 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -81.47 139.89 34.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.257 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -99.63 124.55 44.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.726 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -143.3 109.85 5.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.435 ' HD3' HD12 ' A' ' 202' ' ' ILE . 61.1 Cg_endo -79.18 136.76 13.05 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.736 1.624 . . . . 0.0 111.972 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 153' ' ' GLU . 83.6 mt-30 -126.5 111.55 14.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.648 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.63 178.96 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -43.69 146.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.364 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -56.99 102.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.802 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.762 ' OE1' HG22 ' A' ' 124' ' ' THR . 39.7 mt-10 -155.36 -113.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.146 0.498 . . . . 0.0 110.276 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 32.6 mt -122.41 110.04 25.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.069 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 200' ' ' ASP . 32.2 p-10 -106.0 119.88 40.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -136.01 123.9 22.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.33 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.435 HD12 ' HD3' ' A' ' 193' ' ' PRO . 17.2 tt -107.35 138.77 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -166.05 152.67 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.405 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -115.79 110.96 19.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.446 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -97.52 143.72 27.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.489 ' OD2' ' NZ ' ' A' ' 117' ' ' LYS . 1.1 t0 -70.67 129.64 39.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.368 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -46.54 -33.74 4.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.352 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -64.43 -45.37 87.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.14 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -53.1 -49.09 67.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.965 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ILE . . . . . 0.419 HD12 HG21 ' A' ' 118' ' ' ILE . 96.3 mt -67.24 -19.76 25.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.805 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.42 -13.02 44.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.488 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -98.41 24.46 7.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.487 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.2 m -49.94 -36.49 28.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.797 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 76.5 mmm -53.69 -38.72 64.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.795 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -67.73 -26.26 66.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.662 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -93.65 133.87 36.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.518 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.4 t -113.96 -42.17 3.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.01 -44.06 97.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.748 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.0 mt -124.66 127.17 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.58 135.35 38.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.37 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.468 ' CZ ' ' CE3' ' A' ' 129' ' ' TRP . 53.5 m-85 -107.35 105.23 15.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.712 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.498 ' CE2' ' NE2' ' A' ' 173' ' ' GLN . 23.2 p90 -90.98 -36.57 14.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.423 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 222' ' ' TYR . 2.5 tp -51.19 -45.45 61.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.313 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 228' ' ' MET . 2.8 tp -73.31 -29.69 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.753 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -56.63 -43.56 80.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.552 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.1 t -63.66 -34.31 77.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.598 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 227' ' ' MET . 0.0 OUTLIER -86.76 -29.36 22.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.702 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 228' ' ' MET . . . . . 0.492 ' N ' ' O ' ' A' ' 224' ' ' ILE . 32.0 ttm -54.99 -40.32 69.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.354 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.509 HH11 ' CG ' ' A' ' 229' ' ' ARG . 0.1 OUTLIER -62.1 -64.08 3.48 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.532 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 37.2 Cg_endo -64.97 -47.88 4.36 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.291 1.994 . . . . 0.0 112.235 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 6.0 tt -51.05 -40.7 58.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.627 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 34.9 t -66.8 -49.05 67.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.04 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 8.3 tpp -60.17 -50.89 71.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.264 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.431 ' O ' ' OE1' ' A' ' 238' ' ' GLN . 13.0 m95 -53.83 -66.83 0.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.112 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.429 HD11 ' CZ ' ' A' ' 111' ' ' PHE . 87.3 mt -51.25 -32.32 23.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.027 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -67.35 -29.39 68.93 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.127 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -75.66 -53.64 8.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.751 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.431 ' OE1' ' O ' ' A' ' 234' ' ' TRP . 5.5 mp0 -56.42 -38.57 71.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.8 -26.74 64.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.61 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -72.82 -44.86 60.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.786 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 15.9 mm . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.039 -179.652 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.2 mttt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.1 ttmm -94.8 101.97 13.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.717 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.0 -32.78 7.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.121 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 103' ' ' ILE . 1.3 tt -117.03 108.17 44.61 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.308 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -79.06 140.86 16.13 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.732 1.622 . . . . 0.0 112.045 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.41 141.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.582 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -142.82 145.65 33.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.73 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -128.86 173.46 19.33 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.455 ' HB1' HD11 ' A' ' 182' ' ' ILE . . . -127.54 127.63 44.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 110.749 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.779 ' C ' HD13 ' A' ' 110' ' ' ILE . . . -111.24 113.48 25.99 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.639 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.815 HD13 ' N ' ' A' ' 110' ' ' ILE . 0.0 OUTLIER -110.29 139.6 33.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.018 0.437 . . . . 0.0 110.654 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -117.95 156.28 28.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.216 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.589 HD22 ' N ' ' A' ' 117' ' ' LYS . 14.4 p30 -58.64 172.68 0.48 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.164 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -64.69 -29.23 70.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.737 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -88.96 4.23 48.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.992 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 mp 43.43 43.29 4.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.452 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.437 ' H ' HD22 ' A' ' 112' ' ' ASN . 8.1 t -124.19 -5.23 7.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.726 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.589 ' N ' HD22 ' A' ' 112' ' ' ASN . 86.8 mttt -138.8 157.55 45.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.839 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 25.4 mm -109.66 140.04 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.99 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.514 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 2.2 tt -101.18 111.03 23.14 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.329 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.833 HD22 ' N ' ' A' ' 120' ' ' LEU . 1.7 mm? -104.44 161.0 14.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.0 m -137.69 162.99 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.314 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -98.26 127.45 44.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.63 -165.4 34.6 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 72.4 p -59.92 -24.07 64.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.362 . . . . 0.0 110.38 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.24 160.37 27.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.3 m -72.81 -102.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.97 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -77.07 72.14 3.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.414 ' C ' ' CG ' ' A' ' 129' ' ' TRP . 54.3 p -128.39 156.13 43.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.351 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.414 ' CG ' ' C ' ' A' ' 128' ' ' SER . 56.5 m95 -151.37 110.79 3.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.671 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.56 176.46 6.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.514 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 29.1 m-85 -77.53 153.72 81.37 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.92 149.61 59.75 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.934 1.756 . . . . 0.0 112.03 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.586 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -149.37 177.74 9.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.841 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 160.51 -174.81 37.26 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -79.17 143.47 35.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.64 0.257 . . . . 0.0 110.475 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.5 pt -110.81 152.52 12.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.465 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.8 m -65.08 145.55 56.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.504 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -93.32 161.13 14.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.413 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 63.0 34.79 13.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.511 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -137.13 145.18 43.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.377 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -60.63 130.72 47.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.127 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -50.55 -37.73 41.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.024 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.2 mt -68.77 -54.39 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.584 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -56.95 -37.52 71.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.304 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -32.05 73.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.144 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.44 ' O ' HG23 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -65.02 -48.9 72.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.682 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.52 -48.47 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.872 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -62.11 -40.49 96.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.527 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -82.61 -20.64 36.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.9 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.639 HG13 HD12 ' A' ' 154' ' ' ILE . 20.5 t -85.05 -51.54 13.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.631 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.27 -28.45 69.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.053 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -81.71 -36.34 28.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.899 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -82.11 -61.54 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.284 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.639 HD12 HG13 ' A' ' 150' ' ' VAL . 15.1 mt -72.79 -33.52 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.559 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.27 -14.3 59.7 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.53 ' CE2' ' O ' ' A' ' 157' ' ' ASP . 62.4 t80 -116.41 143.63 45.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.69 0.281 . . . . 0.0 110.506 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.53 ' O ' ' CE2' ' A' ' 156' ' ' PHE . 44.8 p30 -106.6 140.11 40.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.5 111.14 23.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.037 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.7 p -90.22 -61.61 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.721 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.436 ' OD1' ' CD2' ' A' ' 161' ' ' TYR . 55.6 p30 -107.45 8.74 29.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.564 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.436 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 79.1 m-85 -106.87 15.89 24.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 tt -117.38 140.04 41.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.705 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -69.04 148.19 50.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.151 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 165' ' ' ASN . 22.3 p-10 -76.37 -57.87 3.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.229 0.538 . . . . 0.0 111.54 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 91.0 m-20 -131.41 60.75 1.66 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.421 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.483 ' O ' ' CE1' ' A' ' 180' ' ' PHE . 50.0 tt0 -129.61 107.83 9.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.942 0.401 . . . . 0.0 110.387 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -152.94 162.32 41.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.379 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 24.1 pt -129.55 147.64 33.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -121.25 138.76 54.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.039 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.499 ' NH2' ' O ' ' A' ' 226' ' ' SER . 8.1 tpt180 -159.25 132.97 7.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.559 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -107.19 115.07 29.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 61.2 mt -109.48 129.33 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.442 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 52.1 43.24 30.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.385 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.44 -5.81 3.84 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -89.4 128.34 35.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 111.037 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -75.15 123.28 24.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.759 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -132.98 110.08 10.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.44 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -108.92 141.3 41.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.333 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.17 127.63 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.981 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.483 ' CE1' ' O ' ' A' ' 166' ' ' GLN . 1.9 t80 -95.76 123.99 39.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.481 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.69 126.28 29.52 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.494 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.455 HD11 ' HB1' ' A' ' 108' ' ' ALA . 0.8 OUTLIER -140.95 101.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.205 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.1 p -125.38 161.54 26.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.609 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 120.45 8.03 8.67 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 9.0 m -75.18 161.05 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.716 0.294 . . . . 0.0 110.465 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 62.2 m -104.61 158.46 16.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.804 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.91 -2.24 57.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.397 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 46.5 t -71.07 -27.85 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.508 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.448 ' CE1' ' O ' ' A' ' 190' ' ' ASN . 48.7 t80 -100.19 144.37 29.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.349 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.448 ' O ' ' CE1' ' A' ' 189' ' ' PHE . 9.3 p30 -97.99 125.38 42.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -104.83 126.65 52.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.339 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -127.23 149.68 70.3 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.238 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -70.04 143.57 49.88 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.079 1.853 . . . . 0.0 111.986 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -141.3 83.57 1.88 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.536 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.15 -165.0 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.324 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -45.58 152.61 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.142 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -62.39 109.39 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.617 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 2.2 tt0 -161.87 -113.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.057 0.456 . . . . 0.0 110.62 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.473 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 49.7 mt -113.97 131.91 64.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.429 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.08 101.05 6.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.39 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -137.69 140.97 41.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 119' ' ' LEU . 15.9 tt -113.65 140.38 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.455 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -144.55 120.71 10.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.549 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.09 101.5 13.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.172 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.436 ' HB2' HD23 ' A' ' 120' ' ' LEU . 2.2 m-85 -98.72 134.4 41.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.722 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 207' ' ' PHE . 65.2 t0 -72.17 139.94 48.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.486 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.461 ' N ' ' OD1' ' A' ' 206' ' ' ASP . 76.4 t80 -53.86 -31.21 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.566 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -50.76 -52.65 38.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.507 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -58.81 -43.83 90.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.801 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.491 HD13 HD13 ' A' ' 224' ' ' ILE . 83.8 mt -62.45 -35.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.585 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 60.4 p -68.35 -19.33 64.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.373 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -102.61 20.9 16.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.647 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.81 -31.3 1.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.477 ' C ' ' H ' ' A' ' 216' ' ' LYS . 34.0 mtt -54.75 -29.84 54.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.566 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.528 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 51.2 t80 -72.17 22.71 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.116 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 214' ' ' MET . 1.9 pttp -64.55 138.26 58.31 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.44 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.5 p -126.67 -21.46 4.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.707 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.694 ' OD1' HG22 ' A' ' 219' ' ' ILE . 22.5 t-20 -137.02 -102.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.661 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.694 HG22 ' OD1' ' A' ' 218' ' ' ASN . 17.1 tt -113.67 122.61 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.665 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -132.78 162.02 32.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.277 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.55 ' CD1' ' N ' ' A' ' 221' ' ' TYR . 0.1 OUTLIER -91.35 93.6 9.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.688 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -74.78 -10.05 59.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 79.8 mt -53.25 -51.78 61.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.691 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.491 HD13 HD13 ' A' ' 210' ' ' ILE . 15.6 tt -72.24 -29.94 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.8 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -54.28 -44.19 71.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.644 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.499 ' O ' ' NH2' ' A' ' 170' ' ' ARG . 75.3 m -68.68 -33.05 73.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.704 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 73.8 mtm -92.35 2.01 56.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 224' ' ' ILE . 38.2 ttp -60.56 -38.86 85.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.491 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.444 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -56.47 -64.62 2.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.677 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 17.7 Cg_endo -60.81 -52.02 4.16 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.111 1.874 . . . . 0.0 112.019 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.633 ' C ' HD23 ' A' ' 231' ' ' LEU . 6.4 tt -48.99 -50.84 33.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.594 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 23.0 t -64.19 -59.2 4.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.442 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 86.7 mtp -50.99 -53.5 32.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.746 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -62.04 -50.31 72.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.087 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 41.3 tp -57.78 -30.39 65.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.034 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -34.43 77.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.371 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -65.21 -43.27 92.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.686 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -58.91 -36.15 74.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.772 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -64.29 -32.41 73.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.017 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -65.71 -42.05 91.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 11.1 mm -65.24 -29.27 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.808 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -46.34 -27.7 1.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.201 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -54.34 165.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.494 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -68.08 -28.34 67.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.289 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.639 -179.921 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.6 tttp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -85.53 89.18 7.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.685 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.5 m -92.0 -29.43 16.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.491 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.83 107.83 28.56 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.346 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.36 141.52 11.41 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.025 1.817 . . . . 0.0 112.086 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.464 HG11 ' CZ ' ' A' ' 177' ' ' TYR . 2.7 t -127.86 141.84 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.863 ' HE ' HD12 ' A' ' 136' ' ' ILE . 45.7 ttp85 -123.14 152.1 41.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.458 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -125.94 156.83 19.72 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.492 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -103.55 161.15 14.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 0.0 110.844 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 180' ' ' PHE . . . -141.54 111.34 6.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.458 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.57 133.5 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.202 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.86 158.92 41.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.455 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 116' ' ' SER . 37.4 p-10 -55.3 166.42 0.6 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.296 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -63.9 -25.51 68.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.371 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -90.72 6.08 45.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.793 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.8 mt 45.31 44.23 8.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.623 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.605 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 0.7 OUTLIER -125.01 -2.03 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.639 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -133.29 149.42 51.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.2 mm -115.66 127.21 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.92 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.522 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 1.3 tt -89.03 105.61 17.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.563 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -118.78 157.2 28.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.226 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.35 174.35 11.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.762 0.315 . . . . 0.0 110.407 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -88.58 127.76 35.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.386 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.05 -176.04 39.37 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 124' ' ' THR . 25.5 p -52.25 -35.67 50.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 0.0 110.21 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -55.33 -176.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.003 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.2 m -85.21 -76.85 0.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.834 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -109.54 75.82 0.96 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.677 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.1 t -128.14 142.6 51.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.651 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.594 ' NE1' ' CE1' ' A' ' 221' ' ' TYR . 0.0 OUTLIER -122.94 111.88 17.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.449 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.2 168.76 26.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.808 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 43.5 m-85 -82.08 153.04 69.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.236 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -43.68 148.67 0.82 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.837 1.691 . . . . 0.0 111.45 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -126.43 170.01 12.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.648 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 175.12 177.38 44.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -97.35 147.39 24.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.739 0.304 . . . . 0.0 110.538 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.863 HD12 ' HE ' ' A' ' 106' ' ' ARG . 18.2 tt -133.53 140.56 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.594 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.7 m -71.65 150.33 44.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.501 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -93.84 156.24 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.548 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 56.87 42.66 26.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.436 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -142.48 158.57 43.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.011 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -58.09 124.73 20.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.881 0.372 . . . . 0.0 110.396 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 44.8 p-10 -77.95 -32.36 51.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.006 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.512 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 10.7 tp -65.32 -38.27 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 110.326 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.453 ' N ' HG23 ' A' ' 143' ' ' ILE . 63.6 t0 -72.32 -35.32 68.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.415 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 63.6 m -82.48 -37.43 25.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.01 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 142' ' ' ASP . 66.7 m -65.66 -53.06 46.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.815 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.3 tt -64.52 -35.68 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.19 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -65.81 -42.12 91.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.278 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -76.45 -34.87 58.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.97 0.414 . . . . 0.0 110.826 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.587 HG13 HD12 ' A' ' 154' ' ' ILE . 2.5 t -72.78 -49.8 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.99 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -65.52 -38.57 90.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.281 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -70.64 -37.48 73.77 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.965 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -77.52 -56.75 4.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.122 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.587 HD12 HG13 ' A' ' 150' ' ' VAL . 87.3 mt -71.49 -32.28 45.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.994 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.63 -8.43 78.65 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -104.17 125.99 50.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 110.485 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -91.29 126.58 36.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.765 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 8.5 mt -100.42 110.42 22.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.859 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.9 m -90.67 -61.7 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.703 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.514 ' OD1' ' CE2' ' A' ' 161' ' ' TYR . 49.8 p30 -101.7 2.92 39.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.262 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.514 ' CE2' ' OD1' ' A' ' 160' ' ' ASP . 20.9 m-85 -107.21 16.82 23.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.299 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 162' ' ' ILE . 10.8 tp -114.02 129.6 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 181' ' ' LEU . 91.1 m-20 -73.68 144.69 45.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.227 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -70.08 -66.95 0.53 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.461 0.648 . . . . 0.0 111.345 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -133.35 66.6 1.55 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.025 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.465 ' HG2' HD12 ' A' ' 181' ' ' LEU . 6.2 tt0 -128.51 108.56 10.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.539 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -152.89 157.74 41.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.651 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.5 mt -121.45 136.85 57.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.664 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 170' ' ' ARG . 0.9 OUTLIER -89.77 129.35 36.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.006 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.452 ' N ' ' OE1' ' A' ' 169' ' ' GLU . 12.4 tpp180 -149.93 114.63 5.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.55 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -110.24 116.01 30.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.405 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 15.9 pt -116.99 142.2 31.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.69 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.512 ' C ' ' H ' ' A' ' 175' ' ' LYS . 55.1 mt-30 51.97 41.09 29.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.413 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 63.67 -4.01 1.21 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.512 ' H ' ' C ' ' A' ' 173' ' ' GLN . 2.1 tppp? -89.64 125.23 35.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.409 . . . . 0.0 110.451 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -75.98 128.7 35.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.896 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.464 ' CZ ' HG11 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -139.47 119.3 13.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.457 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 107' ' ' GLY . 24.5 mttp -99.92 135.25 41.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.193 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 33.8 mm -113.03 120.23 62.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.96 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.73 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 3.6 t80 -97.65 120.75 38.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.962 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.465 HD12 ' HG2' ' A' ' 166' ' ' GLN . 14.2 mt -78.98 125.68 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.934 0.397 . . . . 0.0 110.874 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.3 mt -137.23 103.59 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.328 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 94.3 p -110.88 150.36 29.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.497 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 103.52 1.48 46.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.3 p -48.69 149.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 110.704 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.9 m -80.34 101.52 9.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.666 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -67.97 -23.85 65.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.7 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.8 m -74.79 -18.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.682 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -96.33 136.92 36.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.319 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -87.16 133.83 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.517 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -111.89 138.34 48.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.01 109.27 10.67 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.037 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.03 156.68 15.18 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.061 1.841 . . . . 0.0 112.68 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.68 115.07 19.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.089 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 10.4 m -134.3 -168.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.472 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -41.52 146.13 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.321 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -69.94 114.19 7.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.831 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 4.6 tt0 -172.53 -112.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.138 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.436 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 94.7 mt -109.05 120.42 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.519 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 200' ' ' ASP . 33.6 p-10 -123.18 101.07 7.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.28 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -137.04 140.4 42.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.655 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 71.5 mt -99.82 135.49 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.473 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -147.22 117.75 7.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.43 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' TRP . . . . . 0.445 ' CZ2' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -89.63 104.04 16.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.51 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -94.22 132.51 38.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.962 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -68.42 137.48 54.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.421 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -55.23 -43.16 74.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -60.43 -45.04 95.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.126 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 213' ' ' THR . 40.7 mttt -62.34 -38.81 90.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.053 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.549 HG21 HG21 ' A' ' 224' ' ' ILE . 90.1 mt -69.91 -30.06 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 9.6 m -66.88 -33.83 76.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.422 ' O ' ' OG1' ' A' ' 213' ' ' THR . 16.8 ptmt -105.44 -33.08 8.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.044 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 209' ' ' LYS . 17.3 p 55.13 65.25 1.54 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.642 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.468 ' C ' ' H ' ' A' ' 216' ' ' LYS . 12.2 tmm? -58.67 -28.27 65.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.48 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 63.3 t80 -67.7 8.77 0.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.114 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 214' ' ' MET . 20.7 tttt -59.7 120.77 10.13 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.824 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.3 p -132.29 -44.75 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.295 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 218' ' ' ASN . 1.0 OUTLIER -144.2 -39.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.447 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 45.1 pt -126.7 154.99 37.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.712 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.19 142.38 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.294 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.594 ' CE1' ' NE1' ' A' ' 129' ' ' TRP . 0.2 OUTLIER -67.06 118.87 11.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -97.63 -6.07 34.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.71 -42.33 91.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 228' ' ' MET . 35.8 mm -96.66 -40.04 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.278 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -48.3 -53.83 15.93 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.779 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 67.5 m -65.68 -38.99 90.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 110.376 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 27.7 ttm -74.59 -15.03 60.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.384 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' MET . . . . . 0.55 ' N ' ' O ' ' A' ' 224' ' ' ILE . 32.0 ttp -57.96 -42.86 85.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.794 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.445 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 5.3 mtt180 -56.58 -65.22 1.75 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.009 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 24.8 Cg_endo -61.58 -48.31 9.53 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.2 1.933 . . . . 0.0 112.42 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.3 tp -55.94 -39.56 71.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.783 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 37.1 t -63.49 -38.64 91.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.08 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 5.0 mtm -71.48 -52.12 20.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.147 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -55.99 -56.98 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.43 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 95.3 mt -54.86 -31.23 59.41 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.68 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -75.42 -28.7 59.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.389 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -72.87 -55.64 6.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.47 ' C ' ' N ' ' A' ' 240' ' ' GLN . 95.8 mm-40 -53.78 -39.39 65.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.543 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 -47.24 -15.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.355 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.47 ' N ' ' C ' ' A' ' 238' ' ' GLN . 3.0 tp-100 -82.69 -59.21 2.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 241' ' ' ILE . 7.6 tt -64.28 -10.15 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.622 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -50.62 -31.45 16.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.464 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -75.79 175.07 9.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.355 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -64.87 136.24 56.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 110.494 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.8 p30 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.669 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -142.51 67.0 1.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.446 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.9 t -73.42 -22.46 60.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.535 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -102.29 109.03 59.37 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.41 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.32 139.03 18.29 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.717 1.611 . . . . 0.0 112.565 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.84 148.13 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.209 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -140.15 158.72 43.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.278 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -138.84 178.18 19.62 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.471 ' O ' ' CB ' ' A' ' 131' ' ' PHE . . . -118.62 163.06 17.37 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.083 0.468 . . . . 0.0 111.289 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.37 113.0 8.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.998 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.488 HG23 HG11 ' A' ' 185' ' ' VAL . 4.0 mp -135.75 131.54 50.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.373 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.37 160.3 43.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.149 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -49.17 139.68 10.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.262 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.34 -30.24 50.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -85.88 6.73 27.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.516 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 mt 47.0 57.71 5.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.385 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.85 -16.67 7.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.933 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -137.07 157.52 46.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.399 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -128.17 132.49 68.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.188 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.509 ' O ' ' CZ ' ' A' ' 131' ' ' PHE . 0.6 OUTLIER -92.06 115.57 28.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.818 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.9 mt -126.34 163.61 22.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.075 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.4 m -143.34 156.69 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.403 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -101.96 150.58 23.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.635 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -134.93 -162.44 9.79 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.0 t -52.22 -27.63 15.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.773 0.321 . . . . 0.0 110.649 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.545 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 53.7 mp0 -55.27 153.7 6.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.189 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.7 t -68.23 -84.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.957 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -113.12 69.29 0.69 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 m -128.43 147.97 50.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.521 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.451 ' CD1' ' N ' ' A' ' 129' ' ' TRP . 1.3 m95 -133.77 116.3 15.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.26 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.448 ' OG ' HD13 ' A' ' 223' ' ' LEU . 0.7 OUTLIER -153.52 167.66 28.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.0 111.081 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.509 ' CZ ' ' O ' ' A' ' 119' ' ' LEU . 41.2 m-85 -77.5 153.9 81.49 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.508 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -41.46 144.76 0.68 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.791 1.661 . . . . 0.0 111.399 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.432 ' CZ ' ' OH ' ' A' ' 177' ' ' TYR . 7.9 ptm180 -139.01 174.85 10.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.747 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.59 177.16 47.68 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 110.23 21.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.711 0.291 . . . . 0.0 110.511 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.9 tt -128.1 136.48 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.541 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.5 m -64.78 157.39 27.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.594 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 22.8 mttp -93.09 178.09 5.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.722 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 6.8 t0 77.07 28.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.492 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -133.11 156.07 48.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.367 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.416 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 71.0 m-80 -58.81 127.66 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.623 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.491 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 67.4 m-20 -73.2 -39.24 65.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.155 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 144' ' ' ASP . 13.6 tt -61.82 -46.58 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.739 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.561 ' N ' HG23 ' A' ' 143' ' ' ILE . 18.4 t70 -68.64 -39.21 80.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.388 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 141' ' ' ASN . 89.0 m -72.92 -35.63 67.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.55 ' SG ' ' CD2' ' A' ' 180' ' ' PHE . 34.8 m -61.45 -53.96 49.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.721 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 83.9 mt -59.1 -41.64 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.729 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -64.74 -41.34 96.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.91 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.03 -31.6 61.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.957 0.408 . . . . 0.0 110.373 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.671 HG13 HD12 ' A' ' 154' ' ' ILE . 2.6 t -73.72 -47.97 41.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.088 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -23.59 63.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.584 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -78.39 -40.69 35.37 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.641 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.434 ' OE1' HG13 ' A' ' 195' ' ' VAL . 77.4 mm-40 -83.69 -58.01 2.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.459 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.671 HD12 HG13 ' A' ' 150' ' ' VAL . 90.0 mt -72.36 -33.67 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.803 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.27 -13.82 64.18 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.473 ' CD2' ' CE2' ' A' ' 189' ' ' PHE . 51.8 t80 -110.9 133.65 53.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.774 0.321 . . . . 0.0 110.223 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -96.81 141.76 29.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.138 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.7 mt -111.92 110.39 20.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.131 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.1 m -91.07 -62.02 1.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.425 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -106.37 1.74 25.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.036 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -99.92 16.46 23.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.576 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.585 ' HA ' HG23 ' A' ' 182' ' ' ILE . 7.4 tt -125.59 136.76 59.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.702 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -70.99 144.1 50.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.681 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.33 -28.74 15.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.478 . . . . 0.0 111.197 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -133.98 59.35 1.74 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.317 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -149.34 108.12 3.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.966 0.412 . . . . 0.0 110.116 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -159.9 158.43 30.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.385 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 169' ' ' GLU . 85.2 mt -133.59 155.58 40.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.714 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.475 ' N ' HG22 ' A' ' 168' ' ' ILE . 1.7 tm-20 -102.73 137.22 41.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.029 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 177' ' ' TYR . 64.4 mtt180 -140.82 112.18 7.35 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.923 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 175' ' ' LYS . 49.5 t-20 -119.72 111.78 18.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.431 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.467 HG22 ' HG3' ' A' ' 173' ' ' GLN . 62.3 mt -119.38 139.09 47.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.376 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.467 ' HG3' HG22 ' A' ' 172' ' ' ILE . 91.0 mt-30 53.16 36.95 23.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.634 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.48 -5.0 11.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 171' ' ' ASN . 49.4 mttp -85.29 119.46 25.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 0.0 110.404 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.1 118.77 19.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.903 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.432 ' OH ' ' CZ ' ' A' ' 133' ' ' ARG . 3.8 m-85 -131.99 109.17 9.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.566 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 107' ' ' GLY . 0.6 OUTLIER -102.78 139.74 37.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.75 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.9 mt -136.67 128.35 43.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.961 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.55 ' CD2' ' SG ' ' A' ' 146' ' ' CYS . 1.8 p90 -93.08 127.65 38.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.356 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' A' ' 168' ' ' ILE . 24.9 mt -74.01 139.86 45.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.082 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.585 HG23 ' HA ' ' A' ' 162' ' ' ILE . 59.9 mt -136.41 107.64 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.127 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 79.9 p -119.03 158.03 26.63 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.876 0.37 . . . . 0.0 110.483 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.68 16.43 48.88 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.488 HG11 HG23 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -94.36 115.73 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.038 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 54.1 m -63.3 151.38 40.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.415 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -99.41 6.29 46.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.354 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.15 -20.64 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.353 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 189' ' ' PHE . 1.3 p90 -99.72 128.03 45.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.913 0.387 . . . . 0.0 110.83 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -125.44 134.17 52.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.393 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.405 ' CZ ' HG23 ' A' ' 154' ' ' ILE . 3.5 p90 -112.15 159.27 18.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.588 ' N ' ' CD ' ' A' ' 192' ' ' LYS . 0.0 OUTLIER -105.19 161.49 22.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.262 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -38.34 116.13 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.918 2.412 . . . . 0.0 112.644 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -145.95 69.7 1.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.028 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.681 HG12 ' N ' ' A' ' 196' ' ' ARG . 38.7 t -139.67 173.61 10.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.638 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.681 ' N ' HG12 ' A' ' 195' ' ' VAL . 36.7 mtt85 -52.42 148.94 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.536 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.9 105.72 0.18 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.495 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 0.9 OUTLIER -171.97 -113.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.406 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.495 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 3.5 mm -123.57 120.03 58.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.246 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -129.77 111.75 12.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.818 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -142.06 128.01 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.234 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.13 136.14 38.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -150.82 126.66 10.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.324 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.13 110.4 22.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.408 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -103.92 150.83 23.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.022 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -65.82 124.4 22.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.867 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -46.04 -35.37 4.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.952 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -56.02 -32.87 64.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.636 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -48.31 -51.46 25.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.1 mt -66.41 -38.74 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 44.0 m -66.75 -45.04 79.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.796 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 214' ' ' MET . 28.8 mttt -56.72 -18.73 13.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.516 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 3.4 m -66.02 56.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.558 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 212' ' ' LYS . 48.8 mtt -95.51 -72.8 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.846 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.15 -9.92 54.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -77.4 106.74 9.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.88 0.371 . . . . 0.0 110.593 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 22.8 t -95.87 -14.08 23.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.646 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -44.4 -62.9 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 219' ' ' ILE . 18.7 tt -137.92 130.23 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.864 0.364 . . . . 0.0 111.072 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -138.93 147.62 42.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.371 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -108.69 86.22 2.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.542 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -50.5 -23.27 2.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.448 HD13 ' OG ' ' A' ' 130' ' ' SER . 75.4 mt -50.68 -57.18 8.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 228' ' ' MET . 76.7 mt -109.7 -28.53 2.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.857 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -53.3 -43.85 67.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.93 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.7 m -72.1 -42.23 66.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 227' ' ' MET . 0.0 OUTLIER -86.98 3.11 47.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.142 -179.541 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 228' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 224' ' ' ILE . 28.0 ttp -51.39 -31.69 23.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.052 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.454 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 2.2 mpp_? -66.76 -65.84 1.48 Allowed Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.345 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 10.3 Cg_endo -53.48 -39.21 83.0 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.039 1.826 . . . . 0.0 111.92 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.8 tt -68.67 -39.41 80.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.539 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 78.5 p -70.46 -34.21 72.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.751 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 13.7 mmt -70.85 -50.7 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.059 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -55.63 -57.35 12.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.859 0.361 . . . . 0.0 110.93 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -57.14 -25.83 59.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.047 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 -57.65 -42.73 84.06 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.066 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -60.8 -40.51 92.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.701 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -63.59 -30.97 72.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -73.09 -32.35 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.621 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.07 -40.55 85.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.687 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 13.5 mm -75.48 -39.75 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.698 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.31 -31.96 62.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.632 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 243' ' ' ASN . 21.2 p-10 -43.5 131.78 4.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.728 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -121.09 146.36 46.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.46 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 52.3 t0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.567 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.4 pttt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm -140.7 50.12 1.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.543 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.7 m -73.57 -21.98 60.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.42 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.9 mt -105.41 107.7 59.75 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.459 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.98 118.84 3.1 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 121.994 1.796 . . . . 0.0 112.154 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.42 141.51 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.982 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -137.19 141.65 42.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.001 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.2 146.77 17.42 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 131' ' ' PHE . . . -100.25 119.22 38.05 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.886 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -109.13 120.55 42.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.431 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mt -127.3 122.84 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.112 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -126.62 161.42 28.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.82 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -61.05 177.87 0.3 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.595 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -61.26 -39.52 90.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.05 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -123.87 39.55 3.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.746 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 235' ' ' LEU . 5.9 mp 51.05 36.57 15.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 93.2 p -67.08 -34.34 77.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -151.05 161.76 42.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.873 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.6 mm -118.89 123.14 71.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.537 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 4.5 tp -80.41 115.09 19.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.319 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.3 mt -123.08 157.23 33.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.615 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.6 163.36 33.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 0.0 110.406 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -93.69 130.46 39.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.634 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -100.91 -171.24 28.77 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.0 t -56.74 -29.41 62.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.625 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -54.94 -172.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.223 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.3 t -86.04 -120.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.716 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -81.21 71.14 8.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.812 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 m -128.3 147.6 50.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -126.49 122.29 34.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.385 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.1 t -166.39 166.42 16.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.946 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.537 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 39.4 m-85 -73.38 152.52 90.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.006 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.22 154.9 51.91 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.032 1.821 . . . . 0.0 112.196 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -131.6 172.16 12.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.206 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 169.21 179.02 40.92 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.7 mttm -101.88 154.64 18.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 pt -129.3 156.0 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.702 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.3 t -82.78 145.23 29.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.554 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -86.91 178.94 6.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.541 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 66.45 33.32 6.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.511 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -141.71 155.56 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.342 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -64.81 142.8 58.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.47 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.48 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 74.6 m-20 -58.32 -38.1 76.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 144' ' ' ASP . 20.8 tt -67.03 -39.1 82.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.773 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.45 ' N ' HG23 ' A' ' 143' ' ' ILE . 95.0 m-20 -66.86 -39.88 87.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.727 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 80.6 m -66.68 -42.53 86.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.771 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.576 ' SG ' ' CD2' ' A' ' 180' ' ' PHE . 64.9 m -62.5 -48.15 80.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.464 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 97.1 mt -60.45 -40.99 85.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.954 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -58.39 -44.14 88.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.003 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.431 ' O ' ' OE2' ' A' ' 153' ' ' GLU . 81.2 mm-40 -78.09 -37.19 46.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.885 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.461 HG11 HD13 ' A' ' 158' ' ' LEU . 2.6 t -70.34 -50.41 46.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.788 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -60.52 -29.51 69.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.559 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -80.32 -45.45 17.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.823 0.344 . . . . 0.0 110.652 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -70.41 -58.68 3.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.22 -179.418 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 154' ' ' ILE . 1.6 mp -72.35 -32.97 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 110.98 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.34 -13.66 61.39 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -119.69 135.04 54.99 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.854 0.359 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -92.61 128.88 38.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.725 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.766 ' N ' HD12 ' A' ' 158' ' ' LEU . 6.2 mp -91.73 113.3 25.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.547 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.5 p -90.02 -54.84 3.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 160' ' ' ASP . 57.0 t0 -105.0 -17.46 14.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.642 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -85.48 20.65 1.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.666 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.4 tt -117.91 136.93 53.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.494 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.54 152.95 43.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.369 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 165' ' ' ASN . 1.2 p30 -75.47 -66.02 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.384 0.612 . . . . 0.0 111.024 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.454 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 67.7 m-80 -130.21 67.72 1.47 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.171 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.53 ' HG3' HD12 ' A' ' 181' ' ' LEU . 2.4 tp-100 -132.16 107.13 8.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.901 0.381 . . . . 0.0 110.688 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.516 ' CD2' ' OE2' ' A' ' 169' ' ' GLU . 45.8 p90 -156.31 154.04 29.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.355 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 234' ' ' TRP . 6.6 tt -123.86 137.87 55.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.516 ' OE2' ' CD2' ' A' ' 167' ' ' PHE . 3.9 mp0 -116.69 133.42 56.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.036 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -160.23 148.43 16.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.987 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.97 112.29 24.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.997 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.4 pt -120.97 152.48 24.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.769 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 175' ' ' LYS . 42.0 mt-30 50.9 32.82 7.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.572 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.33 -25.25 0.72 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 173' ' ' GLN . 41.7 tttt -84.96 137.36 33.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.841 0.353 . . . . 0.0 110.816 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 176' ' ' ASN . 9.1 p-10 -74.94 131.97 41.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.037 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.14 115.48 13.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.494 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -108.37 138.22 45.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.7 mt -137.19 134.74 47.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.15 0.5 . . . . 0.0 111.816 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.576 ' CD2' ' SG ' ' A' ' 146' ' ' CYS . 4.4 t80 -100.26 122.36 42.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.783 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.53 HD12 ' HG3' ' A' ' 166' ' ' GLN . 25.8 mt -69.85 125.95 28.26 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.468 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 3.1 mm -130.58 103.15 7.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.301 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.8 t -130.4 153.23 48.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.625 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 107.31 -1.68 34.92 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 3.8 m -57.72 148.12 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.47 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.71 115.79 17.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.691 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -69.84 -22.03 63.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.57 -8.1 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.265 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -102.36 122.23 43.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.262 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -87.77 134.88 33.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.516 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -99.01 134.59 41.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.62 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.14 156.52 38.23 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.177 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.13 123.8 11.03 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.286 1.991 . . . . 0.0 112.027 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -147.78 69.65 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.766 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.04 -177.88 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.147 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -42.97 148.91 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.11 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -73.38 102.11 3.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 0.0 110.589 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -157.89 -113.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.119 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 57.3 mt -126.58 102.95 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.06 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -131.27 139.1 49.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.92 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -144.26 141.33 29.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.354 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 4.1 pt -102.9 128.5 55.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.76 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -158.03 135.82 10.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.256 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.28 104.49 16.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.498 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -83.81 125.81 32.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.736 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.04 132.44 49.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.266 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -51.13 -37.01 43.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.669 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.1 -36.7 80.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.039 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -59.69 -49.85 76.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.782 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 11.8 mt -56.35 -48.13 80.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.738 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 213' ' ' THR . 5.0 m -60.49 -32.65 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -73.29 20.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.757 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.482 ' H ' ' C ' ' A' ' 211' ' ' SER . 1.3 t -53.36 -31.83 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.556 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 10.8 tpp -47.44 -31.03 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.727 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.522 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 63.1 t80 -87.9 20.38 3.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.763 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 213' ' ' THR . 23.0 pttm -58.61 135.65 57.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.666 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 4.0 m -98.83 -45.53 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -163.59 16.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.682 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 17.1 tt -125.48 137.62 57.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.448 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -134.67 142.1 46.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -66.21 154.15 40.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.059 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -100.26 -73.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.9 tt -74.1 -56.43 4.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.1 mt -58.05 -32.5 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.61 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.459 ' CG ' ' N ' ' A' ' 226' ' ' SER . 0.1 OUTLIER -43.73 -57.9 2.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.393 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.459 ' N ' ' CG ' ' A' ' 225' ' ' ASN . 79.6 p -87.13 -27.81 22.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.435 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 65.9 mtp -84.95 1.7 46.2 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.95 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 224' ' ' ILE . 13.6 ttp -51.28 -37.11 45.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.965 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.459 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -64.9 -65.5 1.91 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.5 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 10.7 Cg_endo -55.42 -44.56 47.47 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.266 1.978 . . . . 0.0 112.258 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 231' ' ' LEU . 0.2 OUTLIER -52.56 -50.99 61.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.171 0.51 . . . . 0.0 110.155 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 28.8 p -71.39 -37.24 71.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.165 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 34.7 ttm -67.25 -62.03 1.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.261 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.622 ' CD1' HD12 ' A' ' 168' ' ' ILE . 45.4 m95 -45.88 -60.85 2.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.82 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.467 ' HB3' HD11 ' A' ' 115' ' ' LEU . 93.4 mt -52.91 -25.45 11.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 41.0 ttm-85 -61.23 -40.52 94.31 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.586 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -68.64 -44.34 74.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.052 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -52.97 -36.7 60.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.84 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -72.41 -28.95 63.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.214 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.16 -51.76 34.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 110.461 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 3.4 mm -64.53 -25.26 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.027 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -51.14 -50.52 58.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.215 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ASN . . . . . 0.566 ' N ' ' OD1' ' A' ' 243' ' ' ASN . 0.2 OUTLIER -79.08 127.16 31.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.376 . . . . 0.0 109.996 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.55 -33.21 74.47 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.615 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 62.9 t0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.441 179.917 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.6 tttm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 tttp 63.44 22.57 13.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.9 m -74.74 -31.82 61.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.083 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 103' ' ' ILE . 13.6 tt -124.36 108.66 29.28 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.809 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.2 137.38 10.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.978 1.785 . . . . 0.0 112.155 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.88 138.7 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.494 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -148.18 145.13 28.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.797 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.603 ' H ' HG22 ' A' ' 179' ' ' ILE . . . -133.24 168.52 23.0 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 180' ' ' PHE . . . -112.15 125.81 54.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.684 0.278 . . . . 0.0 111.036 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.5 117.25 33.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.429 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.88 133.92 65.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.138 0.494 . . . . 0.0 110.941 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -137.27 149.21 46.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.994 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.652 ' ND2' ' H ' ' A' ' 116' ' ' SER . 43.8 p-10 -50.42 155.19 1.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.994 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -57.81 -25.95 61.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.023 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -92.06 7.21 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.078 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.707 HD21 HD12 ' A' ' 235' ' ' LEU . 12.6 mt 42.93 52.5 5.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 0.0 110.532 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.652 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 0.5 OUTLIER -123.55 -13.7 7.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.112 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -133.24 146.42 51.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.261 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.6 mm -115.31 124.58 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.215 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 202' ' ' ILE . 1.2 tt -86.27 103.58 15.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.697 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.7 mt -117.83 162.82 17.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.129 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.15 160.19 40.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.488 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.586 ' NE2' ' O ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -98.89 114.33 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.336 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.586 ' O ' ' NE2' ' A' ' 122' ' ' GLN . . . -96.31 -151.66 28.26 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 87.5 m -53.97 -34.86 60.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 110.656 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -47.02 157.53 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.7 m -69.18 -70.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.852 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -133.53 69.61 1.47 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.508 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -127.45 143.21 51.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.33 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -113.21 115.35 28.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.326 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.9 t -156.87 164.88 37.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.681 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.544 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 44.6 m-85 -73.28 151.9 90.09 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -67.55 139.34 48.56 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.888 1.725 . . . . 0.0 111.667 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -125.0 177.99 5.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.566 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 158.68 179.8 33.79 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -86.63 145.84 26.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.707 0.289 . . . . 0.0 110.641 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.6 tt -127.1 147.33 32.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.219 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.7 p -70.13 153.09 43.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -112.61 176.58 4.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.179 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 53.89 42.33 31.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.258 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -148.44 158.76 44.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.363 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -58.7 125.62 24.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.525 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.421 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 23.3 p-10 -64.38 -39.42 93.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.138 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 7.0 tt -66.85 -37.39 79.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.498 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -69.79 -42.36 73.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.569 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 64.9 m -73.86 -40.18 63.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 142' ' ' ASP . 33.1 m -55.21 -52.89 61.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.24 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.15 -42.76 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -62.2 -41.3 98.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.337 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -79.25 -35.22 41.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.94 0.4 . . . . 0.0 110.561 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.11 -53.8 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -45.3 89.37 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.651 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.32 -28.63 65.21 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.515 ' OE2' HG12 ' A' ' 195' ' ' VAL . 27.3 mm-40 -89.23 -62.6 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 8.8 mt -84.96 -33.65 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.03 -13.37 60.48 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -102.69 135.27 44.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.0 110.385 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 25.0 p30 -106.86 127.45 53.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.814 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 mp -96.38 112.44 24.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.922 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.2 m -89.52 -61.88 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.74 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -98.97 0.19 43.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.122 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -109.63 21.11 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.63 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 162' ' ' ILE . 0.8 OUTLIER -111.91 133.04 58.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.641 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.504 ' H ' HD11 ' A' ' 182' ' ' ILE . 6.4 t0 -101.3 135.68 42.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.242 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -95.9 -10.81 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.938 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -133.74 56.7 1.84 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.303 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -150.53 107.65 3.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.316 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -164.77 166.5 19.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.62 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.519 HD11 HD11 ' A' ' 181' ' ' LEU . 63.4 mt -125.96 130.8 72.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.078 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -113.37 128.08 56.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.296 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.523 ' NH2' ' OG ' ' A' ' 226' ' ' SER . 0.0 OUTLIER -160.06 159.11 31.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.945 0.402 . . . . 0.0 110.911 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -104.48 102.59 12.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.938 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.47 HD13 ' HA ' ' A' ' 223' ' ' LEU . 83.7 mt -97.27 117.02 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.339 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 52.15 40.26 28.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.363 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 80.88 -20.09 6.87 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -83.97 124.32 30.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.412 . . . . 0.0 110.707 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -75.2 136.55 40.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.473 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.423 ' CD2' HD12 ' A' ' 172' ' ' ILE . 0.2 OUTLIER -128.35 140.56 51.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.284 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -143.92 94.86 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 107' ' ' GLY . 10.6 pt -112.57 145.67 18.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.022 0.439 . . . . 0.0 111.628 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 108' ' ' ALA . 11.2 p90 -99.89 132.43 45.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.598 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.639 ' O ' HD12 ' A' ' 182' ' ' ILE . 9.7 mt -91.48 129.06 37.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.548 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.0 OUTLIER -131.02 129.68 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.908 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.1 m -132.14 162.0 31.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.415 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.48 7.91 55.31 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.8 m -75.93 142.99 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.654 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 52.1 p -77.29 137.12 38.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.647 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.455 ' OE1' ' CZ2' ' A' ' 204' ' ' TRP . 70.9 mm-40 -96.55 -8.54 31.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.603 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.0 -27.73 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.473 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -98.23 123.62 42.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.4 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -106.57 132.75 52.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.665 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.68 152.73 39.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.574 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.53 157.23 38.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.291 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.51 142.96 41.56 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.343 2.029 . . . . 0.0 112.219 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -135.65 82.94 1.98 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.105 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.515 HG12 ' OE2' ' A' ' 153' ' ' GLU . 33.6 m -129.09 -177.59 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.719 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -48.46 145.77 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.52 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -46.21 102.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.698 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -147.3 -113.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.415 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.88 122.86 65.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.363 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -93.24 107.55 19.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.753 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -160.3 126.97 4.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.46 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.593 HD11 HD11 ' A' ' 119' ' ' LEU . 17.2 tt -127.32 154.21 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.46 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -167.71 156.59 9.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.698 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' TRP . . . . . 0.455 ' CZ2' ' OE1' ' A' ' 187' ' ' GLU . 0.0 OUTLIER -106.85 100.58 10.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.734 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.71 135.08 33.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.296 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -72.03 133.3 45.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.485 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -49.16 -32.08 9.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -59.2 -43.65 92.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.676 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -54.81 -32.27 60.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.364 . . . . 0.0 110.234 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.436 ' O ' ' OG1' ' A' ' 213' ' ' THR . 82.7 mt -79.17 -23.07 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.358 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.4 t -85.1 -10.66 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -95.44 10.07 37.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.769 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 210' ' ' ILE . 0.2 OUTLIER -43.07 -36.2 1.54 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.345 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 40.6 mtt -52.95 -33.82 52.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.352 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -66.8 -46.58 74.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.446 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 216' ' ' LYS . 11.1 ptmt -113.1 110.25 20.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 57.7 m -92.14 -10.41 38.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.841 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -58.76 -37.67 76.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.684 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 79.2 mt -128.94 134.05 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.539 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -130.43 145.03 51.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.642 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 225' ' ' ASN . 87.2 m-85 -104.66 86.85 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.427 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -66.1 -27.99 68.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.212 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.638 HD12 ' N ' ' A' ' 223' ' ' LEU . 7.8 mp -69.5 -39.13 77.77 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.778 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 228' ' ' MET . 97.0 mt -95.7 -40.2 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.676 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 221' ' ' TYR . 62.4 t-20 -59.98 -47.95 83.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.341 . . . . 0.0 110.561 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.523 ' OG ' ' NH2' ' A' ' 170' ' ' ARG . 7.9 t -68.84 -30.46 69.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.556 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 76.9 mtp -96.54 2.41 52.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 224' ' ' ILE . 18.7 ttt -48.33 -38.97 20.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.221 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.45 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -68.96 -65.51 1.26 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.602 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 19.6 Cg_endo -60.17 -47.56 14.5 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.213 1.942 . . . . 0.0 112.366 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 5.1 tt -56.2 -39.48 72.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.894 0.378 . . . . 0.0 110.626 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 68.9 m -75.74 -40.09 56.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.994 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 10.7 mmt -66.46 -52.89 41.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.289 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -55.06 -54.4 43.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.759 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.707 HD12 HD21 ' A' ' 115' ' ' LEU . 4.0 mm? -56.56 -22.16 31.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.599 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -42.16 72.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.658 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -61.96 -44.28 97.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.598 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.403 HE21 ' HA ' ' A' ' 235' ' ' LEU . 44.2 mt-30 -58.6 -34.64 71.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.673 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -62.07 -24.46 67.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -81.74 -58.72 2.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 6.1 tt -61.5 -12.26 6.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.41 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -50.76 -26.9 6.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.615 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -80.83 12.19 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 48.07 -120.66 1.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.594 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.575 -179.99 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.2 mttp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -108.65 79.9 1.28 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.644 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.0 m -73.51 -32.88 64.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.59 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 103' ' ' ILE . 17.0 tt -117.8 108.39 42.85 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.484 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -82.25 135.88 8.64 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.937 1.758 . . . . 0.0 112.224 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.53 140.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.048 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.1 ttp85 -123.74 146.76 48.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.802 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -122.86 149.44 16.86 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -101.87 142.42 33.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.865 0.364 . . . . 0.0 111.222 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.29 99.34 3.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.263 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.455 HG23 HG11 ' A' ' 185' ' ' VAL . 2.7 mp -108.79 142.2 22.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.505 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -127.34 163.94 22.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.145 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.725 HD21 ' H ' ' A' ' 116' ' ' SER . 26.1 p-10 -65.33 166.16 10.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.886 0.374 . . . . 0.0 110.875 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 185' ' ' VAL . 61.6 mm-40 -58.63 -33.45 70.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.621 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -89.43 6.98 38.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.988 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mp 42.91 45.23 4.26 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.592 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.725 ' H ' HD21 ' A' ' 112' ' ' ASN . 3.9 t -120.95 -9.24 9.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.01 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -136.8 170.32 16.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.771 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.409 ' O ' HG23 ' A' ' 118' ' ' ILE . 11.5 tt -134.03 131.41 55.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.758 0.313 . . . . 0.0 110.584 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.531 ' O ' ' CZ ' ' A' ' 131' ' ' PHE . 2.5 tt -83.11 127.71 33.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.205 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.528 HD22 ' O ' ' A' ' 119' ' ' LEU . 3.3 mm? -121.27 156.68 31.98 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.4 m -143.69 172.69 6.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.669 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.17 124.64 36.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.49 -165.86 32.17 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.462 ' OG1' ' NH2' ' A' ' 196' ' ' ARG . 40.3 m -47.22 -37.1 9.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.891 0.377 . . . . 0.0 110.221 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 125' ' ' GLU . 56.9 mp0 -51.4 160.06 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.04 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.7 t -64.61 -62.57 1.51 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.972 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -137.1 69.53 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.777 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 p -125.08 139.09 54.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.137 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.515 ' C ' HD12 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -94.37 110.45 22.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.586 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.402 ' N ' HD12 ' A' ' 120' ' ' LEU . 14.1 p -153.84 176.57 12.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.732 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 46.1 m-85 -97.83 152.6 38.19 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.317 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.8 155.71 67.85 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.968 1.779 . . . . 0.0 111.4 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -140.85 177.07 8.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.089 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 168.11 178.59 40.08 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -93.94 150.06 20.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.686 0.279 . . . . 0.0 110.617 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 16.6 pt -108.58 149.99 11.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.516 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.9 t -76.24 140.94 41.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.748 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 63.3 mttp -89.2 162.26 16.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.503 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 3.0 t70 75.37 1.89 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.645 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -114.36 155.33 26.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.474 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -64.58 143.77 57.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.379 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -55.37 -39.59 70.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.537 HG23 ' N ' ' A' ' 144' ' ' ASP . 6.7 tt -65.59 -42.59 93.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.709 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.537 ' N ' HG23 ' A' ' 143' ' ' ILE . 43.0 t0 -63.51 -33.14 74.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.692 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 13.8 m -78.27 -42.01 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.559 ' SG ' ' CG ' ' A' ' 180' ' ' PHE . 8.5 t -65.12 -50.53 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.021 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 148' ' ' ARG . 9.7 tt -61.11 -38.49 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.146 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.428 ' N ' ' CG2' ' A' ' 147' ' ' ILE . 17.0 ttm105 -71.32 -38.98 71.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.903 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 153' ' ' GLU . 85.3 tt0 -78.28 -29.82 48.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 110.445 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.3 t -74.17 -52.48 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.783 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -28.2 69.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.668 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -76.33 -41.11 49.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.714 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 149' ' ' GLU . 0.4 OUTLIER -75.35 -53.17 9.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 28.7 mm -71.0 -31.5 45.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 0.0 110.422 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 92.2 -14.31 64.88 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -115.96 133.09 56.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.725 0.298 . . . . 0.0 110.337 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 43.7 p-10 -96.61 125.1 40.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.036 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.409 ' H ' HD12 ' A' ' 158' ' ' LEU . 0.7 OUTLIER -112.13 110.43 20.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.078 179.511 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.0 p -91.0 -55.21 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 0.0 111.054 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -58.97 -39.15 80.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.307 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 184' ' ' GLY . 39.2 m-85 -90.82 18.74 6.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.052 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.659 HD13 ' H ' ' A' ' 163' ' ' ASP . 0.3 OUTLIER -87.4 134.6 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.985 0.421 . . . . 0.0 110.256 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.659 ' H ' HD13 ' A' ' 162' ' ' ILE . 66.7 m-20 -92.27 140.5 29.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.408 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -70.56 -66.18 0.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.339 0.59 . . . . 0.0 110.881 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -133.02 66.89 1.55 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.123 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.554 ' HG3' HD12 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -127.89 107.45 9.87 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.815 0.34 . . . . 0.0 110.606 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -167.23 159.31 12.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.181 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.654 HD11 HD11 ' A' ' 181' ' ' LEU . 3.2 mt -124.05 138.98 51.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.788 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -95.08 136.29 35.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.187 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.73 121.39 6.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.845 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -112.17 112.51 24.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.119 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.5 tt -109.3 132.46 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.261 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.45 ' C ' ' H ' ' A' ' 175' ' ' LYS . 78.9 mt-30 52.32 46.07 27.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.232 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.02 -3.27 1.66 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 173' ' ' GLN . 3.7 tptm -84.14 125.58 32.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.79 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -75.42 123.88 26.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.744 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -140.12 128.99 23.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.566 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 107' ' ' GLY . 26.0 ttmt -120.96 142.29 49.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.013 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.8 mm -123.15 121.29 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.598 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.559 ' CG ' ' SG ' ' A' ' 146' ' ' CYS . 0.2 OUTLIER -98.44 127.47 44.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.387 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 168' ' ' ILE . 47.2 mt -82.93 124.27 30.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 182' ' ' ILE . 3.1 tt -143.71 101.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.411 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.4 t -117.54 154.23 31.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.626 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.51 ' O ' ' CD1' ' A' ' 161' ' ' TYR . . . 106.95 10.07 28.94 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.455 HG11 HG23 ' A' ' 110' ' ' ILE . 1.5 m -67.97 138.99 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.659 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 32.9 t -66.81 120.69 13.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.429 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -85.44 -16.62 39.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.131 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 85.4 t -69.86 -28.13 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.566 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.52 ' CE1' ' O ' ' A' ' 190' ' ' ASN . 63.1 t80 -88.7 133.87 34.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.632 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.52 ' O ' ' CE1' ' A' ' 189' ' ' PHE . 33.5 p-10 -90.79 131.42 36.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.444 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -127.67 158.57 37.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.391 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -139.48 156.57 71.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.308 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.4 142.89 46.25 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.309 2.006 . . . . 0.0 112.09 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -131.02 69.8 1.47 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.458 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.698 HG23 ' N ' ' A' ' 196' ' ' ARG . 11.9 m -130.23 -138.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.698 ' N ' HG23 ' A' ' 195' ' ' VAL . 78.4 mtm-85 -52.75 146.03 11.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.029 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -74.38 108.88 7.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.373 . . . . 0.0 110.771 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.469 ' CG ' ' H ' ' A' ' 199' ' ' ILE . 1.0 OUTLIER -150.61 -113.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.54 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.469 ' H ' ' CG ' ' A' ' 198' ' ' GLU . 19.5 tt -130.39 136.7 57.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.471 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 200' ' ' ASP . 39.8 p-10 -102.68 114.54 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.736 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -133.33 123.18 24.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.389 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.97 146.76 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.421 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -165.89 140.83 4.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.601 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.38 112.91 26.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.481 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -104.83 151.7 23.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.625 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.03 127.79 34.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.4 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.05 -42.77 91.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.994 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -36.65 71.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -59.71 -46.34 89.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.175 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 45.4 pt -71.24 -19.53 20.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.144 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 44.0 m -82.5 -22.07 35.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.796 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -111.37 28.41 8.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 8.8 t -81.44 1.78 31.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.689 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 74.4 mtp -54.84 -30.69 58.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.383 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -67.61 -31.92 72.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.56 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -105.18 121.28 43.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.542 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.4 m -92.06 -11.59 35.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -55.65 -34.35 64.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.606 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.5 mt -125.65 134.05 67.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.506 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -133.65 156.08 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.569 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -113.97 135.95 53.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.364 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -101.49 -72.52 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.187 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.67 -50.86 55.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.177 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.4 mm -56.48 -47.45 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 110.679 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -52.25 -43.2 64.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.568 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.5 m -69.06 -38.37 79.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.983 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 55.4 mtt -88.37 -2.9 58.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.863 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' MET . . . . . 0.483 ' N ' ' O ' ' A' ' 224' ' ' ILE . 5.0 ttp -58.62 -44.04 89.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.721 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.441 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 23.0 mtm-85 -56.14 -64.1 2.67 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.312 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 20.1 Cg_endo -61.3 -51.11 4.73 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.28 1.987 . . . . 0.0 112.423 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -46.86 81.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.2 t -65.77 -38.54 89.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.026 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 49.2 ttm -60.52 -48.34 82.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.24 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.468 ' NE1' ' OE1' ' A' ' 166' ' ' GLN . 1.4 t-105 -70.54 -42.92 70.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.53 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.11 -37.87 81.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.379 . . . . 0.0 110.597 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -60.47 -36.15 77.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.796 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -69.28 -37.06 77.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.781 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -64.23 -29.58 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.052 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' A' ' 243' ' ' ASN . 88.5 mtt180 -72.57 -41.23 65.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 111.028 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.497 ' O ' ' ND2' ' A' ' 243' ' ' ASN . 50.9 mt-30 -58.32 -38.66 77.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.26 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 81.6 mt -70.94 -28.14 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.547 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -58.8 -38.14 77.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.732 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 240' ' ' GLN . 0.5 OUTLIER -84.56 108.31 17.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.941 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -66.49 -28.33 68.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.334 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 . . . . . 0 C--N 1.333 -0.139 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.667 179.874 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.1 pttp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -146.96 48.46 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.243 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 m -79.45 -30.47 42.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.957 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -100.98 108.47 54.51 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.596 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.73 127.4 6.31 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.93 1.753 . . . . 0.0 112.325 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 t -132.71 145.93 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.052 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' A' ' 107' ' ' GLY . 46.3 ttp85 -135.49 150.58 49.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.705 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -129.89 154.37 20.46 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -102.22 149.88 23.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.955 0.407 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -141.86 95.13 2.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.307 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.87 131.4 67.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 121.248 0.547 . . . . 0.0 111.573 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.6 159.39 39.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.92 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -55.95 151.35 11.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.864 0.364 . . . . 0.0 110.373 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -51.07 -40.47 58.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.809 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.625 HD21 ' HB3' ' A' ' 116' ' ' SER . 15.8 t30 -80.55 -1.21 41.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 0.0 110.554 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mt 53.41 56.04 7.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.665 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.625 ' HB3' HD21 ' A' ' 114' ' ' ASN . 39.8 p -122.23 -16.27 7.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.745 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -138.18 156.5 47.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.541 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.0 mm -112.75 136.07 50.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.049 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.526 ' C ' HD22 ' A' ' 120' ' ' LEU . 1.7 tt -102.8 110.91 22.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 111.194 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.823 HD22 ' N ' ' A' ' 120' ' ' LEU . 1.4 mm? -111.93 174.17 6.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.175 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 m -143.88 169.99 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.203 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.648 HE22 ' H ' ' A' ' 128' ' ' SER . 55.0 tp60 -109.04 134.44 51.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -125.37 -145.37 6.49 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 124' ' ' THR . 0.1 OUTLIER -52.67 -43.26 65.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 110.748 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -43.52 151.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.947 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.7 p -61.46 -83.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.025 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -126.67 70.15 1.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.475 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.648 ' H ' HE22 ' A' ' 122' ' ' GLN . 46.5 m -125.8 153.28 44.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.589 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 129' ' ' TRP . 0.9 OUTLIER -115.75 119.14 35.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.379 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 76.1 p -163.71 173.03 13.38 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.882 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 43.3 m-85 -83.29 152.05 63.87 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.207 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.93 142.93 39.8 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.848 1.699 . . . . 0.0 111.831 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -146.41 171.7 14.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.238 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.29 -169.53 34.33 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.97 137.23 35.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.664 0.268 . . . . 0.0 110.57 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 pt -114.02 157.1 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.384 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.9 m -64.59 144.15 57.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.435 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -92.17 173.88 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.636 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 59.63 37.28 22.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -136.36 162.51 32.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.253 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -79.4 146.03 33.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.466 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -49.34 -37.75 25.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.556 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 147' ' ' ILE . 50.0 mt -72.68 -43.84 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -62.31 -41.93 98.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.585 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -73.87 -39.13 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.934 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.593 ' SG ' ' CE1' ' A' ' 180' ' ' PHE . 43.9 t -69.82 -56.82 6.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.043 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 148' ' ' ARG . 2.1 tp -54.44 -39.98 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.005 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.448 ' N ' HG23 ' A' ' 147' ' ' ILE . 31.6 ttm180 -66.27 -39.38 89.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.908 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -76.91 -27.54 54.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.0 110.44 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.12 -54.56 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.846 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -26.72 67.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.903 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -84.75 -34.84 22.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 110.995 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -72.6 -60.48 2.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.677 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 21.8 mt -82.52 -33.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.776 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 104.5 -12.89 51.09 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -103.65 130.73 51.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.672 0.272 . . . . 0.0 110.455 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -104.49 148.46 26.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.985 0.421 . . . . 0.0 111.048 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.0 mt -106.27 115.22 29.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.815 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.31 -61.73 1.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.391 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.518 ' OD1' ' CD2' ' A' ' 161' ' ' TYR . 43.4 p-10 -104.47 0.43 28.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.105 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.518 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 68.3 m-85 -105.3 14.9 28.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.65 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 162' ' ' ILE . 10.1 tp -93.22 130.93 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.601 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.464 ' OD2' ' NE2' ' A' ' 166' ' ' GLN . 77.9 m-20 -72.03 153.54 41.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.364 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -85.57 -67.38 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.497 0.665 . . . . 0.0 111.123 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -132.06 70.46 1.47 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.759 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.464 ' NE2' ' OD2' ' A' ' 163' ' ' ASP . 13.7 tt0 -132.78 107.62 8.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.494 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.5 165.85 20.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.81 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 34.2 pt -128.53 146.3 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.537 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.48 135.01 54.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.265 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -159.74 137.38 9.89 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.661 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -102.93 112.99 26.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.352 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 54.9 mt -99.02 120.78 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.33 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.485 ' C ' ' H ' ' A' ' 175' ' ' LYS . 65.2 mt-30 54.0 49.69 18.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.79 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 69.52 -17.28 0.65 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 173' ' ' GLN . 42.4 mttt -85.4 134.04 34.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -75.16 131.56 40.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.594 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -134.98 105.24 6.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.608 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 107' ' ' GLY . 11.9 mmtp -100.05 130.64 46.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.334 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.96 127.51 61.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 111.081 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.593 ' CE1' ' SG ' ' A' ' 146' ' ' CYS . 0.3 OUTLIER -99.31 133.33 43.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.734 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.41 ' O ' ' OD2' ' A' ' 163' ' ' ASP . 8.8 mt -87.75 137.05 32.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.991 0.424 . . . . 0.0 111.285 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.57 106.64 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.904 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 p -125.24 151.33 46.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.402 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 117.29 -12.49 14.1 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 4.4 m -53.29 146.68 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 34.9 p -77.75 127.75 32.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.795 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -83.06 -10.79 58.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.43 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 25.2 m -72.52 -16.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.249 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -95.92 134.32 39.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.308 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -88.81 127.32 35.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.632 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.427 ' O ' HD13 ' A' ' 202' ' ' ILE . 85.1 m-85 -95.72 128.14 42.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.428 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -105.13 152.8 39.79 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.311 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.53 141.68 28.48 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.305 2.003 . . . . 0.0 112.436 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -149.51 78.18 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.98 177.07 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.756 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -51.73 154.05 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.113 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -46.25 102.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.287 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -150.81 -113.45 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.255 0.55 . . . . 0.0 110.407 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.5 mm -124.99 126.34 71.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.239 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.19 103.94 13.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.498 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.487 ' NZ ' ' OE2' ' A' ' 203' ' ' GLU . 61.4 tttm -163.69 134.87 4.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.012 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.427 HD13 ' O ' ' A' ' 191' ' ' PHE . 18.1 pt -120.9 154.24 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.241 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.487 ' OE2' ' NZ ' ' A' ' 201' ' ' LYS . 44.0 mt-10 -152.44 138.19 17.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.412 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.51 103.2 13.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.348 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.419 ' CE2' ' CE3' ' A' ' 129' ' ' TRP . 60.8 m-85 -105.93 152.72 22.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.904 0.383 . . . . 0.0 110.842 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -81.96 139.25 34.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.643 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -51.71 -55.51 19.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -56.61 -43.36 80.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.82 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -57.58 -48.4 79.48 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.883 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 87.5 mt -55.11 -25.11 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.482 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -89.89 -13.79 35.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -104.38 15.86 27.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.071 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 15.3 p -81.29 10.9 4.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 110.74 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 70.8 mtm -53.96 -35.29 61.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.315 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -55.87 -34.53 65.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.449 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -100.07 109.04 21.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.557 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 82.5 p -92.78 -23.15 18.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.709 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -56.5 -42.4 78.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.542 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.1 mt -126.16 110.34 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.473 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -139.44 148.91 43.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.559 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 221' ' ' TYR . 0.0 OUTLIER -117.05 117.84 30.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.459 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -82.81 -35.72 26.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.042 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 223' ' ' LEU . 10.7 mp -53.69 -48.64 69.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.002 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 tp -69.23 -33.87 60.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.85 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' A' ' 221' ' ' TYR . 72.6 m-20 -58.85 -41.69 87.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.24 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 68.9 m -67.52 -38.32 84.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.053 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -83.44 2.77 35.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.155 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' MET . . . . . . . . . . . . . 42.1 ttp -52.42 -59.92 3.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.124 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.418 ' N ' ' CD ' ' A' ' 230' ' ' PRO . 6.3 mtm-85 -77.5 -51.22 1.94 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.143 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 229' ' ' ARG . 53.6 Cg_exo -49.39 -52.64 8.42 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.099 1.866 . . . . 0.0 112.154 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.34 -36.49 84.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.041 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 86.9 p -66.12 -36.33 82.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.824 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 79.3 mmm -67.4 -56.19 10.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.283 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 30.3 m95 -54.75 -57.91 9.66 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.064 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 97.1 mt -51.94 -24.7 6.79 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.41 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -61.42 -44.3 97.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 0.0 110.11 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -64.72 -44.06 91.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.852 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -59.62 -41.14 89.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.018 0.437 . . . . 0.0 110.597 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -63.98 -30.64 71.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 243' ' ' ASN . 42.2 tt0 -62.97 -41.39 99.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.498 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 10.9 mm -63.96 -37.34 79.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.695 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -57.16 -54.13 50.22 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.413 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 243' ' ' ASN . 38.0 p30 -90.4 138.96 31.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.535 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.8 -35.65 79.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.637 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.493 -179.962 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 41.3 tttm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -129.23 143.39 50.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.564 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.4 t -126.21 -18.75 4.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.635 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.693 HG23 ' O ' ' A' ' 103' ' ' ILE . 10.0 tt -119.21 108.44 40.2 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.278 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.83 130.52 6.73 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.987 1.791 . . . . 0.0 112.206 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -143.83 139.26 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.326 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.538 HH12 ' NZ ' ' A' ' 178' ' ' LYS . 57.7 mtp85 -132.59 149.6 52.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -137.93 -179.29 16.89 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.3 124.21 20.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.223 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 129.99 54.19 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.9 mt -122.88 136.39 59.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.244 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -124.3 153.06 42.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.682 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -56.16 149.18 16.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.294 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -52.29 -28.71 20.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.899 0.38 . . . . 0.0 110.228 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -95.81 3.46 53.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.371 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.446 ' CD2' HD11 ' A' ' 235' ' ' LEU . 6.1 mt 51.99 45.18 28.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.368 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 t -107.29 -21.47 12.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -140.11 176.51 8.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.3 tt -139.32 134.28 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.222 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.526 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 3.0 tt -82.69 126.98 32.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.012 0.434 . . . . 0.0 111.572 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.1 mt -133.23 152.2 51.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.466 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.41 170.99 13.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.615 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -99.48 143.53 29.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.94 -164.85 12.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.522 ' OG1' ' NH2' ' A' ' 196' ' ' ARG . 38.9 m -44.55 -35.75 2.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.262 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -47.39 156.87 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.151 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.6 t -70.08 -59.16 3.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.853 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -137.21 69.15 1.41 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.986 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 t -128.8 141.51 51.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.578 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -115.6 120.86 40.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.467 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.2 p -164.03 175.61 10.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.958 0.408 . . . . 0.0 110.937 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.526 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 36.7 m-85 -80.58 153.11 73.33 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.332 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.53 153.4 54.96 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.016 1.811 . . . . 0.0 112.175 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.707 ' H ' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -159.26 -173.92 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.521 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 175.69 -175.55 47.31 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -89.92 147.01 23.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.316 . . . . 0.0 110.712 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 1.1 pp -130.24 156.84 42.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.438 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.0 m -75.63 141.72 42.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.591 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -76.12 167.38 21.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.057 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 59.71 41.59 18.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.512 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -135.45 148.37 49.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -60.7 134.11 56.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.57 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 29.8 p-10 -63.76 -36.67 84.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.876 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.507 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 3.2 mm -60.09 -54.66 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.841 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -64.87 -38.97 92.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 1.1 m -60.58 -39.85 89.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.903 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 142' ' ' ASP . 71.1 m -63.69 -61.57 2.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.281 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.6 tp -60.93 -17.68 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.29 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.0 ttp85 -77.14 -48.41 17.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.704 0.288 . . . . 0.0 111.337 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -74.21 -35.28 63.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.019 0.438 . . . . 0.0 110.595 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.588 ' O ' HG22 ' A' ' 154' ' ' ILE . 2.5 t -57.12 -61.07 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.09 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 152' ' ' GLU . 16.3 pttm -58.71 -44.35 90.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.79 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 151' ' ' LYS . 47.0 tp10 -60.01 -45.39 92.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.48 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 133' ' ' ARG . 97.3 mt-10 -73.83 -58.15 3.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.84 HG23 ' H ' ' A' ' 156' ' ' PHE . 7.8 tt -71.31 -24.24 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.342 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 151' ' ' LYS . . . 82.89 8.63 85.57 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.84 ' H ' HG23 ' A' ' 154' ' ' ILE . 25.9 t80 -151.36 150.84 30.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -128.3 133.73 48.79 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.932 0.396 . . . . 0.0 111.53 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.84 154.35 25.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.741 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.9 p -72.76 -14.51 61.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.023 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -105.35 13.89 29.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.05 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.27 -7.63 59.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.84 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.4 tp -125.81 137.15 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -106.61 156.11 18.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.248 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 165' ' ' ASN . 3.4 p30 -69.08 -67.81 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.355 0.598 . . . . 0.0 111.052 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 32.6 t30 -134.43 60.72 1.69 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.111 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -145.27 107.9 4.45 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.556 -0.457 . . . . 0.0 111.013 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -156.36 163.84 39.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.309 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.9 tt -127.56 133.41 67.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -110.58 132.05 54.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.806 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -159.75 136.4 9.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.922 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -109.59 116.06 31.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.289 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 19.1 pt -119.74 150.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.612 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.471 ' C ' ' H ' ' A' ' 175' ' ' LYS . 85.1 mt-30 47.11 36.77 4.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.395 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 70.51 -14.65 1.31 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' A' ' 173' ' ' GLN . 51.1 mttm -88.51 129.33 35.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 110.907 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -75.08 120.99 21.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.503 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -117.24 125.21 50.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.993 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.538 ' NZ ' HH12 ' A' ' 106' ' ' ARG . 23.5 mtpt -122.44 129.85 52.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.676 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.7 mt -137.72 134.02 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.361 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.465 ' CZ ' ' SG ' ' A' ' 146' ' ' CYS . 0.0 OUTLIER -93.27 137.49 32.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.303 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.489 HD12 ' CD1' ' A' ' 234' ' ' TRP . 10.8 mt -95.32 125.93 40.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.709 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.14 106.26 3.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.709 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 63.6 p -111.35 154.82 24.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.408 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 99.52 13.23 38.84 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.6 m -88.77 147.33 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.719 0.295 . . . . 0.0 110.554 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 60.5 p -61.96 124.51 20.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.971 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -93.49 -5.56 48.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.579 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.39 -28.29 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.376 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.53 148.93 49.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.237 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -92.56 131.78 37.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.552 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.45 ' O ' HD13 ' A' ' 202' ' ' ILE . 63.2 m-85 -110.83 138.08 47.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.509 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -140.7 122.77 9.52 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.3 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.27 116.43 4.14 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.79 1.66 . . . . 0.0 112.321 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -106.13 99.78 9.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.328 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 32.0 m -147.42 -160.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.7 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.522 ' NH2' ' OG1' ' A' ' 124' ' ' THR . 12.5 mtp180 -42.72 148.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.614 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -70.95 117.2 12.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.538 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 1.9 tt0 -172.65 -111.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.489 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.514 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 58.9 mt -113.9 118.35 58.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.771 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 200' ' ' ASP . 2.9 p30 -128.47 100.49 5.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.045 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -139.88 138.63 35.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.592 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.45 HD13 ' O ' ' A' ' 191' ' ' PHE . 36.0 pt -109.16 145.09 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.199 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -156.78 133.55 10.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.301 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -101.21 113.52 26.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.271 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -107.83 148.54 29.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.047 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.73 136.71 43.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.101 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -51.53 -40.11 59.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.56 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -64.44 -39.78 94.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -60.35 -32.79 71.6 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.512 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 98.0 mt -71.84 -33.05 46.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 50.0 m -80.71 -28.41 36.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.636 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -12.11 61.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.585 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 52.5 p -50.91 -26.46 5.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 62.5 mtt -62.47 -35.36 79.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.604 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -69.4 -43.26 73.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.677 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -86.42 116.02 24.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.403 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 70.9 m -96.21 9.86 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.752 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -75.64 -68.93 0.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.505 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 219' ' ' ILE . 10.0 tp -132.09 123.57 51.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.524 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -138.12 159.28 42.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.385 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -106.48 101.7 11.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.557 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -66.15 -33.87 76.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.55 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 4.9 tp -55.51 -43.57 75.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.0 mm -86.85 -27.43 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.95 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -53.1 -45.67 68.34 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.744 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.1 m -69.82 -37.86 76.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.776 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 34.5 ttm -78.48 -23.79 46.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 224' ' ' ILE . 46.5 ttp -58.65 -38.74 78.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.457 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 2.2 mmm180 -54.31 -65.51 1.26 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.888 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 28.8 Cg_endo -62.56 -44.1 19.13 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.174 1.916 . . . . 0.0 111.85 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.7 tp -53.06 -35.28 59.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.855 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 33.7 t -72.89 -33.77 66.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.752 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 5.6 ttm -70.59 -59.54 2.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.21 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.489 ' CD1' HD12 ' A' ' 181' ' ' LEU . 4.7 t-105 -57.46 -49.32 76.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.946 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.446 HD11 ' CD2' ' A' ' 115' ' ' LEU . 30.0 tp -56.56 -29.02 61.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -41.57 97.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.541 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -57.02 -44.61 83.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.775 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -60.86 -34.71 75.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.966 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -70.44 -36.09 73.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.797 0.332 . . . . 0.0 110.827 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -64.28 -44.89 90.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.736 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.19 -31.13 50.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.821 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -55.91 -26.12 46.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.739 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 243' ' ' ASN . 33.2 p-10 -47.82 139.93 7.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.642 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -101.4 137.21 40.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.545 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.51 179.993 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.4 mttt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -87.18 5.13 39.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.655 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.8 p -73.72 -21.52 60.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.391 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.651 HG23 ' O ' ' A' ' 103' ' ' ILE . 1.3 tt -95.04 110.03 47.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.295 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.8 149.9 23.55 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.835 1.69 . . . . 0.0 112.366 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.21 145.89 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.983 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.543 ' NE ' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -143.59 160.23 41.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.615 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -133.0 161.44 24.12 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 131' ' ' PHE . . . -108.47 120.42 42.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.717 0.294 . . . . 0.0 110.905 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.521 ' HB2' ' CG1' ' A' ' 179' ' ' ILE . . . -103.38 126.92 50.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.422 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mt -124.96 129.25 73.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.972 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 3.5 m-85 -115.76 154.26 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.903 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.726 HD21 ' H ' ' A' ' 116' ' ' SER . 40.5 p-10 -60.02 148.84 34.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.556 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -48.74 -29.82 4.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.64 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -87.8 4.61 43.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.756 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.459 ' O ' ' NH1' ' A' ' 239' ' ' ARG . 1.1 mp 41.7 42.66 2.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.519 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.726 ' H ' HD21 ' A' ' 112' ' ' ASN . 0.1 OUTLIER -123.08 -10.4 8.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.18 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.614 ' NZ ' ' CD1' ' A' ' 204' ' ' TRP . 7.7 mtpm? -134.29 168.55 18.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.044 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.38 144.0 35.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 202' ' ' ILE . 4.8 tt -108.25 121.6 45.22 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.826 0.346 . . . . 0.0 111.008 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.0 mt -120.92 158.86 26.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.093 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.93 170.73 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.706 0.289 . . . . 0.0 110.309 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -93.19 119.79 32.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.758 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -96.18 -157.17 31.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.1 t -54.05 -34.73 60.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.435 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -51.47 158.08 0.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.162 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.6 m -65.72 -62.9 1.25 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.028 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -137.07 73.4 1.44 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.844 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -128.47 145.8 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.599 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.418 ' CD2' ' N ' ' A' ' 129' ' ' TRP . 0.1 OUTLIER -108.49 110.81 22.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.441 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.2 m -161.25 172.06 17.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.481 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 108' ' ' ALA . 37.8 m-85 -80.89 151.42 70.66 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.077 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.83 145.65 63.29 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.011 1.807 . . . . 0.0 111.984 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -104.7 171.78 7.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.793 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -174.42 -151.77 8.61 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -133.48 166.94 21.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.766 0.317 . . . . 0.0 110.532 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.3 mt -115.11 136.62 51.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.9 t -76.61 134.64 39.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.447 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -74.41 151.08 39.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.813 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 54.4 41.75 31.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.674 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -149.45 145.9 27.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.392 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -60.11 137.11 58.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.433 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -59.91 -32.35 70.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.517 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 147' ' ' ILE . 83.9 mt -61.37 -46.51 96.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.541 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -62.37 -37.4 85.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.723 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 47.6 m -72.34 -40.37 67.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.985 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 87.8 m -70.72 -54.69 10.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.508 HG23 ' N ' ' A' ' 148' ' ' ARG . 17.4 tt -57.63 -40.99 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.956 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.508 ' N ' HG23 ' A' ' 147' ' ' ILE . 67.6 ttt-85 -65.01 -39.5 93.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.945 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -78.67 -28.25 45.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.794 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.01 -51.28 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.814 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -36.68 80.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.937 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -71.75 -36.07 70.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.208 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.422 ' O ' ' OE1' ' A' ' 194' ' ' GLN . 86.6 tt0 -77.71 -59.73 2.66 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.414 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.567 HD13 ' CE2' ' A' ' 191' ' ' PHE . 23.1 mt -71.68 -32.38 45.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.763 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.62 -14.56 61.83 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -112.33 133.58 54.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.764 0.316 . . . . 0.0 110.227 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 48.4 p30 -95.03 151.89 18.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.042 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.5 mt -111.6 110.19 20.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.101 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 91.4 m -90.47 -61.7 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.828 0.347 . . . . 0.0 111.239 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -100.23 -5.98 26.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -98.89 16.75 21.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.829 0.347 . . . . 0.0 110.354 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.5 tt -107.71 137.85 36.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -79.9 147.22 31.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.401 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 164' ' ' ASP . 8.6 p-10 -75.62 -64.99 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.395 0.617 . . . . 0.0 111.008 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.48 ' H ' ' CG ' ' A' ' 164' ' ' ASP . 36.5 t30 -131.98 67.84 1.51 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.089 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.545 ' HG3' HD12 ' A' ' 181' ' ' LEU . 4.3 tp60 -129.84 107.49 9.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.322 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -154.73 156.59 36.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.267 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.9 mt -124.62 129.16 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.505 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -99.59 137.62 37.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 tpt85 -159.51 127.65 4.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.607 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -100.29 115.05 29.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.133 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.7 tt -112.67 131.72 63.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.635 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.482 ' C ' ' H ' ' A' ' 175' ' ' LYS . 89.3 mm-40 53.62 43.14 31.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.402 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 63.45 -4.2 1.04 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 173' ' ' GLN . 20.6 tttm -90.66 132.15 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 110.794 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -74.69 119.54 19.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.489 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -129.5 121.99 28.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.573 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 107' ' ' GLY . 55.1 mttp -120.5 144.19 48.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.957 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.521 ' CG1' ' HB2' ' A' ' 109' ' ' ALA . 0.9 OUTLIER -129.76 132.2 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -101.42 123.63 45.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.183 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.545 HD12 ' HG3' ' A' ' 166' ' ' GLN . 13.4 mt -84.01 126.92 33.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.607 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 3.7 pt -145.48 100.9 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.293 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.5 m -114.28 157.2 23.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.515 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 118.63 -6.21 14.17 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.426 HG13 ' H ' ' A' ' 185' ' ' VAL . 2.4 m -61.73 153.02 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.301 . . . . 0.0 110.363 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.6 ' OG ' HG22 ' A' ' 188' ' ' VAL . 20.8 t -98.46 132.89 43.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.613 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -73.59 -7.53 52.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.594 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.6 HG22 ' OG ' ' A' ' 186' ' ' SER . 11.9 m -69.83 -20.28 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.429 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 190' ' ' ASN . 10.8 t80 -86.2 151.86 23.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.351 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.446 ' N ' ' CD1' ' A' ' 189' ' ' PHE . 47.4 t30 -85.55 110.59 19.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.567 ' CE2' HD13 ' A' ' 154' ' ' ILE . 2.4 m-85 -96.89 124.01 40.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.207 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -140.62 147.43 48.96 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.436 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.93 149.46 42.15 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.139 1.893 . . . . 0.0 112.233 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.422 ' OE1' ' O ' ' A' ' 153' ' ' GLU . 89.0 mt-30 -142.41 78.37 1.62 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.203 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.84 -166.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.536 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -46.84 150.5 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.21 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -56.74 125.46 22.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.957 0.408 . . . . 0.0 110.918 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -171.37 -113.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.08 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 199' ' ' ILE . 0.8 OUTLIER -130.46 129.64 64.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.301 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -97.77 108.61 21.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.497 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -137.73 133.89 34.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.422 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.467 HD11 HD11 ' A' ' 119' ' ' LEU . 14.7 tt -121.76 141.82 40.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.169 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -144.84 131.29 19.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.177 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' TRP . . . . . 0.614 ' CD1' ' NZ ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -98.09 101.42 12.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.825 0.345 . . . . 0.0 110.207 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -95.88 136.43 36.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -66.4 131.21 45.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.481 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -62.02 -36.82 82.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' A' ' 208' ' ' LYS . 0.0 OUTLIER -52.44 -42.45 64.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.842 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -65.13 -42.89 93.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.663 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 213' ' ' THR . 96.1 mt -66.56 -26.4 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.554 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 83.9 p -80.49 -59.19 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.77 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 214' ' ' MET . 97.5 mttt -63.24 -48.3 78.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.764 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 210' ' ' ILE . 18.5 p 51.13 7.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.048 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.503 ' H ' ' C ' ' A' ' 212' ' ' LYS . 11.9 mmt -73.62 -43.23 60.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.898 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -72.98 -31.54 64.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.867 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -98.25 120.74 39.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 2.8 t -131.51 -29.42 1.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.43 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -54.81 -46.15 74.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.747 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.7 pt -136.14 144.51 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.692 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -139.32 151.41 46.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.582 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -85.82 81.78 8.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.305 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -49.89 -40.3 42.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.071 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 10.5 mt -57.7 -52.63 64.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.038 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 228' ' ' MET . 47.2 mt -78.39 -27.5 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -50.73 -34.8 28.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.648 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.4 m -76.07 -36.73 58.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.966 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 73.3 mtm -95.24 0.74 54.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.972 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' MET . . . . . 0.523 ' N ' ' O ' ' A' ' 224' ' ' ILE . 2.5 ppp? -62.87 -32.81 74.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.971 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.417 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 7.9 mtt180 -67.18 -63.35 2.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.059 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 29.5 Cg_endo -63.79 -40.83 26.82 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.014 1.809 . . . . 0.0 112.124 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.55 -41.79 90.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.559 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.452 ' O ' ' CG ' ' A' ' 236' ' ' ARG . 44.7 t -61.39 -39.09 89.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.587 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 86.3 mtp -73.57 -46.83 44.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -61.21 -51.51 68.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.738 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 41.8 tp -60.73 -35.72 77.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 110.305 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.452 ' CG ' ' O ' ' A' ' 232' ' ' SER . 9.4 mmt85 -64.26 -33.56 76.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.495 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.17 -43.24 74.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.48 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -53.59 -36.84 62.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.647 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.459 ' NH1' ' O ' ' A' ' 115' ' ' LEU . 62.2 mtp85 -57.12 -15.31 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.416 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -80.91 -52.46 7.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.967 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.18 -17.79 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.997 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -50.43 -50.01 53.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.63 151.72 23.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.958 0.409 . . . . 0.0 111.027 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -129.34 165.24 21.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.26 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 51.1 p30 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.485 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.544 ' HG3' HD21 ' A' ' 176' ' ' ASN . 81.7 tttt -141.46 60.83 1.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.68 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.8 m -73.41 -33.15 64.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.507 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.14 107.71 57.42 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.388 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -82.38 152.62 15.8 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 121.948 1.766 . . . . 0.0 112.33 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.76 127.05 66.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.959 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.59 ' NH1' ' SG ' ' A' ' 145' ' ' CYS . 97.0 mtt180 -132.1 144.11 50.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.292 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -134.71 165.98 24.39 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 131' ' ' PHE . . . -110.1 137.55 47.71 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.137 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.83 120.72 41.72 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.707 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mp -133.15 142.81 41.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.766 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.429 ' CZ ' HD11 ' A' ' 235' ' ' LEU . 0.1 OUTLIER -151.72 160.58 43.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.101 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -47.23 151.93 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.141 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 185' ' ' VAL . 87.1 mt-10 -63.25 -24.48 67.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.926 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -101.92 13.17 35.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.192 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.554 HD22 ' N ' ' A' ' 115' ' ' LEU . 3.9 mm? 50.65 47.25 24.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.109 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.05 -26.49 13.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.1 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.489 ' NZ ' ' OD2' ' A' ' 206' ' ' ASP . 21.2 mtpp -143.93 178.77 7.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.042 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.419 HG21 HD12 ' A' ' 210' ' ' ILE . 14.4 tt -140.74 131.54 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.431 . . . . 0.0 110.49 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.597 ' O ' HD22 ' A' ' 120' ' ' LEU . 0.8 OUTLIER -75.73 121.83 23.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.261 -179.217 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.597 HD22 ' O ' ' A' ' 119' ' ' LEU . 2.6 mm? -125.64 156.35 39.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.7 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.3 m -143.18 173.5 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.52 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -102.34 124.69 48.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.678 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.58 -165.69 36.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.762 HG22 ' OE1' ' A' ' 198' ' ' GLU . 47.0 p -61.1 -25.33 66.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 0.0 110.442 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.405 ' OE1' ' CB ' ' A' ' 128' ' ' SER . 56.7 mt-10 -51.78 165.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.25 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.5 m -67.37 -67.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.021 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -136.99 68.92 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.991 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.405 ' CB ' ' OE1' ' A' ' 125' ' ' GLU . 14.1 m -128.84 143.52 50.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.383 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.487 ' C ' HD12 ' A' ' 120' ' ' LEU . 9.7 m0 -107.68 118.73 37.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.604 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.6 m -156.24 170.33 22.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.759 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.524 ' CZ ' ' O ' ' A' ' 119' ' ' LEU . 39.9 m-85 -81.21 152.78 71.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.061 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.35 137.92 41.26 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.901 1.734 . . . . 0.0 111.735 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.529 ' NE ' ' OH ' ' A' ' 177' ' ' TYR . 45.1 ptt85 -150.07 -170.3 3.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.177 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.76 177.93 25.12 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -81.21 137.0 35.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.9 tt -125.95 155.38 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.451 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.4 p -64.72 157.51 27.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.633 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 65.1 mttm -89.88 -178.9 5.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.603 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 4.6 t0 77.7 38.15 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.406 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -137.77 158.7 43.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.567 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -84.9 151.38 24.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.398 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 36.3 p-10 -53.19 -37.07 61.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.622 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.582 HG23 ' N ' ' A' ' 144' ' ' ASP . 19.1 tt -79.75 -45.73 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.552 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.582 ' N ' HG23 ' A' ' 143' ' ' ILE . 57.2 t0 -62.56 -34.51 77.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.827 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.59 ' SG ' ' NH1' ' A' ' 106' ' ' ARG . 6.1 p -64.62 -41.03 96.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.589 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.676 ' O ' HG23 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -63.75 -46.04 87.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.298 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.526 ' N ' ' SG ' ' A' ' 146' ' ' CYS . 80.0 mt -59.34 -52.16 64.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.969 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -60.04 -40.77 90.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.548 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -79.06 -28.84 43.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.879 0.371 . . . . 0.0 110.726 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 146' ' ' CYS . 4.1 t -64.8 -50.99 72.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.719 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER -70.13 -44.33 69.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.933 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -47.15 -34.43 6.17 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.399 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 194' ' ' GLN . 78.2 mm-40 -91.61 -62.13 1.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.023 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 81.9 mt -81.04 -33.63 13.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 151' ' ' LYS . . . 100.6 -14.15 59.28 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -125.12 137.89 54.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.512 ' C ' HD12 ' A' ' 158' ' ' LEU . 50.1 p30 -135.17 156.92 48.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 111.036 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.796 ' N ' HD12 ' A' ' 158' ' ' LEU . 4.5 mp -103.01 122.91 45.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.958 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 24.0 p -90.4 -61.52 1.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.384 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -103.3 11.79 36.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.662 ' HB3' HD23 ' A' ' 158' ' ' LEU . 0.2 OUTLIER -106.82 17.7 22.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.838 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.777 ' CG2' HG23 ' A' ' 182' ' ' ILE . 2.6 pt -130.95 149.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.06 0.457 . . . . 0.0 111.184 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -71.2 156.19 39.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.649 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.62 -17.88 21.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.078 0.466 . . . . 0.0 110.936 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -134.34 58.02 1.78 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.362 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.675 ' HG2' HD12 ' A' ' 181' ' ' LEU . 38.3 tt0 -139.38 106.99 5.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.105 0.478 . . . . 0.0 110.679 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -166.09 163.32 18.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.651 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.0 pt -129.24 150.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.399 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 169' ' ' GLU . 1.2 pt-20 -144.18 96.43 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.684 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -127.72 153.0 47.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.468 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -106.15 122.11 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.495 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.426 HD11 ' SD ' ' A' ' 227' ' ' MET . 58.9 mt -103.72 121.8 55.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.353 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.498 ' NE2' ' CE2' ' A' ' 222' ' ' TYR . 87.2 mt-30 53.48 43.28 31.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.426 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.48 -11.53 12.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -86.42 124.62 32.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.8 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.544 HD21 ' HG3' ' A' ' 101' ' ' LYS . 11.6 p30 -74.3 119.99 19.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.464 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.529 ' OH ' ' NE ' ' A' ' 133' ' ' ARG . 0.2 OUTLIER -122.91 104.91 9.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.769 -179.403 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -108.18 129.89 55.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 54.7 mt -138.44 136.2 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.529 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -95.5 136.35 35.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.75 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.675 HD12 ' HG2' ' A' ' 166' ' ' GLN . 61.5 mt -84.75 133.32 34.36 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.854 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.777 HG23 ' CG2' ' A' ' 162' ' ' ILE . 65.0 mt -133.05 108.84 13.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.308 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.9 t -117.26 147.94 42.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.563 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 102.74 8.24 43.14 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.483 ' HA ' HD21 ' A' ' 158' ' ' LEU . 5.6 p -50.04 133.05 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 110.625 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 48.6 m -81.67 143.51 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.424 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -93.46 -9.73 37.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.365 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.64 -28.33 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.664 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -83.04 144.63 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.715 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -81.47 139.89 34.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.257 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -99.63 124.55 44.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.726 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -143.3 109.85 5.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.435 ' HD3' HD12 ' A' ' 202' ' ' ILE . 61.1 Cg_endo -79.18 136.76 13.05 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.736 1.624 . . . . 0.0 111.972 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 153' ' ' GLU . 83.6 mt-30 -126.5 111.55 14.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.648 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.63 178.96 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -43.69 146.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.364 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -56.99 102.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.802 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.762 ' OE1' HG22 ' A' ' 124' ' ' THR . 39.7 mt-10 -155.36 -113.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.146 0.498 . . . . 0.0 110.276 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 32.6 mt -122.41 110.04 25.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.069 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 200' ' ' ASP . 32.2 p-10 -106.0 119.88 40.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -136.01 123.9 22.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.33 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.435 HD12 ' HD3' ' A' ' 193' ' ' PRO . 17.2 tt -107.35 138.77 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -166.05 152.67 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.405 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -115.79 110.96 19.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.446 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -97.52 143.72 27.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.489 ' OD2' ' NZ ' ' A' ' 117' ' ' LYS . 1.1 t0 -70.67 129.64 39.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.368 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -46.54 -33.74 4.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.352 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -64.43 -45.37 87.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.14 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -53.1 -49.09 67.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.965 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ILE . . . . . 0.419 HD12 HG21 ' A' ' 118' ' ' ILE . 96.3 mt -67.24 -19.76 25.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.805 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.42 -13.02 44.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.488 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -98.41 24.46 7.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.487 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.2 m -49.94 -36.49 28.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.797 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 76.5 mmm -53.69 -38.72 64.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.795 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -67.73 -26.26 66.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.662 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -93.65 133.87 36.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.518 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.4 t -113.96 -42.17 3.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.01 -44.06 97.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.748 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.0 mt -124.66 127.17 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.58 135.35 38.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.37 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.468 ' CZ ' ' CE3' ' A' ' 129' ' ' TRP . 53.5 m-85 -107.35 105.23 15.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.712 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.498 ' CE2' ' NE2' ' A' ' 173' ' ' GLN . 23.2 p90 -90.98 -36.57 14.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.423 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 222' ' ' TYR . 2.5 tp -51.19 -45.45 61.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.313 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 228' ' ' MET . 2.8 tp -73.31 -29.69 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.753 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -56.63 -43.56 80.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.552 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.1 t -63.66 -34.31 77.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.598 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 227' ' ' MET . 0.0 OUTLIER -86.76 -29.36 22.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.702 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 228' ' ' MET . . . . . 0.492 ' N ' ' O ' ' A' ' 224' ' ' ILE . 32.0 ttm -54.99 -40.32 69.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.354 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.509 HH11 ' CG ' ' A' ' 229' ' ' ARG . 0.1 OUTLIER -62.1 -64.08 3.48 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.532 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 37.2 Cg_endo -64.97 -47.88 4.36 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.291 1.994 . . . . 0.0 112.235 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 6.0 tt -51.05 -40.7 58.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.627 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 34.9 t -66.8 -49.05 67.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.04 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 8.3 tpp -60.17 -50.89 71.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.264 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.431 ' O ' ' OE1' ' A' ' 238' ' ' GLN . 13.0 m95 -53.83 -66.83 0.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.112 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.429 HD11 ' CZ ' ' A' ' 111' ' ' PHE . 87.3 mt -51.25 -32.32 23.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.027 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -67.35 -29.39 68.93 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.127 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -75.66 -53.64 8.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.751 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.431 ' OE1' ' O ' ' A' ' 234' ' ' TRP . 5.5 mp0 -56.42 -38.57 71.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.8 -26.74 64.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.61 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -72.82 -44.86 60.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.786 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 15.9 mm -66.6 -28.67 44.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.039 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -52.82 -54.07 39.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.607 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 243' ' ' ASN . 0.0 OUTLIER -79.54 -45.69 18.77 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.762 0.315 . . . . 0.0 110.871 -179.624 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -92.46 105.54 17.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.62 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 65.7 t0 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.539 179.876 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.1 ttmm . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.836 0.35 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.0 -32.78 7.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.121 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 103' ' ' ILE . 1.3 tt -117.03 108.17 44.61 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.308 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -79.06 140.86 16.13 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.732 1.622 . . . . 0.0 112.045 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.41 141.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.582 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -142.82 145.65 33.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.73 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -128.86 173.46 19.33 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.455 ' HB1' HD11 ' A' ' 182' ' ' ILE . . . -127.54 127.63 44.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 110.749 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.779 ' C ' HD13 ' A' ' 110' ' ' ILE . . . -111.24 113.48 25.99 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.639 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.815 HD13 ' N ' ' A' ' 110' ' ' ILE . 0.0 OUTLIER -110.29 139.6 33.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.018 0.437 . . . . 0.0 110.654 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -117.95 156.28 28.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.216 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.742 HD21 ' N ' ' A' ' 116' ' ' SER . 0.0 OUTLIER -58.64 172.68 0.48 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.164 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -64.69 -29.23 70.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.737 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.96 4.23 48.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.992 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.402 ' CA ' ' ND2' ' A' ' 112' ' ' ASN . 1.5 mp 43.43 43.29 4.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.452 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.742 ' N ' HD21 ' A' ' 112' ' ' ASN . 8.1 t -124.19 -5.23 7.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.726 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.466 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 86.8 mttt -138.8 157.55 45.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.839 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 25.4 mm -109.66 140.04 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.99 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.514 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 2.2 tt -101.18 111.03 23.14 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.329 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.833 HD22 ' N ' ' A' ' 120' ' ' LEU . 1.7 mm? -104.44 161.0 14.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.0 m -137.69 162.99 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.314 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -98.26 127.45 44.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.63 -165.4 34.6 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 72.4 p -59.92 -24.07 64.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.362 . . . . 0.0 110.38 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.24 160.37 27.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.3 m -72.81 -102.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.97 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -77.07 72.14 3.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.414 ' C ' ' CG ' ' A' ' 129' ' ' TRP . 54.3 p -128.39 156.13 43.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.351 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.414 ' CG ' ' C ' ' A' ' 128' ' ' SER . 56.5 m95 -151.37 110.79 3.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.671 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.56 176.46 6.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.514 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 29.1 m-85 -77.53 153.72 81.37 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.92 149.61 59.75 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.934 1.756 . . . . 0.0 112.03 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.586 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -149.37 177.74 9.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.841 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 160.51 -174.81 37.26 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -79.17 143.47 35.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.64 0.257 . . . . 0.0 110.475 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.5 pt -110.81 152.52 12.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.465 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.8 m -65.08 145.55 56.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.504 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -93.32 161.13 14.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.413 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 63.0 34.79 13.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.511 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -137.13 145.18 43.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.377 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -60.63 130.72 47.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.127 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -50.55 -37.73 41.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.024 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.2 mt -68.77 -54.39 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.584 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -56.95 -37.52 71.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.304 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -32.05 73.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.144 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.44 ' O ' HG23 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -65.02 -48.9 72.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.682 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.52 -48.47 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.872 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -62.11 -40.49 96.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.527 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -82.61 -20.64 36.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.9 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.639 HG13 HD12 ' A' ' 154' ' ' ILE . 20.5 t -85.05 -51.54 13.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.631 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.27 -28.45 69.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.053 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -81.71 -36.34 28.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.899 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -82.11 -61.54 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.284 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.639 HD12 HG13 ' A' ' 150' ' ' VAL . 15.1 mt -72.79 -33.52 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.559 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.27 -14.3 59.7 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.53 ' CE2' ' O ' ' A' ' 157' ' ' ASP . 62.4 t80 -116.41 143.63 45.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.69 0.281 . . . . 0.0 110.506 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.53 ' O ' ' CE2' ' A' ' 156' ' ' PHE . 44.8 p30 -106.6 140.11 40.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.5 111.14 23.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.037 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.7 p -90.22 -61.61 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.721 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.436 ' OD1' ' CD2' ' A' ' 161' ' ' TYR . 55.6 p30 -107.45 8.74 29.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.564 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.436 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 79.1 m-85 -106.87 15.89 24.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 tt -117.38 140.04 41.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.705 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -69.04 148.19 50.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.151 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 165' ' ' ASN . 22.3 p-10 -76.37 -57.87 3.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.229 0.538 . . . . 0.0 111.54 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 91.0 m-20 -131.41 60.75 1.66 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.421 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.483 ' O ' ' CE1' ' A' ' 180' ' ' PHE . 50.0 tt0 -129.61 107.83 9.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.942 0.401 . . . . 0.0 110.387 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -152.94 162.32 41.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.379 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 24.1 pt -129.55 147.64 33.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -121.25 138.76 54.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.039 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.499 ' NH2' ' O ' ' A' ' 226' ' ' SER . 8.1 tpt180 -159.25 132.97 7.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.559 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -107.19 115.07 29.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 61.2 mt -109.48 129.33 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.442 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 52.1 43.24 30.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.385 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.44 -5.81 3.84 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -89.4 128.34 35.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 111.037 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -75.15 123.28 24.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.759 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -132.98 110.08 10.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.44 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -108.92 141.3 41.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.333 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.17 127.63 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.981 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.483 ' CE1' ' O ' ' A' ' 166' ' ' GLN . 1.9 t80 -95.76 123.99 39.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.481 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.69 126.28 29.52 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.494 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.455 HD11 ' HB1' ' A' ' 108' ' ' ALA . 0.8 OUTLIER -140.95 101.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.205 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.1 p -125.38 161.54 26.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.609 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 120.45 8.03 8.67 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 9.0 m -75.18 161.05 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.716 0.294 . . . . 0.0 110.465 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 62.2 m -104.61 158.46 16.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.804 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.91 -2.24 57.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.397 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 46.5 t -71.07 -27.85 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.508 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.448 ' CE1' ' O ' ' A' ' 190' ' ' ASN . 48.7 t80 -100.19 144.37 29.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.349 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.448 ' O ' ' CE1' ' A' ' 189' ' ' PHE . 9.3 p30 -97.99 125.38 42.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -104.83 126.65 52.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.339 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -127.23 149.68 70.3 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.238 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -70.04 143.57 49.88 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.079 1.853 . . . . 0.0 111.986 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -141.3 83.57 1.88 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.536 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.15 -165.0 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.324 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -45.58 152.61 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.142 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.39 109.39 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.617 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 2.2 tt0 -161.87 -113.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.057 0.456 . . . . 0.0 110.62 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.473 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 49.7 mt -113.97 131.91 64.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.429 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.08 101.05 6.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.39 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -137.69 140.97 41.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 119' ' ' LEU . 15.9 tt -113.65 140.38 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.455 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -144.55 120.71 10.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.549 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.09 101.5 13.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.172 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.436 ' HB2' HD23 ' A' ' 120' ' ' LEU . 2.2 m-85 -98.72 134.4 41.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.722 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 207' ' ' PHE . 65.2 t0 -72.17 139.94 48.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.486 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.461 ' N ' ' OD1' ' A' ' 206' ' ' ASP . 76.4 t80 -53.86 -31.21 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.566 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -50.76 -52.65 38.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.507 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -58.81 -43.83 90.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.801 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.491 HD13 HD13 ' A' ' 224' ' ' ILE . 83.8 mt -62.45 -35.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.585 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 60.4 p -68.35 -19.33 64.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.373 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -102.61 20.9 16.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.647 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.81 -31.3 1.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.477 ' C ' ' H ' ' A' ' 216' ' ' LYS . 34.0 mtt -54.75 -29.84 54.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.566 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.528 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 51.2 t80 -72.17 22.71 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.116 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 214' ' ' MET . 1.9 pttp -64.55 138.26 58.31 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.44 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.5 p -126.67 -21.46 4.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.707 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.694 ' OD1' HG22 ' A' ' 219' ' ' ILE . 22.5 t-20 -137.02 -102.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.661 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.694 HG22 ' OD1' ' A' ' 218' ' ' ASN . 17.1 tt -113.67 122.61 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.665 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -132.78 162.02 32.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.277 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.55 ' CD1' ' N ' ' A' ' 221' ' ' TYR . 0.1 OUTLIER -91.35 93.6 9.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.688 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -74.78 -10.05 59.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 79.8 mt -53.25 -51.78 61.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.691 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.491 HD13 HD13 ' A' ' 210' ' ' ILE . 15.6 tt -72.24 -29.94 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.8 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -54.28 -44.19 71.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.644 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.499 ' O ' ' NH2' ' A' ' 170' ' ' ARG . 75.3 m -68.68 -33.05 73.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.704 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 73.8 mtm -92.35 2.01 56.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 224' ' ' ILE . 38.2 ttp -60.56 -38.86 85.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.491 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.444 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -56.47 -64.62 2.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.677 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 17.7 Cg_endo -60.81 -52.02 4.16 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.111 1.874 . . . . 0.0 112.019 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.633 ' C ' HD23 ' A' ' 231' ' ' LEU . 6.4 tt -48.99 -50.84 33.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.594 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 23.0 t -64.19 -59.2 4.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.442 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 86.7 mtp -50.99 -53.5 32.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.746 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -62.04 -50.31 72.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.087 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 41.3 tp -57.78 -30.39 65.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.034 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -34.43 77.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.371 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -65.21 -43.27 92.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.686 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -58.91 -36.15 74.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.772 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -64.29 -32.41 73.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.017 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -65.71 -42.05 91.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 11.1 mm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.808 -179.725 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.838 0.351 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.5 m -92.0 -29.43 16.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.491 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.83 107.83 28.56 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.346 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.36 141.52 11.41 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.025 1.817 . . . . 0.0 112.086 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.464 HG11 ' CZ ' ' A' ' 177' ' ' TYR . 2.7 t -127.86 141.84 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.863 ' HE ' HD12 ' A' ' 136' ' ' ILE . 45.7 ttp85 -123.14 152.1 41.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.458 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -125.94 156.83 19.72 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.492 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -103.55 161.15 14.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 0.0 110.844 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 180' ' ' PHE . . . -141.54 111.34 6.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.458 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.57 133.5 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.202 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.86 158.92 41.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.455 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 116' ' ' SER . 37.4 p-10 -55.3 166.42 0.6 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.296 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -63.9 -25.51 68.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.371 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -90.72 6.08 45.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.793 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.8 mt 45.31 44.23 8.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.623 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.605 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 0.7 OUTLIER -125.01 -2.03 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.639 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -133.29 149.42 51.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.2 mm -115.66 127.21 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.92 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.522 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 1.3 tt -89.03 105.61 17.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.563 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -118.78 157.2 28.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.226 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.35 174.35 11.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.762 0.315 . . . . 0.0 110.407 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -88.58 127.76 35.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.386 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.05 -176.04 39.37 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 124' ' ' THR . 25.5 p -52.25 -35.67 50.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 0.0 110.21 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -55.33 -176.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.003 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.2 m -85.21 -76.85 0.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.834 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -109.54 75.82 0.96 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.677 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.1 t -128.14 142.6 51.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.651 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.594 ' NE1' ' CE1' ' A' ' 221' ' ' TYR . 0.0 OUTLIER -122.94 111.88 17.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.449 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.2 168.76 26.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.808 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 43.5 m-85 -82.08 153.04 69.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.236 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -43.68 148.67 0.82 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.837 1.691 . . . . 0.0 111.45 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -126.43 170.01 12.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.648 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 175.12 177.38 44.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -97.35 147.39 24.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.739 0.304 . . . . 0.0 110.538 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.863 HD12 ' HE ' ' A' ' 106' ' ' ARG . 18.2 tt -133.53 140.56 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.594 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.7 m -71.65 150.33 44.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.501 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -93.84 156.24 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.548 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 56.87 42.66 26.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.436 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -142.48 158.57 43.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.011 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -58.09 124.73 20.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.881 0.372 . . . . 0.0 110.396 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 44.8 p-10 -77.95 -32.36 51.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.006 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.512 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 10.7 tp -65.32 -38.27 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 110.326 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.453 ' N ' HG23 ' A' ' 143' ' ' ILE . 63.6 t0 -72.32 -35.32 68.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.415 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 63.6 m -82.48 -37.43 25.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.01 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 142' ' ' ASP . 66.7 m -65.66 -53.06 46.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.815 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.3 tt -64.52 -35.68 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.19 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -65.81 -42.12 91.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.278 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -76.45 -34.87 58.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.97 0.414 . . . . 0.0 110.826 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.587 HG13 HD12 ' A' ' 154' ' ' ILE . 2.5 t -72.78 -49.8 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.99 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -65.52 -38.57 90.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.281 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -70.64 -37.48 73.77 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.965 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -77.52 -56.75 4.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.122 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.587 HD12 HG13 ' A' ' 150' ' ' VAL . 87.3 mt -71.49 -32.28 45.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.994 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.63 -8.43 78.65 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -104.17 125.99 50.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 110.485 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -91.29 126.58 36.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.765 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 8.5 mt -100.42 110.42 22.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.859 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.9 m -90.67 -61.7 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.703 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.514 ' OD1' ' CE2' ' A' ' 161' ' ' TYR . 49.8 p30 -101.7 2.92 39.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.262 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.514 ' CE2' ' OD1' ' A' ' 160' ' ' ASP . 20.9 m-85 -107.21 16.82 23.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.299 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 162' ' ' ILE . 10.8 tp -114.02 129.6 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 181' ' ' LEU . 91.1 m-20 -73.68 144.69 45.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.227 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -70.08 -66.95 0.53 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.461 0.648 . . . . 0.0 111.345 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -133.35 66.6 1.55 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.025 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.465 ' HG2' HD12 ' A' ' 181' ' ' LEU . 6.2 tt0 -128.51 108.56 10.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.539 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -152.89 157.74 41.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.651 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.5 mt -121.45 136.85 57.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.664 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 170' ' ' ARG . 0.9 OUTLIER -89.77 129.35 36.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.006 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.452 ' N ' ' OE1' ' A' ' 169' ' ' GLU . 12.4 tpp180 -149.93 114.63 5.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.55 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -110.24 116.01 30.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.405 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 15.9 pt -116.99 142.2 31.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.69 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.512 ' C ' ' H ' ' A' ' 175' ' ' LYS . 55.1 mt-30 51.97 41.09 29.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.413 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 63.67 -4.01 1.21 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.512 ' H ' ' C ' ' A' ' 173' ' ' GLN . 2.1 tppp? -89.64 125.23 35.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.409 . . . . 0.0 110.451 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -75.98 128.7 35.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.896 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.464 ' CZ ' HG11 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -139.47 119.3 13.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.457 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 107' ' ' GLY . 24.5 mttp -99.92 135.25 41.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.193 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 33.8 mm -113.03 120.23 62.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.96 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.73 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 3.6 t80 -97.65 120.75 38.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.962 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.465 HD12 ' HG2' ' A' ' 166' ' ' GLN . 14.2 mt -78.98 125.68 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.934 0.397 . . . . 0.0 110.874 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.3 mt -137.23 103.59 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.328 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 94.3 p -110.88 150.36 29.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.497 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 103.52 1.48 46.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.3 p -48.69 149.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 110.704 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.9 m -80.34 101.52 9.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.666 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -67.97 -23.85 65.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.7 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.8 m -74.79 -18.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.682 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -96.33 136.92 36.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.319 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -87.16 133.83 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.517 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -111.89 138.34 48.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.01 109.27 10.67 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.037 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.03 156.68 15.18 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.061 1.841 . . . . 0.0 112.68 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.68 115.07 19.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.089 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 10.4 m -134.3 -168.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.472 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -41.52 146.13 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.321 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -69.94 114.19 7.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.831 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 4.6 tt0 -172.53 -112.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.138 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.436 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 94.7 mt -109.05 120.42 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.519 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 200' ' ' ASP . 33.6 p-10 -123.18 101.07 7.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.28 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -137.04 140.4 42.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.655 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 71.5 mt -99.82 135.49 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.473 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -147.22 117.75 7.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.43 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' TRP . . . . . 0.445 ' CZ2' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -89.63 104.04 16.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.51 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -94.22 132.51 38.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.962 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -68.42 137.48 54.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.421 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -55.23 -43.16 74.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -60.43 -45.04 95.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.126 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 213' ' ' THR . 40.7 mttt -62.34 -38.81 90.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.053 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.549 HG21 HG21 ' A' ' 224' ' ' ILE . 90.1 mt -69.91 -30.06 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 9.6 m -66.88 -33.83 76.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.422 ' O ' ' OG1' ' A' ' 213' ' ' THR . 16.8 ptmt -105.44 -33.08 8.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.044 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 209' ' ' LYS . 17.3 p 55.13 65.25 1.54 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.642 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.468 ' C ' ' H ' ' A' ' 216' ' ' LYS . 12.2 tmm? -58.67 -28.27 65.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.48 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 63.3 t80 -67.7 8.77 0.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.114 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 214' ' ' MET . 20.7 tttt -59.7 120.77 10.13 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.824 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.3 p -132.29 -44.75 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.295 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 218' ' ' ASN . 1.0 OUTLIER -144.2 -39.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.447 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 45.1 pt -126.7 154.99 37.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.712 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.19 142.38 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.294 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.594 ' CE1' ' NE1' ' A' ' 129' ' ' TRP . 0.2 OUTLIER -67.06 118.87 11.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -97.63 -6.07 34.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.71 -42.33 91.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 228' ' ' MET . 35.8 mm -96.66 -40.04 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.278 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -48.3 -53.83 15.93 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.779 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 67.5 m -65.68 -38.99 90.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 110.376 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 27.7 ttm -74.59 -15.03 60.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.384 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' MET . . . . . 0.55 ' N ' ' O ' ' A' ' 224' ' ' ILE . 32.0 ttp -57.96 -42.86 85.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.794 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.445 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 5.3 mtt180 -56.58 -65.22 1.75 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.009 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 24.8 Cg_endo -61.58 -48.31 9.53 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.2 1.933 . . . . 0.0 112.42 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.3 tp -55.94 -39.56 71.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.783 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 37.1 t -63.49 -38.64 91.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.08 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 5.0 mtm -71.48 -52.12 20.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.147 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -55.99 -56.98 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.43 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 95.3 mt -54.86 -31.23 59.41 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.68 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -75.42 -28.7 59.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.389 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -72.87 -55.64 6.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.47 ' C ' ' N ' ' A' ' 240' ' ' GLN . 95.8 mm-40 -53.78 -39.39 65.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.543 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 -47.24 -15.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.355 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.47 ' N ' ' C ' ' A' ' 238' ' ' GLN . 3.0 tp-100 -82.69 -59.21 2.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 241' ' ' ILE . 7.6 tt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.622 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.4 pttt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.879 0.371 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.9 t -73.42 -22.46 60.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.535 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -102.29 109.03 59.37 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.41 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.32 139.03 18.29 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.717 1.611 . . . . 0.0 112.565 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.84 148.13 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.209 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -140.15 158.72 43.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.278 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -138.84 178.18 19.62 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.471 ' O ' ' CB ' ' A' ' 131' ' ' PHE . . . -118.62 163.06 17.37 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.083 0.468 . . . . 0.0 111.289 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.37 113.0 8.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.998 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.488 HG23 HG11 ' A' ' 185' ' ' VAL . 4.0 mp -135.75 131.54 50.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.373 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.37 160.3 43.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.149 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -49.17 139.68 10.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.262 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.34 -30.24 50.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -85.88 6.73 27.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.516 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 mt 47.0 57.71 5.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.385 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.85 -16.67 7.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.933 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -137.07 157.52 46.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.399 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -128.17 132.49 68.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.188 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.509 ' O ' ' CZ ' ' A' ' 131' ' ' PHE . 0.6 OUTLIER -92.06 115.57 28.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.818 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.9 mt -126.34 163.61 22.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.075 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.4 m -143.34 156.69 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.403 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -101.96 150.58 23.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.635 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -134.93 -162.44 9.79 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.0 t -52.22 -27.63 15.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.773 0.321 . . . . 0.0 110.649 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.545 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 53.7 mp0 -55.27 153.7 6.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.189 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.7 t -68.23 -84.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.957 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -113.12 69.29 0.69 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 m -128.43 147.97 50.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.521 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.451 ' CD1' ' N ' ' A' ' 129' ' ' TRP . 1.3 m95 -133.77 116.3 15.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.26 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.448 ' OG ' HD13 ' A' ' 223' ' ' LEU . 0.7 OUTLIER -153.52 167.66 28.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.0 111.081 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.509 ' CZ ' ' O ' ' A' ' 119' ' ' LEU . 41.2 m-85 -77.5 153.9 81.49 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.508 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -41.46 144.76 0.68 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.791 1.661 . . . . 0.0 111.399 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.432 ' CZ ' ' OH ' ' A' ' 177' ' ' TYR . 7.9 ptm180 -139.01 174.85 10.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.747 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.59 177.16 47.68 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 110.23 21.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.711 0.291 . . . . 0.0 110.511 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.9 tt -128.1 136.48 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.541 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.5 m -64.78 157.39 27.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.594 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 22.8 mttp -93.09 178.09 5.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.722 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 6.8 t0 77.07 28.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.492 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -133.11 156.07 48.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.367 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.416 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 71.0 m-80 -58.81 127.66 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.623 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.491 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 67.4 m-20 -73.2 -39.24 65.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.155 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 144' ' ' ASP . 13.6 tt -61.82 -46.58 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.739 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.561 ' N ' HG23 ' A' ' 143' ' ' ILE . 18.4 t70 -68.64 -39.21 80.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.388 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 141' ' ' ASN . 89.0 m -72.92 -35.63 67.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.55 ' SG ' ' CD2' ' A' ' 180' ' ' PHE . 34.8 m -61.45 -53.96 49.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.721 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 83.9 mt -59.1 -41.64 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.729 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -64.74 -41.34 96.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.91 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.03 -31.6 61.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.957 0.408 . . . . 0.0 110.373 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.671 HG13 HD12 ' A' ' 154' ' ' ILE . 2.6 t -73.72 -47.97 41.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.088 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -23.59 63.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.584 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -78.39 -40.69 35.37 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.641 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.434 ' OE1' HG13 ' A' ' 195' ' ' VAL . 77.4 mm-40 -83.69 -58.01 2.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.459 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.671 HD12 HG13 ' A' ' 150' ' ' VAL . 90.0 mt -72.36 -33.67 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.803 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.27 -13.82 64.18 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.473 ' CD2' ' CE2' ' A' ' 189' ' ' PHE . 51.8 t80 -110.9 133.65 53.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.774 0.321 . . . . 0.0 110.223 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -96.81 141.76 29.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.138 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.7 mt -111.92 110.39 20.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.131 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.1 m -91.07 -62.02 1.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.425 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -106.37 1.74 25.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.036 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -99.92 16.46 23.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.576 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.585 ' HA ' HG23 ' A' ' 182' ' ' ILE . 7.4 tt -125.59 136.76 59.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.702 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -70.99 144.1 50.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.681 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.33 -28.74 15.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.478 . . . . 0.0 111.197 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -133.98 59.35 1.74 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.317 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -149.34 108.12 3.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.966 0.412 . . . . 0.0 110.116 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -159.9 158.43 30.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.385 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 169' ' ' GLU . 85.2 mt -133.59 155.58 40.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.714 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.475 ' N ' HG22 ' A' ' 168' ' ' ILE . 1.7 tm-20 -102.73 137.22 41.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.029 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 177' ' ' TYR . 64.4 mtt180 -140.82 112.18 7.35 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.923 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 175' ' ' LYS . 49.5 t-20 -119.72 111.78 18.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.431 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.467 HG22 ' HG3' ' A' ' 173' ' ' GLN . 62.3 mt -119.38 139.09 47.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.376 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.467 ' HG3' HG22 ' A' ' 172' ' ' ILE . 91.0 mt-30 53.16 36.95 23.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.634 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.48 -5.0 11.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 171' ' ' ASN . 49.4 mttp -85.29 119.46 25.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 0.0 110.404 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.1 118.77 19.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.903 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.432 ' OH ' ' CZ ' ' A' ' 133' ' ' ARG . 3.8 m-85 -131.99 109.17 9.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.566 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 107' ' ' GLY . 0.6 OUTLIER -102.78 139.74 37.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.75 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.9 mt -136.67 128.35 43.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.961 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.55 ' CD2' ' SG ' ' A' ' 146' ' ' CYS . 1.8 p90 -93.08 127.65 38.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.356 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' A' ' 168' ' ' ILE . 24.9 mt -74.01 139.86 45.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.082 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.585 HG23 ' HA ' ' A' ' 162' ' ' ILE . 59.9 mt -136.41 107.64 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.127 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 79.9 p -119.03 158.03 26.63 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.876 0.37 . . . . 0.0 110.483 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.68 16.43 48.88 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.488 HG11 HG23 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -94.36 115.73 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.038 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 54.1 m -63.3 151.38 40.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.415 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -99.41 6.29 46.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.354 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.15 -20.64 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.353 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 189' ' ' PHE . 1.3 p90 -99.72 128.03 45.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.913 0.387 . . . . 0.0 110.83 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -125.44 134.17 52.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.393 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.405 ' CZ ' HG23 ' A' ' 154' ' ' ILE . 3.5 p90 -112.15 159.27 18.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.588 ' N ' ' CD ' ' A' ' 192' ' ' LYS . 0.0 OUTLIER -105.19 161.49 22.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.262 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -38.34 116.13 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.918 2.412 . . . . 0.0 112.644 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -145.95 69.7 1.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.028 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.681 HG12 ' N ' ' A' ' 196' ' ' ARG . 38.7 t -139.67 173.61 10.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.638 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.681 ' N ' HG12 ' A' ' 195' ' ' VAL . 36.7 mtt85 -52.42 148.94 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.536 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.9 105.72 0.18 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.495 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 0.9 OUTLIER -171.97 -113.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.406 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.495 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 3.5 mm -123.57 120.03 58.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.246 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -129.77 111.75 12.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.818 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -142.06 128.01 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.234 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.13 136.14 38.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -150.82 126.66 10.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.324 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.13 110.4 22.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.408 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -103.92 150.83 23.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.022 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -65.82 124.4 22.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.867 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -46.04 -35.37 4.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.952 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -56.02 -32.87 64.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.636 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -48.31 -51.46 25.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.1 mt -66.41 -38.74 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 44.0 m -66.75 -45.04 79.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.796 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 214' ' ' MET . 28.8 mttt -56.72 -18.73 13.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.516 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 3.4 m -66.02 56.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.558 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 212' ' ' LYS . 48.8 mtt -95.51 -72.8 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.846 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.15 -9.92 54.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -77.4 106.74 9.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.88 0.371 . . . . 0.0 110.593 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 22.8 t -95.87 -14.08 23.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.646 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -44.4 -62.9 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 219' ' ' ILE . 18.7 tt -137.92 130.23 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.864 0.364 . . . . 0.0 111.072 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -138.93 147.62 42.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.371 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -108.69 86.22 2.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.542 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -50.5 -23.27 2.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.448 HD13 ' OG ' ' A' ' 130' ' ' SER . 75.4 mt -50.68 -57.18 8.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 228' ' ' MET . 76.7 mt -109.7 -28.53 2.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.857 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -53.3 -43.85 67.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.93 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.7 m -72.1 -42.23 66.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 227' ' ' MET . 0.0 OUTLIER -86.98 3.11 47.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.142 -179.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 224' ' ' ILE . 28.0 ttp -51.39 -31.69 23.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.052 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.454 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 2.2 mpp_? -66.76 -65.84 1.48 Allowed Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.345 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 10.3 Cg_endo -53.48 -39.21 83.0 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.039 1.826 . . . . 0.0 111.92 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.8 tt -68.67 -39.41 80.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.539 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 78.5 p -70.46 -34.21 72.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.751 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 13.7 mmt -70.85 -50.7 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.059 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -55.63 -57.35 12.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.859 0.361 . . . . 0.0 110.93 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -57.14 -25.83 59.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.047 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 -57.65 -42.73 84.06 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.066 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -60.8 -40.51 92.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.701 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -63.59 -30.97 72.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -73.09 -32.35 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.621 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.07 -40.55 85.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.687 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 13.5 mm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.698 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.745 0.307 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.7 m -73.57 -21.98 60.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.42 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.9 mt -105.41 107.7 59.75 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.459 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.98 118.84 3.1 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 121.994 1.796 . . . . 0.0 112.154 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.42 141.51 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.982 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -137.19 141.65 42.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.001 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.2 146.77 17.42 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 131' ' ' PHE . . . -100.25 119.22 38.05 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.886 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -109.13 120.55 42.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.431 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mt -127.3 122.84 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.112 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -126.62 161.42 28.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.82 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.527 ' ND2' ' OG ' ' A' ' 116' ' ' SER . 4.1 m120 -61.05 177.87 0.3 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.595 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -61.26 -39.52 90.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.05 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -123.87 39.55 3.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.746 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 235' ' ' LEU . 5.9 mp 51.05 36.57 15.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.527 ' OG ' ' ND2' ' A' ' 112' ' ' ASN . 93.2 p -67.08 -34.34 77.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -151.05 161.76 42.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.873 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.6 mm -118.89 123.14 71.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.537 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 4.5 tp -80.41 115.09 19.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.319 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.3 mt -123.08 157.23 33.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.615 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.6 163.36 33.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 0.0 110.406 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -93.69 130.46 39.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.634 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -100.91 -171.24 28.77 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.0 t -56.74 -29.41 62.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.625 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -54.94 -172.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.223 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.3 t -86.04 -120.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.716 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -81.21 71.14 8.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.812 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 m -128.3 147.6 50.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -126.49 122.29 34.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.385 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.1 t -166.39 166.42 16.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.946 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.537 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 39.4 m-85 -73.38 152.52 90.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.006 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.22 154.9 51.91 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.032 1.821 . . . . 0.0 112.196 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -131.6 172.16 12.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.206 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 169.21 179.02 40.92 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.7 mttm -101.88 154.64 18.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 pt -129.3 156.0 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.702 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.3 t -82.78 145.23 29.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.554 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -86.91 178.94 6.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.541 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 66.45 33.32 6.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.511 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -141.71 155.56 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.342 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -64.81 142.8 58.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.47 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.48 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 74.6 m-20 -58.32 -38.1 76.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 144' ' ' ASP . 20.8 tt -67.03 -39.1 82.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.773 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.45 ' N ' HG23 ' A' ' 143' ' ' ILE . 95.0 m-20 -66.86 -39.88 87.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.727 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 80.6 m -66.68 -42.53 86.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.771 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.576 ' SG ' ' CD2' ' A' ' 180' ' ' PHE . 64.9 m -62.5 -48.15 80.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.464 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 97.1 mt -60.45 -40.99 85.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.954 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -58.39 -44.14 88.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.003 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.431 ' O ' ' OE2' ' A' ' 153' ' ' GLU . 81.2 mm-40 -78.09 -37.19 46.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.885 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.461 HG11 HD13 ' A' ' 158' ' ' LEU . 2.6 t -70.34 -50.41 46.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.788 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -60.52 -29.51 69.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.559 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -80.32 -45.45 17.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.823 0.344 . . . . 0.0 110.652 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -70.41 -58.68 3.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.22 -179.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 154' ' ' ILE . 1.6 mp -72.35 -32.97 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 110.98 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.34 -13.66 61.39 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -119.69 135.04 54.99 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.854 0.359 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -92.61 128.88 38.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.725 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.766 ' N ' HD12 ' A' ' 158' ' ' LEU . 6.2 mp -91.73 113.3 25.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.547 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.5 p -90.02 -54.84 3.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 160' ' ' ASP . 57.0 t0 -105.0 -17.46 14.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.642 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -85.48 20.65 1.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.666 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.4 tt -117.91 136.93 53.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.494 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.54 152.95 43.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.369 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 165' ' ' ASN . 1.2 p30 -75.47 -66.02 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.384 0.612 . . . . 0.0 111.024 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.454 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 67.7 m-80 -130.21 67.72 1.47 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.171 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.53 ' HG3' HD12 ' A' ' 181' ' ' LEU . 2.4 tp-100 -132.16 107.13 8.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.901 0.381 . . . . 0.0 110.688 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.516 ' CD2' ' OE2' ' A' ' 169' ' ' GLU . 45.8 p90 -156.31 154.04 29.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.355 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 234' ' ' TRP . 6.6 tt -123.86 137.87 55.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.516 ' OE2' ' CD2' ' A' ' 167' ' ' PHE . 3.9 mp0 -116.69 133.42 56.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.036 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -160.23 148.43 16.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.987 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.97 112.29 24.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.997 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.4 pt -120.97 152.48 24.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.769 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 175' ' ' LYS . 42.0 mt-30 50.9 32.82 7.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.572 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.33 -25.25 0.72 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 173' ' ' GLN . 41.7 tttt -84.96 137.36 33.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.841 0.353 . . . . 0.0 110.816 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 176' ' ' ASN . 9.1 p-10 -74.94 131.97 41.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.037 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.14 115.48 13.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.494 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -108.37 138.22 45.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.7 mt -137.19 134.74 47.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.15 0.5 . . . . 0.0 111.816 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.576 ' CD2' ' SG ' ' A' ' 146' ' ' CYS . 4.4 t80 -100.26 122.36 42.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.783 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.53 HD12 ' HG3' ' A' ' 166' ' ' GLN . 25.8 mt -69.85 125.95 28.26 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.468 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 3.1 mm -130.58 103.15 7.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.301 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.8 t -130.4 153.23 48.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.625 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 107.31 -1.68 34.92 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 3.8 m -57.72 148.12 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.47 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.71 115.79 17.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.691 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -69.84 -22.03 63.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.57 -8.1 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.265 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -102.36 122.23 43.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.262 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -87.77 134.88 33.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.516 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -99.01 134.59 41.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.62 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.14 156.52 38.23 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.177 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.13 123.8 11.03 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.286 1.991 . . . . 0.0 112.027 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -147.78 69.65 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.766 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.04 -177.88 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.147 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -42.97 148.91 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.11 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -73.38 102.11 3.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 0.0 110.589 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -157.89 -113.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.119 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 57.3 mt -126.58 102.95 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.06 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -131.27 139.1 49.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.92 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -144.26 141.33 29.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.354 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 4.1 pt -102.9 128.5 55.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.76 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -158.03 135.82 10.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.256 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.28 104.49 16.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.498 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -83.81 125.81 32.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.736 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.04 132.44 49.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.266 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -51.13 -37.01 43.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.669 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.1 -36.7 80.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.039 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -59.69 -49.85 76.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.782 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 11.8 mt -56.35 -48.13 80.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.738 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 213' ' ' THR . 5.0 m -60.49 -32.65 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -73.29 20.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.757 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . 0.482 ' H ' ' C ' ' A' ' 211' ' ' SER . 1.3 t -53.36 -31.83 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.556 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 10.8 tpp -47.44 -31.03 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.727 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.522 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 63.1 t80 -87.9 20.38 3.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.763 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 213' ' ' THR . 23.0 pttm -58.61 135.65 57.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.666 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 4.0 m -98.83 -45.53 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -163.59 16.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.682 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 17.1 tt -125.48 137.62 57.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.448 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -134.67 142.1 46.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -66.21 154.15 40.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.059 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -100.26 -73.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.9 tt -74.1 -56.43 4.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.1 mt -58.05 -32.5 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.61 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.459 ' CG ' ' N ' ' A' ' 226' ' ' SER . 0.1 OUTLIER -43.73 -57.9 2.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.393 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.459 ' N ' ' CG ' ' A' ' 225' ' ' ASN . 79.6 p -87.13 -27.81 22.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.435 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 65.9 mtp -84.95 1.7 46.2 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.95 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 224' ' ' ILE . 13.6 ttp -51.28 -37.11 45.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.965 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.459 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -64.9 -65.5 1.91 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.5 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 10.7 Cg_endo -55.42 -44.56 47.47 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.266 1.978 . . . . 0.0 112.258 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 231' ' ' LEU . 0.2 OUTLIER -52.56 -50.99 61.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.171 0.51 . . . . 0.0 110.155 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 28.8 p -71.39 -37.24 71.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.165 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 34.7 ttm -67.25 -62.03 1.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.261 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.622 ' CD1' HD12 ' A' ' 168' ' ' ILE . 45.4 m95 -45.88 -60.85 2.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.82 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.467 ' HB3' HD11 ' A' ' 115' ' ' LEU . 93.4 mt -52.91 -25.45 11.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 41.0 ttm-85 -61.23 -40.52 94.31 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.586 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -68.64 -44.34 74.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.052 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -52.97 -36.7 60.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.84 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -72.41 -28.95 63.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.214 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.16 -51.76 34.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 110.461 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 3.4 mm . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.027 -179.727 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 tttp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.88 0.371 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.9 m -74.74 -31.82 61.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.083 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 103' ' ' ILE . 13.6 tt -124.36 108.66 29.28 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.809 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.2 137.38 10.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.978 1.785 . . . . 0.0 112.155 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.88 138.7 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.494 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -148.18 145.13 28.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.797 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.603 ' H ' HG22 ' A' ' 179' ' ' ILE . . . -133.24 168.52 23.0 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 180' ' ' PHE . . . -112.15 125.81 54.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.684 0.278 . . . . 0.0 111.036 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.5 117.25 33.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.429 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.88 133.92 65.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.138 0.494 . . . . 0.0 110.941 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -137.27 149.21 46.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.994 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.652 ' ND2' ' H ' ' A' ' 116' ' ' SER . 43.8 p-10 -50.42 155.19 1.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.994 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -57.81 -25.95 61.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.023 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -92.06 7.21 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.078 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.707 HD21 HD12 ' A' ' 235' ' ' LEU . 12.6 mt 42.93 52.5 5.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 0.0 110.532 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.652 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 0.5 OUTLIER -123.55 -13.7 7.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.112 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -133.24 146.42 51.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.261 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.6 mm -115.31 124.58 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.215 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 202' ' ' ILE . 1.2 tt -86.27 103.58 15.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.697 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.7 mt -117.83 162.82 17.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.129 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.15 160.19 40.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.488 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.436 ' OE1' ' O ' ' A' ' 123' ' ' GLY . 0.4 OUTLIER -98.89 114.33 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.336 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.436 ' O ' ' OE1' ' A' ' 122' ' ' GLN . . . -96.31 -151.66 28.26 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 87.5 m -53.97 -34.86 60.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 110.656 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -47.02 157.53 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.7 m -69.18 -70.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.852 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -133.53 69.61 1.47 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.508 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -127.45 143.21 51.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.33 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -113.21 115.35 28.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.326 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.9 t -156.87 164.88 37.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.681 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.544 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 44.6 m-85 -73.28 151.9 90.09 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -67.55 139.34 48.56 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.888 1.725 . . . . 0.0 111.667 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -125.0 177.99 5.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.566 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 158.68 179.8 33.79 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -86.63 145.84 26.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.707 0.289 . . . . 0.0 110.641 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.6 tt -127.1 147.33 32.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.219 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.7 p -70.13 153.09 43.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -112.61 176.58 4.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.179 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 53.89 42.33 31.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.258 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -148.44 158.76 44.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.363 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -58.7 125.62 24.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.525 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.421 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 23.3 p-10 -64.38 -39.42 93.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.138 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 7.0 tt -66.85 -37.39 79.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.498 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -69.79 -42.36 73.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.569 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 64.9 m -73.86 -40.18 63.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 142' ' ' ASP . 33.1 m -55.21 -52.89 61.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.24 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.15 -42.76 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -62.2 -41.3 98.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.337 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -79.25 -35.22 41.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.94 0.4 . . . . 0.0 110.561 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.11 -53.8 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -45.3 89.37 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.651 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.32 -28.63 65.21 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.515 ' OE2' HG12 ' A' ' 195' ' ' VAL . 27.3 mm-40 -89.23 -62.6 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 8.8 mt -84.96 -33.65 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.03 -13.37 60.48 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -102.69 135.27 44.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.0 110.385 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 25.0 p30 -106.86 127.45 53.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.814 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 mp -96.38 112.44 24.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.922 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.2 m -89.52 -61.88 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.74 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -98.97 0.19 43.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.122 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -109.63 21.11 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.63 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 162' ' ' ILE . 0.8 OUTLIER -111.91 133.04 58.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.641 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.504 ' H ' HD11 ' A' ' 182' ' ' ILE . 6.4 t0 -101.3 135.68 42.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.242 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -95.9 -10.81 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.938 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -133.74 56.7 1.84 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.303 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.546 HE22 ' CG ' ' A' ' 238' ' ' GLN . 35.3 tt0 -150.53 107.65 3.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.316 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -164.77 166.5 19.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.62 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.519 HD11 HD11 ' A' ' 181' ' ' LEU . 63.4 mt -125.96 130.8 72.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.078 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -113.37 128.08 56.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.296 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.523 ' NH2' ' OG ' ' A' ' 226' ' ' SER . 0.0 OUTLIER -160.06 159.11 31.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.945 0.402 . . . . 0.0 110.911 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.491 ' ND2' HD22 ' A' ' 176' ' ' ASN . 4.2 m120 -104.48 102.59 12.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.938 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.47 HD13 ' HA ' ' A' ' 223' ' ' LEU . 83.7 mt -97.27 117.02 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.339 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 52.15 40.26 28.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.363 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 80.88 -20.09 6.87 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -83.97 124.32 30.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.412 . . . . 0.0 110.707 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.491 HD22 ' ND2' ' A' ' 171' ' ' ASN . 21.8 m120 -75.2 136.55 40.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.473 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.423 ' CD2' HD12 ' A' ' 172' ' ' ILE . 0.2 OUTLIER -128.35 140.56 51.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.284 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -143.92 94.86 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 107' ' ' GLY . 10.6 pt -112.57 145.67 18.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.022 0.439 . . . . 0.0 111.628 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 108' ' ' ALA . 11.2 p90 -99.89 132.43 45.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.598 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.639 ' O ' HD12 ' A' ' 182' ' ' ILE . 9.7 mt -91.48 129.06 37.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.548 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.0 OUTLIER -131.02 129.68 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.908 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.1 m -132.14 162.0 31.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.415 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.48 7.91 55.31 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.8 m -75.93 142.99 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.654 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 52.1 p -77.29 137.12 38.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.647 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.455 ' OE1' ' CZ2' ' A' ' 204' ' ' TRP . 70.9 mm-40 -96.55 -8.54 31.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.603 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.0 -27.73 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.473 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -98.23 123.62 42.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.4 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -106.57 132.75 52.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.665 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.68 152.73 39.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.574 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.53 157.23 38.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.291 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.51 142.96 41.56 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.343 2.029 . . . . 0.0 112.219 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -135.65 82.94 1.98 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.105 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.515 HG12 ' OE2' ' A' ' 153' ' ' GLU . 33.6 m -129.09 -177.59 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.719 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -48.46 145.77 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.52 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -46.21 102.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.698 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -147.3 -113.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.415 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.88 122.86 65.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.363 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -93.24 107.55 19.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.753 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -160.3 126.97 4.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.46 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.593 HD11 HD11 ' A' ' 119' ' ' LEU . 17.2 tt -127.32 154.21 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.46 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -167.71 156.59 9.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.698 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' TRP . . . . . 0.455 ' CZ2' ' OE1' ' A' ' 187' ' ' GLU . 0.0 OUTLIER -106.85 100.58 10.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.734 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.71 135.08 33.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.296 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -72.03 133.3 45.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.485 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -49.16 -32.08 9.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -59.2 -43.65 92.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.676 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -54.81 -32.27 60.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.364 . . . . 0.0 110.234 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.436 ' O ' ' OG1' ' A' ' 213' ' ' THR . 82.7 mt -79.17 -23.07 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.358 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.4 t -85.1 -10.66 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -95.44 10.07 37.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.769 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 210' ' ' ILE . 0.2 OUTLIER -43.07 -36.2 1.54 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.345 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 40.6 mtt -52.95 -33.82 52.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.352 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -66.8 -46.58 74.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.446 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 216' ' ' LYS . 11.1 ptmt -113.1 110.25 20.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 57.7 m -92.14 -10.41 38.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.841 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -58.76 -37.67 76.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.684 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 79.2 mt -128.94 134.05 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.539 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -130.43 145.03 51.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.642 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 225' ' ' ASN . 87.2 m-85 -104.66 86.85 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.427 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -66.1 -27.99 68.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.212 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.638 HD12 ' N ' ' A' ' 223' ' ' LEU . 7.8 mp -69.5 -39.13 77.77 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.778 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 228' ' ' MET . 97.0 mt -95.7 -40.2 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.676 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 221' ' ' TYR . 62.4 t-20 -59.98 -47.95 83.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.341 . . . . 0.0 110.561 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.523 ' OG ' ' NH2' ' A' ' 170' ' ' ARG . 7.9 t -68.84 -30.46 69.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.556 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 76.9 mtp -96.54 2.41 52.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 224' ' ' ILE . 18.7 ttt -48.33 -38.97 20.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.221 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.45 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -68.96 -65.51 1.26 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.602 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 19.6 Cg_endo -60.17 -47.56 14.5 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.213 1.942 . . . . 0.0 112.366 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 5.1 tt -56.2 -39.48 72.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.894 0.378 . . . . 0.0 110.626 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 68.9 m -75.74 -40.09 56.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.994 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 10.7 mmt -66.46 -52.89 41.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.289 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -55.06 -54.4 43.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.759 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.707 HD12 HD21 ' A' ' 115' ' ' LEU . 4.0 mm? -56.56 -22.16 31.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.599 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -42.16 72.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.658 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -61.96 -44.28 97.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.598 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.546 ' CG ' HE22 ' A' ' 166' ' ' GLN . 68.8 mt-30 -58.6 -34.64 71.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.673 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -62.07 -24.46 67.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -81.74 -58.72 2.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.41 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.1 pttt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.91 0.386 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.0 m -73.51 -32.88 64.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.59 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 103' ' ' ILE . 17.0 tt -117.8 108.39 42.85 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.484 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -82.25 135.88 8.64 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.937 1.758 . . . . 0.0 112.224 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.53 140.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.048 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.1 ttp85 -123.74 146.76 48.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.802 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -122.86 149.44 16.86 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -101.87 142.42 33.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.865 0.364 . . . . 0.0 111.222 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.29 99.34 3.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.263 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.455 HG23 HG11 ' A' ' 185' ' ' VAL . 2.7 mp -108.79 142.2 22.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.505 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -127.34 163.94 22.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.145 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.725 HD21 ' H ' ' A' ' 116' ' ' SER . 26.1 p-10 -65.33 166.16 10.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.886 0.374 . . . . 0.0 110.875 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 185' ' ' VAL . 61.6 mm-40 -58.63 -33.45 70.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.621 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -89.43 6.98 38.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.988 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mp 42.91 45.23 4.26 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.592 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.725 ' H ' HD21 ' A' ' 112' ' ' ASN . 3.9 t -120.95 -9.24 9.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.01 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -136.8 170.32 16.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.771 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.409 ' O ' HG23 ' A' ' 118' ' ' ILE . 11.5 tt -134.03 131.41 55.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.758 0.313 . . . . 0.0 110.584 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.531 ' O ' ' CZ ' ' A' ' 131' ' ' PHE . 2.5 tt -83.11 127.71 33.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.205 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.528 HD22 ' O ' ' A' ' 119' ' ' LEU . 3.3 mm? -121.27 156.68 31.98 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.4 m -143.69 172.69 6.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.669 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.533 ' NE2' ' CG2' ' A' ' 199' ' ' ILE . 1.4 tm0? -92.17 124.64 36.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.49 -165.86 32.17 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.462 ' OG1' ' NH2' ' A' ' 196' ' ' ARG . 40.3 m -47.22 -37.1 9.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.891 0.377 . . . . 0.0 110.221 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 125' ' ' GLU . 56.9 mp0 -51.4 160.06 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.04 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.7 t -64.61 -62.57 1.51 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.972 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -137.1 69.53 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.777 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 p -125.08 139.09 54.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.137 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.515 ' C ' HD12 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -94.37 110.45 22.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.586 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.402 ' N ' HD12 ' A' ' 120' ' ' LEU . 14.1 p -153.84 176.57 12.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.732 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 46.1 m-85 -97.83 152.6 38.19 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.317 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.8 155.71 67.85 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.968 1.779 . . . . 0.0 111.4 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -140.85 177.07 8.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.089 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 168.11 178.59 40.08 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -93.94 150.06 20.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.686 0.279 . . . . 0.0 110.617 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 16.6 pt -108.58 149.99 11.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.516 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.9 t -76.24 140.94 41.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.748 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 63.3 mttp -89.2 162.26 16.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.503 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 3.0 t70 75.37 1.89 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.645 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -114.36 155.33 26.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.474 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -64.58 143.77 57.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.379 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -55.37 -39.59 70.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.537 HG23 ' N ' ' A' ' 144' ' ' ASP . 6.7 tt -65.59 -42.59 93.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.709 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.537 ' N ' HG23 ' A' ' 143' ' ' ILE . 43.0 t0 -63.51 -33.14 74.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.692 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 13.8 m -78.27 -42.01 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.559 ' SG ' ' CG ' ' A' ' 180' ' ' PHE . 8.5 t -65.12 -50.53 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.021 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 148' ' ' ARG . 9.7 tt -61.11 -38.49 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.146 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.428 ' N ' ' CG2' ' A' ' 147' ' ' ILE . 17.0 ttm105 -71.32 -38.98 71.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.903 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 153' ' ' GLU . 85.3 tt0 -78.28 -29.82 48.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 110.445 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.3 t -74.17 -52.48 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.783 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -28.2 69.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.668 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -76.33 -41.11 49.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.714 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 149' ' ' GLU . 0.4 OUTLIER -75.35 -53.17 9.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 28.7 mm -71.0 -31.5 45.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 0.0 110.422 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 92.2 -14.31 64.88 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -115.96 133.09 56.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.725 0.298 . . . . 0.0 110.337 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 43.7 p-10 -96.61 125.1 40.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.036 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.409 ' H ' HD12 ' A' ' 158' ' ' LEU . 0.7 OUTLIER -112.13 110.43 20.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.078 179.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.0 p -91.0 -55.21 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 0.0 111.054 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -58.97 -39.15 80.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.307 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 184' ' ' GLY . 39.2 m-85 -90.82 18.74 6.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.052 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.659 HD13 ' H ' ' A' ' 163' ' ' ASP . 0.3 OUTLIER -87.4 134.6 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.985 0.421 . . . . 0.0 110.256 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.659 ' H ' HD13 ' A' ' 162' ' ' ILE . 66.7 m-20 -92.27 140.5 29.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.408 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -70.56 -66.18 0.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.339 0.59 . . . . 0.0 110.881 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -133.02 66.89 1.55 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.123 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.624 ' NE2' ' NE1' ' A' ' 234' ' ' TRP . 8.5 tp60 -127.89 107.45 9.87 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.815 0.34 . . . . 0.0 110.606 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -167.23 159.31 12.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.181 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.654 HD11 HD11 ' A' ' 181' ' ' LEU . 3.2 mt -124.05 138.98 51.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.788 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -95.08 136.29 35.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.187 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.534 ' C ' HD22 ' A' ' 171' ' ' ASN . 0.0 OUTLIER -152.73 121.39 6.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.845 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.534 HD22 ' C ' ' A' ' 170' ' ' ARG . 3.0 m120 -112.17 112.51 24.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.119 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.5 tt -109.3 132.46 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.261 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.45 ' C ' ' H ' ' A' ' 175' ' ' LYS . 24.4 mt-30 52.32 46.07 27.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.232 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.02 -3.27 1.66 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 173' ' ' GLN . 3.7 tptm -84.14 125.58 32.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.79 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.405 HD22 ' ND2' ' A' ' 171' ' ' ASN . 2.8 t-20 -75.42 123.88 26.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.744 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -140.12 128.99 23.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.566 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 107' ' ' GLY . 26.0 ttmt -120.96 142.29 49.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.013 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.8 mm -123.15 121.29 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.598 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.559 ' CG ' ' SG ' ' A' ' 146' ' ' CYS . 0.2 OUTLIER -98.44 127.47 44.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.387 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 168' ' ' ILE . 47.2 mt -82.93 124.27 30.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 182' ' ' ILE . 3.1 tt -143.71 101.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.411 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.4 t -117.54 154.23 31.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.626 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.51 ' O ' ' CD1' ' A' ' 161' ' ' TYR . . . 106.95 10.07 28.94 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.455 HG11 HG23 ' A' ' 110' ' ' ILE . 1.5 m -67.97 138.99 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.659 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 32.9 t -66.81 120.69 13.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.429 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -85.44 -16.62 39.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.131 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 85.4 t -69.86 -28.13 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.566 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.52 ' CE1' ' O ' ' A' ' 190' ' ' ASN . 63.1 t80 -88.7 133.87 34.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.632 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.52 ' O ' ' CE1' ' A' ' 189' ' ' PHE . 33.5 p-10 -90.79 131.42 36.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.444 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -127.67 158.57 37.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.391 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -139.48 156.57 71.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.308 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.4 142.89 46.25 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.309 2.006 . . . . 0.0 112.09 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -131.02 69.8 1.47 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.458 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.698 HG23 ' N ' ' A' ' 196' ' ' ARG . 11.9 m -130.23 -138.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.698 ' N ' HG23 ' A' ' 195' ' ' VAL . 78.4 mtm-85 -52.75 146.03 11.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.029 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -74.38 108.88 7.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.373 . . . . 0.0 110.771 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.469 ' CG ' ' H ' ' A' ' 199' ' ' ILE . 1.0 OUTLIER -150.61 -113.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.54 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.533 ' CG2' ' NE2' ' A' ' 122' ' ' GLN . 19.5 tt -130.39 136.7 57.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.471 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 200' ' ' ASP . 39.8 p-10 -102.68 114.54 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.736 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -133.33 123.18 24.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.389 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.97 146.76 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.421 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -165.89 140.83 4.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.601 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.38 112.91 26.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.481 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -104.83 151.7 23.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.625 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.03 127.79 34.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.4 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.05 -42.77 91.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.994 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -36.65 71.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -59.71 -46.34 89.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.175 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 45.4 pt -71.24 -19.53 20.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.144 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 44.0 m -82.5 -22.07 35.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.796 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -111.37 28.41 8.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 8.8 t -81.44 1.78 31.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.689 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 74.4 mtp -54.84 -30.69 58.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.383 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -67.61 -31.92 72.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.56 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -105.18 121.28 43.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.542 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.4 m -92.06 -11.59 35.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 218' ' ' ASN . 2.2 m120 -55.65 -34.35 64.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.606 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.5 mt -125.65 134.05 67.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.506 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -133.65 156.08 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.569 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -113.97 135.95 53.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.364 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -101.49 -72.52 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.187 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.67 -50.86 55.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.177 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.4 mm -56.48 -47.45 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 110.679 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -52.25 -43.2 64.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.568 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.5 m -69.06 -38.37 79.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.983 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 55.4 mtt -88.37 -2.9 58.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.863 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' MET . . . . . 0.483 ' N ' ' O ' ' A' ' 224' ' ' ILE . 5.0 ttp -58.62 -44.04 89.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.721 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.441 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 23.0 mtm-85 -56.14 -64.1 2.67 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.312 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 20.1 Cg_endo -61.3 -51.11 4.73 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.28 1.987 . . . . 0.0 112.423 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -46.86 81.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.2 t -65.77 -38.54 89.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.026 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 49.2 ttm -60.52 -48.34 82.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.24 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.624 ' NE1' ' NE2' ' A' ' 166' ' ' GLN . 1.4 t-105 -70.54 -42.92 70.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.53 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.11 -37.87 81.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.379 . . . . 0.0 110.597 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -60.47 -36.15 77.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.796 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -69.28 -37.06 77.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.781 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -64.23 -29.58 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.052 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -72.57 -41.23 65.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 111.028 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -58.32 -38.66 77.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.26 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 81.6 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.547 179.879 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.811 0.338 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 m -79.45 -30.47 42.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.957 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -100.98 108.47 54.51 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.596 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.73 127.4 6.31 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.93 1.753 . . . . 0.0 112.325 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 t -132.71 145.93 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.052 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' A' ' 107' ' ' GLY . 46.3 ttp85 -135.49 150.58 49.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.705 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -129.89 154.37 20.46 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -102.22 149.88 23.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.955 0.407 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -141.86 95.13 2.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.307 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.87 131.4 67.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 121.248 0.547 . . . . 0.0 111.573 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.6 159.39 39.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.92 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -55.95 151.35 11.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.864 0.364 . . . . 0.0 110.373 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -51.07 -40.47 58.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.809 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -80.55 -1.21 41.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 0.0 110.554 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mt 53.41 56.04 7.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.665 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 p -122.23 -16.27 7.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.745 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -138.18 156.5 47.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.541 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.0 mm -112.75 136.07 50.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.049 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.526 ' C ' HD22 ' A' ' 120' ' ' LEU . 1.7 tt -102.8 110.91 22.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 111.194 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.823 HD22 ' N ' ' A' ' 120' ' ' LEU . 1.4 mm? -111.93 174.17 6.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.175 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 m -143.88 169.99 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.203 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.648 HE22 ' H ' ' A' ' 128' ' ' SER . 55.0 tp60 -109.04 134.44 51.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -125.37 -145.37 6.49 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 124' ' ' THR . 0.1 OUTLIER -52.67 -43.26 65.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 110.748 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -43.52 151.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.947 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.7 p -61.46 -83.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.025 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -126.67 70.15 1.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.475 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.648 ' H ' HE22 ' A' ' 122' ' ' GLN . 46.5 m -125.8 153.28 44.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.589 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 129' ' ' TRP . 0.9 OUTLIER -115.75 119.14 35.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.379 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 76.1 p -163.71 173.03 13.38 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.882 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 43.3 m-85 -83.29 152.05 63.87 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.207 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.93 142.93 39.8 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.848 1.699 . . . . 0.0 111.831 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -146.41 171.7 14.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.238 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.29 -169.53 34.33 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.97 137.23 35.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.664 0.268 . . . . 0.0 110.57 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 pt -114.02 157.1 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.384 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.9 m -64.59 144.15 57.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.435 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -92.17 173.88 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.636 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 59.63 37.28 22.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -136.36 162.51 32.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.253 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -79.4 146.03 33.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.466 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -49.34 -37.75 25.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.556 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 147' ' ' ILE . 50.0 mt -72.68 -43.84 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -62.31 -41.93 98.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.585 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -73.87 -39.13 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.934 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.593 ' SG ' ' CE1' ' A' ' 180' ' ' PHE . 43.9 t -69.82 -56.82 6.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.043 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 148' ' ' ARG . 2.1 tp -54.44 -39.98 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.005 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.448 ' N ' HG23 ' A' ' 147' ' ' ILE . 31.6 ttm180 -66.27 -39.38 89.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.908 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -76.91 -27.54 54.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.0 110.44 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.12 -54.56 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.846 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -26.72 67.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.903 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -84.75 -34.84 22.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 110.995 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -72.6 -60.48 2.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.677 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 21.8 mt -82.52 -33.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.776 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 104.5 -12.89 51.09 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -103.65 130.73 51.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.672 0.272 . . . . 0.0 110.455 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -104.49 148.46 26.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.985 0.421 . . . . 0.0 111.048 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.0 mt -106.27 115.22 29.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.815 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.31 -61.73 1.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.391 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.518 ' OD1' ' CD2' ' A' ' 161' ' ' TYR . 43.4 p-10 -104.47 0.43 28.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.105 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.518 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 68.3 m-85 -105.3 14.9 28.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.65 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 162' ' ' ILE . 10.1 tp -93.22 130.93 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.601 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 181' ' ' LEU . 77.9 m-20 -72.03 153.54 41.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.364 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -85.57 -67.38 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.497 0.665 . . . . 0.0 111.123 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -132.06 70.46 1.47 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.759 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -132.78 107.62 8.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.494 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.5 165.85 20.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.81 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 34.2 pt -128.53 146.3 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.537 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.48 135.01 54.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.265 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -159.74 137.38 9.89 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.661 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -102.93 112.99 26.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.352 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 54.9 mt -99.02 120.78 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.33 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.485 ' C ' ' H ' ' A' ' 175' ' ' LYS . 65.2 mt-30 54.0 49.69 18.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.79 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 69.52 -17.28 0.65 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 173' ' ' GLN . 42.4 mttt -85.4 134.04 34.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -75.16 131.56 40.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.594 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -134.98 105.24 6.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.608 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 107' ' ' GLY . 11.9 mmtp -100.05 130.64 46.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.334 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.96 127.51 61.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 111.081 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.593 ' CE1' ' SG ' ' A' ' 146' ' ' CYS . 0.3 OUTLIER -99.31 133.33 43.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.734 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.41 ' O ' ' OD2' ' A' ' 163' ' ' ASP . 8.8 mt -87.75 137.05 32.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.991 0.424 . . . . 0.0 111.285 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.57 106.64 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.904 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 p -125.24 151.33 46.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.402 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 117.29 -12.49 14.1 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 4.4 m -53.29 146.68 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 34.9 p -77.75 127.75 32.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.795 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -83.06 -10.79 58.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.43 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 25.2 m -72.52 -16.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.249 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -95.92 134.32 39.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.308 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -88.81 127.32 35.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.632 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.427 ' O ' HD13 ' A' ' 202' ' ' ILE . 85.1 m-85 -95.72 128.14 42.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.428 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -105.13 152.8 39.79 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.311 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.53 141.68 28.48 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.305 2.003 . . . . 0.0 112.436 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -149.51 78.18 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.98 177.07 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.756 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -51.73 154.05 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.113 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -46.25 102.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.287 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -150.81 -113.45 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.255 0.55 . . . . 0.0 110.407 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.5 mm -124.99 126.34 71.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.239 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.19 103.94 13.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.498 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.487 ' NZ ' ' OE2' ' A' ' 203' ' ' GLU . 61.4 tttm -163.69 134.87 4.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.012 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.427 HD13 ' O ' ' A' ' 191' ' ' PHE . 18.1 pt -120.9 154.24 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.241 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.487 ' OE2' ' NZ ' ' A' ' 201' ' ' LYS . 44.0 mt-10 -152.44 138.19 17.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.412 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.51 103.2 13.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.348 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.419 ' CE2' ' CE3' ' A' ' 129' ' ' TRP . 60.8 m-85 -105.93 152.72 22.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.904 0.383 . . . . 0.0 110.842 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -81.96 139.25 34.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.643 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -51.71 -55.51 19.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -56.61 -43.36 80.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.82 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -57.58 -48.4 79.48 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.883 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 87.5 mt -55.11 -25.11 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.482 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -89.89 -13.79 35.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -104.38 15.86 27.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.071 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 15.3 p -81.29 10.9 4.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 110.74 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 70.8 mtm -53.96 -35.29 61.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.315 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -55.87 -34.53 65.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.449 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -100.07 109.04 21.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.557 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 82.5 p -92.78 -23.15 18.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.709 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -56.5 -42.4 78.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.542 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.1 mt -126.16 110.34 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.473 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -139.44 148.91 43.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.559 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 221' ' ' TYR . 0.0 OUTLIER -117.05 117.84 30.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.459 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -82.81 -35.72 26.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.042 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 223' ' ' LEU . 10.7 mp -53.69 -48.64 69.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.002 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 tp -69.23 -33.87 60.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.85 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -58.85 -41.69 87.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.24 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 68.9 m -67.52 -38.32 84.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.053 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -83.44 2.77 35.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.155 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' MET . . . . . . . . . . . . . 42.1 ttp -52.42 -59.92 3.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.124 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.418 ' N ' ' CD ' ' A' ' 230' ' ' PRO . 6.3 mtm-85 -77.5 -51.22 1.94 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.143 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 229' ' ' ARG . 53.6 Cg_exo -49.39 -52.64 8.42 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.099 1.866 . . . . 0.0 112.154 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.34 -36.49 84.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.041 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 86.9 p -66.12 -36.33 82.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.824 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 79.3 mmm -67.4 -56.19 10.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.283 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 30.3 m95 -54.75 -57.91 9.66 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.064 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 97.1 mt -51.94 -24.7 6.79 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.41 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -61.42 -44.3 97.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 0.0 110.11 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -64.72 -44.06 91.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.852 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -59.62 -41.14 89.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.018 0.437 . . . . 0.0 110.597 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -63.98 -30.64 71.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -62.97 -41.39 99.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.498 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 10.9 mm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.695 -179.815 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.692 0.282 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.4 t -126.21 -18.75 4.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.635 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.693 HG23 ' O ' ' A' ' 103' ' ' ILE . 10.0 tt -119.21 108.44 40.2 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.278 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.83 130.52 6.73 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.987 1.791 . . . . 0.0 112.206 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -143.83 139.26 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.326 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.538 HH12 ' NZ ' ' A' ' 178' ' ' LYS . 57.7 mtp85 -132.59 149.6 52.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -137.93 -179.29 16.89 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.3 124.21 20.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.223 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 129.99 54.19 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.9 mt -122.88 136.39 59.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.244 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -124.3 153.06 42.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.682 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.456 ' ND2' ' CE2' ' A' ' 204' ' ' TRP . 0.9 OUTLIER -56.16 149.18 16.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.294 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -52.29 -28.71 20.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.899 0.38 . . . . 0.0 110.228 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -95.81 3.46 53.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.371 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.446 ' CD2' HD11 ' A' ' 235' ' ' LEU . 6.1 mt 51.99 45.18 28.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.368 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 t -107.29 -21.47 12.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -140.11 176.51 8.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.3 tt -139.32 134.28 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.222 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.526 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 3.0 tt -82.69 126.98 32.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.012 0.434 . . . . 0.0 111.572 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.1 mt -133.23 152.2 51.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.466 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.41 170.99 13.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.615 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -99.48 143.53 29.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.94 -164.85 12.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.522 ' OG1' ' NH2' ' A' ' 196' ' ' ARG . 38.9 m -44.55 -35.75 2.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.262 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -47.39 156.87 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.151 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.6 t -70.08 -59.16 3.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.853 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -137.21 69.15 1.41 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.986 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 t -128.8 141.51 51.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.578 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -115.6 120.86 40.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.467 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.2 p -164.03 175.61 10.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.958 0.408 . . . . 0.0 110.937 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.526 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 36.7 m-85 -80.58 153.11 73.33 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.332 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.53 153.4 54.96 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.016 1.811 . . . . 0.0 112.175 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.707 ' H ' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -159.26 -173.92 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.521 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 175.69 -175.55 47.31 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -89.92 147.01 23.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.316 . . . . 0.0 110.712 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 1.1 pp -130.24 156.84 42.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.438 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.0 m -75.63 141.72 42.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.591 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -76.12 167.38 21.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.057 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 59.71 41.59 18.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.512 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -135.45 148.37 49.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -60.7 134.11 56.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.57 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 29.8 p-10 -63.76 -36.67 84.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.876 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.507 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 3.2 mm -60.09 -54.66 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.841 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -64.87 -38.97 92.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 1.1 m -60.58 -39.85 89.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.903 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 142' ' ' ASP . 71.1 m -63.69 -61.57 2.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.281 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.6 tp -60.93 -17.68 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.29 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.0 ttp85 -77.14 -48.41 17.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.704 0.288 . . . . 0.0 111.337 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -74.21 -35.28 63.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.019 0.438 . . . . 0.0 110.595 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.588 ' O ' HG22 ' A' ' 154' ' ' ILE . 2.5 t -57.12 -61.07 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.09 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 152' ' ' GLU . 16.3 pttm -58.71 -44.35 90.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.79 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 151' ' ' LYS . 47.0 tp10 -60.01 -45.39 92.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.48 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 133' ' ' ARG . 97.3 mt-10 -73.83 -58.15 3.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.84 HG23 ' H ' ' A' ' 156' ' ' PHE . 7.8 tt -71.31 -24.24 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.342 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 151' ' ' LYS . . . 82.89 8.63 85.57 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.84 ' H ' HG23 ' A' ' 154' ' ' ILE . 25.9 t80 -151.36 150.84 30.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -128.3 133.73 48.79 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.932 0.396 . . . . 0.0 111.53 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.84 154.35 25.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.741 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.9 p -72.76 -14.51 61.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.023 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -105.35 13.89 29.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.05 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.27 -7.63 59.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.84 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.4 tp -125.81 137.15 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -106.61 156.11 18.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.248 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 165' ' ' ASN . 3.4 p30 -69.08 -67.81 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.355 0.598 . . . . 0.0 111.052 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 32.6 t30 -134.43 60.72 1.69 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.111 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -145.27 107.9 4.45 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.556 -0.457 . . . . 0.0 111.013 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -156.36 163.84 39.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.309 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.9 tt -127.56 133.41 67.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -110.58 132.05 54.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.806 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -159.75 136.4 9.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.922 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -109.59 116.06 31.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.289 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 19.1 pt -119.74 150.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.612 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.471 ' C ' ' H ' ' A' ' 175' ' ' LYS . 25.9 mt-30 47.11 36.77 4.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.395 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 70.51 -14.65 1.31 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' A' ' 173' ' ' GLN . 51.1 mttm -88.51 129.33 35.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 110.907 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -75.08 120.99 21.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.503 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -117.24 125.21 50.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.993 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.538 ' NZ ' HH12 ' A' ' 106' ' ' ARG . 23.5 mtpt -122.44 129.85 52.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.676 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.7 mt -137.72 134.02 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.361 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.465 ' CZ ' ' SG ' ' A' ' 146' ' ' CYS . 0.0 OUTLIER -93.27 137.49 32.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.303 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.489 HD12 ' CD1' ' A' ' 234' ' ' TRP . 10.8 mt -95.32 125.93 40.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.709 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.14 106.26 3.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.709 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 63.6 p -111.35 154.82 24.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.408 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 99.52 13.23 38.84 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.6 m -88.77 147.33 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.719 0.295 . . . . 0.0 110.554 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 60.5 p -61.96 124.51 20.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.971 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -93.49 -5.56 48.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.579 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.39 -28.29 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.376 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.53 148.93 49.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.237 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -92.56 131.78 37.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.552 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.45 ' O ' HD13 ' A' ' 202' ' ' ILE . 63.2 m-85 -110.83 138.08 47.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.509 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -140.7 122.77 9.52 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.3 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.27 116.43 4.14 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.79 1.66 . . . . 0.0 112.321 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -106.13 99.78 9.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.328 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 32.0 m -147.42 -160.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.7 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.522 ' NH2' ' OG1' ' A' ' 124' ' ' THR . 12.5 mtp180 -42.72 148.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.614 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -70.95 117.2 12.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.538 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 1.9 tt0 -172.65 -111.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.489 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.514 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 58.9 mt -113.9 118.35 58.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.771 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 200' ' ' ASP . 2.9 p30 -128.47 100.49 5.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.045 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -139.88 138.63 35.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.592 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.45 HD13 ' O ' ' A' ' 191' ' ' PHE . 36.0 pt -109.16 145.09 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.199 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -156.78 133.55 10.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.301 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' TRP . . . . . 0.456 ' CE2' ' ND2' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -101.21 113.52 26.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.271 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -107.83 148.54 29.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.047 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.73 136.71 43.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.101 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -51.53 -40.11 59.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.56 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -64.44 -39.78 94.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -60.35 -32.79 71.6 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.512 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 98.0 mt -71.84 -33.05 46.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 50.0 m -80.71 -28.41 36.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.636 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -12.11 61.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.585 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 52.5 p -50.91 -26.46 5.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 62.5 mtt -62.47 -35.36 79.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.604 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -69.4 -43.26 73.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.677 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -86.42 116.02 24.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.403 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 70.9 m -96.21 9.86 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.752 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -75.64 -68.93 0.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.505 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 219' ' ' ILE . 10.0 tp -132.09 123.57 51.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.524 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -138.12 159.28 42.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.385 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -106.48 101.7 11.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.557 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -66.15 -33.87 76.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.55 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 4.9 tp -55.51 -43.57 75.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.0 mm -86.85 -27.43 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.95 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -53.1 -45.67 68.34 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.744 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.1 m -69.82 -37.86 76.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.776 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 34.5 ttm -78.48 -23.79 46.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 224' ' ' ILE . 46.5 ttp -58.65 -38.74 78.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.457 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 2.2 mmm180 -54.31 -65.51 1.26 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.888 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 28.8 Cg_endo -62.56 -44.1 19.13 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.174 1.916 . . . . 0.0 111.85 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.7 tp -53.06 -35.28 59.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.855 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 33.7 t -72.89 -33.77 66.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.752 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 5.6 ttm -70.59 -59.54 2.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.21 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.489 ' CD1' HD12 ' A' ' 181' ' ' LEU . 4.7 t-105 -57.46 -49.32 76.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.946 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.446 HD11 ' CD2' ' A' ' 115' ' ' LEU . 30.0 tp -56.56 -29.02 61.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -41.57 97.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.541 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -57.02 -44.61 83.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.775 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -60.86 -34.71 75.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.966 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -70.44 -36.09 73.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.797 0.332 . . . . 0.0 110.827 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -64.28 -44.89 90.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.736 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 86.2 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.821 -179.787 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.8 mttt . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.798 0.333 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.8 p -73.72 -21.52 60.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.391 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.651 HG23 ' O ' ' A' ' 103' ' ' ILE . 1.3 tt -95.04 110.03 47.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.295 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.8 149.9 23.55 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.835 1.69 . . . . 0.0 112.366 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.21 145.89 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.983 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.543 ' NE ' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -143.59 160.23 41.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.615 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -133.0 161.44 24.12 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 131' ' ' PHE . . . -108.47 120.42 42.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.717 0.294 . . . . 0.0 110.905 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.521 ' HB2' ' CG1' ' A' ' 179' ' ' ILE . . . -103.38 126.92 50.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.422 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mt -124.96 129.25 73.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.972 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 3.5 m-85 -115.76 154.26 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.903 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.726 HD21 ' H ' ' A' ' 116' ' ' SER . 40.5 p-10 -60.02 148.84 34.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.556 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -48.74 -29.82 4.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.64 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -87.8 4.61 43.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.756 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.459 ' O ' ' NH1' ' A' ' 239' ' ' ARG . 1.1 mp 41.7 42.66 2.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.519 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.726 ' H ' HD21 ' A' ' 112' ' ' ASN . 0.1 OUTLIER -123.08 -10.4 8.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.18 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.614 ' NZ ' ' CD1' ' A' ' 204' ' ' TRP . 7.7 mtpm? -134.29 168.55 18.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.044 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.38 144.0 35.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 202' ' ' ILE . 4.8 tt -108.25 121.6 45.22 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.826 0.346 . . . . 0.0 111.008 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.0 mt -120.92 158.86 26.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.093 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.93 170.73 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.706 0.289 . . . . 0.0 110.309 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -93.19 119.79 32.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.758 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -96.18 -157.17 31.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.1 t -54.05 -34.73 60.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.435 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -51.47 158.08 0.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.162 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.6 m -65.72 -62.9 1.25 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.028 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -137.07 73.4 1.44 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.844 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -128.47 145.8 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.599 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.418 ' CD2' ' N ' ' A' ' 129' ' ' TRP . 0.1 OUTLIER -108.49 110.81 22.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.441 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.2 m -161.25 172.06 17.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.481 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 108' ' ' ALA . 37.8 m-85 -80.89 151.42 70.66 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.077 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.83 145.65 63.29 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.011 1.807 . . . . 0.0 111.984 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -104.7 171.78 7.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.793 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -174.42 -151.77 8.61 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -133.48 166.94 21.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.766 0.317 . . . . 0.0 110.532 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.3 mt -115.11 136.62 51.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.9 t -76.61 134.64 39.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.447 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -74.41 151.08 39.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.813 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 54.4 41.75 31.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.674 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -149.45 145.9 27.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.392 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -60.11 137.11 58.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.433 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -59.91 -32.35 70.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.517 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 147' ' ' ILE . 83.9 mt -61.37 -46.51 96.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.541 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -62.37 -37.4 85.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.723 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 47.6 m -72.34 -40.37 67.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.985 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 87.8 m -70.72 -54.69 10.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.508 HG23 ' N ' ' A' ' 148' ' ' ARG . 17.4 tt -57.63 -40.99 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.956 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.508 ' N ' HG23 ' A' ' 147' ' ' ILE . 67.6 ttt-85 -65.01 -39.5 93.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.945 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -78.67 -28.25 45.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.794 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.01 -51.28 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.814 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -36.68 80.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.937 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -71.75 -36.07 70.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.208 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.422 ' O ' ' OE1' ' A' ' 194' ' ' GLN . 86.6 tt0 -77.71 -59.73 2.66 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.414 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.567 HD13 ' CE2' ' A' ' 191' ' ' PHE . 23.1 mt -71.68 -32.38 45.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.763 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.62 -14.56 61.83 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -112.33 133.58 54.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.764 0.316 . . . . 0.0 110.227 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 48.4 p30 -95.03 151.89 18.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.042 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.5 mt -111.6 110.19 20.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.101 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 91.4 m -90.47 -61.7 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.828 0.347 . . . . 0.0 111.239 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -100.23 -5.98 26.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -98.89 16.75 21.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.829 0.347 . . . . 0.0 110.354 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.5 tt -107.71 137.85 36.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -79.9 147.22 31.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.401 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 164' ' ' ASP . 8.6 p-10 -75.62 -64.99 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.395 0.617 . . . . 0.0 111.008 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.48 ' H ' ' CG ' ' A' ' 164' ' ' ASP . 36.5 t30 -131.98 67.84 1.51 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.089 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.545 ' HG3' HD12 ' A' ' 181' ' ' LEU . 4.3 tp60 -129.84 107.49 9.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.322 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -154.73 156.59 36.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.267 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.9 mt -124.62 129.16 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.505 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -99.59 137.62 37.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 tpt85 -159.51 127.65 4.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.607 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -100.29 115.05 29.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.133 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.7 tt -112.67 131.72 63.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.635 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.482 ' C ' ' H ' ' A' ' 175' ' ' LYS . 89.3 mm-40 53.62 43.14 31.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.402 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 63.45 -4.2 1.04 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 173' ' ' GLN . 20.6 tttm -90.66 132.15 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 110.794 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -74.69 119.54 19.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.489 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -129.5 121.99 28.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.573 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 107' ' ' GLY . 55.1 mttp -120.5 144.19 48.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.957 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.521 ' CG1' ' HB2' ' A' ' 109' ' ' ALA . 0.9 OUTLIER -129.76 132.2 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -101.42 123.63 45.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.183 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.545 HD12 ' HG3' ' A' ' 166' ' ' GLN . 13.4 mt -84.01 126.92 33.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.607 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 3.7 pt -145.48 100.9 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.293 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.5 m -114.28 157.2 23.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.515 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 118.63 -6.21 14.17 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.426 HG13 ' H ' ' A' ' 185' ' ' VAL . 2.4 m -61.73 153.02 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.301 . . . . 0.0 110.363 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.6 ' OG ' HG22 ' A' ' 188' ' ' VAL . 20.8 t -98.46 132.89 43.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.613 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -73.59 -7.53 52.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.594 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.6 HG22 ' OG ' ' A' ' 186' ' ' SER . 11.9 m -69.83 -20.28 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.429 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 190' ' ' ASN . 10.8 t80 -86.2 151.86 23.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.351 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.446 ' N ' ' CD1' ' A' ' 189' ' ' PHE . 47.4 t30 -85.55 110.59 19.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.567 ' CE2' HD13 ' A' ' 154' ' ' ILE . 2.4 m-85 -96.89 124.01 40.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.207 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -140.62 147.43 48.96 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.436 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.93 149.46 42.15 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.139 1.893 . . . . 0.0 112.233 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.422 ' OE1' ' O ' ' A' ' 153' ' ' GLU . 89.0 mt-30 -142.41 78.37 1.62 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.203 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.84 -166.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.536 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -46.84 150.5 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.21 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -56.74 125.46 22.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.957 0.408 . . . . 0.0 110.918 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -171.37 -113.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.08 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 199' ' ' ILE . 0.8 OUTLIER -130.46 129.64 64.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.301 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -97.77 108.61 21.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.497 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -137.73 133.89 34.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.422 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.467 HD11 HD11 ' A' ' 119' ' ' LEU . 14.7 tt -121.76 141.82 40.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.169 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -144.84 131.29 19.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.177 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' TRP . . . . . 0.614 ' CD1' ' NZ ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -98.09 101.42 12.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.825 0.345 . . . . 0.0 110.207 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -95.88 136.43 36.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -66.4 131.21 45.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.481 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -62.02 -36.82 82.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' A' ' 208' ' ' LYS . 0.0 OUTLIER -52.44 -42.45 64.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.842 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -65.13 -42.89 93.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.663 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 213' ' ' THR . 96.1 mt -66.56 -26.4 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.554 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 83.9 p -80.49 -59.19 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.77 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 214' ' ' MET . 97.5 mttt -63.24 -48.3 78.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.764 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 210' ' ' ILE . 18.5 p 51.13 7.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.048 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.503 ' H ' ' C ' ' A' ' 212' ' ' LYS . 11.9 mmt -73.62 -43.23 60.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.898 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -72.98 -31.54 64.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.867 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -98.25 120.74 39.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 2.8 t -131.51 -29.42 1.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.43 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -54.81 -46.15 74.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.747 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.7 pt -136.14 144.51 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.692 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -139.32 151.41 46.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.582 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -85.82 81.78 8.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.305 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -49.89 -40.3 42.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.071 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 10.5 mt -57.7 -52.63 64.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.038 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 228' ' ' MET . 47.2 mt -78.39 -27.5 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -50.73 -34.8 28.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.648 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.4 m -76.07 -36.73 58.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.966 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 73.3 mtm -95.24 0.74 54.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.972 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' MET . . . . . 0.523 ' N ' ' O ' ' A' ' 224' ' ' ILE . 2.5 ppp? -62.87 -32.81 74.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.971 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.417 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 7.9 mtt180 -67.18 -63.35 2.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.059 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 29.5 Cg_endo -63.79 -40.83 26.82 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.014 1.809 . . . . 0.0 112.124 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.55 -41.79 90.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.559 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . 0.452 ' O ' ' CG ' ' A' ' 236' ' ' ARG . 44.7 t -61.39 -39.09 89.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.587 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 86.3 mtp -73.57 -46.83 44.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -61.21 -51.51 68.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.738 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 41.8 tp -60.73 -35.72 77.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 110.305 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.452 ' CG ' ' O ' ' A' ' 232' ' ' SER . 9.4 mmt85 -64.26 -33.56 76.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.495 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.17 -43.24 74.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.48 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -53.59 -36.84 62.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.647 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.459 ' NH1' ' O ' ' A' ' 115' ' ' LEU . 62.2 mtp85 -57.12 -15.31 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.416 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -80.91 -52.46 7.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.967 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 94.8 mt . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.997 -179.49 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 81.7 tttt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.781 0.324 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.8 m -73.41 -33.15 64.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.507 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.14 107.71 57.42 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.388 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -82.38 152.62 15.8 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 121.948 1.766 . . . . 0.0 112.33 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.76 127.05 66.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.959 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.59 ' NH1' ' SG ' ' A' ' 145' ' ' CYS . 97.0 mtt180 -132.1 144.11 50.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.292 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -134.71 165.98 24.39 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 131' ' ' PHE . . . -110.1 137.55 47.71 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.137 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.83 120.72 41.72 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.707 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mp -133.15 142.81 41.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.766 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.429 ' CZ ' HD11 ' A' ' 235' ' ' LEU . 0.1 OUTLIER -151.72 160.58 43.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.101 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -47.23 151.93 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.141 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 185' ' ' VAL . 87.1 mt-10 -63.25 -24.48 67.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.926 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -101.92 13.17 35.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.192 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.554 HD22 ' N ' ' A' ' 115' ' ' LEU . 3.9 mm? 50.65 47.25 24.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.109 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.05 -26.49 13.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.1 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.489 ' NZ ' ' OD2' ' A' ' 206' ' ' ASP . 21.2 mtpp -143.93 178.77 7.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.042 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.419 HG21 HD12 ' A' ' 210' ' ' ILE . 14.4 tt -140.74 131.54 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.431 . . . . 0.0 110.49 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.597 ' O ' HD22 ' A' ' 120' ' ' LEU . 0.8 OUTLIER -75.73 121.83 23.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.261 -179.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.597 HD22 ' O ' ' A' ' 119' ' ' LEU . 2.6 mm? -125.64 156.35 39.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.7 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.3 m -143.18 173.5 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.52 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -102.34 124.69 48.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.678 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.58 -165.69 36.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.762 HG22 ' OE1' ' A' ' 198' ' ' GLU . 47.0 p -61.1 -25.33 66.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 0.0 110.442 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.405 ' OE1' ' CB ' ' A' ' 128' ' ' SER . 56.7 mt-10 -51.78 165.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.25 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.5 m -67.37 -67.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.021 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -136.99 68.92 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.991 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.405 ' CB ' ' OE1' ' A' ' 125' ' ' GLU . 14.1 m -128.84 143.52 50.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.383 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.487 ' C ' HD12 ' A' ' 120' ' ' LEU . 9.7 m0 -107.68 118.73 37.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.604 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.6 m -156.24 170.33 22.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.759 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.524 ' CZ ' ' O ' ' A' ' 119' ' ' LEU . 39.9 m-85 -81.21 152.78 71.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.061 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.35 137.92 41.26 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.901 1.734 . . . . 0.0 111.735 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.529 ' NE ' ' OH ' ' A' ' 177' ' ' TYR . 45.1 ptt85 -150.07 -170.3 3.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.177 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.76 177.93 25.12 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -81.21 137.0 35.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.9 tt -125.95 155.38 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.451 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.4 p -64.72 157.51 27.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.633 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 65.1 mttm -89.88 -178.9 5.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.603 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 4.6 t0 77.7 38.15 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.406 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -137.77 158.7 43.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.567 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -84.9 151.38 24.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.398 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 36.3 p-10 -53.19 -37.07 61.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.622 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.582 HG23 ' N ' ' A' ' 144' ' ' ASP . 19.1 tt -79.75 -45.73 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.552 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.582 ' N ' HG23 ' A' ' 143' ' ' ILE . 57.2 t0 -62.56 -34.51 77.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.827 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.59 ' SG ' ' NH1' ' A' ' 106' ' ' ARG . 6.1 p -64.62 -41.03 96.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.589 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.676 ' O ' HG23 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -63.75 -46.04 87.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.298 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.526 ' N ' ' SG ' ' A' ' 146' ' ' CYS . 80.0 mt -59.34 -52.16 64.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.969 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -60.04 -40.77 90.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.548 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -79.06 -28.84 43.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.879 0.371 . . . . 0.0 110.726 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 146' ' ' CYS . 4.1 t -64.8 -50.99 72.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.719 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER -70.13 -44.33 69.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.933 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -47.15 -34.43 6.17 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.399 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 194' ' ' GLN . 78.2 mm-40 -91.61 -62.13 1.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.023 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 81.9 mt -81.04 -33.63 13.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 151' ' ' LYS . . . 100.6 -14.15 59.28 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -125.12 137.89 54.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.512 ' C ' HD12 ' A' ' 158' ' ' LEU . 50.1 p30 -135.17 156.92 48.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 111.036 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.796 ' N ' HD12 ' A' ' 158' ' ' LEU . 4.5 mp -103.01 122.91 45.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.958 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 24.0 p -90.4 -61.52 1.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.384 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -103.3 11.79 36.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.662 ' HB3' HD23 ' A' ' 158' ' ' LEU . 0.2 OUTLIER -106.82 17.7 22.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.838 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.777 ' CG2' HG23 ' A' ' 182' ' ' ILE . 2.6 pt -130.95 149.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.06 0.457 . . . . 0.0 111.184 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -71.2 156.19 39.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.649 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.62 -17.88 21.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.078 0.466 . . . . 0.0 110.936 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -134.34 58.02 1.78 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.362 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.675 ' HG2' HD12 ' A' ' 181' ' ' LEU . 38.3 tt0 -139.38 106.99 5.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.105 0.478 . . . . 0.0 110.679 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -166.09 163.32 18.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.651 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.0 pt -129.24 150.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.399 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 169' ' ' GLU . 1.2 pt-20 -144.18 96.43 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.684 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -127.72 153.0 47.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.468 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -106.15 122.11 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.495 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.426 HD11 ' SD ' ' A' ' 227' ' ' MET . 58.9 mt -103.72 121.8 55.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.353 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.498 ' NE2' ' CE2' ' A' ' 222' ' ' TYR . 87.2 mt-30 53.48 43.28 31.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.426 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.48 -11.53 12.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -86.42 124.62 32.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.8 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.582 HD22 ' N ' ' A' ' 176' ' ' ASN . 0.0 OUTLIER -74.3 119.99 19.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.464 -178.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.529 ' OH ' ' NE ' ' A' ' 133' ' ' ARG . 0.2 OUTLIER -122.91 104.91 9.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.769 -179.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -108.18 129.89 55.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 54.7 mt -138.44 136.2 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.529 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -95.5 136.35 35.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.75 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.675 HD12 ' HG2' ' A' ' 166' ' ' GLN . 61.5 mt -84.75 133.32 34.36 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.854 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.777 HG23 ' CG2' ' A' ' 162' ' ' ILE . 65.0 mt -133.05 108.84 13.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.308 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.9 t -117.26 147.94 42.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.563 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 102.74 8.24 43.14 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.483 ' HA ' HD21 ' A' ' 158' ' ' LEU . 5.6 p -50.04 133.05 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 110.625 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 48.6 m -81.67 143.51 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.424 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -93.46 -9.73 37.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.365 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.64 -28.33 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.664 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -83.04 144.63 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.715 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -81.47 139.89 34.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.257 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -99.63 124.55 44.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.726 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -143.3 109.85 5.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.435 ' HD3' HD12 ' A' ' 202' ' ' ILE . 61.1 Cg_endo -79.18 136.76 13.05 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.736 1.624 . . . . 0.0 111.972 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 153' ' ' GLU . 83.6 mt-30 -126.5 111.55 14.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.648 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.63 178.96 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -43.69 146.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.364 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -56.99 102.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.802 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.762 ' OE1' HG22 ' A' ' 124' ' ' THR . 39.7 mt-10 -155.36 -113.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.146 0.498 . . . . 0.0 110.276 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 32.6 mt -122.41 110.04 25.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.069 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 200' ' ' ASP . 32.2 p-10 -106.0 119.88 40.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -136.01 123.9 22.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.33 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.435 HD12 ' HD3' ' A' ' 193' ' ' PRO . 17.2 tt -107.35 138.77 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -166.05 152.67 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.405 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -115.79 110.96 19.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.446 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -97.52 143.72 27.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.489 ' OD2' ' NZ ' ' A' ' 117' ' ' LYS . 1.1 t0 -70.67 129.64 39.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.368 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -46.54 -33.74 4.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.352 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -64.43 -45.37 87.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.14 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -53.1 -49.09 67.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.965 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . 0.419 HD12 HG21 ' A' ' 118' ' ' ILE . 96.3 mt -67.24 -19.76 25.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.805 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.42 -13.02 44.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.488 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -98.41 24.46 7.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.487 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.2 m -49.94 -36.49 28.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.797 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 76.5 mmm -53.69 -38.72 64.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.795 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -67.73 -26.26 66.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.662 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -93.65 133.87 36.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.518 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.4 t -113.96 -42.17 3.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.01 -44.06 97.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.748 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.0 mt -124.66 127.17 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.58 135.35 38.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.37 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.468 ' CZ ' ' CE3' ' A' ' 129' ' ' TRP . 53.5 m-85 -107.35 105.23 15.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.712 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.498 ' CE2' ' NE2' ' A' ' 173' ' ' GLN . 23.2 p90 -90.98 -36.57 14.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.423 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 222' ' ' TYR . 2.5 tp -51.19 -45.45 61.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.313 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 228' ' ' MET . 2.8 tp -73.31 -29.69 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.753 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -56.63 -43.56 80.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.552 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.1 t -63.66 -34.31 77.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.598 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 227' ' ' MET . 0.0 OUTLIER -86.76 -29.36 22.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.702 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' MET . . . . . 0.492 ' N ' ' O ' ' A' ' 224' ' ' ILE . 32.0 ttm -54.99 -40.32 69.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.354 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.509 HH11 ' CG ' ' A' ' 229' ' ' ARG . 0.1 OUTLIER -62.1 -64.08 3.48 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.532 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 37.2 Cg_endo -64.97 -47.88 4.36 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.291 1.994 . . . . 0.0 112.235 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 6.0 tt -51.05 -40.7 58.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.627 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 34.9 t -66.8 -49.05 67.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.04 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 8.3 tpp -60.17 -50.89 71.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.264 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.431 ' O ' ' OE1' ' A' ' 238' ' ' GLN . 13.0 m95 -53.83 -66.83 0.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.112 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.429 HD11 ' CZ ' ' A' ' 111' ' ' PHE . 87.3 mt -51.25 -32.32 23.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.027 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -67.35 -29.39 68.93 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.127 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -75.66 -53.64 8.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.751 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.431 ' OE1' ' O ' ' A' ' 234' ' ' TRP . 5.5 mp0 -56.42 -38.57 71.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.8 -26.74 64.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.61 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -72.82 -44.86 60.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.786 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 15.9 mm . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.039 -179.652 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.2 mttt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.1 ttmm -94.8 101.97 13.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.717 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.0 -32.78 7.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.121 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 103' ' ' ILE . 1.3 tt -117.03 108.17 44.61 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.308 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -79.06 140.86 16.13 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.732 1.622 . . . . 0.0 112.045 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.41 141.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.582 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -142.82 145.65 33.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.73 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -128.86 173.46 19.33 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.455 ' HB1' HD11 ' A' ' 182' ' ' ILE . . . -127.54 127.63 44.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.3 . . . . 0.0 110.749 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.779 ' C ' HD13 ' A' ' 110' ' ' ILE . . . -111.24 113.48 25.99 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.639 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.815 HD13 ' N ' ' A' ' 110' ' ' ILE . 0.0 OUTLIER -110.29 139.6 33.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.018 0.437 . . . . 0.0 110.654 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -117.95 156.28 28.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.216 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.742 HD21 ' N ' ' A' ' 116' ' ' SER . 0.0 OUTLIER -58.64 172.68 0.48 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.164 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -64.69 -29.23 70.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.737 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.96 4.23 48.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.992 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.402 ' CA ' ' ND2' ' A' ' 112' ' ' ASN . 1.5 mp 43.43 43.29 4.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.452 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.742 ' N ' HD21 ' A' ' 112' ' ' ASN . 8.1 t -124.19 -5.23 7.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.726 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.466 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 86.8 mttt -138.8 157.55 45.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.839 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 25.4 mm -109.66 140.04 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.99 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.514 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 2.2 tt -101.18 111.03 23.14 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.329 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.833 HD22 ' N ' ' A' ' 120' ' ' LEU . 1.7 mm? -104.44 161.0 14.46 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.0 m -137.69 162.99 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.314 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -98.26 127.45 44.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.63 -165.4 34.6 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 72.4 p -59.92 -24.07 64.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.362 . . . . 0.0 110.38 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.24 160.37 27.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.3 m -72.81 -102.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.97 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -77.07 72.14 3.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.414 ' C ' ' CG ' ' A' ' 129' ' ' TRP . 54.3 p -128.39 156.13 43.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.351 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.414 ' CG ' ' C ' ' A' ' 128' ' ' SER . 56.5 m95 -151.37 110.79 3.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.671 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.56 176.46 6.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.514 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 29.1 m-85 -77.53 153.72 81.37 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.92 149.61 59.75 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.934 1.756 . . . . 0.0 112.03 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.586 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -149.37 177.74 9.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.841 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 160.51 -174.81 37.26 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -79.17 143.47 35.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.64 0.257 . . . . 0.0 110.475 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.5 pt -110.81 152.52 12.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.465 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.8 m -65.08 145.55 56.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.504 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -93.32 161.13 14.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.413 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 63.0 34.79 13.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.511 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -137.13 145.18 43.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.377 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -60.63 130.72 47.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.127 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -50.55 -37.73 41.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.024 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.2 mt -68.77 -54.39 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.584 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -56.95 -37.52 71.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.304 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -32.05 73.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.144 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.44 ' O ' HG23 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -65.02 -48.9 72.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.682 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.0 mm -54.52 -48.47 70.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.872 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -62.11 -40.49 96.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.527 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -82.61 -20.64 36.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.9 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.639 HG13 HD12 ' A' ' 154' ' ' ILE . 20.5 t -85.05 -51.54 13.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.631 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.27 -28.45 69.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.053 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -81.71 -36.34 28.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.811 0.339 . . . . 0.0 110.899 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -82.11 -61.54 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.284 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.639 HD12 HG13 ' A' ' 150' ' ' VAL . 15.1 mt -72.79 -33.52 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.559 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.27 -14.3 59.7 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.53 ' CE2' ' O ' ' A' ' 157' ' ' ASP . 62.4 t80 -116.41 143.63 45.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.69 0.281 . . . . 0.0 110.506 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.53 ' O ' ' CE2' ' A' ' 156' ' ' PHE . 44.8 p30 -106.6 140.11 40.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.5 111.14 23.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.037 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.7 p -90.22 -61.61 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.721 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.436 ' OD1' ' CD2' ' A' ' 161' ' ' TYR . 55.6 p30 -107.45 8.74 29.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.564 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.436 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 79.1 m-85 -106.87 15.89 24.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 tt -117.38 140.04 41.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.705 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -69.04 148.19 50.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.151 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 165' ' ' ASN . 22.3 p-10 -76.37 -57.87 3.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.229 0.538 . . . . 0.0 111.54 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 91.0 m-20 -131.41 60.75 1.66 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.421 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.483 ' O ' ' CE1' ' A' ' 180' ' ' PHE . 50.0 tt0 -129.61 107.83 9.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.942 0.401 . . . . 0.0 110.387 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -152.94 162.32 41.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.379 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 24.1 pt -129.55 147.64 33.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -121.25 138.76 54.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.039 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.499 ' NH2' ' O ' ' A' ' 226' ' ' SER . 8.1 tpt180 -159.25 132.97 7.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.559 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -107.19 115.07 29.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 61.2 mt -109.48 129.33 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.442 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 52.1 43.24 30.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.385 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.44 -5.81 3.84 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -89.4 128.34 35.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 111.037 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -75.15 123.28 24.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.759 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -132.98 110.08 10.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.44 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -108.92 141.3 41.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.333 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.17 127.63 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.981 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.483 ' CE1' ' O ' ' A' ' 166' ' ' GLN . 1.9 t80 -95.76 123.99 39.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.481 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.69 126.28 29.52 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.494 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.455 HD11 ' HB1' ' A' ' 108' ' ' ALA . 0.8 OUTLIER -140.95 101.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.205 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.1 p -125.38 161.54 26.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.609 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 120.45 8.03 8.67 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 9.0 m -75.18 161.05 4.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.716 0.294 . . . . 0.0 110.465 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 62.2 m -104.61 158.46 16.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.804 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.91 -2.24 57.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.397 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 46.5 t -71.07 -27.85 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.508 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.448 ' CE1' ' O ' ' A' ' 190' ' ' ASN . 48.7 t80 -100.19 144.37 29.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.349 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.448 ' O ' ' CE1' ' A' ' 189' ' ' PHE . 9.3 p30 -97.99 125.38 42.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -104.83 126.65 52.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.339 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -127.23 149.68 70.3 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.238 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -70.04 143.57 49.88 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.079 1.853 . . . . 0.0 111.986 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -141.3 83.57 1.88 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.536 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.15 -165.0 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.324 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -45.58 152.61 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.142 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.39 109.39 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.617 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 2.2 tt0 -161.87 -113.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.057 0.456 . . . . 0.0 110.62 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.473 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 49.7 mt -113.97 131.91 64.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.429 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.08 101.05 6.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.39 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -137.69 140.97 41.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 119' ' ' LEU . 15.9 tt -113.65 140.38 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.455 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -144.55 120.71 10.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.549 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.09 101.5 13.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.172 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.436 ' HB2' HD23 ' A' ' 120' ' ' LEU . 2.2 m-85 -98.72 134.4 41.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.722 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 207' ' ' PHE . 65.2 t0 -72.17 139.94 48.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.486 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.461 ' N ' ' OD1' ' A' ' 206' ' ' ASP . 76.4 t80 -53.86 -31.21 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.566 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -50.76 -52.65 38.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.507 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -58.81 -43.83 90.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.801 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.491 HD13 HD13 ' A' ' 224' ' ' ILE . 83.8 mt -62.45 -35.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.585 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 60.4 p -68.35 -19.33 64.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.373 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -102.61 20.9 16.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.647 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.81 -31.3 1.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.679 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.477 ' C ' ' H ' ' A' ' 216' ' ' LYS . 34.0 mtt -54.75 -29.84 54.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.566 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.528 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 51.2 t80 -72.17 22.71 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.116 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 214' ' ' MET . 1.9 pttp -64.55 138.26 58.31 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.44 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.5 p -126.67 -21.46 4.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.707 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.694 ' OD1' HG22 ' A' ' 219' ' ' ILE . 22.5 t-20 -137.02 -102.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.661 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.694 HG22 ' OD1' ' A' ' 218' ' ' ASN . 17.1 tt -113.67 122.61 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.665 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -132.78 162.02 32.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.277 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.55 ' CD1' ' N ' ' A' ' 221' ' ' TYR . 0.1 OUTLIER -91.35 93.6 9.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.688 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -74.78 -10.05 59.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 79.8 mt -53.25 -51.78 61.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.691 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.491 HD13 HD13 ' A' ' 210' ' ' ILE . 15.6 tt -72.24 -29.94 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.8 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -54.28 -44.19 71.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.644 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.499 ' O ' ' NH2' ' A' ' 170' ' ' ARG . 75.3 m -68.68 -33.05 73.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.704 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 73.8 mtm -92.35 2.01 56.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 224' ' ' ILE . 38.2 ttp -60.56 -38.86 85.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.491 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.444 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -56.47 -64.62 2.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.677 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 17.7 Cg_endo -60.81 -52.02 4.16 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.111 1.874 . . . . 0.0 112.019 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.633 ' C ' HD23 ' A' ' 231' ' ' LEU . 6.4 tt -48.99 -50.84 33.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.594 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 23.0 t -64.19 -59.2 4.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.442 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 86.7 mtp -50.99 -53.5 32.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.746 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -62.04 -50.31 72.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.087 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 41.3 tp -57.78 -30.39 65.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.0 110.034 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -34.43 77.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.371 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -65.21 -43.27 92.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.686 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -58.91 -36.15 74.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.772 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -64.29 -32.41 73.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.017 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -65.71 -42.05 91.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 11.1 mm -65.24 -29.27 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.808 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -46.34 -27.7 1.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.201 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -54.34 165.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.494 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -68.08 -28.34 67.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.289 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.639 -179.921 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 38.6 tttp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -85.53 89.18 7.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.685 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.5 m -92.0 -29.43 16.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.491 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.83 107.83 28.56 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.346 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.36 141.52 11.41 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 122.025 1.817 . . . . 0.0 112.086 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.464 HG11 ' CZ ' ' A' ' 177' ' ' TYR . 2.7 t -127.86 141.84 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.863 ' HE ' HD12 ' A' ' 136' ' ' ILE . 45.7 ttp85 -123.14 152.1 41.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.458 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -125.94 156.83 19.72 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.492 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -103.55 161.15 14.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 0.0 110.844 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 180' ' ' PHE . . . -141.54 111.34 6.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.458 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.57 133.5 63.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.202 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.86 158.92 41.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.455 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 116' ' ' SER . 37.4 p-10 -55.3 166.42 0.6 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.296 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -63.9 -25.51 68.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.371 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -90.72 6.08 45.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.793 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.8 mt 45.31 44.23 8.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.623 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.605 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 0.7 OUTLIER -125.01 -2.03 7.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.639 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -133.29 149.42 51.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 34.2 mm -115.66 127.21 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.92 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.522 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 1.3 tt -89.03 105.61 17.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.563 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.1 mt -118.78 157.2 28.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.226 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.35 174.35 11.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.762 0.315 . . . . 0.0 110.407 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -88.58 127.76 35.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.386 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.05 -176.04 39.37 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 124' ' ' THR . 25.5 p -52.25 -35.67 50.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 0.0 110.21 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -55.33 -176.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.003 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.2 m -85.21 -76.85 0.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.834 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -109.54 75.82 0.96 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.677 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.1 t -128.14 142.6 51.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.651 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.594 ' NE1' ' CE1' ' A' ' 221' ' ' TYR . 0.0 OUTLIER -122.94 111.88 17.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.449 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.2 168.76 26.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.808 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 43.5 m-85 -82.08 153.04 69.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.236 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -43.68 148.67 0.82 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.837 1.691 . . . . 0.0 111.45 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -126.43 170.01 12.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.648 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 175.12 177.38 44.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -97.35 147.39 24.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.739 0.304 . . . . 0.0 110.538 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.863 HD12 ' HE ' ' A' ' 106' ' ' ARG . 18.2 tt -133.53 140.56 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.594 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.7 m -71.65 150.33 44.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.501 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -93.84 156.24 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.548 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 56.87 42.66 26.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.436 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -142.48 158.57 43.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.011 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -58.09 124.73 20.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.881 0.372 . . . . 0.0 110.396 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 44.8 p-10 -77.95 -32.36 51.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.006 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.512 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 10.7 tp -65.32 -38.27 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 110.326 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.453 ' N ' HG23 ' A' ' 143' ' ' ILE . 63.6 t0 -72.32 -35.32 68.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.415 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 63.6 m -82.48 -37.43 25.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.01 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 142' ' ' ASP . 66.7 m -65.66 -53.06 46.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.815 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.3 tt -64.52 -35.68 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.19 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -65.81 -42.12 91.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.278 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -76.45 -34.87 58.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.97 0.414 . . . . 0.0 110.826 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.587 HG13 HD12 ' A' ' 154' ' ' ILE . 2.5 t -72.78 -49.8 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.99 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -65.52 -38.57 90.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.281 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -70.64 -37.48 73.77 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.965 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -77.52 -56.75 4.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.122 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.587 HD12 HG13 ' A' ' 150' ' ' VAL . 87.3 mt -71.49 -32.28 45.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.994 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.63 -8.43 78.65 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -104.17 125.99 50.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 110.485 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -91.29 126.58 36.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.765 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 8.5 mt -100.42 110.42 22.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.859 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.9 m -90.67 -61.7 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.703 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.514 ' OD1' ' CE2' ' A' ' 161' ' ' TYR . 49.8 p30 -101.7 2.92 39.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.262 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.514 ' CE2' ' OD1' ' A' ' 160' ' ' ASP . 20.9 m-85 -107.21 16.82 23.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.299 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 162' ' ' ILE . 10.8 tp -114.02 129.6 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 181' ' ' LEU . 91.1 m-20 -73.68 144.69 45.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.227 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -70.08 -66.95 0.53 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.461 0.648 . . . . 0.0 111.345 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -133.35 66.6 1.55 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.025 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.465 ' HG2' HD12 ' A' ' 181' ' ' LEU . 6.2 tt0 -128.51 108.56 10.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.539 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -152.89 157.74 41.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.651 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.5 mt -121.45 136.85 57.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.664 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 170' ' ' ARG . 0.9 OUTLIER -89.77 129.35 36.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.006 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.452 ' N ' ' OE1' ' A' ' 169' ' ' GLU . 12.4 tpp180 -149.93 114.63 5.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.55 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -110.24 116.01 30.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.405 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 15.9 pt -116.99 142.2 31.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.69 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.512 ' C ' ' H ' ' A' ' 175' ' ' LYS . 55.1 mt-30 51.97 41.09 29.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.413 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 63.67 -4.01 1.21 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.512 ' H ' ' C ' ' A' ' 173' ' ' GLN . 2.1 tppp? -89.64 125.23 35.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.409 . . . . 0.0 110.451 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -75.98 128.7 35.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.896 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.464 ' CZ ' HG11 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -139.47 119.3 13.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.457 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 107' ' ' GLY . 24.5 mttp -99.92 135.25 41.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.193 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 33.8 mm -113.03 120.23 62.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.96 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.73 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 3.6 t80 -97.65 120.75 38.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.962 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.465 HD12 ' HG2' ' A' ' 166' ' ' GLN . 14.2 mt -78.98 125.68 29.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.934 0.397 . . . . 0.0 110.874 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.3 mt -137.23 103.59 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.328 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 94.3 p -110.88 150.36 29.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.497 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 103.52 1.48 46.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.3 p -48.69 149.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 110.704 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.9 m -80.34 101.52 9.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.666 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -67.97 -23.85 65.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.7 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.8 m -74.79 -18.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.682 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -96.33 136.92 36.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.319 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -87.16 133.83 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.517 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -111.89 138.34 48.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.01 109.27 10.67 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.037 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.03 156.68 15.18 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.061 1.841 . . . . 0.0 112.68 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.68 115.07 19.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.089 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 10.4 m -134.3 -168.24 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.472 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -41.52 146.13 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.321 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -69.94 114.19 7.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.831 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 4.6 tt0 -172.53 -112.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.138 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.436 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 94.7 mt -109.05 120.42 60.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.519 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 200' ' ' ASP . 33.6 p-10 -123.18 101.07 7.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.28 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -137.04 140.4 42.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.655 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 71.5 mt -99.82 135.49 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.473 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -147.22 117.75 7.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.43 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' TRP . . . . . 0.445 ' CZ2' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -89.63 104.04 16.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.51 -179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -94.22 132.51 38.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.962 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -68.42 137.48 54.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.421 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -55.23 -43.16 74.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -60.43 -45.04 95.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.126 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 213' ' ' THR . 40.7 mttt -62.34 -38.81 90.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.053 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.549 HG21 HG21 ' A' ' 224' ' ' ILE . 90.1 mt -69.91 -30.06 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 9.6 m -66.88 -33.83 76.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.422 ' O ' ' OG1' ' A' ' 213' ' ' THR . 16.8 ptmt -105.44 -33.08 8.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.044 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 209' ' ' LYS . 17.3 p 55.13 65.25 1.54 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.642 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.468 ' C ' ' H ' ' A' ' 216' ' ' LYS . 12.2 tmm? -58.67 -28.27 65.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.48 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 63.3 t80 -67.7 8.77 0.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.114 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 214' ' ' MET . 20.7 tttt -59.7 120.77 10.13 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.824 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.3 p -132.29 -44.75 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.295 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 218' ' ' ASN . 1.0 OUTLIER -144.2 -39.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.447 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 45.1 pt -126.7 154.99 37.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.712 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.19 142.38 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.294 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.594 ' CE1' ' NE1' ' A' ' 129' ' ' TRP . 0.2 OUTLIER -67.06 118.87 11.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -97.63 -6.07 34.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.71 -42.33 91.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 228' ' ' MET . 35.8 mm -96.66 -40.04 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.278 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -48.3 -53.83 15.93 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.779 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 67.5 m -65.68 -38.99 90.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 110.376 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 27.7 ttm -74.59 -15.03 60.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.384 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' MET . . . . . 0.55 ' N ' ' O ' ' A' ' 224' ' ' ILE . 32.0 ttp -57.96 -42.86 85.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.794 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.445 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 5.3 mtt180 -56.58 -65.22 1.75 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.009 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 24.8 Cg_endo -61.58 -48.31 9.53 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.2 1.933 . . . . 0.0 112.42 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.3 tp -55.94 -39.56 71.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.783 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 37.1 t -63.49 -38.64 91.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.08 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 5.0 mtm -71.48 -52.12 20.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.147 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -55.99 -56.98 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.43 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 95.3 mt -54.86 -31.23 59.41 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.68 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -75.42 -28.7 59.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.389 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -72.87 -55.64 6.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.47 ' C ' ' N ' ' A' ' 240' ' ' GLN . 95.8 mm-40 -53.78 -39.39 65.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.543 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 9.1 tpp85 -47.24 -15.89 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.355 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.47 ' N ' ' C ' ' A' ' 238' ' ' GLN . 3.0 tp-100 -82.69 -59.21 2.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 241' ' ' ILE . 7.6 tt -64.28 -10.15 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.622 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -50.62 -31.45 16.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.464 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -75.79 175.07 9.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.355 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -64.87 136.24 56.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 110.494 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 30.8 p30 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.669 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -142.51 67.0 1.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.446 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.9 t -73.42 -22.46 60.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.535 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 pt -102.29 109.03 59.37 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.41 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.32 139.03 18.29 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.717 1.611 . . . . 0.0 112.565 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.84 148.13 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.209 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -140.15 158.72 43.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.278 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -138.84 178.18 19.62 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.471 ' O ' ' CB ' ' A' ' 131' ' ' PHE . . . -118.62 163.06 17.37 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.083 0.468 . . . . 0.0 111.289 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.37 113.0 8.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.998 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.488 HG23 HG11 ' A' ' 185' ' ' VAL . 4.0 mp -135.75 131.54 50.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.373 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.37 160.3 43.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.149 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -49.17 139.68 10.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.262 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.34 -30.24 50.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -85.88 6.73 27.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.516 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 mt 47.0 57.71 5.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.385 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.85 -16.67 7.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.933 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -137.07 157.52 46.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.399 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -128.17 132.49 68.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.188 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.509 ' O ' ' CZ ' ' A' ' 131' ' ' PHE . 0.6 OUTLIER -92.06 115.57 28.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.818 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.9 mt -126.34 163.61 22.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.075 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.4 m -143.34 156.69 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.403 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -101.96 150.58 23.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.635 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -134.93 -162.44 9.79 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.0 t -52.22 -27.63 15.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.773 0.321 . . . . 0.0 110.649 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.545 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 53.7 mp0 -55.27 153.7 6.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.189 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.7 t -68.23 -84.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.957 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -113.12 69.29 0.69 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 m -128.43 147.97 50.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.521 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.451 ' CD1' ' N ' ' A' ' 129' ' ' TRP . 1.3 m95 -133.77 116.3 15.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.26 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.448 ' OG ' HD13 ' A' ' 223' ' ' LEU . 0.7 OUTLIER -153.52 167.66 28.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.0 111.081 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.509 ' CZ ' ' O ' ' A' ' 119' ' ' LEU . 41.2 m-85 -77.5 153.9 81.49 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.508 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -41.46 144.76 0.68 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.791 1.661 . . . . 0.0 111.399 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.432 ' CZ ' ' OH ' ' A' ' 177' ' ' TYR . 7.9 ptm180 -139.01 174.85 10.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.747 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 179.59 177.16 47.68 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 110.23 21.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.711 0.291 . . . . 0.0 110.511 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.9 tt -128.1 136.48 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.541 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.5 m -64.78 157.39 27.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.594 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 22.8 mttp -93.09 178.09 5.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.722 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 6.8 t0 77.07 28.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.492 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -133.11 156.07 48.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.367 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.416 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 71.0 m-80 -58.81 127.66 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.623 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.491 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 67.4 m-20 -73.2 -39.24 65.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.155 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 144' ' ' ASP . 13.6 tt -61.82 -46.58 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.739 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.561 ' N ' HG23 ' A' ' 143' ' ' ILE . 18.4 t70 -68.64 -39.21 80.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.388 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 141' ' ' ASN . 89.0 m -72.92 -35.63 67.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.55 ' SG ' ' CD2' ' A' ' 180' ' ' PHE . 34.8 m -61.45 -53.96 49.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.721 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 83.9 mt -59.1 -41.64 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.729 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -64.74 -41.34 96.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.91 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.03 -31.6 61.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.957 0.408 . . . . 0.0 110.373 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.671 HG13 HD12 ' A' ' 154' ' ' ILE . 2.6 t -73.72 -47.97 41.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.088 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -23.59 63.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.584 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -78.39 -40.69 35.37 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.641 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.434 ' OE1' HG13 ' A' ' 195' ' ' VAL . 77.4 mm-40 -83.69 -58.01 2.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.459 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.671 HD12 HG13 ' A' ' 150' ' ' VAL . 90.0 mt -72.36 -33.67 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.803 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.27 -13.82 64.18 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.473 ' CD2' ' CE2' ' A' ' 189' ' ' PHE . 51.8 t80 -110.9 133.65 53.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.774 0.321 . . . . 0.0 110.223 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -96.81 141.76 29.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.138 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.7 mt -111.92 110.39 20.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.131 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.1 m -91.07 -62.02 1.54 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.425 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -106.37 1.74 25.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.036 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -99.92 16.46 23.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.576 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.585 ' HA ' HG23 ' A' ' 182' ' ' ILE . 7.4 tt -125.59 136.76 59.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.702 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -70.99 144.1 50.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.681 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.33 -28.74 15.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.478 . . . . 0.0 111.197 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -133.98 59.35 1.74 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.317 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -149.34 108.12 3.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.966 0.412 . . . . 0.0 110.116 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -159.9 158.43 30.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.385 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 169' ' ' GLU . 85.2 mt -133.59 155.58 40.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.714 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.475 ' N ' HG22 ' A' ' 168' ' ' ILE . 1.7 tm-20 -102.73 137.22 41.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.029 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 177' ' ' TYR . 64.4 mtt180 -140.82 112.18 7.35 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.923 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 175' ' ' LYS . 49.5 t-20 -119.72 111.78 18.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.431 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.467 HG22 ' HG3' ' A' ' 173' ' ' GLN . 62.3 mt -119.38 139.09 47.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.376 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.467 ' HG3' HG22 ' A' ' 172' ' ' ILE . 91.0 mt-30 53.16 36.95 23.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.634 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.48 -5.0 11.5 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 171' ' ' ASN . 49.4 mttp -85.29 119.46 25.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 0.0 110.404 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -76.1 118.77 19.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.903 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.432 ' OH ' ' CZ ' ' A' ' 133' ' ' ARG . 3.8 m-85 -131.99 109.17 9.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.566 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 107' ' ' GLY . 0.6 OUTLIER -102.78 139.74 37.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.75 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.9 mt -136.67 128.35 43.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.961 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.55 ' CD2' ' SG ' ' A' ' 146' ' ' CYS . 1.8 p90 -93.08 127.65 38.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.356 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.424 HD11 ' CD1' ' A' ' 168' ' ' ILE . 24.9 mt -74.01 139.86 45.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.082 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.585 HG23 ' HA ' ' A' ' 162' ' ' ILE . 59.9 mt -136.41 107.64 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.127 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 79.9 p -119.03 158.03 26.63 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.876 0.37 . . . . 0.0 110.483 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 92.68 16.43 48.88 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.488 HG11 HG23 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -94.36 115.73 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.038 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 54.1 m -63.3 151.38 40.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.415 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -99.41 6.29 46.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.354 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.15 -20.64 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.353 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 189' ' ' PHE . 1.3 p90 -99.72 128.03 45.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.913 0.387 . . . . 0.0 110.83 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -125.44 134.17 52.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.393 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.405 ' CZ ' HG23 ' A' ' 154' ' ' ILE . 3.5 p90 -112.15 159.27 18.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.588 ' N ' ' CD ' ' A' ' 192' ' ' LYS . 0.0 OUTLIER -105.19 161.49 22.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.262 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -38.34 116.13 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.918 2.412 . . . . 0.0 112.644 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -145.95 69.7 1.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.028 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.681 HG12 ' N ' ' A' ' 196' ' ' ARG . 38.7 t -139.67 173.61 10.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.638 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.681 ' N ' HG12 ' A' ' 195' ' ' VAL . 36.7 mtt85 -52.42 148.94 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.536 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.9 105.72 0.18 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.495 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 0.9 OUTLIER -171.97 -113.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.406 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.495 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 3.5 mm -123.57 120.03 58.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.246 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -129.77 111.75 12.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.818 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -142.06 128.01 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.234 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.13 136.14 38.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -150.82 126.66 10.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.324 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.13 110.4 22.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.408 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -103.92 150.83 23.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.022 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -65.82 124.4 22.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.867 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -46.04 -35.37 4.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.952 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -56.02 -32.87 64.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.892 0.377 . . . . 0.0 110.636 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -48.31 -51.46 25.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 7.1 mt -66.41 -38.74 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 44.0 m -66.75 -45.04 79.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.796 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 214' ' ' MET . 28.8 mttt -56.72 -18.73 13.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.516 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 3.4 m -66.02 56.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.558 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 212' ' ' LYS . 48.8 mtt -95.51 -72.8 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.846 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.15 -9.92 54.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.986 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -77.4 106.74 9.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.88 0.371 . . . . 0.0 110.593 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 22.8 t -95.87 -14.08 23.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.646 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -44.4 -62.9 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.02 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 219' ' ' ILE . 18.7 tt -137.92 130.23 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.864 0.364 . . . . 0.0 111.072 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -138.93 147.62 42.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.371 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -108.69 86.22 2.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.542 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -50.5 -23.27 2.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.448 HD13 ' OG ' ' A' ' 130' ' ' SER . 75.4 mt -50.68 -57.18 8.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 228' ' ' MET . 76.7 mt -109.7 -28.53 2.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.857 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -53.3 -43.85 67.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.93 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.7 m -72.1 -42.23 66.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 227' ' ' MET . 0.0 OUTLIER -86.98 3.11 47.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.142 -179.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 224' ' ' ILE . 28.0 ttp -51.39 -31.69 23.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.052 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.454 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 2.2 mpp_? -66.76 -65.84 1.48 Allowed Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.345 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 10.3 Cg_endo -53.48 -39.21 83.0 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.039 1.826 . . . . 0.0 111.92 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.8 tt -68.67 -39.41 80.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.539 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 78.5 p -70.46 -34.21 72.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.751 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 13.7 mmt -70.85 -50.7 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.059 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -55.63 -57.35 12.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.859 0.361 . . . . 0.0 110.93 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -57.14 -25.83 59.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.047 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 -57.65 -42.73 84.06 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.066 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -60.8 -40.51 92.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.701 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -63.59 -30.97 72.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -73.09 -32.35 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.621 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.07 -40.55 85.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.687 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 13.5 mm -75.48 -39.75 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.698 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.31 -31.96 62.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.632 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 243' ' ' ASN . 21.2 p-10 -43.5 131.78 4.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.728 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -121.09 146.36 46.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.46 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 52.3 t0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.567 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.4 pttt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm -140.7 50.12 1.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.543 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.7 m -73.57 -21.98 60.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.42 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.9 mt -105.41 107.7 59.75 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.459 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.98 118.84 3.1 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 121.994 1.796 . . . . 0.0 112.154 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.42 141.51 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.982 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -137.19 141.65 42.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.001 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.2 146.77 17.42 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.519 ' O ' ' CD1' ' A' ' 131' ' ' PHE . . . -100.25 119.22 38.05 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.886 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -109.13 120.55 42.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.431 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mt -127.3 122.84 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.112 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -126.62 161.42 28.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.82 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.527 ' ND2' ' OG ' ' A' ' 116' ' ' SER . 4.1 m120 -61.05 177.87 0.3 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.595 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -61.26 -39.52 90.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.05 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -123.87 39.55 3.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.746 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 235' ' ' LEU . 5.9 mp 51.05 36.57 15.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.527 ' OG ' ' ND2' ' A' ' 112' ' ' ASN . 93.2 p -67.08 -34.34 77.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -151.05 161.76 42.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.873 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.6 mm -118.89 123.14 71.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.537 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 4.5 tp -80.41 115.09 19.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.319 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.3 mt -123.08 157.23 33.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.615 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.7 m -136.6 163.36 33.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.695 0.283 . . . . 0.0 110.406 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -93.69 130.46 39.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.634 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -100.91 -171.24 28.77 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.0 t -56.74 -29.41 62.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.625 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -54.94 -172.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.223 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.3 t -86.04 -120.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.716 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -81.21 71.14 8.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.812 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 m -128.3 147.6 50.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -126.49 122.29 34.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.385 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.1 t -166.39 166.42 16.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.946 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.537 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 39.4 m-85 -73.38 152.52 90.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.006 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.22 154.9 51.91 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.032 1.821 . . . . 0.0 112.196 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -131.6 172.16 12.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.206 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 169.21 179.02 40.92 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.7 mttm -101.88 154.64 18.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 pt -129.3 156.0 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.702 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.3 t -82.78 145.23 29.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.554 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -86.91 178.94 6.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.541 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 66.45 33.32 6.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.511 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -141.71 155.56 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.342 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -64.81 142.8 58.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.47 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.48 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 74.6 m-20 -58.32 -38.1 76.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 144' ' ' ASP . 20.8 tt -67.03 -39.1 82.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.773 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.45 ' N ' HG23 ' A' ' 143' ' ' ILE . 95.0 m-20 -66.86 -39.88 87.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.727 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 80.6 m -66.68 -42.53 86.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.771 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.576 ' SG ' ' CD2' ' A' ' 180' ' ' PHE . 64.9 m -62.5 -48.15 80.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.464 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 97.1 mt -60.45 -40.99 85.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.954 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -58.39 -44.14 88.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.003 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.431 ' O ' ' OE2' ' A' ' 153' ' ' GLU . 81.2 mm-40 -78.09 -37.19 46.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.885 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.461 HG11 HD13 ' A' ' 158' ' ' LEU . 2.6 t -70.34 -50.41 46.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.788 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -60.52 -29.51 69.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.559 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -80.32 -45.45 17.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.823 0.344 . . . . 0.0 110.652 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -70.41 -58.68 3.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.22 -179.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 154' ' ' ILE . 1.6 mp -72.35 -32.97 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.694 0.283 . . . . 0.0 110.98 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.34 -13.66 61.39 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -119.69 135.04 54.99 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.854 0.359 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -92.61 128.88 38.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.725 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.766 ' N ' HD12 ' A' ' 158' ' ' LEU . 6.2 mp -91.73 113.3 25.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.547 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.5 p -90.02 -54.84 3.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 160' ' ' ASP . 57.0 t0 -105.0 -17.46 14.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.642 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -85.48 20.65 1.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.666 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.4 tt -117.91 136.93 53.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.494 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.54 152.95 43.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.369 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 165' ' ' ASN . 1.2 p30 -75.47 -66.02 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.384 0.612 . . . . 0.0 111.024 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.454 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 67.7 m-80 -130.21 67.72 1.47 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.171 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.53 ' HG3' HD12 ' A' ' 181' ' ' LEU . 2.4 tp-100 -132.16 107.13 8.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.901 0.381 . . . . 0.0 110.688 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.516 ' CD2' ' OE2' ' A' ' 169' ' ' GLU . 45.8 p90 -156.31 154.04 29.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.355 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 234' ' ' TRP . 6.6 tt -123.86 137.87 55.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.516 ' OE2' ' CD2' ' A' ' 167' ' ' PHE . 3.9 mp0 -116.69 133.42 56.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.036 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -160.23 148.43 16.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.987 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.97 112.29 24.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.997 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.4 pt -120.97 152.48 24.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.769 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 175' ' ' LYS . 42.0 mt-30 50.9 32.82 7.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.572 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.33 -25.25 0.72 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 173' ' ' GLN . 41.7 tttt -84.96 137.36 33.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.841 0.353 . . . . 0.0 110.816 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 176' ' ' ASN . 9.1 p-10 -74.94 131.97 41.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.037 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.14 115.48 13.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.494 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -108.37 138.22 45.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.7 mt -137.19 134.74 47.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.15 0.5 . . . . 0.0 111.816 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.576 ' CD2' ' SG ' ' A' ' 146' ' ' CYS . 4.4 t80 -100.26 122.36 42.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.783 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.53 HD12 ' HG3' ' A' ' 166' ' ' GLN . 25.8 mt -69.85 125.95 28.26 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.468 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 3.1 mm -130.58 103.15 7.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.301 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.8 t -130.4 153.23 48.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.625 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 107.31 -1.68 34.92 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 3.8 m -57.72 148.12 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.47 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.71 115.79 17.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.691 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -69.84 -22.03 63.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.648 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.57 -8.1 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.265 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -102.36 122.23 43.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.262 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -87.77 134.88 33.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.516 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -99.01 134.59 41.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.62 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.14 156.52 38.23 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.177 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.13 123.8 11.03 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.286 1.991 . . . . 0.0 112.027 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -147.78 69.65 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.766 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.04 -177.88 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.147 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -42.97 148.91 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.11 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -73.38 102.11 3.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 0.0 110.589 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -157.89 -113.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.119 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 57.3 mt -126.58 102.95 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.06 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -131.27 139.1 49.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.92 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -144.26 141.33 29.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.354 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 4.1 pt -102.9 128.5 55.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.76 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -158.03 135.82 10.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.256 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.28 104.49 16.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.498 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -83.81 125.81 32.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.736 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -65.04 132.44 49.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.266 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -51.13 -37.01 43.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.669 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.1 -36.7 80.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.039 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -59.69 -49.85 76.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.782 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 11.8 mt -56.35 -48.13 80.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.738 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 213' ' ' THR . 5.0 m -60.49 -32.65 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -73.29 20.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.757 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.482 ' H ' ' C ' ' A' ' 211' ' ' SER . 1.3 t -53.36 -31.83 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.556 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 10.8 tpp -47.44 -31.03 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.727 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.522 ' O ' ' CD2' ' A' ' 215' ' ' TYR . 63.1 t80 -87.9 20.38 3.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.763 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 213' ' ' THR . 23.0 pttm -58.61 135.65 57.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.666 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 4.0 m -98.83 -45.53 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -163.59 16.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.682 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 17.1 tt -125.48 137.62 57.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.448 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -134.67 142.1 46.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -66.21 154.15 40.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.059 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -100.26 -73.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.788 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.9 tt -74.1 -56.43 4.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.1 mt -58.05 -32.5 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.61 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.459 ' CG ' ' N ' ' A' ' 226' ' ' SER . 0.1 OUTLIER -43.73 -57.9 2.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.393 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.459 ' N ' ' CG ' ' A' ' 225' ' ' ASN . 79.6 p -87.13 -27.81 22.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.435 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 65.9 mtp -84.95 1.7 46.2 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.95 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 224' ' ' ILE . 13.6 ttp -51.28 -37.11 45.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.965 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.459 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -64.9 -65.5 1.91 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.5 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 10.7 Cg_endo -55.42 -44.56 47.47 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.266 1.978 . . . . 0.0 112.258 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 231' ' ' LEU . 0.2 OUTLIER -52.56 -50.99 61.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.171 0.51 . . . . 0.0 110.155 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 28.8 p -71.39 -37.24 71.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.165 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 34.7 ttm -67.25 -62.03 1.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.261 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.622 ' CD1' HD12 ' A' ' 168' ' ' ILE . 45.4 m95 -45.88 -60.85 2.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.82 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.467 ' HB3' HD11 ' A' ' 115' ' ' LEU . 93.4 mt -52.91 -25.45 11.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 41.0 ttm-85 -61.23 -40.52 94.31 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.586 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -68.64 -44.34 74.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.052 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -52.97 -36.7 60.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.84 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -72.41 -28.95 63.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.214 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.16 -51.76 34.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 110.461 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 3.4 mm -64.53 -25.26 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.027 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -51.14 -50.52 58.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.215 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.566 ' N ' ' OD1' ' A' ' 243' ' ' ASN . 0.2 OUTLIER -79.08 127.16 31.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.374 -0.376 . . . . 0.0 109.996 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.55 -33.21 74.47 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.615 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 62.9 t0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.441 179.917 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.6 tttm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 tttp 63.44 22.57 13.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.9 m -74.74 -31.82 61.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.083 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 103' ' ' ILE . 13.6 tt -124.36 108.66 29.28 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.809 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.2 137.38 10.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.978 1.785 . . . . 0.0 112.155 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.88 138.7 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.494 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -148.18 145.13 28.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.797 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.603 ' H ' HG22 ' A' ' 179' ' ' ILE . . . -133.24 168.52 23.0 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 180' ' ' PHE . . . -112.15 125.81 54.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.684 0.278 . . . . 0.0 111.036 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.5 117.25 33.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.429 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.88 133.92 65.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.138 0.494 . . . . 0.0 110.941 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -137.27 149.21 46.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.994 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.652 ' ND2' ' H ' ' A' ' 116' ' ' SER . 43.8 p-10 -50.42 155.19 1.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.994 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -57.81 -25.95 61.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.023 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -92.06 7.21 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.078 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.707 HD21 HD12 ' A' ' 235' ' ' LEU . 12.6 mt 42.93 52.5 5.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 0.0 110.532 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.652 ' H ' ' ND2' ' A' ' 112' ' ' ASN . 0.5 OUTLIER -123.55 -13.7 7.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.112 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -133.24 146.42 51.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.261 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.6 mm -115.31 124.58 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.215 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 202' ' ' ILE . 1.2 tt -86.27 103.58 15.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.697 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.7 mt -117.83 162.82 17.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.129 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.9 m -135.15 160.19 40.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.488 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.436 ' OE1' ' O ' ' A' ' 123' ' ' GLY . 0.4 OUTLIER -98.89 114.33 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.336 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.436 ' O ' ' OE1' ' A' ' 122' ' ' GLN . . . -96.31 -151.66 28.26 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 87.5 m -53.97 -34.86 60.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 110.656 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -47.02 157.53 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.7 m -69.18 -70.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.852 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -133.53 69.61 1.47 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.508 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -127.45 143.21 51.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.33 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -113.21 115.35 28.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.326 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.9 t -156.87 164.88 37.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.681 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.544 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 44.6 m-85 -73.28 151.9 90.09 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -67.55 139.34 48.56 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.888 1.725 . . . . 0.0 111.667 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -125.0 177.99 5.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.566 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 158.68 179.8 33.79 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -86.63 145.84 26.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.707 0.289 . . . . 0.0 110.641 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.6 tt -127.1 147.33 32.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.219 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.7 p -70.13 153.09 43.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -112.61 176.58 4.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.179 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 53.89 42.33 31.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.258 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -148.44 158.76 44.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.363 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -58.7 125.62 24.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.525 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.421 ' O ' ' SG ' ' A' ' 146' ' ' CYS . 23.3 p-10 -64.38 -39.42 93.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.138 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 7.0 tt -66.85 -37.39 79.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.498 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -69.79 -42.36 73.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.569 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 64.9 m -73.86 -40.18 63.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 142' ' ' ASP . 33.1 m -55.21 -52.89 61.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.24 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.15 -42.76 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -62.2 -41.3 98.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.337 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -79.25 -35.22 41.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.94 0.4 . . . . 0.0 110.561 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.2 t -66.11 -53.8 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -45.3 89.37 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.651 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.32 -28.63 65.21 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.55 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.515 ' OE2' HG12 ' A' ' 195' ' ' VAL . 27.3 mm-40 -89.23 -62.6 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 8.8 mt -84.96 -33.65 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.03 -13.37 60.48 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -102.69 135.27 44.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.0 110.385 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 25.0 p30 -106.86 127.45 53.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.814 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 mp -96.38 112.44 24.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.922 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 5.2 m -89.52 -61.88 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.74 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -98.97 0.19 43.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.122 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -109.63 21.11 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.63 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 162' ' ' ILE . 0.8 OUTLIER -111.91 133.04 58.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.641 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.504 ' H ' HD11 ' A' ' 182' ' ' ILE . 6.4 t0 -101.3 135.68 42.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.242 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -95.9 -10.81 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.938 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -133.74 56.7 1.84 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.303 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.546 HE22 ' CG ' ' A' ' 238' ' ' GLN . 35.3 tt0 -150.53 107.65 3.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.316 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -164.77 166.5 19.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.62 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.519 HD11 HD11 ' A' ' 181' ' ' LEU . 63.4 mt -125.96 130.8 72.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.078 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -113.37 128.08 56.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.296 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.523 ' NH2' ' OG ' ' A' ' 226' ' ' SER . 0.0 OUTLIER -160.06 159.11 31.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.945 0.402 . . . . 0.0 110.911 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.491 ' ND2' HD22 ' A' ' 176' ' ' ASN . 4.2 m120 -104.48 102.59 12.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.938 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.47 HD13 ' HA ' ' A' ' 223' ' ' LEU . 83.7 mt -97.27 117.02 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.339 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 52.15 40.26 28.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.363 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 80.88 -20.09 6.87 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -83.97 124.32 30.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.412 . . . . 0.0 110.707 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.491 HD22 ' ND2' ' A' ' 171' ' ' ASN . 21.8 m120 -75.2 136.55 40.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.473 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.423 ' CD2' HD12 ' A' ' 172' ' ' ILE . 0.2 OUTLIER -128.35 140.56 51.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.284 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -143.92 94.86 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 107' ' ' GLY . 10.6 pt -112.57 145.67 18.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.022 0.439 . . . . 0.0 111.628 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 108' ' ' ALA . 11.2 p90 -99.89 132.43 45.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.598 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.639 ' O ' HD12 ' A' ' 182' ' ' ILE . 9.7 mt -91.48 129.06 37.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.548 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.0 OUTLIER -131.02 129.68 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.908 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.1 m -132.14 162.0 31.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.415 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 98.48 7.91 55.31 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.8 m -75.93 142.99 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.654 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 52.1 p -77.29 137.12 38.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.647 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.455 ' OE1' ' CZ2' ' A' ' 204' ' ' TRP . 70.9 mm-40 -96.55 -8.54 31.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.603 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.0 -27.73 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.473 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -98.23 123.62 42.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.4 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -106.57 132.75 52.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.665 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.68 152.73 39.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.574 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -93.53 157.23 38.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.291 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.51 142.96 41.56 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.343 2.029 . . . . 0.0 112.219 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -135.65 82.94 1.98 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.105 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.515 HG12 ' OE2' ' A' ' 153' ' ' GLU . 33.6 m -129.09 -177.59 2.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.719 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 79.2 mtt85 -48.46 145.77 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.52 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -46.21 102.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.698 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -147.3 -113.14 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.415 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.88 122.86 65.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.363 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -93.24 107.55 19.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.753 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -160.3 126.97 4.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.46 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.593 HD11 HD11 ' A' ' 119' ' ' LEU . 17.2 tt -127.32 154.21 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.46 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -167.71 156.59 9.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.698 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' TRP . . . . . 0.455 ' CZ2' ' OE1' ' A' ' 187' ' ' GLU . 0.0 OUTLIER -106.85 100.58 10.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.734 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.71 135.08 33.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.296 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -72.03 133.3 45.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.485 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -49.16 -32.08 9.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -59.2 -43.65 92.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.676 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -54.81 -32.27 60.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.364 . . . . 0.0 110.234 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.436 ' O ' ' OG1' ' A' ' 213' ' ' THR . 82.7 mt -79.17 -23.07 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.358 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.4 t -85.1 -10.66 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -95.44 10.07 37.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.769 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 210' ' ' ILE . 0.2 OUTLIER -43.07 -36.2 1.54 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.345 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 40.6 mtt -52.95 -33.82 52.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.352 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -66.8 -46.58 74.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.446 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.413 ' CG ' ' O ' ' A' ' 216' ' ' LYS . 11.1 ptmt -113.1 110.25 20.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 57.7 m -92.14 -10.41 38.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.841 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -58.76 -37.67 76.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.684 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 79.2 mt -128.94 134.05 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.539 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -130.43 145.03 51.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.642 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 225' ' ' ASN . 87.2 m-85 -104.66 86.85 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.427 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -66.1 -27.99 68.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.212 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.638 HD12 ' N ' ' A' ' 223' ' ' LEU . 7.8 mp -69.5 -39.13 77.77 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.778 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 228' ' ' MET . 97.0 mt -95.7 -40.2 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.676 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 221' ' ' TYR . 62.4 t-20 -59.98 -47.95 83.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.341 . . . . 0.0 110.561 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.523 ' OG ' ' NH2' ' A' ' 170' ' ' ARG . 7.9 t -68.84 -30.46 69.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.556 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 76.9 mtp -96.54 2.41 52.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.596 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 224' ' ' ILE . 18.7 ttt -48.33 -38.97 20.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.221 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.45 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.0 OUTLIER -68.96 -65.51 1.26 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.602 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 19.6 Cg_endo -60.17 -47.56 14.5 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.213 1.942 . . . . 0.0 112.366 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 5.1 tt -56.2 -39.48 72.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.894 0.378 . . . . 0.0 110.626 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 68.9 m -75.74 -40.09 56.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.994 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 10.7 mmt -66.46 -52.89 41.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.289 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -55.06 -54.4 43.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.759 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.707 HD12 HD21 ' A' ' 115' ' ' LEU . 4.0 mm? -56.56 -22.16 31.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.599 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -42.16 72.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.658 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -61.96 -44.28 97.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.598 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.546 ' CG ' HE22 ' A' ' 166' ' ' GLN . 68.8 mt-30 -58.6 -34.64 71.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.673 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -62.07 -24.46 67.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.628 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -81.74 -58.72 2.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 6.1 tt -61.5 -12.26 6.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.41 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -50.76 -26.9 6.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.615 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -80.83 12.19 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 48.07 -120.66 1.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.594 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.575 -179.99 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.2 mttp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -108.65 79.9 1.28 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.644 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.0 m -73.51 -32.88 64.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.59 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 103' ' ' ILE . 17.0 tt -117.8 108.39 42.85 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.484 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -82.25 135.88 8.64 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.937 1.758 . . . . 0.0 112.224 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.53 140.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.048 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.1 ttp85 -123.74 146.76 48.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.802 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -122.86 149.44 16.86 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -101.87 142.42 33.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.865 0.364 . . . . 0.0 111.222 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.29 99.34 3.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.263 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.455 HG23 HG11 ' A' ' 185' ' ' VAL . 2.7 mp -108.79 142.2 22.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.505 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -127.34 163.94 22.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.145 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.725 HD21 ' H ' ' A' ' 116' ' ' SER . 26.1 p-10 -65.33 166.16 10.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.886 0.374 . . . . 0.0 110.875 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 185' ' ' VAL . 61.6 mm-40 -58.63 -33.45 70.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.621 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -89.43 6.98 38.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.988 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mp 42.91 45.23 4.26 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.592 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.725 ' H ' HD21 ' A' ' 112' ' ' ASN . 3.9 t -120.95 -9.24 9.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.01 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -136.8 170.32 16.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.771 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.409 ' O ' HG23 ' A' ' 118' ' ' ILE . 11.5 tt -134.03 131.41 55.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.758 0.313 . . . . 0.0 110.584 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.531 ' O ' ' CZ ' ' A' ' 131' ' ' PHE . 2.5 tt -83.11 127.71 33.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.205 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.528 HD22 ' O ' ' A' ' 119' ' ' LEU . 3.3 mm? -121.27 156.68 31.98 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.4 m -143.69 172.69 6.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.669 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.533 ' NE2' ' CG2' ' A' ' 199' ' ' ILE . 1.4 tm0? -92.17 124.64 36.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.49 -165.86 32.17 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.462 ' OG1' ' NH2' ' A' ' 196' ' ' ARG . 40.3 m -47.22 -37.1 9.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.891 0.377 . . . . 0.0 110.221 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 125' ' ' GLU . 56.9 mp0 -51.4 160.06 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.04 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.7 t -64.61 -62.57 1.51 Allowed 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.972 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -137.1 69.53 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.777 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 p -125.08 139.09 54.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.137 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.515 ' C ' HD12 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -94.37 110.45 22.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.586 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.402 ' N ' HD12 ' A' ' 120' ' ' LEU . 14.1 p -153.84 176.57 12.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.732 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 46.1 m-85 -97.83 152.6 38.19 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.317 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.8 155.71 67.85 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.968 1.779 . . . . 0.0 111.4 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -140.85 177.07 8.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.089 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 168.11 178.59 40.08 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -93.94 150.06 20.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.686 0.279 . . . . 0.0 110.617 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 16.6 pt -108.58 149.99 11.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.516 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.9 t -76.24 140.94 41.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.748 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 63.3 mttp -89.2 162.26 16.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.503 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 3.0 t70 75.37 1.89 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.645 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -114.36 155.33 26.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.474 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -64.58 143.77 57.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.379 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -55.37 -39.59 70.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.537 HG23 ' N ' ' A' ' 144' ' ' ASP . 6.7 tt -65.59 -42.59 93.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.709 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.537 ' N ' HG23 ' A' ' 143' ' ' ILE . 43.0 t0 -63.51 -33.14 74.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.692 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 13.8 m -78.27 -42.01 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.559 ' SG ' ' CG ' ' A' ' 180' ' ' PHE . 8.5 t -65.12 -50.53 65.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.021 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 148' ' ' ARG . 9.7 tt -61.11 -38.49 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.146 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.428 ' N ' ' CG2' ' A' ' 147' ' ' ILE . 17.0 ttm105 -71.32 -38.98 71.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.903 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 153' ' ' GLU . 85.3 tt0 -78.28 -29.82 48.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 110.445 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.3 t -74.17 -52.48 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.783 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -28.2 69.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.668 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -76.33 -41.11 49.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.714 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 149' ' ' GLU . 0.4 OUTLIER -75.35 -53.17 9.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 28.7 mm -71.0 -31.5 45.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.778 0.323 . . . . 0.0 110.422 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 92.2 -14.31 64.88 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -115.96 133.09 56.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.725 0.298 . . . . 0.0 110.337 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 43.7 p-10 -96.61 125.1 40.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.036 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.409 ' H ' HD12 ' A' ' 158' ' ' LEU . 0.7 OUTLIER -112.13 110.43 20.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.078 179.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.0 p -91.0 -55.21 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.912 0.387 . . . . 0.0 111.054 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -58.97 -39.15 80.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.307 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 184' ' ' GLY . 39.2 m-85 -90.82 18.74 6.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.052 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.659 HD13 ' H ' ' A' ' 163' ' ' ASP . 0.3 OUTLIER -87.4 134.6 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.985 0.421 . . . . 0.0 110.256 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.659 ' H ' HD13 ' A' ' 162' ' ' ILE . 66.7 m-20 -92.27 140.5 29.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.408 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -70.56 -66.18 0.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.339 0.59 . . . . 0.0 110.881 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -133.02 66.89 1.55 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.123 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.624 ' NE2' ' NE1' ' A' ' 234' ' ' TRP . 8.5 tp60 -127.89 107.45 9.87 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.815 0.34 . . . . 0.0 110.606 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -167.23 159.31 12.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.181 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.654 HD11 HD11 ' A' ' 181' ' ' LEU . 3.2 mt -124.05 138.98 51.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.788 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -95.08 136.29 35.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.187 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.534 ' C ' HD22 ' A' ' 171' ' ' ASN . 0.0 OUTLIER -152.73 121.39 6.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.845 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.534 HD22 ' C ' ' A' ' 170' ' ' ARG . 3.0 m120 -112.17 112.51 24.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.119 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.5 tt -109.3 132.46 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.261 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.45 ' C ' ' H ' ' A' ' 175' ' ' LYS . 24.4 mt-30 52.32 46.07 27.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.232 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.02 -3.27 1.66 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 173' ' ' GLN . 3.7 tptm -84.14 125.58 32.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.79 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.405 HD22 ' ND2' ' A' ' 171' ' ' ASN . 2.8 t-20 -75.42 123.88 26.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.744 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -140.12 128.99 23.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.566 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 107' ' ' GLY . 26.0 ttmt -120.96 142.29 49.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.013 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.8 mm -123.15 121.29 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.598 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.559 ' CG ' ' SG ' ' A' ' 146' ' ' CYS . 0.2 OUTLIER -98.44 127.47 44.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.387 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 168' ' ' ILE . 47.2 mt -82.93 124.27 30.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 182' ' ' ILE . 3.1 tt -143.71 101.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.411 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.4 t -117.54 154.23 31.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.626 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.51 ' O ' ' CD1' ' A' ' 161' ' ' TYR . . . 106.95 10.07 28.94 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.455 HG11 HG23 ' A' ' 110' ' ' ILE . 1.5 m -67.97 138.99 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.659 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 32.9 t -66.81 120.69 13.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.429 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -85.44 -16.62 39.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.131 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 85.4 t -69.86 -28.13 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.566 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.52 ' CE1' ' O ' ' A' ' 190' ' ' ASN . 63.1 t80 -88.7 133.87 34.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.632 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.52 ' O ' ' CE1' ' A' ' 189' ' ' PHE . 33.5 p-10 -90.79 131.42 36.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.444 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -127.67 158.57 37.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.391 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -139.48 156.57 71.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.308 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.4 142.89 46.25 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.309 2.006 . . . . 0.0 112.09 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -131.02 69.8 1.47 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.458 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.698 HG23 ' N ' ' A' ' 196' ' ' ARG . 11.9 m -130.23 -138.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.698 ' N ' HG23 ' A' ' 195' ' ' VAL . 78.4 mtm-85 -52.75 146.03 11.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.029 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -74.38 108.88 7.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.373 . . . . 0.0 110.771 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.469 ' CG ' ' H ' ' A' ' 199' ' ' ILE . 1.0 OUTLIER -150.61 -113.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.54 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.533 ' CG2' ' NE2' ' A' ' 122' ' ' GLN . 19.5 tt -130.39 136.7 57.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.471 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 200' ' ' ASP . 39.8 p-10 -102.68 114.54 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.736 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -133.33 123.18 24.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.389 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.97 146.76 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.421 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -165.89 140.83 4.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.601 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.38 112.91 26.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.481 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -104.83 151.7 23.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.625 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.03 127.79 34.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.4 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.05 -42.77 91.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.994 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -36.65 71.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -59.71 -46.34 89.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.175 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 45.4 pt -71.24 -19.53 20.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.144 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 44.0 m -82.5 -22.07 35.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.796 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -111.37 28.41 8.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 8.8 t -81.44 1.78 31.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.689 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 74.4 mtp -54.84 -30.69 58.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.383 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -67.61 -31.92 72.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.56 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -105.18 121.28 43.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.542 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.4 m -92.06 -11.59 35.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 218' ' ' ASN . 2.2 m120 -55.65 -34.35 64.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.606 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.5 mt -125.65 134.05 67.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.506 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -133.65 156.08 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.569 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -113.97 135.95 53.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.364 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -101.49 -72.52 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.187 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.67 -50.86 55.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.177 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.4 mm -56.48 -47.45 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 110.679 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -52.25 -43.2 64.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.568 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.5 m -69.06 -38.37 79.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.983 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 55.4 mtt -88.37 -2.9 58.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.863 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' MET . . . . . 0.483 ' N ' ' O ' ' A' ' 224' ' ' ILE . 5.0 ttp -58.62 -44.04 89.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.721 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.441 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 23.0 mtm-85 -56.14 -64.1 2.67 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.312 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 20.1 Cg_endo -61.3 -51.11 4.73 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.28 1.987 . . . . 0.0 112.423 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -46.86 81.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.2 t -65.77 -38.54 89.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.026 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 49.2 ttm -60.52 -48.34 82.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.24 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.624 ' NE1' ' NE2' ' A' ' 166' ' ' GLN . 1.4 t-105 -70.54 -42.92 70.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.53 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.11 -37.87 81.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.379 . . . . 0.0 110.597 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -60.47 -36.15 77.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.796 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -69.28 -37.06 77.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.781 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -64.23 -29.58 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.052 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' A' ' 243' ' ' ASN . 88.5 mtt180 -72.57 -41.23 65.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.762 0.315 . . . . 0.0 111.028 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.497 ' O ' ' ND2' ' A' ' 243' ' ' ASN . 50.9 mt-30 -58.32 -38.66 77.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.26 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 81.6 mt -70.94 -28.14 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.547 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -58.8 -38.14 77.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.732 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 240' ' ' GLN . 0.5 OUTLIER -84.56 108.31 17.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.941 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -66.49 -28.33 68.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.334 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 . . . . . 0 C--N 1.333 -0.139 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.667 179.874 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.1 pttp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -146.96 48.46 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.243 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 m -79.45 -30.47 42.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.957 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -100.98 108.47 54.51 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.596 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.73 127.4 6.31 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.93 1.753 . . . . 0.0 112.325 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 t -132.71 145.93 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.052 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' A' ' 107' ' ' GLY . 46.3 ttp85 -135.49 150.58 49.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.705 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -129.89 154.37 20.46 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' A' ' 131' ' ' PHE . . . -102.22 149.88 23.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.955 0.407 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -141.86 95.13 2.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.307 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.4 mt -114.87 131.4 67.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 121.248 0.547 . . . . 0.0 111.573 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.6 159.39 39.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.92 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -55.95 151.35 11.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.864 0.364 . . . . 0.0 110.373 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -51.07 -40.47 58.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.809 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.659 HD22 ' NZ ' ' A' ' 242' ' ' LYS . 28.4 t-20 -80.55 -1.21 41.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 0.0 110.554 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.6 mt 53.41 56.04 7.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.665 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 p -122.23 -16.27 7.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.745 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -138.18 156.5 47.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.541 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.0 mm -112.75 136.07 50.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.049 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.526 ' C ' HD22 ' A' ' 120' ' ' LEU . 1.7 tt -102.8 110.91 22.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 111.194 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.823 HD22 ' N ' ' A' ' 120' ' ' LEU . 1.4 mm? -111.93 174.17 6.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.175 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 m -143.88 169.99 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.203 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.648 HE22 ' H ' ' A' ' 128' ' ' SER . 55.0 tp60 -109.04 134.44 51.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -125.37 -145.37 6.49 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 124' ' ' THR . 0.1 OUTLIER -52.67 -43.26 65.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 110.748 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -43.52 151.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.947 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.7 p -61.46 -83.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.025 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -126.67 70.15 1.26 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.475 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.648 ' H ' HE22 ' A' ' 122' ' ' GLN . 46.5 m -125.8 153.28 44.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.589 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 129' ' ' TRP . 0.9 OUTLIER -115.75 119.14 35.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.379 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 76.1 p -163.71 173.03 13.38 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.882 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 108' ' ' ALA . 43.3 m-85 -83.29 152.05 63.87 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.207 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.93 142.93 39.8 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.848 1.699 . . . . 0.0 111.831 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 ppt_? -146.41 171.7 14.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.238 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 157.29 -169.53 34.33 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.97 137.23 35.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.664 0.268 . . . . 0.0 110.57 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 pt -114.02 157.1 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.384 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.9 m -64.59 144.15 57.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.435 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -92.17 173.88 7.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.636 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 59.63 37.28 22.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -136.36 162.51 32.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.253 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -79.4 146.03 33.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.466 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -49.34 -37.75 25.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.556 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 147' ' ' ILE . 50.0 mt -72.68 -43.84 60.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.32 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -62.31 -41.93 98.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.585 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -73.87 -39.13 64.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.934 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.593 ' SG ' ' CE1' ' A' ' 180' ' ' PHE . 43.9 t -69.82 -56.82 6.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.043 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 148' ' ' ARG . 2.1 tp -54.44 -39.98 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.005 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.448 ' N ' HG23 ' A' ' 147' ' ' ILE . 31.6 ttm180 -66.27 -39.38 89.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.908 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -76.91 -27.54 54.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.0 110.44 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.12 -54.56 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.846 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -26.72 67.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.903 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -84.75 -34.84 22.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 110.995 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -72.6 -60.48 2.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.677 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 21.8 mt -82.52 -33.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.776 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 104.5 -12.89 51.09 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -103.65 130.73 51.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.672 0.272 . . . . 0.0 110.455 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -104.49 148.46 26.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.985 0.421 . . . . 0.0 111.048 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.0 mt -106.27 115.22 29.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.815 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.31 -61.73 1.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.391 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.518 ' OD1' ' CD2' ' A' ' 161' ' ' TYR . 43.4 p-10 -104.47 0.43 28.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.105 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.518 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 68.3 m-85 -105.3 14.9 28.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.65 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 162' ' ' ILE . 10.1 tp -93.22 130.93 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.601 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 181' ' ' LEU . 77.9 m-20 -72.03 153.54 41.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.364 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -85.57 -67.38 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.497 0.665 . . . . 0.0 111.123 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -132.06 70.46 1.47 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.759 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -132.78 107.62 8.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.494 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -164.5 165.85 20.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.81 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 34.2 pt -128.53 146.3 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.537 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.48 135.01 54.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.265 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -159.74 137.38 9.89 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.661 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -102.93 112.99 26.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.352 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 54.9 mt -99.02 120.78 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.33 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.485 ' C ' ' H ' ' A' ' 175' ' ' LYS . 65.2 mt-30 54.0 49.69 18.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.79 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 69.52 -17.28 0.65 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 173' ' ' GLN . 42.4 mttt -85.4 134.04 34.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -75.16 131.56 40.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.594 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -134.98 105.24 6.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.608 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 107' ' ' GLY . 11.9 mmtp -100.05 130.64 46.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.334 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.96 127.51 61.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 111.081 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.593 ' CE1' ' SG ' ' A' ' 146' ' ' CYS . 0.3 OUTLIER -99.31 133.33 43.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.734 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.41 ' O ' ' OD2' ' A' ' 163' ' ' ASP . 8.8 mt -87.75 137.05 32.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.991 0.424 . . . . 0.0 111.285 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.57 106.64 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.904 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 p -125.24 151.33 46.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.402 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 117.29 -12.49 14.1 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 4.4 m -53.29 146.68 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 34.9 p -77.75 127.75 32.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.795 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -83.06 -10.79 58.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.43 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 25.2 m -72.52 -16.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.249 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -95.92 134.32 39.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.308 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -88.81 127.32 35.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.632 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.427 ' O ' HD13 ' A' ' 202' ' ' ILE . 85.1 m-85 -95.72 128.14 42.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.428 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -105.13 152.8 39.79 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.311 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.53 141.68 28.48 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.305 2.003 . . . . 0.0 112.436 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -149.51 78.18 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.98 177.07 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.756 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -51.73 154.05 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.113 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -46.25 102.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.287 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -150.81 -113.45 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.255 0.55 . . . . 0.0 110.407 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.5 mm -124.99 126.34 71.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.239 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.19 103.94 13.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.498 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.487 ' NZ ' ' OE2' ' A' ' 203' ' ' GLU . 61.4 tttm -163.69 134.87 4.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.012 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.427 HD13 ' O ' ' A' ' 191' ' ' PHE . 18.1 pt -120.9 154.24 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.241 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.487 ' OE2' ' NZ ' ' A' ' 201' ' ' LYS . 44.0 mt-10 -152.44 138.19 17.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.412 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.51 103.2 13.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.348 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.419 ' CE2' ' CE3' ' A' ' 129' ' ' TRP . 60.8 m-85 -105.93 152.72 22.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.904 0.383 . . . . 0.0 110.842 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -81.96 139.25 34.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.643 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -51.71 -55.51 19.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -56.61 -43.36 80.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.82 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -57.58 -48.4 79.48 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.883 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 87.5 mt -55.11 -25.11 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.482 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -89.89 -13.79 35.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -104.38 15.86 27.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.071 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 15.3 p -81.29 10.9 4.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 110.74 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 70.8 mtm -53.96 -35.29 61.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.315 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -55.87 -34.53 65.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.449 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -100.07 109.04 21.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.557 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 82.5 p -92.78 -23.15 18.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.709 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -56.5 -42.4 78.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.542 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.1 mt -126.16 110.34 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.473 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -139.44 148.91 43.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.559 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 221' ' ' TYR . 0.0 OUTLIER -117.05 117.84 30.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.459 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -82.81 -35.72 26.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.042 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 223' ' ' LEU . 10.7 mp -53.69 -48.64 69.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.002 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.3 tp -69.23 -33.87 60.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.85 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -58.85 -41.69 87.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.24 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 68.9 m -67.52 -38.32 84.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.053 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -83.44 2.77 35.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.155 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' MET . . . . . . . . . . . . . 42.1 ttp -52.42 -59.92 3.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.124 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.418 ' N ' ' CD ' ' A' ' 230' ' ' PRO . 6.3 mtm-85 -77.5 -51.22 1.94 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.143 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 229' ' ' ARG . 53.6 Cg_exo -49.39 -52.64 8.42 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.099 1.866 . . . . 0.0 112.154 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 2.5 tp -64.34 -36.49 84.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.041 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 86.9 p -66.12 -36.33 82.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.824 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 79.3 mmm -67.4 -56.19 10.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.283 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 30.3 m95 -54.75 -57.91 9.66 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.064 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 97.1 mt -51.94 -24.7 6.79 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.41 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -61.42 -44.3 97.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 0.0 110.11 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -64.72 -44.06 91.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.852 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -59.62 -41.14 89.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.018 0.437 . . . . 0.0 110.597 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -63.98 -30.64 71.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 243' ' ' ASN . 42.2 tt0 -62.97 -41.39 99.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.498 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 10.9 mm -63.96 -37.34 79.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.695 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.659 ' NZ ' HD22 ' A' ' 114' ' ' ASN . 70.9 tttt -57.16 -54.13 50.22 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.413 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 243' ' ' ASN . 38.0 p30 -90.4 138.96 31.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.535 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.8 -35.65 79.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.637 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.493 -179.962 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 41.3 tttm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -129.23 143.39 50.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.564 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.4 t -126.21 -18.75 4.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.635 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.693 HG23 ' O ' ' A' ' 103' ' ' ILE . 10.0 tt -119.21 108.44 40.2 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.278 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.83 130.52 6.73 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.987 1.791 . . . . 0.0 112.206 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -143.83 139.26 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.326 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.538 HH12 ' NZ ' ' A' ' 178' ' ' LYS . 57.7 mtp85 -132.59 149.6 52.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -137.93 -179.29 16.89 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.3 124.21 20.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.223 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 129.99 54.19 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.62 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.9 mt -122.88 136.39 59.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.244 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -124.3 153.06 42.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.682 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.456 ' ND2' ' CE2' ' A' ' 204' ' ' TRP . 0.9 OUTLIER -56.16 149.18 16.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.294 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -52.29 -28.71 20.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.899 0.38 . . . . 0.0 110.228 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -95.81 3.46 53.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.371 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.446 ' CD2' HD11 ' A' ' 235' ' ' LEU . 6.1 mt 51.99 45.18 28.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.368 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 t -107.29 -21.47 12.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -140.11 176.51 8.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 13.3 tt -139.32 134.28 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.222 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.526 ' O ' ' CE1' ' A' ' 131' ' ' PHE . 3.0 tt -82.69 126.98 32.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.012 0.434 . . . . 0.0 111.572 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.1 mt -133.23 152.2 51.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.466 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.41 170.99 13.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.615 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -99.48 143.53 29.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.577 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.94 -164.85 12.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.522 ' OG1' ' NH2' ' A' ' 196' ' ' ARG . 38.9 m -44.55 -35.75 2.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.262 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -47.39 156.87 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.151 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.6 t -70.08 -59.16 3.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.853 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -137.21 69.15 1.41 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.986 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 t -128.8 141.51 51.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.578 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -115.6 120.86 40.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.467 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.2 p -164.03 175.61 10.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.958 0.408 . . . . 0.0 110.937 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.526 ' CE1' ' O ' ' A' ' 119' ' ' LEU . 36.7 m-85 -80.58 153.11 73.33 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.332 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.53 153.4 54.96 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.016 1.811 . . . . 0.0 112.175 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.707 ' H ' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -159.26 -173.92 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.521 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 175.69 -175.55 47.31 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -89.92 147.01 23.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.316 . . . . 0.0 110.712 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 1.1 pp -130.24 156.84 42.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.438 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.0 m -75.63 141.72 42.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.591 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -76.12 167.38 21.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.057 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 59.71 41.59 18.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.512 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -135.45 148.37 49.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -60.7 134.11 56.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.57 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 29.8 p-10 -63.76 -36.67 84.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.876 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.507 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 3.2 mm -60.09 -54.66 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.841 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -64.87 -38.97 92.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 1.1 m -60.58 -39.85 89.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.903 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 142' ' ' ASP . 71.1 m -63.69 -61.57 2.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.281 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.6 tp -60.93 -17.68 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.29 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.0 ttp85 -77.14 -48.41 17.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.704 0.288 . . . . 0.0 111.337 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -74.21 -35.28 63.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.019 0.438 . . . . 0.0 110.595 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.588 ' O ' HG22 ' A' ' 154' ' ' ILE . 2.5 t -57.12 -61.07 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.09 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.46 ' CG ' ' N ' ' A' ' 152' ' ' GLU . 16.3 pttm -58.71 -44.35 90.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.79 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 151' ' ' LYS . 47.0 tp10 -60.01 -45.39 92.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.48 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 133' ' ' ARG . 97.3 mt-10 -73.83 -58.15 3.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.84 HG23 ' H ' ' A' ' 156' ' ' PHE . 7.8 tt -71.31 -24.24 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.342 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 151' ' ' LYS . . . 82.89 8.63 85.57 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.84 ' H ' HG23 ' A' ' 154' ' ' ILE . 25.9 t80 -151.36 150.84 30.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -128.3 133.73 48.79 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.932 0.396 . . . . 0.0 111.53 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.84 154.35 25.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.741 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 49.9 p -72.76 -14.51 61.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.023 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -105.35 13.89 29.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.05 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.27 -7.63 59.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.84 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.4 tp -125.81 137.15 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -106.61 156.11 18.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.248 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 165' ' ' ASN . 3.4 p30 -69.08 -67.81 0.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.355 0.598 . . . . 0.0 111.052 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 164' ' ' ASP . 32.6 t30 -134.43 60.72 1.69 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.111 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -145.27 107.9 4.45 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.556 -0.457 . . . . 0.0 111.013 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -156.36 163.84 39.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.309 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.9 tt -127.56 133.41 67.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -110.58 132.05 54.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.806 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -159.75 136.4 9.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.922 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -109.59 116.06 31.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.289 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 19.1 pt -119.74 150.4 22.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.612 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.471 ' C ' ' H ' ' A' ' 175' ' ' LYS . 25.9 mt-30 47.11 36.77 4.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.395 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 70.51 -14.65 1.31 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' A' ' 173' ' ' GLN . 51.1 mttm -88.51 129.33 35.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 0.0 110.907 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -75.08 120.99 21.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.503 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -117.24 125.21 50.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.993 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.538 ' NZ ' HH12 ' A' ' 106' ' ' ARG . 23.5 mtpt -122.44 129.85 52.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.676 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.7 mt -137.72 134.02 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.361 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.465 ' CZ ' ' SG ' ' A' ' 146' ' ' CYS . 0.0 OUTLIER -93.27 137.49 32.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.303 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.489 HD12 ' CD1' ' A' ' 234' ' ' TRP . 10.8 mt -95.32 125.93 40.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.709 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.14 106.26 3.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.709 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 63.6 p -111.35 154.82 24.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.408 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 99.52 13.23 38.84 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.6 m -88.77 147.33 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.719 0.295 . . . . 0.0 110.554 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 60.5 p -61.96 124.51 20.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.971 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -93.49 -5.56 48.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.579 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.39 -28.29 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.376 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.53 148.93 49.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.237 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -92.56 131.78 37.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.552 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.45 ' O ' HD13 ' A' ' 202' ' ' ILE . 63.2 m-85 -110.83 138.08 47.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.509 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -140.7 122.77 9.52 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.3 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.27 116.43 4.14 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.79 1.66 . . . . 0.0 112.321 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -106.13 99.78 9.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.328 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 32.0 m -147.42 -160.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.7 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.522 ' NH2' ' OG1' ' A' ' 124' ' ' THR . 12.5 mtp180 -42.72 148.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.614 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -70.95 117.2 12.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.538 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 199' ' ' ILE . 1.9 tt0 -172.65 -111.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.489 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.514 ' N ' ' CG ' ' A' ' 198' ' ' GLU . 58.9 mt -113.9 118.35 58.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.771 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 200' ' ' ASP . 2.9 p30 -128.47 100.49 5.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.045 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -139.88 138.63 35.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.592 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.45 HD13 ' O ' ' A' ' 191' ' ' PHE . 36.0 pt -109.16 145.09 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.199 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -156.78 133.55 10.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.301 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' TRP . . . . . 0.456 ' CE2' ' ND2' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -101.21 113.52 26.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.271 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -107.83 148.54 29.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.047 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.73 136.71 43.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.101 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -51.53 -40.11 59.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.56 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -64.44 -39.78 94.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.054 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -60.35 -32.79 71.6 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.512 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 98.0 mt -71.84 -33.05 46.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 50.0 m -80.71 -28.41 36.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.636 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -12.11 61.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.585 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 52.5 p -50.91 -26.46 5.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 62.5 mtt -62.47 -35.36 79.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.604 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -69.4 -43.26 73.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.677 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -86.42 116.02 24.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.403 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 70.9 m -96.21 9.86 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.752 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -75.64 -68.93 0.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.505 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 219' ' ' ILE . 10.0 tp -132.09 123.57 51.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.524 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -138.12 159.28 42.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.385 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -106.48 101.7 11.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.557 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -66.15 -33.87 76.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.55 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 4.9 tp -55.51 -43.57 75.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 228' ' ' MET . 3.0 mm -86.85 -27.43 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.95 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -53.1 -45.67 68.34 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.744 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.1 m -69.82 -37.86 76.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.776 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 34.5 ttm -78.48 -23.79 46.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 224' ' ' ILE . 46.5 ttp -58.65 -38.74 78.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.457 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 2.2 mmm180 -54.31 -65.51 1.26 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.888 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 28.8 Cg_endo -62.56 -44.1 19.13 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.174 1.916 . . . . 0.0 111.85 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.7 tp -53.06 -35.28 59.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.855 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 33.7 t -72.89 -33.77 66.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.752 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 5.6 ttm -70.59 -59.54 2.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.21 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.489 ' CD1' HD12 ' A' ' 181' ' ' LEU . 4.7 t-105 -57.46 -49.32 76.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.946 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.446 HD11 ' CD2' ' A' ' 115' ' ' LEU . 30.0 tp -56.56 -29.02 61.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -41.57 97.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.541 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -57.02 -44.61 83.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.775 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -60.86 -34.71 75.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.966 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -70.44 -36.09 73.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.797 0.332 . . . . 0.0 110.827 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -64.28 -44.89 90.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.736 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.19 -31.13 50.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.821 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -55.91 -26.12 46.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.739 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 243' ' ' ASN . 33.2 p-10 -47.82 139.93 7.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.642 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -101.4 137.21 40.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.545 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.51 179.993 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.4 mttt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -87.18 5.13 39.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.655 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.8 p -73.72 -21.52 60.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.391 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.651 HG23 ' O ' ' A' ' 103' ' ' ILE . 1.3 tt -95.04 110.03 47.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.295 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.8 149.9 23.55 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.835 1.69 . . . . 0.0 112.366 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.21 145.89 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.983 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.543 ' NE ' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -143.59 160.23 41.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.615 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 178' ' ' LYS . . . -133.0 161.44 24.12 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.505 ' O ' ' CD1' ' A' ' 131' ' ' PHE . . . -108.47 120.42 42.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.717 0.294 . . . . 0.0 110.905 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.521 ' HB2' ' CG1' ' A' ' 179' ' ' ILE . . . -103.38 126.92 50.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.422 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mt -124.96 129.25 73.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.972 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 3.5 m-85 -115.76 154.26 29.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.903 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.726 HD21 ' H ' ' A' ' 116' ' ' SER . 40.5 p-10 -60.02 148.84 34.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.556 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -48.74 -29.82 4.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.64 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -87.8 4.61 43.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.756 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.459 ' O ' ' NH1' ' A' ' 239' ' ' ARG . 1.1 mp 41.7 42.66 2.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.519 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.726 ' H ' HD21 ' A' ' 112' ' ' ASN . 0.1 OUTLIER -123.08 -10.4 8.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.18 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.614 ' NZ ' ' CD1' ' A' ' 204' ' ' TRP . 7.7 mtpm? -134.29 168.55 18.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.044 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.38 144.0 35.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 202' ' ' ILE . 4.8 tt -108.25 121.6 45.22 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.826 0.346 . . . . 0.0 111.008 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.0 mt -120.92 158.86 26.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.093 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.93 170.73 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.706 0.289 . . . . 0.0 110.309 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -93.19 119.79 32.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.758 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -96.18 -157.17 31.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.1 t -54.05 -34.73 60.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.435 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -51.47 158.08 0.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.162 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.6 m -65.72 -62.9 1.25 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.028 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -137.07 73.4 1.44 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.844 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -128.47 145.8 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.599 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.418 ' CD2' ' N ' ' A' ' 129' ' ' TRP . 0.1 OUTLIER -108.49 110.81 22.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.441 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.2 m -161.25 172.06 17.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.481 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 108' ' ' ALA . 37.8 m-85 -80.89 151.42 70.66 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.077 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.83 145.65 63.29 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.011 1.807 . . . . 0.0 111.984 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -104.7 171.78 7.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.793 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -174.42 -151.77 8.61 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -133.48 166.94 21.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.766 0.317 . . . . 0.0 110.532 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.3 mt -115.11 136.62 51.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.9 t -76.61 134.64 39.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.447 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -74.41 151.08 39.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.813 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 54.4 41.75 31.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.674 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -149.45 145.9 27.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.392 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -60.11 137.11 58.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.433 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -59.91 -32.35 70.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.517 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 147' ' ' ILE . 83.9 mt -61.37 -46.51 96.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.541 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -62.37 -37.4 85.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.723 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 47.6 m -72.34 -40.37 67.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.985 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 87.8 m -70.72 -54.69 10.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.508 HG23 ' N ' ' A' ' 148' ' ' ARG . 17.4 tt -57.63 -40.99 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.956 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.508 ' N ' HG23 ' A' ' 147' ' ' ILE . 67.6 ttt-85 -65.01 -39.5 93.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.945 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -78.67 -28.25 45.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.794 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.01 -51.28 19.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.814 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -36.68 80.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.937 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -71.75 -36.07 70.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.208 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.422 ' O ' ' OE1' ' A' ' 194' ' ' GLN . 86.6 tt0 -77.71 -59.73 2.66 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.414 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.567 HD13 ' CE2' ' A' ' 191' ' ' PHE . 23.1 mt -71.68 -32.38 45.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.763 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.62 -14.56 61.83 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -112.33 133.58 54.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.764 0.316 . . . . 0.0 110.227 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 157' ' ' ASP . 48.4 p30 -95.03 151.89 18.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.042 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.5 mt -111.6 110.19 20.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.101 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 91.4 m -90.47 -61.7 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.828 0.347 . . . . 0.0 111.239 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -100.23 -5.98 26.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -98.89 16.75 21.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.829 0.347 . . . . 0.0 110.354 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.5 tt -107.71 137.85 36.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -79.9 147.22 31.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.401 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 164' ' ' ASP . 8.6 p-10 -75.62 -64.99 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.395 0.617 . . . . 0.0 111.008 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.48 ' H ' ' CG ' ' A' ' 164' ' ' ASP . 36.5 t30 -131.98 67.84 1.51 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.089 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.545 ' HG3' HD12 ' A' ' 181' ' ' LEU . 4.3 tp60 -129.84 107.49 9.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.322 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -154.73 156.59 36.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.267 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.9 mt -124.62 129.16 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.505 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -99.59 137.62 37.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 tpt85 -159.51 127.65 4.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.607 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -100.29 115.05 29.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.133 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.7 tt -112.67 131.72 63.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.635 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.482 ' C ' ' H ' ' A' ' 175' ' ' LYS . 89.3 mm-40 53.62 43.14 31.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.402 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 63.45 -4.2 1.04 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 173' ' ' GLN . 20.6 tttm -90.66 132.15 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 110.794 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -74.69 119.54 19.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.489 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -129.5 121.99 28.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.573 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 107' ' ' GLY . 55.1 mttp -120.5 144.19 48.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.957 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.521 ' CG1' ' HB2' ' A' ' 109' ' ' ALA . 0.9 OUTLIER -129.76 132.2 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -101.42 123.63 45.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.183 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.545 HD12 ' HG3' ' A' ' 166' ' ' GLN . 13.4 mt -84.01 126.92 33.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.607 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 3.7 pt -145.48 100.9 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.293 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.5 m -114.28 157.2 23.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.515 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 118.63 -6.21 14.17 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.426 HG13 ' H ' ' A' ' 185' ' ' VAL . 2.4 m -61.73 153.02 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.301 . . . . 0.0 110.363 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.6 ' OG ' HG22 ' A' ' 188' ' ' VAL . 20.8 t -98.46 132.89 43.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.613 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -73.59 -7.53 52.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.594 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.6 HG22 ' OG ' ' A' ' 186' ' ' SER . 11.9 m -69.83 -20.28 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.429 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 190' ' ' ASN . 10.8 t80 -86.2 151.86 23.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.351 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.446 ' N ' ' CD1' ' A' ' 189' ' ' PHE . 47.4 t30 -85.55 110.59 19.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.567 ' CE2' HD13 ' A' ' 154' ' ' ILE . 2.4 m-85 -96.89 124.01 40.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.207 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -140.62 147.43 48.96 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.436 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.93 149.46 42.15 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.139 1.893 . . . . 0.0 112.233 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.422 ' OE1' ' O ' ' A' ' 153' ' ' GLU . 89.0 mt-30 -142.41 78.37 1.62 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.203 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.84 -166.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.536 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -46.84 150.5 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.21 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -56.74 125.46 22.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.957 0.408 . . . . 0.0 110.918 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -171.37 -113.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.08 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 199' ' ' ILE . 0.8 OUTLIER -130.46 129.64 64.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.301 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -97.77 108.61 21.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.497 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -137.73 133.89 34.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.422 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.467 HD11 HD11 ' A' ' 119' ' ' LEU . 14.7 tt -121.76 141.82 40.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.169 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -144.84 131.29 19.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.177 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' TRP . . . . . 0.614 ' CD1' ' NZ ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -98.09 101.42 12.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.825 0.345 . . . . 0.0 110.207 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -95.88 136.43 36.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -66.4 131.21 45.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.481 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -62.02 -36.82 82.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' A' ' 208' ' ' LYS . 0.0 OUTLIER -52.44 -42.45 64.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.842 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -65.13 -42.89 93.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.663 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 213' ' ' THR . 96.1 mt -66.56 -26.4 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.554 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 83.9 p -80.49 -59.19 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.77 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 214' ' ' MET . 97.5 mttt -63.24 -48.3 78.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.764 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 210' ' ' ILE . 18.5 p 51.13 7.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.048 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.503 ' H ' ' C ' ' A' ' 212' ' ' LYS . 11.9 mmt -73.62 -43.23 60.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.898 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -72.98 -31.54 64.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.867 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -98.25 120.74 39.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.566 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 2.8 t -131.51 -29.42 1.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.43 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -54.81 -46.15 74.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.747 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.7 pt -136.14 144.51 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.692 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -139.32 151.41 46.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.582 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -85.82 81.78 8.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.305 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -49.89 -40.3 42.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.071 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 10.5 mt -57.7 -52.63 64.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.038 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 228' ' ' MET . 47.2 mt -78.39 -27.5 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -50.73 -34.8 28.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.648 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.4 m -76.07 -36.73 58.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.966 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 73.3 mtm -95.24 0.74 54.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.972 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' MET . . . . . 0.523 ' N ' ' O ' ' A' ' 224' ' ' ILE . 2.5 ppp? -62.87 -32.81 74.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.971 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.417 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 7.9 mtt180 -67.18 -63.35 2.84 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.059 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 29.5 Cg_endo -63.79 -40.83 26.82 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.014 1.809 . . . . 0.0 112.124 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.55 -41.79 90.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.559 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.452 ' O ' ' CG ' ' A' ' 236' ' ' ARG . 44.7 t -61.39 -39.09 89.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.587 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 86.3 mtp -73.57 -46.83 44.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -61.21 -51.51 68.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.738 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 41.8 tp -60.73 -35.72 77.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 0.0 110.305 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.452 ' CG ' ' O ' ' A' ' 232' ' ' SER . 9.4 mmt85 -64.26 -33.56 76.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.495 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.17 -43.24 74.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.48 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -53.59 -36.84 62.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.647 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.459 ' NH1' ' O ' ' A' ' 115' ' ' LEU . 62.2 mtp85 -57.12 -15.31 5.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.416 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -80.91 -52.46 7.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.967 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.18 -17.79 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.997 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -50.43 -50.01 53.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.63 151.72 23.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.958 0.409 . . . . 0.0 111.027 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -129.34 165.24 21.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.26 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 51.1 p30 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.485 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -141.46 60.83 1.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.68 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.8 m -73.41 -33.15 64.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.507 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.14 107.71 57.42 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.388 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -82.38 152.62 15.8 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 121.948 1.766 . . . . 0.0 112.33 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.76 127.05 66.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.959 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.59 ' NH1' ' SG ' ' A' ' 145' ' ' CYS . 97.0 mtt180 -132.1 144.11 50.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.292 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -134.71 165.98 24.39 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 131' ' ' PHE . . . -110.1 137.55 47.71 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 111.137 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.83 120.72 41.72 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.707 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.2 mp -133.15 142.81 41.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.766 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.429 ' CZ ' HD11 ' A' ' 235' ' ' LEU . 0.1 OUTLIER -151.72 160.58 43.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.101 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -47.23 151.93 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.141 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 185' ' ' VAL . 87.1 mt-10 -63.25 -24.48 67.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.926 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -101.92 13.17 35.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.192 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.554 HD22 ' N ' ' A' ' 115' ' ' LEU . 3.9 mm? 50.65 47.25 24.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.109 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.05 -26.49 13.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.1 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.489 ' NZ ' ' OD2' ' A' ' 206' ' ' ASP . 21.2 mtpp -143.93 178.77 7.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.042 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.419 HG21 HD12 ' A' ' 210' ' ' ILE . 14.4 tt -140.74 131.54 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.431 . . . . 0.0 110.49 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.597 ' O ' HD22 ' A' ' 120' ' ' LEU . 0.8 OUTLIER -75.73 121.83 23.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.261 -179.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.597 HD22 ' O ' ' A' ' 119' ' ' LEU . 2.6 mm? -125.64 156.35 39.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.7 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.3 m -143.18 173.5 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.52 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -102.34 124.69 48.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.678 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.58 -165.69 36.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.762 HG22 ' OE1' ' A' ' 198' ' ' GLU . 47.0 p -61.1 -25.33 66.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 0.0 110.442 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.405 ' OE1' ' CB ' ' A' ' 128' ' ' SER . 56.7 mt-10 -51.78 165.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.25 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.5 m -67.37 -67.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.021 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -136.99 68.92 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.991 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.405 ' CB ' ' OE1' ' A' ' 125' ' ' GLU . 14.1 m -128.84 143.52 50.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.383 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.487 ' C ' HD12 ' A' ' 120' ' ' LEU . 9.7 m0 -107.68 118.73 37.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.604 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.6 m -156.24 170.33 22.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.759 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.524 ' CZ ' ' O ' ' A' ' 119' ' ' LEU . 39.9 m-85 -81.21 152.78 71.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.061 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.35 137.92 41.26 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.901 1.734 . . . . 0.0 111.735 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.529 ' NE ' ' OH ' ' A' ' 177' ' ' TYR . 45.1 ptt85 -150.07 -170.3 3.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.177 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.76 177.93 25.12 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -81.21 137.0 35.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.9 tt -125.95 155.38 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.451 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.4 p -64.72 157.51 27.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.633 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 65.1 mttm -89.88 -178.9 5.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.603 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 138' ' ' LYS . 4.6 t0 77.7 38.15 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.406 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -137.77 158.7 43.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.567 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -84.9 151.38 24.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.398 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 143' ' ' ILE . 36.3 p-10 -53.19 -37.07 61.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.622 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.582 HG23 ' N ' ' A' ' 144' ' ' ASP . 19.1 tt -79.75 -45.73 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.552 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.582 ' N ' HG23 ' A' ' 143' ' ' ILE . 57.2 t0 -62.56 -34.51 77.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.827 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.59 ' SG ' ' NH1' ' A' ' 106' ' ' ARG . 6.1 p -64.62 -41.03 96.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.589 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.676 ' O ' HG23 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -63.75 -46.04 87.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.298 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.526 ' N ' ' SG ' ' A' ' 146' ' ' CYS . 80.0 mt -59.34 -52.16 64.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.969 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -60.04 -40.77 90.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.548 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -79.06 -28.84 43.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.879 0.371 . . . . 0.0 110.726 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 146' ' ' CYS . 4.1 t -64.8 -50.99 72.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.719 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER -70.13 -44.33 69.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.933 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -47.15 -34.43 6.17 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.399 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 194' ' ' GLN . 78.2 mm-40 -91.61 -62.13 1.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.023 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 81.9 mt -81.04 -33.63 13.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 151' ' ' LYS . . . 100.6 -14.15 59.28 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -125.12 137.89 54.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.512 ' C ' HD12 ' A' ' 158' ' ' LEU . 50.1 p30 -135.17 156.92 48.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 111.036 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.796 ' N ' HD12 ' A' ' 158' ' ' LEU . 4.5 mp -103.01 122.91 45.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.958 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 24.0 p -90.4 -61.52 1.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.384 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -103.3 11.79 36.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.662 ' HB3' HD23 ' A' ' 158' ' ' LEU . 0.2 OUTLIER -106.82 17.7 22.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.838 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.777 ' CG2' HG23 ' A' ' 182' ' ' ILE . 2.6 pt -130.95 149.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.06 0.457 . . . . 0.0 111.184 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -71.2 156.19 39.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.649 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.62 -17.88 21.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.078 0.466 . . . . 0.0 110.936 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -134.34 58.02 1.78 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.362 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.675 ' HG2' HD12 ' A' ' 181' ' ' LEU . 38.3 tt0 -139.38 106.99 5.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.105 0.478 . . . . 0.0 110.679 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -166.09 163.32 18.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.651 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.0 pt -129.24 150.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.399 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 169' ' ' GLU . 1.2 pt-20 -144.18 96.43 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.684 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -127.72 153.0 47.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.468 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -106.15 122.11 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.495 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.426 HD11 ' SD ' ' A' ' 227' ' ' MET . 58.9 mt -103.72 121.8 55.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.353 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.498 ' NE2' ' CE2' ' A' ' 222' ' ' TYR . 87.2 mt-30 53.48 43.28 31.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.426 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.48 -11.53 12.96 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -86.42 124.62 32.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.8 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.582 HD22 ' N ' ' A' ' 176' ' ' ASN . 0.0 OUTLIER -74.3 119.99 19.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.464 -178.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.529 ' OH ' ' NE ' ' A' ' 133' ' ' ARG . 0.2 OUTLIER -122.91 104.91 9.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.769 -179.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -108.18 129.89 55.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 54.7 mt -138.44 136.2 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.529 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -95.5 136.35 35.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.75 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.675 HD12 ' HG2' ' A' ' 166' ' ' GLN . 61.5 mt -84.75 133.32 34.36 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.854 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.777 HG23 ' CG2' ' A' ' 162' ' ' ILE . 65.0 mt -133.05 108.84 13.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.308 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.9 t -117.26 147.94 42.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.563 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 102.74 8.24 43.14 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.483 ' HA ' HD21 ' A' ' 158' ' ' LEU . 5.6 p -50.04 133.05 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 110.625 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 48.6 m -81.67 143.51 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.424 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -93.46 -9.73 37.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.365 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.64 -28.33 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.664 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -83.04 144.63 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.715 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -81.47 139.89 34.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.257 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -99.63 124.55 44.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.726 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -143.3 109.85 5.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.435 ' HD3' HD12 ' A' ' 202' ' ' ILE . 61.1 Cg_endo -79.18 136.76 13.05 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.736 1.624 . . . . 0.0 111.972 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 153' ' ' GLU . 83.6 mt-30 -126.5 111.55 14.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.648 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.63 178.96 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -43.69 146.73 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.364 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -56.99 102.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.802 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.762 ' OE1' HG22 ' A' ' 124' ' ' THR . 39.7 mt-10 -155.36 -113.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.146 0.498 . . . . 0.0 110.276 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 32.6 mt -122.41 110.04 25.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.069 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 200' ' ' ASP . 32.2 p-10 -106.0 119.88 40.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -136.01 123.9 22.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.33 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.435 HD12 ' HD3' ' A' ' 193' ' ' PRO . 17.2 tt -107.35 138.77 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -166.05 152.67 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.405 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -115.79 110.96 19.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.446 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -97.52 143.72 27.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.576 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.489 ' OD2' ' NZ ' ' A' ' 117' ' ' LYS . 1.1 t0 -70.67 129.64 39.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.368 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -46.54 -33.74 4.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.352 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.8 mtpt -64.43 -45.37 87.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.14 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -53.1 -49.09 67.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.965 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . 0.419 HD12 HG21 ' A' ' 118' ' ' ILE . 96.3 mt -67.24 -19.76 25.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.805 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.42 -13.02 44.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.488 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -98.41 24.46 7.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.487 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.2 m -49.94 -36.49 28.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.797 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 76.5 mmm -53.69 -38.72 64.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.795 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -67.73 -26.26 66.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.662 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -93.65 133.87 36.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.518 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.4 t -113.96 -42.17 3.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.01 -44.06 97.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.748 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.0 mt -124.66 127.17 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.583 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.58 135.35 38.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.37 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.468 ' CZ ' ' CE3' ' A' ' 129' ' ' TRP . 53.5 m-85 -107.35 105.23 15.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.712 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.498 ' CE2' ' NE2' ' A' ' 173' ' ' GLN . 23.2 p90 -90.98 -36.57 14.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.423 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 222' ' ' TYR . 2.5 tp -51.19 -45.45 61.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.313 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 228' ' ' MET . 2.8 tp -73.31 -29.69 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.753 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -56.63 -43.56 80.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.552 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.1 t -63.66 -34.31 77.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.598 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 227' ' ' MET . 0.0 OUTLIER -86.76 -29.36 22.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.702 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' MET . . . . . 0.492 ' N ' ' O ' ' A' ' 224' ' ' ILE . 32.0 ttm -54.99 -40.32 69.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.354 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.509 HH11 ' CG ' ' A' ' 229' ' ' ARG . 0.1 OUTLIER -62.1 -64.08 3.48 Favored Pre-proline 0 C--N 1.327 -0.372 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.532 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 229' ' ' ARG . 37.2 Cg_endo -64.97 -47.88 4.36 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.291 1.994 . . . . 0.0 112.235 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 6.0 tt -51.05 -40.7 58.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.627 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 34.9 t -66.8 -49.05 67.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.04 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 8.3 tpp -60.17 -50.89 71.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.264 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.431 ' O ' ' OE1' ' A' ' 238' ' ' GLN . 13.0 m95 -53.83 -66.83 0.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.112 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.429 HD11 ' CZ ' ' A' ' 111' ' ' PHE . 87.3 mt -51.25 -32.32 23.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.027 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -67.35 -29.39 68.93 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.127 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -75.66 -53.64 8.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.751 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.431 ' OE1' ' O ' ' A' ' 234' ' ' TRP . 5.5 mp0 -56.42 -38.57 71.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.685 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.8 -26.74 64.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.61 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -72.82 -44.86 60.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.786 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 15.9 mm -66.6 -28.67 44.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.039 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -52.82 -54.07 39.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.607 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 243' ' ' ASN . 0.0 OUTLIER -79.54 -45.69 18.77 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.762 0.315 . . . . 0.0 110.871 -179.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -92.46 105.54 17.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.62 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 65.7 t0 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.539 179.876 . . . . . . . . 0 0 . 1 stop_ save_